Section 1 PE Tables – Results from the 2022 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

230629

Table 1.1A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Numbers in Thousands, 2021 and 2022
Drug	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
ILLICIT DRUGS^1,2	139,677^a	143,116	61,995^b	70,338	40,564^b	46,603
Marijuana	128,961	132,296	53,181^b	61,901	36,950^b	42,317
Cocaine	41,371	42,231	4,760	5,274	1,846	2,015
Crack	10,625	10,167	1,003	918	519	573
Heroin	6,684	6,558	1,089	1,049	590	709
Hallucinogens	46,474	48,850	7,572^a	8,509	2,301	2,289
LSD	30,114	31,074	2,579	2,322	569	423
PCP	6,570	6,394	198	204	106	89
Ecstasy	21,436	22,103	2,228	2,109	603	389
Inhalants	25,436	27,242	2,119	2,254	787	842
Methamphetamine	17,461	16,588	2,640	2,705	1,630	1,685
Misuse of Prescription Psychotherapeutics	nr	nr	14,529	14,204	4,288	4,612
Pain Relievers	nr	nr	8,885	8,457	2,427	2,439
Stimulants	nr	nr	3,910	4,298	1,124	1,348
Tranquilizers or Sedatives	nr	nr	4,813	4,848	1,341	1,529
Tranquilizers	nr	nr	4,284	4,153	1,145	1,304
Sedatives	nr	nr	878	959	225	278
Benzodiazepines	--	--	3,931	3,681	--	--
Opioids²	nr	nr	9,420	8,918	2,817	2,944
Central Nervous System Stimulants	nr	nr	9,379	10,188	4,173	4,469
Illicit Drugs Other Than Marijuana^2,3	nr	nr	23,579	24,692	9,108	9,560
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	--	nr	--	9,062	--	3,052
Illegally Made Fentanyl	--	1,607	--	686	--	330
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). ³ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.1B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Percentages, 2021 and 2022
Drug	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
ILLICIT DRUGS^1,2	49.9	50.7	22.2^b	24.9	14.5^b	16.5
Marijuana	46.1	46.9	19.0^b	22.0	13.2^b	15.0
Cocaine	14.8	15.0	1.7	1.9	0.7	0.7
Crack	3.8	3.6	0.4	0.3	0.2	0.2
Heroin	2.4	2.3	0.4	0.4	0.2	0.3
Hallucinogens	16.6	17.3	2.7	3.0	0.8	0.8
LSD	10.8	11.0	0.9	0.8	0.2	0.1
PCP	2.3	2.3	0.1	0.1	0.0	0.0
Ecstasy	7.7	7.8	0.8	0.7	0.2	0.1
Inhalants	9.1	9.7	0.8	0.8	0.3	0.3
Methamphetamine	6.2	5.9	0.9	1.0	0.6	0.6
Misuse of Prescription Psychotherapeutics	nr	nr	5.2	5.0	1.5	1.6
Pain Relievers	nr	nr	3.2	3.0	0.9	0.9
Stimulants	nr	nr	1.4	1.5	0.4	0.5
Tranquilizers or Sedatives	nr	nr	1.7	1.7	0.5	0.5
Tranquilizers	nr	nr	1.5	1.5	0.4	0.5
Sedatives	nr	nr	0.3	0.3	0.1	0.1
Benzodiazepines	--	--	1.4	1.3	--	--
Opioids²	nr	nr	3.4	3.2	1.0	1.0
Central Nervous System Stimulants	nr	nr	3.4	3.6	1.5	1.6
Illicit Drugs Other Than Marijuana^2,3	nr	nr	8.4	8.8	3.3	3.4
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	--	nr	--	3.2	--	1.1
Illegally Made Fentanyl	--	0.6	--	0.2	--	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). ³ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.2A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Numbers in Thousands, 2021 and 2022
Drug	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
ILLICIT DRUGS^1,2	5,738	5,377	3,802	3,688	1,964	1,884
Marijuana	3,555	3,466	2,845	2,947	1,586	1,647
Cocaine	103	65	35	40	5	5
Crack	18	4	3	*	*	*
Heroin	7	10	*	3	*	*
Hallucinogens	626	533	377	358	91	99
LSD	451^b	283	272^a	169	53	39
PCP	32	28	22	15	4	2
Ecstasy	155	124	96	63	9	10
Inhalants	2,356^b	1,940	643	554	222	170
Methamphetamine	52	37	35	18	16	3
Misuse of Prescription Psychotherapeutics	nr	nr	908^b	640	226	157
Pain Relievers	nr	nr	550	406	133	116
Stimulants	nr	nr	302	226	80^a	33
Tranquilizers or Sedatives	nr	nr	248^a	137	52	37
Tranquilizers	nr	nr	220	115	36	34
Sedatives	nr	nr	43	27	20	7
Benzodiazepines	--	--	203	113	--	--
Opioids²	nr	nr	550	406	133	117
Central Nervous System Stimulants	nr	nr	338	272	100^a	40
Illicit Drugs Other Than Marijuana^2,3	nr	nr	1,635^a	1,343	527	399
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	--	nr	--	420	--	127
Illegally Made Fentanyl	--	33	--	20	--	11
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). ³ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.2B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Percentages, 2021 and 2022
Drug	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
ILLICIT DRUGS^1,2	22.1	20.9	14.6	14.3	7.5	7.3
Marijuana	13.7	13.5	10.9	11.5	6.1	6.4
Cocaine	0.4	0.3	0.1	0.2	0.0	0.0
Crack	0.1	0.0	0.0	*	*	*
Heroin	0.0	0.0	*	0.0	*	*
Hallucinogens	2.4	2.1	1.4	1.4	0.3	0.4
LSD	1.7^a	1.1	1.0^a	0.7	0.2	0.1
PCP	0.1	0.1	0.1	0.1	0.0	0.0
Ecstasy	0.6	0.5	0.4	0.2	0.0	0.0
Inhalants	9.1^b	7.5	2.5	2.2	0.9	0.7
Methamphetamine	0.2	0.1	0.1	0.1	0.1	0.0
Misuse of Prescription Psychotherapeutics	nr	nr	3.5^b	2.5	0.9	0.6
Pain Relievers	nr	nr	2.1	1.6	0.5	0.5
Stimulants	nr	nr	1.2	0.9	0.3^a	0.1
Tranquilizers or Sedatives	nr	nr	1.0	0.5	0.2	0.1
Tranquilizers	nr	nr	0.8	0.4	0.1	0.1
Sedatives	nr	nr	0.2	0.1	0.1	0.0
Benzodiazepines	--	--	0.8	0.4	--	--
Opioids²	nr	nr	2.1	1.6	0.5	0.5
Central Nervous System Stimulants	nr	nr	1.3	1.1	0.4^a	0.2
Illicit Drugs Other Than Marijuana^2,3	nr	nr	6.3^a	5.2	2.0	1.6
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	--	nr	--	1.6	--	0.5
Illegally Made Fentanyl	--	0.1	--	0.1	--	0.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). ³ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.3A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Numbers in Thousands, 2021 and 2022
Drug	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
ILLICIT DRUGS^1,2	133,939^a	137,739	58,192^b	66,650	38,600^b	44,719
Marijuana	125,406^a	128,829	50,337^b	58,955	35,364^b	40,670
Cocaine	41,268	42,165	4,725	5,235	1,841	2,010
Crack	10,606	10,163	1,000	917	519	572
Heroin	6,677	6,549	1,088	1,046	590	708
Hallucinogens	45,848	48,316	7,195^a	8,151	2,210	2,190
LSD	29,663	30,791	2,307	2,154	516	384
PCP	6,538	6,366	175	190	102	87
Ecstasy	21,281	21,979	2,132	2,046	593	379
Inhalants	23,080^a	25,302	1,475	1,700	565	672
Methamphetamine	17,409	16,551	2,605	2,687	1,614	1,682
Misuse of Prescription Psychotherapeutics	nr	nr	13,621	13,564	4,062	4,456
Pain Relievers	nr	nr	8,335	8,051	2,294	2,323
Stimulants	nr	nr	3,608	4,072	1,044	1,315
Tranquilizers or Sedatives	nr	nr	4,565	4,711	1,289	1,492
Tranquilizers	nr	nr	4,063	4,038	1,109	1,270
Sedatives	nr	nr	834	931	205	271
Benzodiazepines	--	--	3,729	3,569	--	--
Opioids²	nr	nr	8,871	8,513	2,685	2,827
Central Nervous System Stimulants	nr	nr	9,042	9,916	4,073	4,429
Illicit Drugs Other Than Marijuana^2,3	nr	nr	21,944	23,348	8,581	9,161
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	--	nr	--	8,642	--	2,925
Illegally Made Fentanyl	--	1,575	--	666	--	319
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). ³ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.3B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Percentages, 2021 and 2022
Drug	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
ILLICIT DRUGS^1,2	52.8	53.7	22.9^b	26.0	15.2^b	17.4
Marijuana	49.4	50.3	19.8^b	23.0	13.9^b	15.9
Cocaine	16.3	16.5	1.9	2.0	0.7	0.8
Crack	4.2	4.0	0.4	0.4	0.2	0.2
Heroin	2.6	2.6	0.4	0.4	0.2	0.3
Hallucinogens	18.1	18.9	2.8	3.2	0.9	0.9
LSD	11.7	12.0	0.9	0.8	0.2	0.1
PCP	2.6	2.5	0.1	0.1	0.0	0.0
Ecstasy	8.4	8.6	0.8	0.8	0.2	0.1
Inhalants	9.1^a	9.9	0.6	0.7	0.2	0.3
Methamphetamine	6.9	6.5	1.0	1.0	0.6	0.7
Misuse of Prescription Psychotherapeutics	nr	nr	5.4	5.3	1.6	1.7
Pain Relievers	nr	nr	3.3	3.1	0.9	0.9
Stimulants	nr	nr	1.4	1.6	0.4	0.5
Tranquilizers or Sedatives	nr	nr	1.8	1.8	0.5	0.6
Tranquilizers	nr	nr	1.6	1.6	0.4	0.5
Sedatives	nr	nr	0.3	0.4	0.1	0.1
Benzodiazepines	--	--	1.5	1.4	--	--
Opioids²	nr	nr	3.5	3.3	1.1	1.1
Central Nervous System Stimulants	nr	nr	3.6	3.9	1.6	1.7
Illicit Drugs Other Than Marijuana^2,3	nr	nr	8.6	9.1	3.4	3.6
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	--	nr	--	3.4	--	1.1
Illegally Made Fentanyl	--	0.6	--	0.3	--	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). ³ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.4A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Numbers in Thousands, 2021 and 2022
Drug	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
ILLICIT DRUGS^1,2	18,275^a	19,121	13,036^b	14,221	8,648^b	9,478
Marijuana	17,030^b	18,053	12,133^b	13,299	8,236^a	9,013
Cocaine	2,924	3,127	1,225	1,295	363	403
Crack	315	215	75	39	31	13
Heroin	349^a	218	71	55	26	11
Hallucinogens	5,349^a	5,889	2,462	2,676	553	554
LSD	3,317	3,583	1,077	894	184	125
PCP	226	180	54	13	22	3
Ecstasy	2,756	2,628	709	639	178	99
Inhalants	2,754	3,073	507	647	119	193
Methamphetamine	606	682	183	161	103	54
Misuse of Prescription Psychotherapeutics	nr	nr	2,638	2,542	608	654
Pain Relievers	nr	nr	1,050	1,099	232	214
Stimulants	nr	nr	1,359	1,278	307	376
Tranquilizers or Sedatives	nr	nr	916	842	156	181
Tranquilizers	nr	nr	855	779	134	158
Sedatives	nr	nr	144	93	32	32
Benzodiazepines	--	--	825	747	--	--
Opioids²	nr	nr	1,070	1,120	239	221
Central Nervous System Stimulants	nr	nr	2,230	2,272	675	767
Illicit Drugs Other Than Marijuana^2,3	nr	nr	4,807	5,092	1,395	1,531
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	--	nr	--	1,145	--	243
Illegally Made Fentanyl	--	135	--	48	--	28
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). ³ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.4B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Percentages, 2021 and 2022
Drug	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
ILLICIT DRUGS^1,2	54.6	55.0	39.0	40.9	25.8	27.2
Marijuana	50.9	51.9	36.3	38.2	24.6	25.9
Cocaine	8.7	9.0	3.7	3.7	1.1	1.2
Crack	0.9	0.6	0.2	0.1	0.1	0.0
Heroin	1.0^a	0.6	0.2	0.2	0.1	0.0
Hallucinogens	16.0	16.9	7.4	7.7	1.7	1.6
LSD	9.9	10.3	3.2	2.6	0.6	0.4
PCP	0.7	0.5	0.2	0.0	0.1	0.0
Ecstasy	8.2	7.6	2.1	1.8	0.5^a	0.3
Inhalants	8.2	8.8	1.5	1.9	0.4	0.6
Methamphetamine	1.8	2.0	0.5	0.5	0.3	0.2
Misuse of Prescription Psychotherapeutics	nr	nr	7.9	7.3	1.8	1.9
Pain Relievers	nr	nr	3.1	3.2	0.7	0.6
Stimulants	nr	nr	4.1	3.7	0.9	1.1
Tranquilizers or Sedatives	nr	nr	2.7	2.4	0.5	0.5
Tranquilizers	nr	nr	2.6	2.2	0.4	0.5
Sedatives	nr	nr	0.4	0.3	0.1	0.1
Benzodiazepines	--	--	2.5	2.1	--	--
Opioids²	nr	nr	3.2	3.2	0.7	0.6
Central Nervous System Stimulants	nr	nr	6.7	6.5	2.0	2.2
Illicit Drugs Other Than Marijuana^2,3	nr	nr	14.4	14.6	4.2	4.4
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	--	nr	--	3.3	--	0.7
Illegally Made Fentanyl	--	0.4	--	0.1	--	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). ³ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.5A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Numbers in Thousands, 2021 and 2022
Drug	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
ILLICIT DRUGS^1,2	115,664	118,618	45,156^b	52,429	29,952^b	35,241
Marijuana	108,376	110,776	38,204^b	45,656	27,128^b	31,657
Cocaine	38,344	39,038	3,500	3,939	1,478	1,607
Crack	10,292	9,948	925	877	488	559
Heroin	6,328	6,331	1,018	991	564	697
Hallucinogens	40,499	42,427	4,733	5,475	1,657	1,636
LSD	26,346	27,207	1,230	1,259	332	259
PCP	6,312	6,186	121	177	80	84
Ecstasy	18,524	19,351	1,423	1,407	415	281
Inhalants	20,326^a	22,229	968	1,053	446	479
Methamphetamine	16,803	15,869	2,422	2,526	1,511	1,628
Misuse of Prescription Psychotherapeutics	nr	nr	10,983	11,022	3,454	3,802
Pain Relievers	nr	nr	7,286	6,953	2,061	2,109
Stimulants	nr	nr	2,249^a	2,794	737	939
Tranquilizers or Sedatives	nr	nr	3,649	3,869	1,133	1,312
Tranquilizers	nr	nr	3,209	3,259	975	1,112
Sedatives	nr	nr	690	839	173	239
Benzodiazepines	--	--	2,904	2,822	--	--
Opioids²	nr	nr	7,801	7,393	2,446	2,606
Central Nervous System Stimulants	nr	nr	6,812	7,644	3,398	3,662
Illicit Drugs Other Than Marijuana^2,3	nr	nr	17,137	18,256	7,186	7,630
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	--	nr	--	7,497	--	2,683
Illegally Made Fentanyl	--	1,440	--	617	--	291
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). ³ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.5B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Percentages, 2021 and 2022
Drug	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
ILLICIT DRUGS^1,2	52.5	53.6	20.5^b	23.7	13.6^b	15.9
Marijuana	49.2	50.0	17.3^b	20.6	12.3^b	14.3
Cocaine	17.4	17.6	1.6	1.8	0.7	0.7
Crack	4.7	4.5	0.4	0.4	0.2	0.3
Heroin	2.9	2.9	0.5	0.4	0.3	0.3
Hallucinogens	18.4	19.2	2.1	2.5	0.8	0.7
LSD	12.0	12.3	0.6	0.6	0.2	0.1
PCP	2.9	2.8	0.1	0.1	0.0	0.0
Ecstasy	8.4	8.7	0.6	0.6	0.2	0.1
Inhalants	9.2	10.0	0.4	0.5	0.2	0.2
Methamphetamine	7.6	7.2	1.1	1.1	0.7	0.7
Misuse of Prescription Psychotherapeutics	nr	nr	5.0	5.0	1.6	1.7
Pain Relievers	nr	nr	3.3	3.1	0.9	1.0
Stimulants	nr	nr	1.0^a	1.3	0.3	0.4
Tranquilizers or Sedatives	nr	nr	1.7	1.7	0.5	0.6
Tranquilizers	nr	nr	1.5	1.5	0.4	0.5
Sedatives	nr	nr	0.3	0.4	0.1	0.1
Benzodiazepines	--	--	1.3	1.3	--	--
Opioids²	nr	nr	3.5	3.3	1.1	1.2
Central Nervous System Stimulants	nr	nr	3.1	3.5	1.5	1.7
Illicit Drugs Other Than Marijuana^2,3	nr	nr	7.8	8.2	3.3	3.4
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	--	nr	--	3.4	--	1.2
Illegally Made Fentanyl	--	0.7	--	0.3	--	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). ³ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.6A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	139,677^a	143,116	61,995^b	70,338	40,564^b	46,603
12-20	11,583	11,515	8,252	8,477	4,691	4,954
21 or Older	128,094	131,601	53,742^b	61,861	35,873^b	41,649
12-17	5,738	5,377	3,802	3,688	1,964	1,884
12-13	1,050	947	576	531	235	193
14-15	1,731	1,778	1,049	1,184	502	614
16-17	2,957	2,652	2,178	1,973	1,227	1,076
18 or Older	133,939^a	137,739	58,192^b	66,650	38,600^b	44,719
18-25	18,275^a	19,121	13,036^b	14,221	8,648^b	9,478
18-20	5,845	6,138	4,450	4,789	2,727	3,070
21-25	12,430	12,983	8,586	9,431	5,921	6,408
26 or Older	115,664	118,618	45,156^b	52,429	29,952^b	35,241
26-49	60,148	60,208	29,188^b	32,809	19,582^b	22,656
26-29	10,834	10,536	6,544	6,919	4,659	4,707
30-34	13,563	14,328	7,185^b	8,837	4,961^b	6,154
35-39	13,491	12,994	6,070	6,582	3,957	4,419
40-44	11,974	11,625	5,304	5,537	3,407	3,813
45-49	10,286	10,725	4,086^a	4,935	2,598^b	3,563
50 or Older	55,517^a	58,410	15,968^b	19,620	10,371^b	12,585
50-54	11,052	10,264	3,895	4,487	2,513	2,927
55-59	11,282	11,543	3,758	4,482	2,451	3,044
60-64	12,545	13,689	3,392^b	4,673	2,365^a	3,144
65 or Older	20,638^b	22,915	4,923^a	5,978	3,041	3,471
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.6B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	49.9	50.7	22.2^b	24.9	14.5^b	16.5
12-20	29.6	29.8	21.1	21.9	12.0	12.8
21 or Older	53.2	54.1	22.3^b	25.4	14.9^b	17.1
12-17	22.1	20.9	14.6	14.3	7.5	7.3
12-13	11.8	11.2	6.5	6.3	2.7	2.3
14-15	20.3	19.6	12.3	13.1	5.9	6.8
16-17	34.3	32.3	25.3	24.0	14.2	13.1
18 or Older	52.8	53.7	22.9^b	26.0	15.2^b	17.4
18-25	54.6	55.0	39.0	40.9	25.8	27.2
18-20	44.7	47.5	34.0	37.0	20.9^a	23.7
21-25	61.0	59.4	42.1	43.1	29.0	29.3
26 or Older	52.5	53.6	20.5^b	23.7	13.6^b	15.9
26-49	58.8	58.7	28.5^b	32.0	19.1^b	22.1
26-29	62.1	61.9	37.5	40.6	26.7	27.6
30-34	59.7	61.8	31.6^b	38.1	21.8^b	26.5
35-39	60.6	59.0	27.3	29.9	17.8	20.0
40-44	58.7	55.9	26.0	26.6	16.7	18.3
45-49	52.8	55.0	21.0^a	25.3	13.3^b	18.3
50 or Older	47.0	49.1	13.5^b	16.5	8.8^b	10.6
50-54	56.3	51.9	19.8	22.7	12.8	14.8
55-59	52.9	57.7	17.6^a	22.4	11.5^a	15.2
60-64	56.3	60.4	15.2^b	20.6	10.6^a	13.9
65 or Older	37.7	40.6	9.0	10.6	5.5	6.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.7A – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	128,961	132,296	53,181^b	61,901	36,950^b	42,317
12-20	8,824	9,077	6,996	7,422	4,220	4,557
21 or Older	120,138	123,219	46,186^b	54,479	32,730^b	37,760
12-17	3,555	3,466	2,845	2,947	1,586	1,647
12-13	272	304	224	268	90	96
14-15	974	1,081	783	941	397^a	532
16-17	2,310	2,081	1,838	1,738	1,099	1,019
18 or Older	125,406^a	128,829	50,337^b	58,955	35,364^b	40,670
18-25	17,030^b	18,053	12,133^b	13,299	8,236^a	9,013
18-20	5,268	5,611	4,151	4,475	2,634	2,910
21-25	11,762	12,443	7,982^a	8,824	5,602	6,102
26 or Older	108,376	110,776	38,204^b	45,656	27,128^b	31,657
26-49	56,446	56,557	25,373^b	29,525	18,123^b	20,726
26-29	10,313	10,112	5,943	6,462	4,397	4,458
30-34	12,926	13,707	6,453^b	8,067	4,601^b	5,708
35-39	12,627	12,183	5,148	5,863	3,665	3,976
40-44	11,114	10,875	4,530	4,883	3,097	3,377
45-49	9,467	9,681	3,299^b	4,250	2,363^b	3,207
50 or Older	51,929	54,219	12,831^b	16,130	9,006^b	10,931
50-54	10,112	9,337	3,120	3,645	2,244	2,556
55-59	10,666	10,665	3,055	3,744	2,099	2,745
60-64	11,986	13,017	2,810^b	4,019	2,093	2,680
65 or Older	19,166^a	21,200	3,846	4,723	2,569	2,950
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.7B – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	46.1	46.9	19.0^b	22.0	13.2^b	15.0
12-20	22.6	23.5	17.9	19.2	10.8	11.8
21 or Older	49.9	50.6	19.2^b	22.4	13.6^b	15.5
12-17	13.7	13.5	10.9	11.5	6.1	6.4
12-13	3.1	3.6	2.5	3.2	1.0	1.1
14-15	11.4	11.9	9.2	10.4	4.6	5.9
16-17	26.8	25.3	21.3	21.1	12.8	12.4
18 or Older	49.4	50.3	19.8^b	23.0	13.9^b	15.9
18-25	50.9	51.9	36.3	38.2	24.6	25.9
18-20	40.3	43.4	31.8	34.6	20.1	22.5
21-25	57.7	56.9	39.2	40.4	27.5	27.9
26 or Older	49.2	50.0	17.3^b	20.6	12.3^b	14.3
26-49	55.2	55.1	24.8^b	28.8	17.7^b	20.2
26-29	59.1	59.4	34.1^a	37.9	25.2	26.2
30-34	56.9	59.1	28.4^b	34.8	20.3^b	24.6
35-39	56.7	55.3	23.1^a	26.6	16.5	18.0
40-44	54.5	52.3	22.2	23.5	15.2	16.2
45-49	48.6	49.6	16.9^b	21.8	12.1^b	16.4
50 or Older	44.0	45.6	10.9^b	13.6	7.6^b	9.2
50-54	51.5	47.2	15.9	18.4	11.4	12.9
55-59	50.0	53.3	14.3^a	18.7	9.8^a	13.7
60-64	53.8	57.4	12.6^b	17.7	9.4	11.8
65 or Older	35.0	37.5	7.0	8.4	4.7	5.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.8A – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	41,371	42,231	4,760	5,274	1,846	2,015
12-20	514	566	261	281	69	75
21 or Older	40,856	41,664	4,500	4,994	1,778	1,940
12-17	103	65	35	40	5	5
12-13	10	26	*	20	*	1
14-15	28	6	4	4	4	*
16-17	65	33	31	16	1	4
18 or Older	41,268	42,165	4,725	5,235	1,841	2,010
18-25	2,924	3,127	1,225	1,295	363	403
18-20	411	501	226	241	64	70
21-25	2,512	2,626	999	1,055	300	333
26 or Older	38,344	39,038	3,500	3,939	1,478	1,607
26-49	18,144	17,916	2,500	2,824	1,017	1,045
26-29	3,072	2,779	772	863	391^a	203
30-34	3,864	4,237	639	821	205	300
35-39	4,292	3,990	393	470	93^a	224
40-44	3,805	3,663	431	352	205	155
45-49	3,110	3,247	265	318	122	163
50 or Older	20,201	21,122	1,000	1,115	461	562
50-54	3,474	3,829	391	289	153	90
55-59	4,908	4,550	218	293	153	98
60-64	5,657	6,156	157	336	42^b	252
65 or Older	6,161	6,586	234	198	114	123
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.8B – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	14.8	15.0	1.7	1.9	0.7	0.7
12-20	1.3	1.5	0.7	0.7	0.2	0.2
21 or Older	17.0	17.1	1.9	2.1	0.7	0.8
12-17	0.4	0.3	0.1	0.2	0.0	0.0
12-13	0.1	0.3	*	0.2	*	0.0
14-15	0.3	0.1	0.1	0.0	0.0	*
16-17	0.8	0.4	0.4	0.2	0.0	0.0
18 or Older	16.3	16.5	1.9	2.0	0.7	0.8
18-25	8.7	9.0	3.7	3.7	1.1	1.2
18-20	3.1	3.9	1.7	1.9	0.5	0.5
21-25	12.3	12.0	4.9	4.8	1.5	1.5
26 or Older	17.4	17.6	1.6	1.8	0.7	0.7
26-49	17.7	17.5	2.4	2.8	1.0	1.0
26-29	17.6	16.3	4.4	5.1	2.2^a	1.2
30-34	17.0	18.3	2.8	3.5	0.9	1.3
35-39	19.3	18.1	1.8	2.1	0.4^a	1.0
40-44	18.7	17.6	2.1	1.7	1.0	0.7
45-49	16.0	16.6	1.4	1.6	0.6	0.8
50 or Older	17.1	17.8	0.8	0.9	0.4	0.5
50-54	17.7	19.4	2.0	1.5	0.8	0.5
55-59	23.0	22.8	1.0	1.5	0.7	0.5
60-64	25.4	27.2	0.7	1.5	0.2^b	1.1
65 or Older	11.2	11.7	0.4	0.3	0.2	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.9A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	10,625	10,167	1,003	918	519	573
12-20	77	48	8	5	2	4
21 or Older	10,548	10,119	994	912	517	569
12-17	18	4	3	*	*	*
12-13	*	0	*	0	*	*
14-15	12	*	1	*	1	*
16-17	6	4	2	0	*	0
18 or Older	10,606	10,163	1,000	917	519	572
18-25	315	215	75	39	31	13
18-20	59	44	5	4	2	4
21-25	256	171	69	35	29	9
26 or Older	10,292	9,948	925	877	488	559
26-49	4,421	4,557	415	426	194	254
26-29	477	347	68	48	1	13
30-34	691	877	49	92	25	44
35-39	1,167	947	59	39	24	19
40-44	1,165	1,246	168	84	104	55
45-49	921	1,140	71	164	40	123
50 or Older	5,871	5,391	510	451	294	305
50-54	1,329	1,108	198	59	81	42
55-59	1,580	1,476	129	107	119	84
60-64	1,749	1,660	92	195	34	145
65 or Older	1,213	1,147	92	90	60	33
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.9B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	3.8	3.6	0.4	0.3	0.2	0.2
12-20	0.2	0.1	0.0	0.0	0.0	0.0
21 or Older	4.4	4.2	0.4	0.4	0.2	0.2
12-17	0.1	0.0	0.0	*	*	*
12-13	*	0.0	*	0.0	*	*
14-15	0.1	*	0.0	*	0.0	*
16-17	0.1	0.0	0.0	0.0	*	0.0
18 or Older	4.2	4.0	0.4	0.4	0.2	0.2
18-25	0.9	0.6	0.2	0.1	0.1	0.0
18-20	0.5	0.3	0.0	0.0	0.0	0.0
21-25	1.3	0.8	0.3	0.2	0.1	0.0
26 or Older	4.7	4.5	0.4	0.4	0.2	0.3
26-49	4.3	4.4	0.4	0.4	0.2	0.2
26-29	2.7	2.0	0.4	0.3	0.0	0.1
30-34	3.0	3.8	0.2	0.4	0.1	0.2
35-39	5.2	4.3	0.3	0.2	0.1	0.1
40-44	5.7	6.0	0.8	0.4	0.5	0.3
45-49	4.7	5.8	0.4	0.8	0.2	0.6
50 or Older	5.0	4.5	0.4	0.4	0.2	0.3
50-54	6.8	5.6	1.0	0.3	0.4	0.2
55-59	7.4	7.4	0.6	0.5	0.6	0.4
60-64	7.8	7.3	0.4	0.9	0.2	0.6
65 or Older	2.2	2.0	0.2	0.2	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.10A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	46,474	48,850	7,572^a	8,509	2,301	2,289
12-20	1,995	1,969	1,183	1,152	229	259
21 or Older	44,479	46,881	6,389^a	7,356	2,072	2,030
12-17	626	533	377	358	91	99
12-13	63	60	44	37	8	21
14-15	141	141	75	100	24	19
16-17	422	332	258	221	59	60
18 or Older	45,848	48,316	7,195^a	8,151	2,210	2,190
18-25	5,349^a	5,889	2,462	2,676	553	554
18-20	1,370	1,435	806	795	138	160
21-25	3,980	4,454	1,655	1,881	415	394
26 or Older	40,499	42,427	4,733	5,475	1,657	1,636
26-49	23,015	23,394	4,160	4,599	1,385	1,308
26-29	4,278	3,981	1,522	1,313	617^a	279
30-34	5,215	5,545	989	1,218	327	364
35-39	4,961	4,768	711	917	163	282
40-44	4,725	4,799	573	684	174	256
45-49	3,836	4,302	364	468	104	127
50 or Older	17,484	19,033	574	876	272	328
50-54	3,241	3,950	219	353	110	58
55-59	3,674	3,587	128	106	85	51
60-64	4,927	4,919	137	253	72	124
65 or Older	5,642	6,578	90	165	4^a	96
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.10B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	16.6	17.3	2.7	3.0	0.8	0.8
12-20	5.1	5.1	3.0	3.0	0.6	0.7
21 or Older	18.5	19.3	2.7^a	3.0	0.9	0.8
12-17	2.4	2.1	1.4	1.4	0.3	0.4
12-13	0.7	0.7	0.5	0.4	0.1	0.2
14-15	1.6	1.6	0.9	1.1	0.3	0.2
16-17	4.9	4.0	3.0	2.7	0.7	0.7
18 or Older	18.1	18.9	2.8	3.2	0.9	0.9
18-25	16.0	16.9	7.4	7.7	1.7	1.6
18-20	10.5	11.1	6.2	6.1	1.1	1.2
21-25	19.5	20.4	8.1	8.6	2.0	1.8
26 or Older	18.4	19.2	2.1	2.5	0.8	0.7
26-49	22.5	22.8	4.1	4.5	1.4	1.3
26-29	24.5	23.4	8.7	7.7	3.5^b	1.6
30-34	23.0	23.9	4.4	5.3	1.4	1.6
35-39	22.3	21.6	3.2	4.2	0.7	1.3
40-44	23.2	23.1	2.8	3.3	0.9	1.2
45-49	19.7	22.0	1.9	2.4	0.5	0.6
50 or Older	14.8	16.0	0.5	0.7	0.2	0.3
50-54	16.5	20.0	1.1	1.8	0.6	0.3
55-59	17.2	17.9	0.6	0.5	0.4	0.3
60-64	22.1	21.7	0.6	1.1	0.3	0.5
65 or Older	10.3	11.6	0.2	0.3	0.0^a	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.11A – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	25,436	27,242	2,119	2,254	787	842
12-20	3,234	2,866	801	767	262	253
21 or Older	22,201^a	24,377	1,318	1,487	526	589
12-17	2,356^b	1,940	643	554	222	170
12-13	676	534	245	185	110	71
14-15	795	719	170	208	48	46
16-17	885^a	687	228	160	64	53
18 or Older	23,080^a	25,302	1,475	1,700	565	672
18-25	2,754	3,073	507	647	119	193
18-20	879	926	157	214	40	83
21-25	1,875	2,148	350	434	79	110
26 or Older	20,326^a	22,229	968	1,053	446	479
26-49	11,459	12,257	801	857	340	349
26-29	2,011	1,787	281	249	83	63
30-34	2,276	2,741	192	201	77	88
35-39	2,379	2,530	125	109	53	54
40-44	2,567	2,538	95	174	46	103
45-49	2,225	2,661	109	125	81	40
50 or Older	8,867	9,972	167	196	106	130
50-54	1,980	2,399	68	16	64	3
55-59	2,442	2,380	69^a	18	20	10
60-64	2,178	2,758	10	89	7	58
65 or Older	2,267	2,435	20	74	15	60
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.11B – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	9.1	9.7	0.8	0.8	0.3	0.3
12-20	8.3	7.4	2.0	2.0	0.7	0.7
21 or Older	9.2^a	10.0	0.5	0.6	0.2	0.2
12-17	9.1^b	7.5	2.5	2.2	0.9	0.7
12-13	7.6	6.3	2.8	2.2	1.2	0.8
14-15	9.3	7.9	2.0	2.3	0.6	0.5
16-17	10.3	8.4	2.6	2.0	0.7	0.6
18 or Older	9.1^a	9.9	0.6	0.7	0.2	0.3
18-25	8.2	8.8	1.5	1.9	0.4	0.6
18-20	6.7	7.2	1.2	1.7	0.3	0.6
21-25	9.2	9.8	1.7	2.0	0.4	0.5
26 or Older	9.2	10.0	0.4	0.5	0.2	0.2
26-49	11.2	11.9	0.8	0.8	0.3	0.3
26-29	11.5	10.5	1.6	1.5	0.5	0.4
30-34	10.0	11.8	0.8	0.9	0.3	0.4
35-39	10.7	11.5	0.6	0.5	0.2	0.2
40-44	12.6	12.2	0.5	0.8	0.2	0.5
45-49	11.4	13.6	0.6	0.6	0.4	0.2
50 or Older	7.5	8.4	0.1	0.2	0.1	0.1
50-54	10.1	12.1	0.3	0.1	0.3	0.0
55-59	11.5	11.9	0.3	0.1	0.1	0.0
60-64	9.8	12.2	0.0	0.4	0.0	0.3
65 or Older	4.1	4.3	0.0	0.1	0.0	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.12A – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	17,461	16,588	2,640	2,705	1,630	1,685
12-20	186	164	90	55	22	16
21 or Older	17,275	16,425	2,550	2,650	1,609	1,669
12-17	52	37	35	18	16	3
12-13	5	11	5	3	5	2
14-15	10	8	10	4	3	*
16-17	36	18	20	11	8	1
18 or Older	17,409	16,551	2,605	2,687	1,614	1,682
18-25	606	682	183	161	103	54
18-20	134	126	55	37	5	13
21-25	472	555	128	124	98	42
26 or Older	16,803	15,869	2,422	2,526	1,511	1,628
26-49	8,425	7,955	1,472	1,652	803	1,011
26-29	1,118^a	768	292	190	175	131
30-34	1,453	1,529	299	406	149	224
35-39	2,134	1,909	394	390	165	239
40-44	2,124	1,907	270	311	176	200
45-49	1,596	1,842	217	355	137	218
50 or Older	8,378	7,915	950	874	708	616
50-54	1,930	1,707	293	252	179	166
55-59	2,210	1,685	281	146	178	124
60-64	2,058	1,886	171	400	146	278
65 or Older	2,179	2,636	205	76	205	48
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.12B – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	6.2	5.9	0.9	1.0	0.6	0.6
12-20	0.5	0.4	0.2	0.1	0.1	0.0
21 or Older	7.2	6.7	1.1	1.1	0.7	0.7
12-17	0.2	0.1	0.1	0.1	0.1	0.0
12-13	0.1	0.1	0.1	0.0	0.1	0.0
14-15	0.1	0.1	0.1	0.0	0.0	*
16-17	0.4	0.2	0.2	0.1	0.1	0.0
18 or Older	6.9	6.5	1.0	1.0	0.6	0.7
18-25	1.8	2.0	0.5	0.5	0.3	0.2
18-20	1.0	1.0	0.4	0.3	0.0	0.1
21-25	2.3	2.5	0.6	0.6	0.5	0.2
26 or Older	7.6	7.2	1.1	1.1	0.7	0.7
26-49	8.2	7.8	1.4	1.6	0.8	1.0
26-29	6.4^a	4.5	1.7	1.1	1.0	0.8
30-34	6.4	6.6	1.3	1.7	0.7	1.0
35-39	9.6	8.7	1.8	1.8	0.7	1.1
40-44	10.4	9.2	1.3	1.5	0.9	1.0
45-49	8.2	9.4	1.1	1.8	0.7	1.1
50 or Older	7.1	6.7	0.8	0.7	0.6	0.5
50-54	9.8	8.6	1.5	1.3	0.9	0.8
55-59	10.4	8.4	1.3	0.7	0.8	0.6
60-64	9.2	8.3	0.8	1.8	0.7	1.2
65 or Older	4.0	4.7	0.4	0.1	0.4	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.13A – Any Use of Prescription Pain Relievers in Past Year and Misuse of Prescription Pain Relievers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	72,811	73,833	8,885	8,457	2,427	2,439
12-20	5,562	5,607	882	809	206	199
21 or Older	67,249	68,226	8,003	7,649	2,221	2,240
12-17	3,492	3,191	550	406	133	116
12-13	958	847	175	115	33	27
14-15	1,077	1,185	148	132	43	55
16-17	1,457^b	1,159	227	160	56	35
18 or Older	69,319	70,642	8,335	8,051	2,294	2,323
18-25	6,265	6,489	1,050	1,099	232	214
18-20	2,070^a	2,416	332	403	73	83
21-25	4,195	4,073	718	696	159	131
26 or Older	63,054	64,153	7,286	6,953	2,061	2,109
26-49	26,310	26,540	4,194	4,074	1,027	1,260
26-29	3,722	3,668	783	633	302	186
30-34	5,789	5,762	1,022	991	214	240
35-39	5,808	5,450	871	783	165	294
40-44	5,487	5,902	929	927	211	326
45-49	5,504	5,758	589	740	135	214
50 or Older	36,744	37,614	3,091	2,878	1,034	848
50-54	6,740	6,394	835	581	215	197
55-59	6,579	6,172	573	637	164	207
60-64	7,013	7,455	768	674	332	188
65 or Older	16,413	17,592	915	986	323	256
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.13B – Any Use of Prescription Pain Relievers in Past Year and Misuse of Prescription Pain Relievers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	26.0	26.2	3.2	3.0	0.9	0.9
12-20	14.2	14.5	2.3	2.1	0.5	0.5
21 or Older	27.9	28.0	3.3	3.1	0.9	0.9
12-17	13.4	12.4	2.1	1.6	0.5	0.5
12-13	10.8	10.0	2.0	1.4	0.4	0.3
14-15	12.6	13.1	1.7	1.5	0.5	0.6
16-17	16.9^a	14.1	2.6	1.9	0.7	0.4
18 or Older	27.3	27.6	3.3	3.1	0.9	0.9
18-25	18.7	18.7	3.1	3.2	0.7	0.6
18-20	15.8^a	18.7	2.5	3.1	0.6	0.6
21-25	20.6^a	18.6	3.5	3.2	0.8	0.6
26 or Older	28.6	29.0	3.3	3.1	0.9	1.0
26-49	25.7	25.9	4.1	4.0	1.0	1.2
26-29	21.3	21.5	4.5	3.7	1.7	1.1
30-34	25.5	24.9	4.5	4.3	0.9	1.0
35-39	26.1	24.7	3.9	3.6	0.7	1.3
40-44	26.9	28.4	4.6	4.5	1.0	1.6
45-49	28.2	29.5	3.0	3.8	0.7	1.1
50 or Older	31.1	31.6	2.6	2.4	0.9	0.7
50-54	34.3	32.3	4.3	2.9	1.1	1.0
55-59	30.9	30.9	2.7	3.2	0.8	1.0
60-64	31.5	32.9	3.4	3.0	1.5	0.8
65 or Older	29.9	31.1	1.7	1.7	0.6	0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.14A – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	16,878^b	19,674	3,910	4,298	1,124	1,348
12-20	2,940	3,042	664	597	156	136
21 or Older	13,938^b	16,632	3,246	3,701	968	1,212
12-17	1,829	1,845	302	226	80^a	33
12-13	431	461	24	32	7	8
14-15	596	635	88	57	25	11
16-17	803	749	191	137	49^a	14
18 or Older	15,049^b	17,830	3,608	4,072	1,044	1,315
18-25	3,473	3,794	1,359	1,278	307	376
18-20	1,111	1,198	361	371	76	103
21-25	2,362	2,597	997	906	231	273
26 or Older	11,576^b	14,035	2,249^a	2,794	737	939
26-49	7,651^b	9,485	1,958	2,365	633	815
26-29	1,649	1,898	541	631	108	200
30-34	1,841^a	2,390	483^a	737	211	293
35-39	1,747	2,063	524	462	149	95
40-44	1,334^a	1,777	232	293	81	144
45-49	1,081	1,356	180	243	84	84
50 or Older	3,925	4,550	290	429	104	123
50-54	1,277	1,159	90^a	273	56	88
55-59	964	1,167	79	49	33	6
60-64	632	887	89	77	13	4
65 or Older	1,053	1,337	32	29	*	25
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.14B – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	6.0^b	7.0	1.4	1.5	0.4	0.5
12-20	7.5	7.9	1.7	1.5	0.4	0.4
21 or Older	5.8^b	6.8	1.3	1.5	0.4	0.5
12-17	7.0	7.2	1.2	0.9	0.3^a	0.1
12-13	4.9	5.5	0.3	0.4	0.1	0.1
14-15	7.0	7.0	1.0	0.6	0.3	0.1
16-17	9.3	9.1	2.2	1.7	0.6^a	0.2
18 or Older	5.9^b	7.0	1.4	1.6	0.4	0.5
18-25	10.4	10.9	4.1	3.7	0.9	1.1
18-20	8.5	9.3	2.8	2.9	0.6	0.8
21-25	11.6	11.9	4.9	4.1	1.1	1.2
26 or Older	5.3^b	6.3	1.0^a	1.3	0.3	0.4
26-49	7.5^b	9.2	1.9	2.3	0.6	0.8
26-29	9.5	11.1	3.1	3.7	0.6	1.2
30-34	8.1^a	10.3	2.1^a	3.2	0.9	1.3
35-39	7.8	9.4	2.4	2.1	0.7	0.4
40-44	6.5^a	8.5	1.1	1.4	0.4	0.7
45-49	5.5	7.0	0.9	1.2	0.4	0.4
50 or Older	3.3	3.8	0.2	0.4	0.1	0.1
50-54	6.5	5.9	0.5^a	1.4	0.3	0.4
55-59	4.5	5.8	0.4	0.2	0.2	0.0
60-64	2.8	3.9	0.4	0.3	0.1	0.0
65 or Older	1.9	2.4	0.1	0.1	*	0.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.15A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	40,986	41,314	4,813	4,848	1,341	1,529
12-20	1,933	2,078	529	387	93	66
21 or Older	39,054	39,236	4,285	4,461	1,248	1,463
12-17	1,052	1,085	248^a	137	52	37
12-13	229	280	13	11	3	5
14-15	316	414	68	44	29	24
16-17	507	390	167	82	21	8
18 or Older	39,934	40,229	4,565	4,711	1,289	1,492
18-25	2,941	3,227	916	842	156	181
18-20	881	993	280	250	41	29
21-25	2,060	2,234	635	592	115	152
26 or Older	36,994	37,002	3,649	3,869	1,133	1,312
26-49	15,036	14,552	2,385	2,277	642	779
26-29	2,170	1,795	473	355	160	88
30-34	2,946	3,116	700	666	140	202
35-39	3,300	2,953	482	410	131	168
40-44	3,316	3,377	381	465	116	197
45-49	3,304	3,310	349	382	95	125
50 or Older	21,957	22,450	1,264	1,591	491	532
50-54	3,742	3,813	243	398	93	123
55-59	4,096	3,758	429	325	178	83
60-64	4,235	4,053	264	384	64	119
65 or Older	9,884	10,826	328	485	156	208
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.15B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	14.6	14.7	1.7	1.7	0.5	0.5
12-20	4.9	5.4	1.4	1.0	0.2	0.2
21 or Older	16.2	16.1	1.8	1.8	0.5	0.6
12-17	4.0	4.2	1.0	0.5	0.2	0.1
12-13	2.6	3.3	0.1	0.1	0.0	0.1
14-15	3.7	4.6	0.8	0.5	0.3	0.3
16-17	5.9	4.7	1.9	1.0	0.2	0.1
18 or Older	15.7	15.7	1.8	1.8	0.5	0.6
18-25	8.8	9.3	2.7	2.4	0.5	0.5
18-20	6.7	7.7	2.1	1.9	0.3	0.2
21-25	10.1	10.2	3.1	2.7	0.6	0.7
26 or Older	16.8	16.7	1.7	1.7	0.5	0.6
26-49	14.7	14.2	2.3	2.2	0.6	0.8
26-29	12.4	10.5	2.7	2.1	0.9	0.5
30-34	13.0	13.4	3.1	2.9	0.6	0.9
35-39	14.8	13.4	2.2	1.9	0.6	0.8
40-44	16.3	16.2	1.9	2.2	0.6	0.9
45-49	17.0	17.0	1.8	2.0	0.5	0.6
50 or Older	18.6	18.9	1.1	1.3	0.4	0.4
50-54	19.1	19.3	1.2	2.0	0.5	0.6
55-59	19.2	18.8	2.0	1.6	0.8	0.4
60-64	19.0	17.9	1.2	1.7	0.3	0.5
65 or Older	18.0	19.2	0.6	0.9	0.3	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.16A – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	32,794	32,783	4,284	4,153	1,145	1,304
12-20	1,470	1,443	477	330	68	55
21 or Older	31,325	31,340	3,807	3,823	1,077	1,249
12-17	782	717	220	115	36	34
12-13	153	146	9	9	*	4
14-15	217	288	51	40	20	23
16-17	413	284	160	66	16	7
18 or Older	32,012	32,066	4,063	4,038	1,109	1,270
18-25	2,467	2,592	855	779	134	158
18-20	687	726	257	215	32	20
21-25	1,780	1,866	598	565	102	138
26 or Older	29,545	29,474	3,209	3,259	975	1,112
26-49	12,647	11,929	2,220	2,028	564	691
26-29	1,972^a	1,493	440	318	135	75
30-34	2,565	2,601	679	546	119	157
35-39	2,774	2,416	426	379	126	139
40-44	2,729	2,778	343	437	97	197
45-49	2,607	2,641	332	348	87	123
50 or Older	16,898	17,545	988	1,231	411	421
50-54	2,898	2,919	177	348	92	114
55-59	3,165	3,164	344	210	167	53
60-64	3,237	3,102	216	310	37	65
65 or Older	7,598	8,360	252	362	115	189
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.16B – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	11.7	11.6	1.5	1.5	0.4	0.5
12-20	3.8	3.7	1.2	0.9	0.2	0.1
21 or Older	13.0	12.9	1.6	1.6	0.4	0.5
12-17	3.0	2.8	0.8	0.4	0.1	0.1
12-13	1.7	1.7	0.1	0.1	*	0.0
14-15	2.5	3.2	0.6	0.4	0.2	0.3
16-17	4.8	3.5	1.9	0.8	0.2	0.1
18 or Older	12.6	12.5	1.6	1.6	0.4	0.5
18-25	7.4	7.5	2.6	2.2	0.4	0.5
18-20	5.3	5.6	2.0	1.7	0.2	0.2
21-25	8.7	8.5	2.9	2.6	0.5	0.6
26 or Older	13.4	13.3	1.5	1.5	0.4	0.5
26-49	12.4	11.6	2.2	2.0	0.6	0.7
26-29	11.3^a	8.8	2.5	1.9	0.8	0.4
30-34	11.3	11.2	3.0	2.4	0.5	0.7
35-39	12.5	11.0	1.9	1.7	0.6	0.6
40-44	13.4	13.4	1.7	2.1	0.5	0.9
45-49	13.4	13.5	1.7	1.8	0.4	0.6
50 or Older	14.3	14.8	0.8	1.0	0.3	0.4
50-54	14.8	14.8	0.9	1.8	0.5	0.6
55-59	14.8	15.8	1.6	1.1	0.8	0.3
60-64	14.5	13.7	1.0	1.4	0.2	0.3
65 or Older	13.9	14.8	0.5	0.6	0.2	0.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.17A – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	14,602	15,399	878	959	225	278
12-20	678^b	919	71	64	31	16
21 or Older	13,924	14,481	806	894	195	262
12-17	410	521	43	27	20	7
12-13	98^a	174	7	2	3	1
14-15	154	193	21	8	12	4
16-17	159	153	15	18	5	2
18 or Older	14,192	14,878	834	931	205	271
18-25	815^a	1,082	144	93	32	32
18-20	268^a	398	28	37	10	9
21-25	547	684	116^a	56	21	24
26 or Older	13,376	13,797	690	839	173	239
26-49	4,645	4,903	394	369	92	118
26-29	524	484	96	48	30	12
30-34	744	988	88	141	21	50
35-39	978	944	79	78	6	36
40-44	1,223	1,227	100	56	21	15
45-49	1,175	1,259	31	45	13	4
50 or Older	8,731	8,894	296	470	81	121
50-54	1,415	1,575	66	74	*	8
55-59	1,602	1,498	86	139	12	30
60-64	1,893	1,727	54	94	28	54
65 or Older	3,822	4,095	90	163	41	28
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.17B – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	5.2	5.5	0.3	0.3	0.1	0.1
12-20	1.7^b	2.4	0.2	0.2	0.1	0.0
21 or Older	5.8	6.0	0.3	0.4	0.1	0.1
12-17	1.6	2.0	0.2	0.1	0.1	0.0
12-13	1.1^a	2.1	0.1	0.0	0.0	0.0
14-15	1.8	2.1	0.2	0.1	0.1	0.0
16-17	1.8	1.9	0.2	0.2	0.1	0.0
18 or Older	5.6	5.8	0.3	0.4	0.1	0.1
18-25	2.4^a	3.1	0.4	0.3	0.1	0.1
18-20	2.0^a	3.1	0.2	0.3	0.1	0.1
21-25	2.7	3.1	0.6^a	0.3	0.1	0.1
26 or Older	6.1	6.2	0.3	0.4	0.1	0.1
26-49	4.5	4.8	0.4	0.4	0.1	0.1
26-29	3.0	2.8	0.6	0.3	0.2	0.1
30-34	3.3	4.3	0.4	0.6	0.1	0.2
35-39	4.4	4.3	0.4	0.4	0.0	0.2
40-44	6.0	5.9	0.5	0.3	0.1	0.1
45-49	6.0	6.5	0.2	0.2	0.1	0.0
50 or Older	7.4	7.5	0.3	0.4	0.1	0.1
50-54	7.2	8.0	0.3	0.4	*	0.0
55-59	7.5	7.5	0.4	0.7	0.1	0.2
60-64	8.5	7.6	0.2	0.4	0.1	0.2
65 or Older	7.0	7.2	0.2	0.3	0.1	0.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.18A – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)
TOTAL	25,735	25,703	3,931	3,681
12-20	1,119	1,110	452	320
21 or Older	24,617	24,593	3,480	3,362
12-17	492	480	203	113
12-13	74	95	10	9
14-15	129	167	41	37
16-17	288	219	152	66
18 or Older	25,244	25,223	3,729	3,569
18-25	2,162	2,178	825	747
18-20	627	630	249	207
21-25	1,535	1,548	576	540
26 or Older	23,082	23,045	2,904	2,822
26-49	10,341	9,592	2,070	1,845
26-29	1,594	1,266	409	307
30-34	2,202	2,161	657	491
35-39	2,227	1,905	389	350
40-44	2,333	2,204	315	386
45-49	1,985	2,056	301	311
50 or Older	12,740	13,454	834	976
50-54	2,184	2,225	151	246
55-59	2,291	2,404	260	190
60-64	2,705	2,284	211	238
65 or Older	5,560	6,540	211	302
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.18B – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)
TOTAL	9.2	9.1	1.4	1.3
12-20	2.9	2.9	1.2	0.8
21 or Older	10.2	10.1	1.4	1.4
12-17	1.9	1.9	0.8	0.4
12-13	0.8	1.1	0.1	0.1
14-15	1.5	1.8	0.5	0.4
16-17	3.3	2.7	1.8	0.8
18 or Older	9.9	9.8	1.5	1.4
18-25	6.5	6.3	2.5	2.1
18-20	4.8	4.9	1.9	1.6
21-25	7.5	7.1	2.8	2.5
26 or Older	10.5	10.4	1.3	1.3
26-49	10.1	9.4	2.0	1.8
26-29	9.1	7.4	2.3	1.8
30-34	9.7	9.3	2.9	2.1
35-39	10.0	8.6	1.7	1.6
40-44	11.4	10.6	1.5	1.9
45-49	10.2	10.5	1.5	1.6
50 or Older	10.8	11.3	0.7	0.8
50-54	11.1	11.3	0.8	1.2
55-59	10.7	12.0	1.2	0.9
60-64	12.1	10.1	0.9	1.1
65 or Older	10.1	11.6	0.4	0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.19A – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Any Use in Past Year¹(2021)	Any Use in Past Year¹(2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	73,020	74,052	9,420	8,918	2,817	2,944
12-20	5,563	5,613	888	817	209	201
21 or Older	67,457	68,439	8,533	8,101	2,609	2,743
12-17	3,492	3,191	550	406	133	117
12-13	958	847	175	115	33	27
14-15	1,077	1,185	148	132	43	55
16-17	1,457^b	1,159	227	160	56	36
18 or Older	69,528	70,861	8,871	8,513	2,685	2,827
18-25	6,277	6,504	1,070	1,120	239	221
18-20	2,071^a	2,423	338	411	76	84
21-25	4,206	4,081	732	708	163	137
26 or Older	63,251	64,358	7,801	7,393	2,446	2,606
26-49	26,439	26,624	4,471	4,364	1,294	1,572
26-29	3,738	3,673	825	655	340	196
30-34	5,806	5,773	1,078	1,039	278	277
35-39	5,837	5,480	956	842	220^a	375
40-44	5,525	5,916	993	982	305	380
45-49	5,533	5,782	619	847	152^a	344
50 or Older	36,812	37,734	3,330	3,029	1,152	1,034
50-54	6,741	6,406	837	605	225	236
55-59	6,579	6,199	578	682	171	254
60-64	7,013	7,528	862	747	359	265
65 or Older	16,478	17,600	1,054	995	396	278
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, opioid use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of opioids includes the use of heroin or any use of prescription pain relievers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.19B – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Any Use in Past Year¹(2021)	Any Use in Past Year¹(2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	26.1	26.3	3.4	3.2	1.0	1.0
12-20	14.2	14.5	2.3	2.1	0.5	0.5
21 or Older	28.0	28.1	3.5	3.3	1.1	1.1
12-17	13.4	12.4	2.1	1.6	0.5	0.5
12-13	10.8	10.0	2.0	1.4	0.4	0.3
14-15	12.6	13.1	1.7	1.5	0.5	0.6
16-17	16.9^a	14.1	2.6	1.9	0.7	0.4
18 or Older	27.4	27.6	3.5	3.3	1.1	1.1
18-25	18.8	18.7	3.2	3.2	0.7	0.6
18-20	15.8^a	18.7	2.6	3.2	0.6	0.7
21-25	20.6^a	18.7	3.6	3.2	0.8	0.6
26 or Older	28.7	29.1	3.5	3.3	1.1	1.2
26-49	25.8	26.0	4.4	4.3	1.3	1.5
26-29	21.4	21.6	4.7	3.8	1.9	1.1
30-34	25.6	24.9	4.7	4.5	1.2	1.2
35-39	26.2	24.9	4.3	3.8	1.0^a	1.7
40-44	27.1	28.4	4.9	4.7	1.5	1.8
45-49	28.4	29.6	3.2	4.3	0.8^a	1.8
50 or Older	31.2	31.7	2.8	2.5	1.0	0.9
50-54	34.3	32.4	4.3	3.1	1.1	1.2
55-59	30.9	31.0	2.7	3.4	0.8	1.3
60-64	31.5	33.2	3.9	3.3	1.6	1.2
65 or Older	30.1	31.2	1.9	1.8	0.7	0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, opioid use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of opioids includes the use of heroin or any use of prescription pain relievers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.20A – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Any Use in Past Year¹(2021)	Any Use in Past Year¹(2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	21,614^b	24,425	9,379	10,188	4,173	4,469
12-20	3,081	3,220	863	794	237	205
21 or Older	18,533^b	21,205	8,516	9,394	3,936	4,264
12-17	1,849	1,889	338	272	100^a	40
12-13	431	481	29	54	12	11
14-15	599	640	93	63	30	11
16-17	819	767	215	155	58^a	18
18 or Older	19,765^b	22,536	9,042	9,916	4,073	4,429
18-25	4,198	4,581	2,230	2,272	675	767
18-20	1,232	1,331	525	522	137	165
21-25	2,966	3,249	1,705	1,750	538	602
26 or Older	15,567^b	17,956	6,812	7,644	3,398	3,662
26-49	10,101^b	12,078	4,846	5,476	2,202	2,443
26-29	2,276	2,506	1,297	1,338	618	470
30-34	2,332^b	3,026	1,109^b	1,563	511	686
35-39	2,288	2,587	1,139	1,089	383	495
40-44	1,764	2,145	724	751	368	405
45-49	1,442	1,814	578	736	322	388
50 or Older	5,466	5,877	1,966	2,168	1,196	1,218
50-54	1,858	1,521	696	721	350	343
55-59	1,347	1,485	470	464	329	208
60-64	843^a	1,387	345^a	711	200	489
65 or Older	1,417	1,485	454	272	317	179
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.20B – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Any Use in Past Year¹(2021)	Any Use in Past Year¹(2022)	Misuse in Past Year (2021)	Misuse in Past Year (2022)	Misuse in Past Month (2021)	Misuse in Past Month (2022)
TOTAL	7.7^b	8.7	3.4	3.6	1.5	1.6
12-20	7.9	8.3	2.2	2.1	0.6	0.5
21 or Older	7.7^b	8.7	3.5	3.9	1.6	1.8
12-17	7.1	7.3	1.3	1.1	0.4^a	0.2
12-13	4.9	5.7	0.3	0.6	0.1	0.1
14-15	7.0	7.1	1.1	0.7	0.4	0.1
16-17	9.5	9.3	2.5	1.9	0.7^a	0.2
18 or Older	7.8^b	8.8	3.6	3.9	1.6	1.7
18-25	12.5	13.2	6.7	6.5	2.0	2.2
18-20	9.4	10.3	4.0	4.0	1.0	1.3
21-25	14.6	14.9	8.4	8.0	2.6	2.8
26 or Older	7.1^b	8.1	3.1	3.5	1.5	1.7
26-49	9.9^b	11.8	4.7	5.3	2.2	2.4
26-29	13.0	14.7	7.4	7.9	3.5	2.8
30-34	10.3^b	13.1	4.9^b	6.7	2.2	3.0
35-39	10.3	11.7	5.1	4.9	1.7	2.2
40-44	8.6	10.3	3.5	3.6	1.8	1.9
45-49	7.4	9.3	3.0	3.8	1.7	2.0
50 or Older	4.6	4.9	1.7	1.8	1.0	1.0
50-54	9.5	7.7	3.5	3.6	1.8	1.7
55-59	6.3	7.4	2.2	2.3	1.5	1.0
60-64	3.8^a	6.1	1.6^a	3.1	0.9	2.2
65 or Older	2.6	2.6	0.8	0.5	0.6	0.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.21A – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	23,579	24,692	9,108	9,560
12-20	3,103	2,846	899	825
21 or Older	20,476	21,846	8,209	8,736
12-17	1,635^a	1,343	527	399
12-13	416	325	147	118
14-15	412	440	135	128
16-17	808^a	578	245	154
18 or Older	21,944	23,348	8,581	9,161
18-25	4,807	5,092	1,395	1,531
18-20	1,468	1,502	371	425
21-25	3,339	3,590	1,023	1,106
26 or Older	17,137	18,256	7,186	7,630
26-49	11,457	11,977	4,610	4,857
26-29	2,845	2,515	1,403^b	883
30-34	2,647	3,123	1,063	1,221
35-39	2,478	2,373	822	992
40-44	1,984	2,187	799	1,036
45-49	1,503	1,778	524	724
50 or Older	5,680	6,279	2,575	2,773
50-54	1,488	1,628	609	683
55-59	1,293	1,290	660	556
60-64	1,279	1,592	530	812
65 or Older	1,620	1,769	776	722
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use other than marijuana estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.21B – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	8.4	8.8	3.3	3.4
12-20	7.9	7.4	2.3	2.1
21 or Older	8.5	9.0	3.4	3.6
12-17	6.3^a	5.2	2.0	1.6
12-13	4.7	3.9	1.7	1.4
14-15	4.8	4.9	1.6	1.4
16-17	9.4^a	7.0	2.8	1.9
18 or Older	8.6	9.1	3.4	3.6
18-25	14.4	14.6	4.2	4.4
18-20	11.2	11.6	2.8	3.3
21-25	16.4	16.4	5.0	5.1
26 or Older	7.8	8.2	3.3	3.4
26-49	11.2	11.7	4.5	4.7
26-29	16.3	14.8	8.0^b	5.2
30-34	11.7	13.5	4.7	5.3
35-39	11.1	10.8	3.7	4.5
40-44	9.7	10.5	3.9	5.0
45-49	7.7	9.1	2.7	3.7
50 or Older	4.8	5.3	2.2	2.3
50-54	7.6	8.2	3.1	3.5
55-59	6.1	6.5	3.1	2.8
60-64	5.7	7.0	2.4	3.6
65 or Older	3.0	3.1	1.4	1.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use other than marijuana estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.22A – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Numbers in Thousands, 2021 and 2022
Prescription Drug/Age Group	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Past Year Any Users (2021)	Misuse in Past Year among Past Year Any Users (2022)
PSYCHOTHERAPEUTICS	98,748	101,637	14,529	14,204	14,529	14,204
12-17	5,126	4,920	908^b	640	908^b	640
18 or Older	93,622^a	96,717	13,621	13,564	13,621	13,564
18-25	9,765^a	10,367	2,638	2,542	2,638	2,542
26 or Older	83,857	86,350	10,983	11,022	10,983	11,022
PAIN RELIEVERS	72,811	73,833	8,885	8,457	8,885	8,457
12-17	3,492	3,191	550	406	550	406
18 or Older	69,319	70,642	8,335	8,051	8,335	8,051
18-25	6,265	6,489	1,050	1,099	1,050	1,099
26 or Older	63,054	64,153	7,286	6,953	7,286	6,953
STIMULANTS	16,878^b	19,674	3,910	4,298	3,910	4,298
12-17	1,829	1,845	302	226	302	226
18 or Older	15,049^b	17,830	3,608	4,072	3,608	4,072
18-25	3,473	3,794	1,359	1,278	1,359	1,278
26 or Older	11,576^b	14,035	2,249^a	2,794	2,249^a	2,794
TRANQUILIZERS OR SEDATIVES	40,986	41,314	4,813	4,848	4,813	4,848
12-17	1,052	1,085	248^a	137	248	137
18 or Older	39,934	40,229	4,565	4,711	4,565	4,711
18-25	2,941	3,227	916	842	916	842
26 or Older	36,994	37,002	3,649	3,869	3,649	3,869
TRANQUILIZERS	32,794	32,783	4,284	4,153	4,284	4,153
12-17	782	717	220	115	220	115
18 or Older	32,012	32,066	4,063	4,038	4,063	4,038
18-25	2,467	2,592	855	779	855	779
26 or Older	29,545	29,474	3,209	3,259	3,209	3,259
SEDATIVES	14,602	15,399	878	959	878	959
12-17	410	521	43	27	43	27
18 or Older	14,192	14,878	834	931	834	931
18-25	815^a	1,082	144	93	144	93
26 or Older	13,376	13,797	690	839	690	839
BENZODIAZEPINES	25,735	25,703	3,931	3,681	3,931	3,681
12-17	492	480	203	113	*	113
18 or Older	25,244	25,223	3,729	3,569	3,729	3,569
18-25	2,162	2,178	825	747	825	747
26 or Older	23,082	23,045	2,904	2,822	2,904	2,822
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.22B – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Percentages, 2021 and 2022
Prescription Drug/Age Group	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Past Year Any Users (2021)	Misuse in Past Year among Past Year Any Users (2022)
PSYCHOTHERAPEUTICS	35.3	36.0	5.2	5.0	14.7	14.0
12-17	19.7	19.1	3.5^b	2.5	17.7^b	13.0
18 or Older	36.9	37.7	5.4	5.3	14.5	14.0
18-25	29.2	29.8	7.9	7.3	27.0	24.5
26 or Older	38.1	39.0	5.0	5.0	13.1	12.8
PAIN RELIEVERS	26.0	26.2	3.2	3.0	12.2	11.5
12-17	13.4	12.4	2.1	1.6	15.7	12.7
18 or Older	27.3	27.6	3.3	3.1	12.0	11.4
18-25	18.7	18.7	3.1	3.2	16.8	16.9
26 or Older	28.6	29.0	3.3	3.1	11.6	10.8
STIMULANTS	6.0^b	7.0	1.4	1.5	23.2	21.8
12-17	7.0	7.2	1.2	0.9	16.5	12.2
18 or Older	5.9^b	7.0	1.4	1.6	24.0	22.8
18-25	10.4	10.9	4.1	3.7	39.1	33.7
26 or Older	5.3^b	6.3	1.0^a	1.3	19.4	19.9
TRANQUILIZERS OR SEDATIVES	14.6	14.7	1.7	1.7	11.7	11.7
12-17	4.0	4.2	1.0	0.5	23.6^a	12.6
18 or Older	15.7	15.7	1.8	1.8	11.4	11.7
18-25	8.8	9.3	2.7	2.4	31.1	26.1
26 or Older	16.8	16.7	1.7	1.7	9.9	10.5
TRANQUILIZERS	11.7	11.6	1.5	1.5	13.1	12.7
12-17	3.0	2.8	0.8	0.4	28.2^a	16.1
18 or Older	12.6	12.5	1.6	1.6	12.7	12.6
18-25	7.4	7.5	2.6	2.2	34.6	30.1
26 or Older	13.4	13.3	1.5	1.5	10.9	11.1
SEDATIVES	5.2	5.5	0.3	0.3	6.0	6.2
12-17	1.6	2.0	0.2	0.1	10.5	5.3
18 or Older	5.6	5.8	0.3	0.4	5.9	6.3
18-25	2.4^a	3.1	0.4	0.3	17.7^b	8.6
26 or Older	6.1	6.2	0.3	0.4	5.2	6.1
BENZODIAZEPINES	9.2	9.1	1.4	1.3	15.3	14.3
12-17	1.9	1.9	0.8	0.4	*	23.5
18 or Older	9.9	9.8	1.5	1.4	14.8	14.1
18-25	6.5	6.3	2.5	2.1	38.1	34.3
26 or Older	10.5	10.4	1.3	1.3	12.6	12.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.23A – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	139,677^a	143,116	5,738	5,377	133,939^a	137,739	18,275^a	19,121	115,664	118,618
GENDER
Male	72,108^a	74,761	2,675	2,431	69,432^a	72,330	9,213	9,689	60,220^a	62,641
Female	67,569	68,355	3,062	2,946	64,507	65,409	9,063	9,432	55,444	55,978
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	120,080	122,138	4,268^a	3,891	115,812	118,247	14,420	14,846	101,392	103,401
AIAN	1,213^a	785	*	48	1,131^a	737	*	*	866	618
Asian	4,175	4,436	223	212	3,951	4,224	686	837	3,265	3,387
Black or African American	16,402	16,512	686	778	15,716	15,734	2,283	2,398	13,432	13,336
NHOPI	*	*	*	*	*	*	*	*	*	*
White	94,235	96,397	2,948	2,650	91,287	93,747	10,527	10,851	80,760	82,895
Two or More Races	3,388	3,476	239	195	3,149	3,281	567	592	2,582	2,689
Hispanic or Latino	19,597	20,978	1,470	1,486	18,128	19,492	3,855^a	4,275	14,273	15,217
EDUCATION LEVEL
< High School	da	da	da	da	11,193^a	10,001	1,740	1,842	9,453^a	8,159
High School Graduate	da	da	da	da	33,656	34,400	5,427	5,901	28,229	28,500
Some College/Associate’s Degree	da	da	da	da	46,094	46,557	7,964	7,919	38,129	38,638
College Graduate	da	da	da	da	42,997^b	46,780	3,144	3,459	39,853^a	43,321
EMPLOYMENT STATUS
Full-Time	da	da	da	da	65,994	69,646	7,772^a	8,709	58,221	60,937
Part-Time	da	da	da	da	17,064	17,962	4,341	4,624	12,724	13,338
Unemployed	da	da	da	da	7,878^b	6,102	1,814	1,777	6,063^b	4,326
Other¹	da	da	da	da	43,004	44,028	4,348	4,011	38,656	40,018
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.23B – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	49.9	50.7	22.1	20.9	52.8	53.7	54.6	55.0	52.5	53.6
GENDER
Male	52.7	54.1	20.1	18.5	56.2	57.8	55.1	55.4	56.4	58.2
Female	47.2	47.5	24.1	23.4	49.5	49.9	54.2	54.5	48.8	49.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	52.2	52.8	22.0	20.4	55.0	55.8	56.2	56.0	54.8	55.7
AIAN	66.8^a	53.6	*	21.6	68.9	59.3	*	*	66.3	59.8
Asian	25.5	26.1	15.3	13.2	26.5	27.4	35.1	37.0	25.2	25.8
Black or African American	48.1	47.9	19.5	22.2	51.4	50.9	50.4	51.4	51.5	50.8
NHOPI	*	*	*	*	*	*	*	*	*	*
White	55.1	56.4	22.4	20.6	57.8	59.3	59.4	59.5	57.6	59.2
Two or More Races	61.9	59.1	26.5	23.4	68.9	65.0	61.2	59.0	70.9	66.5
Hispanic or Latino	39.4	41.2	22.1	22.4	42.0	44.0	49.3	51.8	40.4	42.3
EDUCATION LEVEL
< High School	da	da	da	da	39.6	41.1	47.2	51.4	38.5	39.3
High School Graduate	da	da	da	da	48.5	49.8	51.5	50.8	48.0	49.5
Some College/Associate’s Degree	da	da	da	da	59.7	59.9	56.3	57.0	60.5	60.5
College Graduate	da	da	da	da	54.4	55.0	61.9	60.7	53.9	54.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	57.7	58.8	61.1	61.9	57.3	58.4
Part-Time	da	da	da	da	56.2	54.7	53.2	52.6	57.3	55.5
Unemployed	da	da	da	da	60.2	55.4	57.2	55.4	61.1	55.4
Other¹	da	da	da	da	44.8	46.8	46.2	46.0	44.6	46.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.24A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	61,995^b	70,338	3,802	3,688	58,192^b	66,650	13,036^b	14,221	45,156^b	52,429
GENDER
Male	32,936^b	37,740	1,655	1,708	31,281^b	36,033	6,711^a	7,281	24,570^b	28,752
Female	29,058^b	32,598	2,147	1,980	26,911^b	30,618	6,325^b	6,940	20,586^b	23,678
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	52,216^b	58,392	2,853	2,680	49,363^b	55,712	10,414^a	11,020	38,949^b	44,693
AIAN	677	464	*	38	625	426	*	*	420	326
Asian	1,849	2,322	114	144	1,735	2,178	490	585	1,245	1,593
Black or African American	8,277	9,188	447	535	7,831	8,653	1,807	1,881	6,023	6,773
NHOPI	*	*	*	*	*	*	*	*	*	*
White	39,075^b	44,085	1,987	1,832	37,088^b	42,252	7,439	7,941	29,649^b	34,312
Two or More Races	1,921	2,064	189	124	1,732	1,940	423	469	1,309	1,471
Hispanic or Latino	9,779^b	11,946	949	1,008	8,829^b	10,938	2,622^b	3,201	6,208^b	7,737
EDUCATION LEVEL
< High School	da	da	da	da	5,650	5,355	1,273	1,402	4,377	3,953
High School Graduate	da	da	da	da	15,149^b	17,447	3,969	4,426	11,180^b	13,021
Some College/Associate’s Degree	da	da	da	da	21,350^b	23,869	5,713	5,957	15,637^b	17,912
College Graduate	da	da	da	da	16,043^b	19,979	2,081	2,436	13,961^b	17,543
EMPLOYMENT STATUS
Full-Time	da	da	da	da	27,557^b	33,245	5,261^b	6,400	22,297^b	26,845
Part-Time	da	da	da	da	8,623^b	10,266	3,316	3,681	5,307^b	6,585
Unemployed	da	da	da	da	4,736^a	3,981	1,400	1,321	3,337^a	2,660
Other¹	da	da	da	da	17,275^a	19,159	3,060	2,819	14,215^a	16,340
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.24B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	22.2^b	24.9	14.6	14.3	22.9^b	26.0	39.0	40.9	20.5^b	23.7
GENDER
Male	24.1^b	27.3	12.5	13.0	25.3^b	28.8	40.1	41.6	23.0^b	26.7
Female	20.3^b	22.7	16.9	15.8	20.6^b	23.3	37.8	40.1	18.1^b	20.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22.7^b	25.3	14.7	14.0	23.4^b	26.3	40.6	41.5	21.0^b	24.1
AIAN	37.3	31.7	*	17.4	38.1	34.3	*	*	32.1	31.6
Asian	11.3	13.6	7.8	9.0	11.6	14.1	25.1	25.8	9.6	12.1
Black or African American	24.3	26.7	12.7	15.2	25.6	28.0	39.9	40.3	23.1	25.8
NHOPI	*	*	*	*	*	*	*	*	*	*
White	22.8^b	25.8	15.1	14.3	23.5^b	26.7	42.0	43.5	21.1^b	24.5
Two or More Races	35.1	35.1	20.9	14.8	37.9	38.4	45.7	46.7	35.9	36.4
Hispanic or Latino	19.6^b	23.5	14.3	15.2	20.5^b	24.7	33.5^a	38.8	17.6^b	21.5
EDUCATION LEVEL
< High School	da	da	da	da	20.0	22.0	34.5	39.1	17.8	19.0
High School Graduate	da	da	da	da	21.8^b	25.2	37.6	38.1	19.0^b	22.6
Some College/Associate’s Degree	da	da	da	da	27.7^b	30.7	40.4	42.9	24.8^b	28.0
College Graduate	da	da	da	da	20.3^b	23.5	41.0	42.8	18.9^b	22.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	24.1^b	28.1	41.4^b	45.5	21.9^b	25.7
Part-Time	da	da	da	da	28.4	31.3	40.6	41.9	23.9^a	27.4
Unemployed	da	da	da	da	36.2	36.1	44.2	41.2	33.7	34.1
Other¹	da	da	da	da	18.0^b	20.4	32.5	32.4	16.4^b	19.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.25A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	40,564^b	46,603	1,964	1,884	38,600^b	44,719	8,648^b	9,478	29,952^b	35,241
GENDER
Male	22,469^b	26,081	887	827	21,582^b	25,254	4,604	5,047	16,978^b	20,207
Female	18,096^b	20,522	1,077	1,057	17,019^b	19,465	4,044	4,431	12,974^b	15,034
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	34,541^b	39,143	1,517	1,371	33,024^b	37,771	6,944	7,318	26,081^b	30,453
AIAN	521^b	275	*	25	487^b	250	*	*	353^a	183
Asian	964	1,255	32	62	932	1,193	299	340	633	853
Black or African American	5,629	6,392	264	314	5,365	6,078	1,247	1,304	4,118	4,774
NHOPI	*	200	*	*	*	*	*	*	*	*
White	25,877^b	29,447	1,057	881	24,820^b	28,565	4,906	5,248	19,914^b	23,317
Two or More Races	1,329	1,575	94	83	1,235	1,492	317	319	918	1,173
Hispanic or Latino	6,023^b	7,461	447	513	5,576^b	6,948	1,705^b	2,160	3,872^a	4,788
EDUCATION LEVEL
< High School	da	da	da	da	3,799	3,885	923	1,034	2,876	2,851
High School Graduate	da	da	da	da	10,584^b	12,288	2,668	3,020	7,916^a	9,268
Some College/Associate’s Degree	da	da	da	da	14,554^a	16,213	3,659	3,905	10,895^a	12,309
College Graduate	da	da	da	da	9,664^b	12,333	1,399	1,520	8,265^b	10,813
EMPLOYMENT STATUS
Full-Time	da	da	da	da	17,724^b	22,295	3,592^b	4,363	14,132^b	17,932
Part-Time	da	da	da	da	5,617^b	6,820	2,056	2,371	3,561^a	4,450
Unemployed	da	da	da	da	3,424	2,859	1,031	907	2,393	1,952
Other¹	da	da	da	da	11,835	12,745	1,969	1,838	9,866	10,908
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.25B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	14.5^b	16.5	7.5	7.3	15.2^b	17.4	25.8	27.2	13.6^b	15.9
GENDER
Male	16.4^b	18.9	6.7	6.3	17.5^b	20.2	27.5	28.9	15.9^b	18.8
Female	12.6^b	14.3	8.5	8.4	13.1^b	14.8	24.2	25.6	11.4^b	13.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.0^b	16.9	7.8	7.2	15.7^b	17.8	27.1	27.6	14.1^b	16.4
AIAN	28.7^a	18.8	*	11.4	29.7	20.1	*	*	27.0	17.7
Asian	5.9	7.4	2.2	3.8	6.2	7.7	15.3	15.0	4.9	6.5
Black or African American	16.5	18.6	7.5	8.9	17.5	19.7	27.5	27.9	15.8	18.2
NHOPI	*	15.7	*	*	*	*	*	*	*	*
White	15.1^b	17.2	8.0	6.9	15.7^b	18.1	27.7	28.8	14.2^b	16.7
Two or More Races	24.3	26.8	10.4	10.0	27.0	29.5	34.2	31.8	25.2	29.0
Hispanic or Latino	12.1^b	14.7	6.7	7.7	12.9^b	15.7	21.8^a	26.2	11.0^a	13.3
EDUCATION LEVEL
< High School	da	da	da	da	13.4^a	15.9	25.0	28.8	11.7	13.7
High School Graduate	da	da	da	da	15.3^b	17.8	25.3	26.0	13.5^b	16.1
Some College/Associate’s Degree	da	da	da	da	18.9^a	20.8	25.9	28.1	17.3^a	19.3
College Graduate	da	da	da	da	12.2^b	14.5	27.6	26.7	11.2^b	13.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	15.5^b	18.8	28.3	31.0	13.9^b	17.2
Part-Time	da	da	da	da	18.5	20.8	25.2	27.0	16.0	18.5
Unemployed	da	da	da	da	26.2	26.0	32.5	28.3	24.1	25.0
Other¹	da	da	da	da	12.3	13.6	20.9	21.1	11.4^a	12.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.26A – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	128,961	132,296	3,555	3,466	125,406^a	128,829	17,030^b	18,053	108,376	110,776
GENDER
Male	66,833^a	69,667	1,622	1,553	65,211^a	68,114	8,620	9,058	56,591^a	59,056
Female	62,128	62,629	1,934	1,913	60,195	60,715	8,410^a	8,996	51,785	51,720
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	111,792	113,865	2,680	2,422	109,113	111,443	13,469	13,987	95,643	97,456
AIAN	1,134^b	700	*	32	1,081^a	668	*	*	826	552
Asian	3,574	3,889	89	88	3,485	3,800	587	750	2,898	3,050
Black or African American	15,138	15,213	387	491	14,752	14,722	2,191	2,284	12,560	12,438
NHOPI	*	*	*	*	*	*	*	*	*	*
White	88,228	90,413	1,917	1,677	86,311	88,736	9,839	10,231	76,472	78,505
Two or More Races	3,152	3,206	157	126	2,995	3,080	505	558	2,489	2,522
Hispanic or Latino	17,169	18,431	875	1,044	16,294	17,386	3,561^b	4,066	12,732	13,320
EDUCATION LEVEL
< High School	da	da	da	da	9,956	9,042	1,577	1,687	8,379	7,355
High School Graduate	da	da	da	da	31,536	31,969	5,008^a	5,577	26,528	26,391
Some College/Associate’s Degree	da	da	da	da	43,652	44,025	7,444	7,460	36,209	36,565
College Graduate	da	da	da	da	40,262^b	43,793	3,001	3,328	37,260^a	40,464
EMPLOYMENT STATUS
Full-Time	da	da	da	da	62,327	65,482	7,412^a	8,341	54,915	57,141
Part-Time	da	da	da	da	15,885	17,012	4,018	4,364	11,867	12,647
Unemployed	da	da	da	da	7,370^b	5,784	1,626	1,674	5,744^b	4,110
Other¹	da	da	da	da	39,824	40,552	3,974	3,675	35,850	36,877
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.26B – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	46.1	46.9	13.7	13.5	49.4	50.3	50.9	51.9	49.2	50.0
GENDER
Male	48.9	50.4	12.2	11.8	52.8	54.5	51.5	51.8	53.0	54.9
Female	43.4	43.6	15.2	15.2	46.2	46.3	50.3	52.0	45.6	45.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	48.6	49.3	13.8	12.7	51.8	52.6	52.5	52.7	51.7	52.5
AIAN	62.5^b	47.8	*	14.3	65.9^a	53.7	*	*	63.2	53.5
Asian	21.8	22.9	6.1	5.5	23.4	24.7	30.0	33.1	22.4	23.2
Black or African American	44.4	44.2	11.0	14.0	48.2	47.6	48.3	49.0	48.2	47.4
NHOPI	*	*	*	*	*	*	*	*	*	*
White	51.6	52.9	14.6	13.1	54.6	56.1	55.5	56.1	54.5	56.1
Two or More Races	57.6	54.5	17.4	15.1	65.6	61.0	54.6	55.7	68.4	62.4
Hispanic or Latino	34.5	36.2	13.2	15.7	37.8	39.3	45.5	49.2	36.1	37.0
EDUCATION LEVEL
< High School	da	da	da	da	35.2	37.1	42.8	47.0	34.1	35.4
High School Graduate	da	da	da	da	45.4	46.2	47.5	48.0	45.1	45.9
Some College/Associate’s Degree	da	da	da	da	56.6	56.6	52.6	53.7	57.4	57.2
College Graduate	da	da	da	da	51.0	51.5	59.1	58.4	50.4	51.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	54.5	55.3	58.3	59.3	54.1	54.8
Part-Time	da	da	da	da	52.3	51.8	49.2	49.6	53.4	52.6
Unemployed	da	da	da	da	56.3	52.5	51.3	52.1	57.9	52.6
Other¹	da	da	da	da	41.5	43.1	42.2	42.2	41.4	43.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.27A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	53,181^b	61,901	2,845	2,947	50,337^b	58,955	12,133^b	13,299	38,204^b	45,656
GENDER
Male	28,781^b	33,475	1,286	1,319	27,495^b	32,156	6,280^a	6,800	21,215^b	25,355
Female	24,401^b	28,427	1,559	1,628	22,842^b	26,799	5,853^b	6,499	16,989^b	20,300
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	45,225^b	51,562	2,199	2,080	43,026^b	49,481	9,674^a	10,333	33,353^b	39,148
AIAN	655^a	399	*	29	617^a	371	*	*	414	275
Asian	1,444	1,905	72	72	1,373	1,833	430	538	943	1,295
Black or African American	7,277	8,090	332	431	6,945	7,659	1,740	1,789	5,205	5,869
NHOPI	*	*	*	*	*	*	*	*	*	*
White	33,814^b	39,132	1,556	1,443	32,257^b	37,690	6,880	7,428	25,377^b	30,262
Two or More Races	1,696	1,827	139	100	1,557	1,727	380	439	1,177	1,288
Hispanic or Latino	7,956^b	10,340	646^a	866	7,310^b	9,473	2,459^b	2,966	4,851^b	6,507
EDUCATION LEVEL
< High School	da	da	da	da	4,526	4,474	1,173	1,283	3,353	3,192
High School Graduate	da	da	da	da	12,987^b	15,555	3,614^a	4,134	9,373^b	11,421
Some College/Associate’s Degree	da	da	da	da	19,008^b	21,425	5,399	5,628	13,609^b	15,796
College Graduate	da	da	da	da	13,816^b	17,501	1,947	2,255	11,869^b	15,246
EMPLOYMENT STATUS
Full-Time	da	da	da	da	24,111^b	29,999	4,904^b	6,013	19,208^b	23,986
Part-Time	da	da	da	da	7,760^b	9,285	3,108	3,466	4,651^a	5,819
Unemployed	da	da	da	da	4,231	3,607	1,295	1,244	2,936^a	2,363
Other¹	da	da	da	da	14,235^a	16,063	2,826	2,575	11,408^b	13,488
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.27B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	19.0^b	22.0	10.9	11.5	19.8^b	23.0	36.3	38.2	17.3^b	20.6
GENDER
Male	21.0^b	24.2	9.7	10.0	22.3^b	25.7	37.6	38.9	19.9^b	23.6
Female	17.1^b	19.8	12.2	13.0	17.5^b	20.4	35.0	37.6	15.0^b	17.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	19.7^b	22.3	11.4	10.9	20.4^b	23.3	37.7	39.0	18.0^b	21.1
AIAN	36.1	27.3	*	13.0	37.6	29.8	*	*	31.7	26.6
Asian	8.8	11.2	4.9	4.5	9.2	11.9	22.0	23.8	7.3	9.8
Black or African American	21.3	23.5	9.4^a	12.3	22.7	24.8	38.4	38.4	20.0	22.3
NHOPI	*	*	*	*	*	*	*	*	*	*
White	19.8^b	22.9	11.8	11.2	20.4^b	23.8	38.8	40.7	18.1^b	21.6
Two or More Races	31.0	31.1	15.4	12.0	34.1	34.2	41.0	43.7	32.3	31.8
Hispanic or Latino	16.0^b	20.3	9.7^a	13.0	16.9^b	21.4	31.4^a	35.9	13.7^b	18.1
EDUCATION LEVEL
< High School	da	da	da	da	16.0	18.4	31.8	35.8	13.6	15.4
High School Graduate	da	da	da	da	18.7^b	22.5	34.3	35.6	15.9^b	19.9
Some College/Associate’s Degree	da	da	da	da	24.6^b	27.5	38.2	40.5	21.6^b	24.7
College Graduate	da	da	da	da	17.5^b	20.6	38.4	39.6	16.1^b	19.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	21.1^b	25.3	38.6^b	42.7	18.9^b	23.0
Part-Time	da	da	da	da	25.5	28.3	38.1	39.4	20.9	24.2
Unemployed	da	da	da	da	32.3	32.7	40.8	38.8	29.6	30.3
Other¹	da	da	da	da	14.8^b	17.1	30.0	29.6	13.2^b	15.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.28A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	36,950^b	42,317	1,586	1,647	35,364^b	40,670	8,236^a	9,013	27,128^b	31,657
GENDER
Male	20,920^b	23,578	740	697	20,180^b	22,881	4,456	4,777	15,724^b	18,104
Female	16,030^b	18,739	846	950	15,184^b	17,789	3,780^a	4,235	11,404^b	13,554
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	31,656^b	35,449	1,241	1,170	30,415^b	34,279	6,630	6,952	23,785^b	27,327
AIAN	497^a	263	*	25	476^b	238	*	*	342^a	171
Asian	885	1,060	18	30	867	1,030	280	308	587	721
Black or African American	5,269	5,797	201	264	5,068	5,533	1,209	1,270	3,859	4,263
NHOPI	*	118	*	*	*	112	*	*	*	73
White	23,587^b	26,764	902	775	22,685^b	25,989	4,662	4,955	18,023^b	21,034
Two or More Races	1,206	1,447	64	71	1,142	1,376	313	312	830	1,064
Hispanic or Latino	5,294^b	6,868	345	477	4,949^b	6,392	1,606^b	2,061	3,344^a	4,331
EDUCATION LEVEL
< High School	da	da	da	da	3,379	3,439	888	976	2,492	2,464
High School Graduate	da	da	da	da	9,583^b	11,117	2,497^a	2,874	7,086^a	8,243
Some College/Associate’s Degree	da	da	da	da	13,660	14,936	3,537	3,739	10,122	11,197
College Graduate	da	da	da	da	8,742^b	11,177	1,314	1,424	7,429^b	9,754
EMPLOYMENT STATUS
Full-Time	da	da	da	da	16,602^b	20,548	3,445^b	4,174	13,157^b	16,374
Part-Time	da	da	da	da	5,248^a	6,296	1,950	2,270	3,298	4,026
Unemployed	da	da	da	da	3,189^a	2,516	973	822	2,216^a	1,694
Other¹	da	da	da	da	10,324	11,311	1,867	1,747	8,457	9,564
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.28B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	13.2^b	15.0	6.1	6.4	13.9^b	15.9	24.6	25.9	12.3^b	14.3
GENDER
Male	15.3^b	17.1	5.6	5.3	16.3^b	18.3	26.6	27.3	14.7^b	16.8
Female	11.2^b	13.0	6.6	7.6	11.6^b	13.6	22.6	24.5	10.0^b	11.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	13.8^b	15.3	6.4	6.1	14.4^b	16.2	25.9	26.2	12.9^b	14.7
AIAN	27.4^a	18.0	*	11.2	29.0^a	19.2	*	*	26.2	16.6
Asian	5.4	6.2	1.2	1.9	5.8	6.7	14.3	13.6	4.5	5.5
Black or African American	15.4	16.8	5.7	7.5	16.6	17.9	26.7	27.2	14.8	16.2
NHOPI	*	9.3	*	*	*	9.3	*	*	*	6.8
White	13.8^b	15.6	6.9	6.0	14.4^b	16.4	26.3	27.1	12.9^b	15.0
Two or More Races	22.0	24.6	7.1	8.5	25.0	27.3	33.7	31.1	22.8	26.3
Hispanic or Latino	10.6^b	13.5	5.2	7.2	11.5^b	14.4	20.5^b	25.0	9.5^a	12.0
EDUCATION LEVEL
< High School	da	da	da	da	12.0	14.1	24.1	27.2	10.1	11.9
High School Graduate	da	da	da	da	13.8^b	16.1	23.7	24.7	12.0^b	14.3
Some College/Associate’s Degree	da	da	da	da	17.7	19.2	25.0	26.9	16.1	17.5
College Graduate	da	da	da	da	11.1^b	13.1	25.9	25.0	10.1^b	12.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	14.5^b	17.4	27.1	29.7	13.0^b	15.7
Part-Time	da	da	da	da	17.3	19.2	23.9	25.8	14.8	16.7
Unemployed	da	da	da	da	24.4	22.8	30.7	25.6	22.4	21.7
Other¹	da	da	da	da	10.7^a	12.0	19.8	20.1	9.8^a	11.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.29A – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	41,371	42,231	103	65	41,268	42,165	2,924	3,127	38,344	39,038
GENDER
Male	23,647	25,205	69^a	21	23,578	25,184	1,679	1,591	21,899	23,593
Female	17,724	17,026	34	44	17,690	16,981	1,245^a	1,536	16,445	15,445
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	36,059	36,276	65	50	35,994	36,227	2,344	2,456	33,650	33,770
AIAN	410	278	0	*	409	276	*	*	355	256
Asian	820	907	*	2	820	905	123	55	696	850
Black or African American	3,391	2,957	4	5	3,387	2,952	65^b	170	3,323	2,782
NHOPI	*	*	*	*	*	*	*	*	*	*
White	30,180	30,766	60	39	30,121	30,726	1,994	2,112	28,126	28,615
Two or More Races	1,140	1,088	2	1	1,139	1,086	100	84	1,039	1,002
Hispanic or Latino	5,312	5,954	38	15	5,274	5,939	580	671	4,694	5,268
EDUCATION LEVEL
< High School	da	da	da	da	3,709	3,564	259	266	3,450	3,299
High School Graduate	da	da	da	da	10,897	10,909	779	813	10,118	10,096
Some College/Associate’s Degree	da	da	da	da	15,077	15,566	1,214	1,293	13,863	14,272
College Graduate	da	da	da	da	11,585	12,126	672	755	10,913	11,371
EMPLOYMENT STATUS
Full-Time	da	da	da	da	19,440	20,863	1,335	1,565	18,106	19,297
Part-Time	da	da	da	da	5,015	5,791	601	675	4,415	5,116
Unemployed	da	da	da	da	2,887^a	2,184	352	365	2,535^a	1,819
Other¹	da	da	da	da	13,925	13,327	636	522	13,289	12,806
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.29B – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	14.8	15.0	0.4	0.3	16.3	16.5	8.7	9.0	17.4	17.6
GENDER
Male	17.3	18.2	0.5^a	0.2	19.1	20.1	10.0	9.1	20.5	21.9
Female	12.4	11.8	0.3	0.4	13.6	12.9	7.4	8.9	14.5	13.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.7	15.7	0.3	0.3	17.1	17.1	9.1	9.3	18.2	18.2
AIAN	22.6	19.0	0.3	*	25.0	22.2	*	*	27.1	24.8
Asian	5.0	5.3	*	0.1	5.5	5.9	6.3^a	2.4	5.4	6.5
Black or African American	9.9	8.6	0.1	0.2	11.1	9.5	1.4^a	3.6	12.7	10.6
NHOPI	*	*	*	*	*	*	*	*	*	*
White	17.6	18.0	0.5	0.3	19.1	19.4	11.3	11.6	20.1	20.4
Two or More Races	20.9	18.5	0.2	0.2	24.9	21.5	10.8	8.4	28.5	24.8
Hispanic or Latino	10.7	11.7	0.6	0.2	12.2	13.4	7.4	8.1	13.3	14.6
EDUCATION LEVEL
< High School	da	da	da	da	13.1	14.6	7.0	7.4	14.0	15.9
High School Graduate	da	da	da	da	15.7	15.8	7.4	7.0	17.2	17.6
Some College/Associate’s Degree	da	da	da	da	19.5	20.0	8.6	9.3	22.0	22.3
College Graduate	da	da	da	da	14.7	14.3	13.2	13.3	14.8	14.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	17.0	17.6	10.5	11.1	17.8	18.5
Part-Time	da	da	da	da	16.5	17.6	7.4	7.7	19.9	21.3
Unemployed	da	da	da	da	22.1	19.8	11.1	11.4	25.6	23.3
Other¹	da	da	da	da	14.5	14.2	6.8	6.0	15.3	15.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.30A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	4,760	5,274	35	40	4,725	5,235	1,225	1,295	3,500	3,939
GENDER
Male	2,959^a	3,601	20	9	2,939^a	3,592	687	716	2,252^a	2,877
Female	1,802	1,673	15	31	1,787	1,642	538	580	1,249	1,063
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,905	4,283	29	27	3,876	4,256	1,022	1,041	2,854	3,215
AIAN	51	33	0	*	51	31	*	*	12	19
Asian	155	156	*	*	155	156	84	35	71	121
Black or African American	569	543	*	1	569	542	42	57	527	486
NHOPI	*	*	*	*	*	*	*	*	*	*
White	2,961	3,369	28	25	2,933	3,345	832	898	2,101	2,447
Two or More Races	163	132	1	*	162	132	25	24	137	108
Hispanic or Latino	856	992	6	13	850	979	203	255	647	724
EDUCATION LEVEL
< High School	da	da	da	da	646	455	85	81	561	374
High School Graduate	da	da	da	da	1,268	1,288	268	256	1,000	1,032
Some College/Associate’s Degree	da	da	da	da	1,798	1,934	597	545	1,200	1,389
College Graduate	da	da	da	da	1,014^b	1,557	275	414	739^b	1,144
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,055^a	2,593	535	666	1,520	1,926
Part-Time	da	da	da	da	706	815	300	290	406	525
Unemployed	da	da	da	da	597	658	167	163	430	495
Other¹	da	da	da	da	1,368	1,169	223	177	1,145	992
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.30B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.7	1.9	0.1	0.2	1.9	2.0	3.7	3.7	1.6	1.8
GENDER
Male	2.2	2.6	0.1	0.1	2.4	2.9	4.1	4.1	2.1^a	2.7
Female	1.3	1.2	0.1	0.2	1.4	1.3	3.2	3.4	1.1	0.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.7	1.9	0.1	0.1	1.8	2.0	4.0	3.9	1.5	1.7
AIAN	2.8	2.3	0.0	*	3.1	2.5	*	*	0.9	1.9
Asian	0.9	0.9	*	*	1.0	1.0	4.3	1.5	0.5	0.9
Black or African American	1.7	1.6	*	0.0	1.9	1.8	0.9	1.2	2.0	1.8
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1.7	2.0	0.2	0.2	1.9	2.1	4.7	4.9	1.5	1.7
Two or More Races	3.0	2.2	0.1	*	3.5	2.6	2.7	2.3	3.8	2.7
Hispanic or Latino	1.7	1.9	0.1	0.2	2.0	2.2	2.6	3.1	1.8	2.0
EDUCATION LEVEL
< High School	da	da	da	da	2.3	1.9	2.3	2.3	2.3	1.8
High School Graduate	da	da	da	da	1.8	1.9	2.5	2.2	1.7	1.8
Some College/Associate’s Degree	da	da	da	da	2.3	2.5	4.2	3.9	1.9	2.2
College Graduate	da	da	da	da	1.3^b	1.8	5.4	7.3	1.0^a	1.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.8^a	2.2	4.2	4.7	1.5	1.8
Part-Time	da	da	da	da	2.3	2.5	3.7	3.3	1.8	2.2
Unemployed	da	da	da	da	4.6	6.0	5.3	5.1	4.3	6.3
Other¹	da	da	da	da	1.4	1.2	2.4	2.0	1.3	1.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.31A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1,846	2,015	5	5	1,841	2,010	363	403	1,478	1,607
GENDER
Male	1,105	1,450	5	2	1,100	1,448	192	240	909	1,208
Female	741	565	*	3	741	562	172	163	569	399
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,479	1,633	4	3	1,475	1,631	290	308	1,185	1,323
AIAN	15	10	*	*	15	10	7	*	9	4
Asian	41	95	*	*	41	95	31	14	11	81
Black or African American	272	329	*	1	272	328	8	23	264	305
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1,111	1,142	4	2	1,107	1,140	242	259	865	881
Two or More Races	39	27	*	*	39	27	2	4	37	23
Hispanic or Latino	368	382	1	2	367	379	74	95	293	285
EDUCATION LEVEL
< High School	da	da	da	da	332	173	33	43	299^a	130
High School Graduate	da	da	da	da	506	658	88	93	417	565
Some College/Associate’s Degree	da	da	da	da	696	696	177	157	520	539
College Graduate	da	da	da	da	307^a	483	66	110	242	373
EMPLOYMENT STATUS
Full-Time	da	da	da	da	733	805	152	194	581	611
Part-Time	da	da	da	da	292	341	120	85	172	256
Unemployed	da	da	da	da	228	278	39	67	189	211
Other¹	da	da	da	da	588	585	52	56	535	529
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.31B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.7	0.7	0.0	0.0	0.7	0.8	1.1	1.2	0.7	0.7
GENDER
Male	0.8	1.0	0.0	0.0	0.9	1.2	1.1	1.4	0.9	1.1
Female	0.5	0.4	*	0.0	0.6	0.4	1.0	0.9	0.5	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6	0.7	0.0	0.0	0.7	0.8	1.1	1.2	0.6	0.7
AIAN	0.8	0.7	*	*	0.9	0.8	2.0	*	0.7	0.3
Asian	0.3	0.6	*	*	0.3	0.6	1.6	0.6	0.1	0.6
Black or African American	0.8	1.0	*	0.0	0.9	1.1	0.2	0.5	1.0	1.2
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.6	0.7	0.0	0.0	0.7	0.7	1.4	1.4	0.6	0.6
Two or More Races	0.7	0.5	*	*	0.9	0.5	0.2	0.4	1.0	0.6
Hispanic or Latino	0.7	0.7	0.0	0.0	0.8	0.9	0.9	1.1	0.8	0.8
EDUCATION LEVEL
< High School	da	da	da	da	1.2	0.7	0.9	1.2	1.2	0.6
High School Graduate	da	da	da	da	0.7	1.0	0.8	0.8	0.7	1.0
Some College/Associate’s Degree	da	da	da	da	0.9	0.9	1.2	1.1	0.8	0.8
College Graduate	da	da	da	da	0.4	0.6	1.3	1.9	0.3	0.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.6	0.7	1.2	1.4	0.6	0.6
Part-Time	da	da	da	da	1.0	1.0	1.5	1.0	0.8	1.1
Unemployed	da	da	da	da	1.7	2.5	1.2	2.1	1.9	2.7
Other¹	da	da	da	da	0.6	0.6	0.6	0.6	0.6	0.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.32A – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	10,625	10,167	18	4	10,606	10,163	315	215	10,292	9,948
GENDER
Male	6,473	6,513	15	*	6,458	6,513	178	113	6,280	6,400
Female	4,151	3,654	3	4	4,149	3,650	136	102	4,012	3,548
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9,396	8,840	18	2	9,378	8,838	256^a	148	9,122	8,690
AIAN	127	89	0	*	127	89	*	*	101	82
Asian	77	102	*	*	77	102	15	5	62	97
Black or African American	1,688	1,503	*	*	1,688	1,503	1	15	1,687	1,488
NHOPI	*	85	*	*	*	85	*	*	*	*
White	7,186	6,699	18	1	7,169	6,699	202^a	111	6,967	6,587
Two or More Races	248	361	*	1	248	360	6	9	242	351
Hispanic or Latino	1,228	1,326	*	2	1,228	1,324	58	66	1,170	1,258
EDUCATION LEVEL
< High School	da	da	da	da	1,809	1,654	82	50	1,727	1,604
High School Graduate	da	da	da	da	4,063	3,516	134	100	3,929	3,416
Some College/Associate’s Degree	da	da	da	da	3,656	3,664	82	59	3,574	3,605
College Graduate	da	da	da	da	1,079	1,329	17	5	1,062	1,324
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4,073	4,091	118	100	3,955	3,991
Part-Time	da	da	da	da	1,055	1,464	41	27	1,013	1,437
Unemployed	da	da	da	da	1,120	842	61	41	1,059	801
Other¹	da	da	da	da	4,359	3,766	94	47	4,265	3,720
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.32B – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3.8	3.6	0.1	0.0	4.2	4.0	0.9	0.6	4.7	4.5
GENDER
Male	4.7	4.7	0.1	*	5.2	5.2	1.1	0.6	5.9	5.9
Female	2.9	2.5	0.0	0.0	3.2	2.8	0.8	0.6	3.5	3.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4.1	3.8	0.1	0.0	4.5	4.2	1.0^a	0.6	4.9	4.7
AIAN	7.0	6.1	0.2	*	7.7	7.2	*	*	7.8	7.9
Asian	0.5	0.6	*	*	0.5	0.7	0.8	0.2	0.5	0.7
Black or African American	4.9	4.4	*	*	5.5	4.9	0.0	0.3	6.5	5.7
NHOPI	*	6.7	*	*	*	7.0	*	*	*	*
White	4.2	3.9	0.1	0.0	4.5	4.2	1.1^a	0.6	5.0	4.7
Two or More Races	4.5	6.1	*	0.2	5.4	7.1	0.7	0.9	6.6	8.7
Hispanic or Latino	2.5	2.6	*	0.0	2.8	3.0	0.7	0.8	3.3	3.5
EDUCATION LEVEL
< High School	da	da	da	da	6.4	6.8	2.2	1.4	7.0	7.7
High School Graduate	da	da	da	da	5.9	5.1	1.3	0.9	6.7	5.9
Some College/Associate’s Degree	da	da	da	da	4.7	4.7	0.6	0.4	5.7	5.6
College Graduate	da	da	da	da	1.4	1.6	0.3	0.1	1.4	1.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.6	3.5	0.9	0.7	3.9	3.8
Part-Time	da	da	da	da	3.5	4.5	0.5	0.3	4.6	6.0
Unemployed	da	da	da	da	8.6	7.6	1.9	1.3	10.7	10.3
Other¹	da	da	da	da	4.5	4.0	1.0	0.5	4.9	4.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.33A – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1,003	918	3	*	1,000	917	75	39	925	877
GENDER
Male	664	640	*	*	664	639	26	30	638	609
Female	338	278	2	*	336	277	49	9	287	268
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	928	853	3	*	925	853	55	37	871	815
AIAN	*	5	*	*	*	5	*	*	3	2
Asian	9	*	*	*	9	*	*	*	*	*
Black or African American	294	295	*	*	294	295	*	10	294	285
NHOPI	*	*	*	*	*	*	*	*	*	*
White	547	488	3	1	544	487	23	21	521	466
Two or More Races	54	37	*	*	54	37	2	3	52	34
Hispanic or Latino	74	64	*	*	74	64	20	2	54	62
EDUCATION LEVEL
< High School	da	da	da	da	223	195	19	12	203	183
High School Graduate	da	da	da	da	403	358	34	19	369	339
Some College/Associate’s Degree	da	da	da	da	309	272	10	8	300	263
College Graduate	da	da	da	da	65	92	12	*	53	92
EMPLOYMENT STATUS
Full-Time	da	da	da	da	262	183	34	15	228	168
Part-Time	da	da	da	da	55	131	2	4	53	126
Unemployed	da	da	da	da	261	228	36	16	225	211
Other¹	da	da	da	da	422	375	2	4	420	371
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.33B – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.4	0.3	0.0	*	0.4	0.4	0.2	0.1	0.4	0.4
GENDER
Male	0.5	0.5	*	*	0.5	0.5	0.2	0.2	0.6	0.6
Female	0.2	0.2	0.0	*	0.3	0.2	0.3	0.1	0.3	0.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.4	0.0	*	0.4	0.4	0.2	0.1	0.5	0.4
AIAN	*	0.3	*	*	*	0.4	*	*	0.2	0.2
Asian	0.1	*	*	*	0.1	*	*	*	*	*
Black or African American	0.9	0.9	*	*	1.0	1.0	*	0.2	1.1	1.1
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.3	0.3	0.0	0.0	0.3	0.3	0.1	0.1	0.4	0.3
Two or More Races	1.0	0.6	*	*	1.2	0.7	0.2	0.3	1.4	0.8
Hispanic or Latino	0.1	0.1	*	*	0.2	0.1	0.3	0.0	0.2	0.2
EDUCATION LEVEL
< High School	da	da	da	da	0.8	0.8	0.5	0.3	0.8	0.9
High School Graduate	da	da	da	da	0.6	0.5	0.3	0.2	0.6	0.6
Some College/Associate’s Degree	da	da	da	da	0.4	0.3	0.1	0.1	0.5	0.4
College Graduate	da	da	da	da	0.1	0.1	0.2	*	0.1	0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.2	0.2	0.3	0.1	0.2	0.2
Part-Time	da	da	da	da	0.2	0.4	0.0	0.0	0.2	0.5
Unemployed	da	da	da	da	2.0	2.1	1.1	0.5	2.3	2.7
Other¹	da	da	da	da	0.4	0.4	0.0	0.1	0.5	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.34A – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	519	573	*	*	519	572	31	13	488	559
GENDER
Male	321	420	*	*	320	420	11	8	309	412
Female	199	153	*	*	199	152	20	5	179	147
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	494	528	*	*	493	528	11	12	483	516
AIAN	0	5	*	*	0	5	*	*	0	2
Asian	*	*	*	*	*	*	*	*	*	*
Black or African American	152	213	*	*	152	213	*	1	152	211
NHOPI	*	*	*	*	*	*	*	*	*	*
White	330	277	*	*	329	276	11	8	319	269
Two or More Races	11	5	*	*	11	5	*	0	11	5
Hispanic or Latino	25	44	*	*	25	44	20	1	5	44
EDUCATION LEVEL
< High School	da	da	da	da	155	79	13	5	142	74
High School Graduate	da	da	da	da	151	281	9	8	141	274
Some College/Associate’s Degree	da	da	da	da	179	164	9	*	170	163
College Graduate	da	da	da	da	35	48	*	*	35	48
EMPLOYMENT STATUS
Full-Time	da	da	da	da	111	87	22	3	89	84
Part-Time	da	da	da	da	42	71	*	1	42	71
Unemployed	da	da	da	da	117	140	9	5	109	136
Other¹	da	da	da	da	248	274	*	4	248	269
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.34B – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.2	0.2	*	*	0.2	0.2	0.1	0.0	0.2	0.3
GENDER
Male	0.2	0.3	*	*	0.3	0.3	0.1	0.0	0.3	0.4
Female	0.1	0.1	*	*	0.2	0.1	0.1	0.0	0.2	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.2	0.2	*	*	0.2	0.2	0.0	0.0	0.3	0.3
AIAN	0.0	0.3	*	*	0.0	0.4	*	*	0.0	0.2
Asian	*	*	*	*	*	*	*	*	*	*
Black or African American	0.4	0.6	*	*	0.5	0.7	*	0.0	0.6	0.8
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.2	0.2	*	*	0.2	0.2	0.1	0.0	0.2	0.2
Two or More Races	0.2	0.1	*	*	0.3	0.1	*	0.0	0.3	0.1
Hispanic or Latino	0.1	0.1	*	*	0.1	0.1	0.3	0.0	0.0	0.1
EDUCATION LEVEL
< High School	da	da	da	da	0.5	0.3	0.3	0.1	0.6	0.4
High School Graduate	da	da	da	da	0.2	0.4	0.1	0.1	0.2	0.5
Some College/Associate’s Degree	da	da	da	da	0.2	0.2	0.1	*	0.3	0.3
College Graduate	da	da	da	da	0.0	0.1	*	*	0.0	0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.1	0.1	0.2	0.0	0.1	0.1
Part-Time	da	da	da	da	0.1	0.2	*	0.0	0.2	0.3
Unemployed	da	da	da	da	0.9	1.3	0.3	0.1	1.1	1.7
Other¹	da	da	da	da	0.3	0.3	*	0.1	0.3	0.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.35A – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	46,474	48,850	626	533	45,848	48,316	5,349^a	5,889	40,499	42,427
GENDER
Male	27,157	28,664	386^a	234	26,771	28,430	3,068	3,277	23,703	25,152
Female	19,317	20,186	240	299	19,077	19,886	2,281^a	2,612	16,796	17,275
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	40,766	42,306	421	367	40,345	41,938	4,426	4,634	35,919	37,305
AIAN	460	299	*	5	455	294	*	36	356	257
Asian	1,082	1,280	1	11	1,081	1,268	289	249	792	1,020
Black or African American	3,046	3,393	29	52	3,016	3,341	367	478	2,649	2,863
NHOPI	*	*	*	*	*	*	*	*	*	*
White	34,569	35,796	333	283	34,236	35,513	3,452	3,637	30,784	31,876
Two or More Races	1,419	1,340	18	16	1,401	1,324	202	225	1,199	1,099
Hispanic or Latino	5,708	6,544	205	166	5,503	6,378	924^b	1,255	4,580	5,122
EDUCATION LEVEL
< High School	da	da	da	da	3,162	3,288	448	582	2,714	2,706
High School Graduate	da	da	da	da	11,153	11,555	1,642	1,661	9,511	9,894
Some College/Associate’s Degree	da	da	da	da	16,574	17,819	2,271	2,501	14,303	15,318
College Graduate	da	da	da	da	14,959	15,654	987	1,146	13,972	14,508
EMPLOYMENT STATUS
Full-Time	da	da	da	da	22,744^a	25,250	2,290^b	2,958	20,454	22,292
Part-Time	da	da	da	da	6,141	6,970	1,208	1,353	4,933	5,617
Unemployed	da	da	da	da	3,174^b	2,413	618	593	2,557^b	1,820
Other¹	da	da	da	da	13,788	13,683	1,234	986	12,555	12,698
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.35B – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	16.6	17.3	2.4	2.1	18.1	18.9	16.0	16.9	18.4	19.2
GENDER
Male	19.9	20.7	2.9^a	1.8	21.7	22.7	18.3	18.7	22.2	23.4
Female	13.5	14.0	1.9	2.4	14.6	15.2	13.6	15.1	14.8	15.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	17.7	18.3	2.2	1.9	19.1	19.8	17.3	17.5	19.4	20.1
AIAN	25.3	20.4	*	2.4	27.7	23.6	*	17.3	27.2	24.9
Asian	6.6	7.5	0.1	0.7	7.2	8.2	14.8	11.0	6.1	7.8
Black or African American	8.9	9.9	0.8	1.5	9.9	10.8	8.1	10.2	10.2	10.9
NHOPI	*	*	*	*	*	*	*	*	*	*
White	20.2	20.9	2.5	2.2	21.7	22.5	19.5	19.9	22.0	22.8
Two or More Races	25.9	22.8	2.0	1.9	30.7	26.2	21.8	22.4	32.9	27.2
Hispanic or Latino	11.5	12.9	3.1	2.5	12.8	14.4	11.8^a	15.2	13.0	14.2
EDUCATION LEVEL
< High School	da	da	da	da	11.2	13.5	12.2^a	16.2	11.0	13.0
High School Graduate	da	da	da	da	16.1	16.7	15.6	14.3	16.2	17.2
Some College/Associate’s Degree	da	da	da	da	21.5	22.9	16.1	18.0	22.7	24.0
College Graduate	da	da	da	da	18.9	18.4	19.4	20.1	18.9	18.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	19.9^a	21.3	18.0^a	21.0	20.1	21.4
Part-Time	da	da	da	da	20.2	21.2	14.8	15.4	22.2	23.4
Unemployed	da	da	da	da	24.3	21.9	19.5	18.5	25.8	23.3
Other¹	da	da	da	da	14.4	14.5	13.1	11.3	14.5	14.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.36A – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	7,572^a	8,509	377	358	7,195^a	8,151	2,462	2,676	4,733	5,475
GENDER
Male	4,565	5,163	209	169	4,355	4,994	1,346	1,509	3,009	3,485
Female	3,007	3,346	168	189	2,840	3,157	1,116	1,166	1,724	1,990
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6,361	7,083	258	256	6,103	6,827	2,013	2,118	4,090	4,708
AIAN	75	32	*	2	71	30	*	16	28	15
Asian	220	378	*	2	220	376	124	132	96	244
Black or African American	575	723	16	27	559	696	188	214	371	481
NHOPI	57	*	*	*	29	*	*	*	*	*
White	5,141	5,629	201	211	4,940	5,418	1,554	1,659	3,386	3,759
Two or More Races	294	267	10	14	284	254	91	90	193	163
Hispanic or Latino	1,211	1,426	119	102	1,092	1,324	449	557	643	767
EDUCATION LEVEL
< High School	da	da	da	da	399	527	180	278	219	249
High School Graduate	da	da	da	da	1,776	1,742	762	725	1,014	1,017
Some College/Associate’s Degree	da	da	da	da	2,748	3,052	1,094	1,200	1,654	1,851
College Graduate	da	da	da	da	2,272^a	2,830	425	472	1,847^a	2,358
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3,541^b	4,570	1,002^a	1,249	2,539^a	3,321
Part-Time	da	da	da	da	1,309	1,441	623	727	686	714
Unemployed	da	da	da	da	777	575	261	266	516	309
Other¹	da	da	da	da	1,568	1,565	575	434	993	1,132
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.36B – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	2.7	3.0	1.4	1.4	2.8	3.2	7.4	7.7	2.1	2.5
GENDER
Male	3.3	3.7	1.6	1.3	3.5	4.0	8.0	8.6	2.8	3.2
Female	2.1	2.3	1.3	1.5	2.2	2.4	6.7	6.7	1.5	1.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2.8	3.1	1.3	1.3	2.9	3.2	7.9	8.0	2.2	2.5
AIAN	4.1	2.2	*	0.7	4.4	2.5	*	7.4	2.1	1.5
Asian	1.3	2.2	*	0.1	1.5	2.4	6.3	5.8	0.7	1.9
Black or African American	1.7	2.1	0.5	0.8	1.8	2.2	4.2	4.6	1.4	1.8
NHOPI	4.9	*	*	*	2.9	*	*	*	*	*
White	3.0	3.3	1.5	1.6	3.1	3.4	8.8	9.1	2.4	2.7
Two or More Races	5.4	4.5	1.1	1.6	6.2	5.0	9.8	9.0	5.3	4.0
Hispanic or Latino	2.4	2.8	1.8	1.5	2.5	3.0	5.7	6.7	1.8	2.1
EDUCATION LEVEL
< High School	da	da	da	da	1.4^a	2.2	4.9^a	7.8	0.9	1.2
High School Graduate	da	da	da	da	2.6	2.5	7.2	6.2	1.7	1.8
Some College/Associate’s Degree	da	da	da	da	3.6	3.9	7.7	8.6	2.6	2.9
College Graduate	da	da	da	da	2.9	3.3	8.4	8.3	2.5	3.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.1^b	3.9	7.9	8.9	2.5^a	3.2
Part-Time	da	da	da	da	4.3	4.4	7.6	8.3	3.1	3.0
Unemployed	da	da	da	da	5.9	5.2	8.2	8.3	5.2	4.0
Other¹	da	da	da	da	1.6	1.7	6.1	5.0	1.1	1.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.37A – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	2,301	2,289	91	99	2,210	2,190	553	554	1,657	1,636
GENDER
Male	1,374	1,458	65	54	1,309	1,404	327	353	981	1,052
Female	927	831	25	46	901	786	225	202	676	584
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,865	1,995	85	79	1,780	1,916	430	425	1,350	1,490
AIAN	13	17	*	*	10	17	*	4	6	13
Asian	44	135	*	2	44	133	24	37	20	96
Black or African American	165	228	9	6	156	221	53	29	103	192
NHOPI	29	*	*	*	29	*	*	*	*	*
White	1,536	1,549	70	66	1,466	1,483	322	339	1,144	1,145
Two or More Races	79	67	3	5	76	62	15	17	61	45
Hispanic or Latino	435	294	6	20	430	274	123	129	307	145
EDUCATION LEVEL
< High School	da	da	da	da	108	127	25	34	83	93
High School Graduate	da	da	da	da	603	502	191	184	412	318
Some College/Associate’s Degree	da	da	da	da	844	819	225	204	619	614
College Graduate	da	da	da	da	654	743	111	132	543	610
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,016	1,197	270	289	746	908
Part-Time	da	da	da	da	332	361	129	127	203	234
Unemployed	da	da	da	da	267	181	56	65	211	115
Other¹	da	da	da	da	595	451	98	73	497	378
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.37B – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.8	0.8	0.3	0.4	0.9	0.9	1.7	1.6	0.8	0.7
GENDER
Male	1.0	1.1	0.5	0.4	1.1	1.1	2.0	2.0	0.9	1.0
Female	0.6	0.6	0.2	0.4	0.7	0.6	1.3	1.2	0.6	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.8	0.9	0.4	0.4	0.8	0.9	1.7	1.6	0.7	0.8
AIAN	0.7	1.1	*	*	0.6	1.3	*	1.7	0.4	1.3
Asian	0.3	0.8	*	0.1	0.3	0.9	1.2	1.6	0.2	0.7
Black or African American	0.5	0.7	0.2	0.2	0.5	0.7	1.2	0.6	0.4	0.7
NHOPI	2.4	*	*	*	2.8	*	*	*	*	*
White	0.9	0.9	0.5	0.5	0.9	0.9	1.8	1.9	0.8	0.8
Two or More Races	1.4	1.1	0.3	0.6	1.7	1.2	1.6	1.7	1.7	1.1
Hispanic or Latino	0.9	0.6	0.1	0.3	1.0	0.6	1.6	1.6	0.9	0.4
EDUCATION LEVEL
< High School	da	da	da	da	0.4	0.5	0.7	1.0	0.3	0.4
High School Graduate	da	da	da	da	0.9	0.7	1.8	1.6	0.7	0.6
Some College/Associate’s Degree	da	da	da	da	1.1	1.1	1.6	1.5	1.0	1.0
College Graduate	da	da	da	da	0.8	0.9	2.2	2.3	0.7	0.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.9	1.0	2.1	2.1	0.7	0.9
Part-Time	da	da	da	da	1.1	1.1	1.6	1.4	0.9	1.0
Unemployed	da	da	da	da	2.0	1.6	1.8	2.0	2.1	1.5
Other¹	da	da	da	da	0.6	0.5	1.0	0.8	0.6	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.38A – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	25,436	27,242	2,356^b	1,940	23,080^a	25,302	2,754	3,073	20,326^a	22,229
GENDER
Male	15,022^b	17,127	1,128^a	879	13,894^b	16,248	1,519	1,714	12,375^b	14,534
Female	10,414	10,115	1,228	1,061	9,186	9,054	1,235	1,359	7,951	7,695
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22,252	23,324	1,797^a	1,497	20,455	21,827	2,194	2,474	18,261	19,353
AIAN	150	141	*	23	122	119	*	16	85	102
Asian	684	712	100	103	584	609	124	151	459	458
Black or African American	1,248	1,500	270	257	978	1,243	150	210	828	1,033
NHOPI	*	*	*	*	*	*	*	*	*	*
White	19,301	20,154	1,311^a	1,055	17,990	19,099	1,760	1,989	16,230	17,110
Two or More Races	740	700	68	59	672	640	113	105	558	535
Hispanic or Latino	3,184^a	3,918	559	443	2,625^a	3,475	560	599	2,065^a	2,876
EDUCATION LEVEL
< High School	da	da	da	da	1,653	1,602	306	299	1,347	1,303
High School Graduate	da	da	da	da	4,962^a	6,087	814	892	4,148^a	5,195
Some College/Associate’s Degree	da	da	da	da	8,380	8,748	1,164	1,316	7,216	7,432
College Graduate	da	da	da	da	8,085	8,866	470	566	7,615	8,299
EMPLOYMENT STATUS
Full-Time	da	da	da	da	12,026^a	13,681	1,083^b	1,443	10,943	12,238
Part-Time	da	da	da	da	3,219	3,667	671	671	2,547	2,997
Unemployed	da	da	da	da	1,467^a	1,103	285	266	1,182^a	837
Other¹	da	da	da	da	6,369	6,851	715	694	5,654	6,157
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.38B – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	9.1	9.7	9.1^b	7.5	9.1^a	9.9	8.2	8.8	9.2	10.0
GENDER
Male	11.0^a	12.4	8.5^a	6.7	11.3^b	13.0	9.1	9.8	11.6^b	13.5
Female	7.3	7.0	9.6	8.4	7.0	6.9	7.4	7.9	7.0	6.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.7	10.1	9.3^a	7.8	9.7	10.3	8.6	9.3	9.9	10.4
AIAN	8.3	9.7	*	10.3	7.4	9.5	*	7.8	6.5	9.9
Asian	4.2	4.2	6.9	6.4	3.9	4.0	6.4	6.7	3.5	3.5
Black or African American	3.7	4.4	7.6	7.3	3.2	4.0	3.3	4.5	3.2	3.9
NHOPI	*	*	*	*	*	*	*	*	*	*
White	11.3	11.8	10.0^a	8.2	11.4	12.1	9.9	10.9	11.6	12.2
Two or More Races	13.5	11.9	7.6	7.1	14.7	12.7	12.2	10.5	15.3	13.2
Hispanic or Latino	6.4	7.7	8.4	6.7	6.1^a	7.9	7.2	7.3	5.8^a	8.0
EDUCATION LEVEL
< High School	da	da	da	da	5.8	6.6	8.3	8.3	5.5	6.3
High School Graduate	da	da	da	da	7.2^a	8.8	7.7	7.7	7.0^b	9.0
Some College/Associate’s Degree	da	da	da	da	10.9	11.2	8.2	9.5	11.4	11.6
College Graduate	da	da	da	da	10.2	10.4	9.3	9.9	10.3	10.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	10.5	11.6	8.5	10.3	10.8	11.7
Part-Time	da	da	da	da	10.6	11.2	8.2	7.6	11.5	12.5
Unemployed	da	da	da	da	11.2	10.0	9.0	8.3	11.9	10.7
Other¹	da	da	da	da	6.6	7.3	7.6	8.0	6.5	7.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.39A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	2,119	2,254	643	554	1,475	1,700	507	647	968	1,053
GENDER
Male	1,362	1,522	317	298	1,045	1,224	313	389	731	835
Female	757	732	326	256	431	476	194	258	237	218
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,759	1,859	500	458	1,259	1,401	419	463	839	938
AIAN	19	10	*	8	6	1	1	1	6	1
Asian	147	171	31	58	117	113	52	28	64	85
Black or African American	177	157	80	58	97	100	22	27	74	73
NHOPI	3	0	*	*	1	0	*	*	1	0
White	1,348	1,453	358	328	990	1,125	320	401	670	725
Two or More Races	64	68	17	7	48	62	24	8	24	54
Hispanic or Latino	360	395	143	96	217	299	88^a	184	129	115
EDUCATION LEVEL
< High School	da	da	da	da	75	110	31	64	44	46
High School Graduate	da	da	da	da	385	259	157	168	229	91
Some College/Associate’s Degree	da	da	da	da	458^a	720	212	290	246	431
College Graduate	da	da	da	da	557	612	107	126	450	485
EMPLOYMENT STATUS
Full-Time	da	da	da	da	687	874	180	269	507	604
Part-Time	da	da	da	da	206	343	105^a	197	100	146
Unemployed	da	da	da	da	152	95	84	45	68	50
Other¹	da	da	da	da	431	389	138	136	293	253
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.39B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.8	0.8	2.5	2.2	0.6	0.7	1.5	1.9	0.4	0.5
GENDER
Male	1.0	1.1	2.4	2.3	0.8	1.0	1.9	2.2	0.7	0.8
Female	0.5	0.5	2.6	2.0	0.3	0.4	1.2	1.5	0.2	0.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.8	0.8	2.6	2.4	0.6	0.7	1.6	1.7	0.5	0.5
AIAN	1.1	0.7	*	3.7	0.4	0.1	0.2	0.4	0.4	0.1
Asian	0.9	1.0	2.1	3.6	0.8	0.7	2.7	1.2	0.5	0.6
Black or African American	0.5	0.5	2.3	1.6	0.3	0.3	0.5	0.6	0.3	0.3
NHOPI	0.2	0.0	*	*	0.1	0.0	*	*	0.2	0.0
White	0.8	0.8	2.7	2.6	0.6	0.7	1.8	2.2	0.5	0.5
Two or More Races	1.2	1.2	1.9	0.8	1.0	1.2	2.6	0.8	0.7	1.3
Hispanic or Latino	0.7	0.8	2.2	1.4	0.5	0.7	1.1^a	2.2	0.4	0.3
EDUCATION LEVEL
< High School	da	da	da	da	0.3	0.5	0.8	1.8	0.2	0.2
High School Graduate	da	da	da	da	0.6	0.4	1.5	1.4	0.4	0.2
Some College/Associate’s Degree	da	da	da	da	0.6^a	0.9	1.5	2.1	0.4	0.7
College Graduate	da	da	da	da	0.7	0.7	2.1	2.2	0.6	0.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.6	0.7	1.4	1.9	0.5	0.6
Part-Time	da	da	da	da	0.7	1.0	1.3	2.2	0.5	0.6
Unemployed	da	da	da	da	1.2	0.9	2.7	1.4	0.7	0.6
Other¹	da	da	da	da	0.4	0.4	1.5	1.6	0.3	0.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.40A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	787	842	222	170	565	672	119	193	446	479
GENDER
Male	550	636	115	87	435	549	69	116	366	433
Female	237	206	107	83	130	123	50	78	80	46
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	629	715	171	152	458	563	89	162	370	401
AIAN	18	4	*	*	5	1	0	0	*	1
Asian	29	59	13	31	16	28	5	13	11	16
Black or African American	77	68	42	26	35	42	6	17	28	24
NHOPI	1	*	*	*	*	*	*	*	*	*
White	488	560	92	90	396	470	76	128	320	342
Two or More Races	16	24	9	2	7	22	1	4	6	18
Hispanic or Latino	158	127	52	18	107	109	30	31	77	78
EDUCATION LEVEL
< High School	da	da	da	da	23	50	2^a	27	21	23
High School Graduate	da	da	da	da	170	86	41	39	130	47
Some College/Associate’s Degree	da	da	da	da	128^a	308	51	98	78	210
College Graduate	da	da	da	da	244	228	26	29	218	199
EMPLOYMENT STATUS
Full-Time	da	da	da	da	264	348	31	63	233	285
Part-Time	da	da	da	da	61	120	32	76	29	45
Unemployed	da	da	da	da	67	44	25	26	42	19
Other¹	da	da	da	da	174	159	31	29	142	130
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.40B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.3	0.3	0.9	0.7	0.2	0.3	0.4	0.6	0.2	0.2
GENDER
Male	0.4	0.5	0.9	0.7	0.4	0.4	0.4	0.7	0.3	0.4
Female	0.2	0.1	0.8	0.7	0.1	0.1	0.3	0.4	0.1	0.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.3	0.3	0.9	0.8	0.2	0.3	0.3	0.6	0.2	0.2
AIAN	1.0	0.3	*	*	0.3	0.1	0.0	0.1	*	0.1
Asian	0.2	0.3	0.9	1.9	0.1	0.2	0.2	0.6	0.1	0.1
Black or African American	0.2	0.2	1.2	0.7	0.1	0.1	0.1	0.4	0.1	0.1
NHOPI	0.1	*	*	*	*	*	*	*	*	*
White	0.3	0.3	0.7	0.7	0.3	0.3	0.4	0.7	0.2	0.2
Two or More Races	0.3	0.4	1.0	0.2	0.2	0.4	0.1	0.4	0.2	0.4
Hispanic or Latino	0.3	0.2	0.8	0.3	0.2	0.2	0.4	0.4	0.2	0.2
EDUCATION LEVEL
< High School	da	da	da	da	0.1	0.2	0.0^a	0.8	0.1	0.1
High School Graduate	da	da	da	da	0.2	0.1	0.4	0.3	0.2	0.1
Some College/Associate’s Degree	da	da	da	da	0.2^a	0.4	0.4	0.7	0.1	0.3
College Graduate	da	da	da	da	0.3	0.3	0.5	0.5	0.3	0.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.2	0.3	0.2	0.4	0.2	0.3
Part-Time	da	da	da	da	0.2	0.4	0.4	0.9	0.1	0.2
Unemployed	da	da	da	da	0.5	0.4	0.8	0.8	0.4	0.2
Other¹	da	da	da	da	0.2	0.2	0.3	0.3	0.2	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.41A – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	17,461	16,588	52	37	17,409	16,551	606	682	16,803	15,869
GENDER
Male	9,934	10,274	24	19	9,910	10,256	332	361	9,578	9,895
Female	7,528^a	6,314	28	19	7,499^a	6,295	275	321	7,225^a	5,975
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15,259	14,278	38	28	15,221	14,250	511	579	14,710	13,671
AIAN	215	153	1	*	214	153	*	11	177	142
Asian	221	235	*	*	221	229	19	6	202	224
Black or African American	512	619	10	2	502	617	23	50	479	567
NHOPI	28	*	*	*	28	*	*	*	28	*
White	13,704	12,708	26	17	13,678	12,690	408	496	13,270	12,194
Two or More Races	579	434	1	4	578	430	24	15	554	415
Hispanic or Latino	2,202	2,310	14	9	2,188	2,301	95	103	2,093	2,199
EDUCATION LEVEL
< High School	da	da	da	da	1,867	1,952	173	178	1,693	1,774
High School Graduate	da	da	da	da	5,759	5,447	262	265	5,497	5,182
Some College/Associate’s Degree	da	da	da	da	6,725	6,272	143	207	6,582	6,065
College Graduate	da	da	da	da	3,059	2,881	28	32	3,031	2,849
EMPLOYMENT STATUS
Full-Time	da	da	da	da	7,045	7,381	264	322	6,781	7,058
Part-Time	da	da	da	da	2,252	2,243	76	105	2,176	2,138
Unemployed	da	da	da	da	1,487^a	1,036	100	78	1,387^a	958
Other¹	da	da	da	da	6,625	5,891	166	176	6,458	5,715
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.41B – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	6.2	5.9	0.2	0.1	6.9	6.5	1.8	2.0	7.6	7.2
GENDER
Male	7.3	7.4	0.2	0.1	8.0	8.2	2.0	2.1	9.0	9.2
Female	5.3^a	4.4	0.2	0.1	5.8^a	4.8	1.6	1.9	6.4^a	5.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6.6	6.2	0.2	0.1	7.2	6.7	2.0	2.2	7.9	7.4
AIAN	11.9	10.5	0.6	*	13.1	12.3	*	5.1	13.6	13.8
Asian	1.4	1.4	*	*	1.5	1.5	1.0	0.3	1.6	1.7
Black or African American	1.5	1.8	0.3	0.1	1.6	2.0	0.5	1.1	1.8	2.2
NHOPI	2.4	*	*	*	2.8	*	*	*	3.4	*
White	8.0	7.4	0.2	0.1	8.7	8.0	2.3	2.7	9.5	8.7
Two or More Races	10.6	7.4	0.1	0.4	12.7	8.5	2.6	1.5	15.2	10.3
Hispanic or Latino	4.4	4.5	0.2	0.1	5.1	5.2	1.2	1.2	5.9	6.1
EDUCATION LEVEL
< High School	da	da	da	da	6.6	8.0	4.7	5.0	6.9	8.5
High School Graduate	da	da	da	da	8.3	7.9	2.5	2.3	9.3	9.0
Some College/Associate’s Degree	da	da	da	da	8.7	8.1	1.0	1.5	10.4	9.5
College Graduate	da	da	da	da	3.9	3.4	0.6	0.6	4.1	3.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	6.2	6.2	2.1	2.3	6.7	6.8
Part-Time	da	da	da	da	7.4	6.8	0.9	1.2	9.8	8.9
Unemployed	da	da	da	da	11.4	9.4	3.2	2.4	14.0	12.3
Other¹	da	da	da	da	6.9	6.3	1.8	2.0	7.5	6.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.42A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	2,640	2,705	35	18	2,605	2,687	183	161	2,422	2,526
GENDER
Male	1,728	1,794	18	7	1,710	1,787	86	90	1,624	1,697
Female	912	911	17	11	895	900	97	71	798	829
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,268	2,280	22	13	2,246	2,267	145	136	2,101	2,131
AIAN	30	25	*	*	30	25	3	*	27	22
Asian	45	82	*	*	45	82	*	*	32	82
Black or African American	149	124	10	*	140	124	5	13	134	111
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1,946	1,902	12	12	1,934	1,890	117	117	1,817	1,773
Two or More Races	91	87	*	2	91	85	7	2	84	83
Hispanic or Latino	373	425	13	5	359	420	38	25	322	395
EDUCATION LEVEL
< High School	da	da	da	da	337	497	54	59	282	439
High School Graduate	da	da	da	da	1,110	800	82	52	1,027	748
Some College/Associate’s Degree	da	da	da	da	919	1,166	38	39	881	1,128
College Graduate	da	da	da	da	239	223	7	12	232	212
EMPLOYMENT STATUS
Full-Time	da	da	da	da	601	774	42	47	559	727
Part-Time	da	da	da	da	404	414	32	28	372	385
Unemployed	da	da	da	da	443	317	35	31	407	286
Other¹	da	da	da	da	1,157	1,183	73	55	1,084	1,128
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.42B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.9	1.0	0.1	0.1	1.0	1.0	0.5	0.5	1.1	1.1
GENDER
Male	1.3	1.3	0.1	0.1	1.4	1.4	0.5	0.5	1.5	1.6
Female	0.6	0.6	0.1	0.1	0.7	0.7	0.6	0.4	0.7	0.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.0	1.0	0.1	0.1	1.1	1.1	0.6	0.5	1.1	1.1
AIAN	1.7	1.7	*	*	1.9	2.0	1.0	*	2.1	2.1
Asian	0.3	0.5	*	*	0.3	0.5	*	*	0.2	0.6
Black or African American	0.4	0.4	0.3	*	0.5	0.4	0.1	0.3	0.5	0.4
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1.1	1.1	0.1	0.1	1.2	1.2	0.7	0.6	1.3	1.3
Two or More Races	1.7	1.5	*	0.2	2.0	1.7	0.7	0.2	2.3	2.1
Hispanic or Latino	0.7	0.8	0.2	0.1	0.8	0.9	0.5	0.3	0.9	1.1
EDUCATION LEVEL
< High School	da	da	da	da	1.2	2.0	1.5	1.6	1.1	2.1
High School Graduate	da	da	da	da	1.6	1.2	0.8	0.4	1.7	1.3
Some College/Associate’s Degree	da	da	da	da	1.2	1.5	0.3	0.3	1.4	1.8
College Graduate	da	da	da	da	0.3	0.3	0.1	0.2	0.3	0.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.5	0.7	0.3	0.3	0.5	0.7
Part-Time	da	da	da	da	1.3	1.3	0.4	0.3	1.7	1.6
Unemployed	da	da	da	da	3.4	2.9	1.1	1.0	4.1	3.7
Other¹	da	da	da	da	1.2	1.3	0.8	0.6	1.3	1.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.43A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1,630	1,685	16	3	1,614	1,682	103	54	1,511	1,628
GENDER
Male	1,034	1,045	3	1	1,031	1,044	60	19	971	1,024
Female	596	640	13	2	583	638	43	35	540	603
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,336	1,462	16	2	1,320	1,460	81	44	1,239	1,416
AIAN	16	9	*	*	16	9	1	*	16	5
Asian	30	59	*	*	30	59	*	*	30	59
Black or African American	59	55	10	*	49	55	5	3	44	51
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1,154	1,205	6	2	1,148	1,203	70	37	1,078	1,166
Two or More Races	70	75	*	*	70	75	5	0	65	75
Hispanic or Latino	295	223	1	1	294	222	22	10	272	212
EDUCATION LEVEL
< High School	da	da	da	da	232	328	30	21	202	307
High School Graduate	da	da	da	da	691	490	55	27	636	464
Some College/Associate’s Degree	da	da	da	da	569	757	14	6	554	750
College Graduate	da	da	da	da	123	107	4	*	119	107
EMPLOYMENT STATUS
Full-Time	da	da	da	da	384	480	17	15	368	465
Part-Time	da	da	da	da	180	199	6	12	175	187
Unemployed	da	da	da	da	265	219	22	9	243	210
Other¹	da	da	da	da	785	785	59	19	725	767
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.43B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.6	0.6	0.1	0.0	0.6	0.7	0.3	0.2	0.7	0.7
GENDER
Male	0.8	0.8	0.0	0.0	0.8	0.8	0.4	0.1	0.9	1.0
Female	0.4	0.4	0.1	0.0	0.4	0.5	0.3	0.2	0.5	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6	0.6	0.1	0.0	0.6	0.7	0.3	0.2	0.7	0.8
AIAN	0.9	0.6	*	*	1.0	0.7	0.3	*	1.2	0.5
Asian	0.2	0.3	*	*	0.2	0.4	*	*	0.2	0.4
Black or African American	0.2	0.2	0.3	*	0.2	0.2	0.1	0.1	0.2	0.2
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.7	0.7	0.0	0.0	0.7	0.8	0.4	0.2	0.8	0.8
Two or More Races	1.3	1.3	*	*	1.5	1.5	0.6	0.0	1.8	1.8
Hispanic or Latino	0.6	0.4	0.0	0.0	0.7	0.5	0.3	0.1	0.8	0.6
EDUCATION LEVEL
< High School	da	da	da	da	0.8	1.3	0.8	0.6	0.8	1.5
High School Graduate	da	da	da	da	1.0	0.7	0.5	0.2	1.1	0.8
Some College/Associate’s Degree	da	da	da	da	0.7	1.0	0.1	0.0	0.9	1.2
College Graduate	da	da	da	da	0.2	0.1	0.1	*	0.2	0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.3	0.4	0.1	0.1	0.4	0.4
Part-Time	da	da	da	da	0.6	0.6	0.1	0.1	0.8	0.8
Unemployed	da	da	da	da	2.0	2.0	0.7	0.3	2.5	2.7
Other¹	da	da	da	da	0.8	0.8	0.6	0.2	0.8	0.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.44A – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	72,811	73,833	3,492	3,191	69,319	70,642	6,265	6,489	63,054	64,153
GENDER
Male	32,906	33,489	1,548	1,516	31,358	31,973	2,758	2,784	28,600	29,189
Female	39,906	40,345	1,944^a	1,675	37,961	38,670	3,507	3,705	34,454	34,964
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	62,232	62,625	2,543	2,344	59,688	60,281	4,897	5,025	54,792	55,257
AIAN	605	493	*	34	563	459	*	*	461	420
Asian	2,404	2,863	172	112	2,232	2,751	239	326	1,993	2,424
Black or African American	9,952	9,765	495	556	9,457	9,209	961	923	8,496	8,286
NHOPI	*	317	*	*	*	*	*	*	*	*
White	47,455	47,316	1,699	1,524	45,756	45,793	3,370	3,480	42,386	42,312
Two or More Races	1,520	1,871	126	108	1,394	1,763	204	224	1,189	1,538
Hispanic or Latino	10,580	11,208	949	847	9,631	10,361	1,368	1,465	8,263	8,897
EDUCATION LEVEL
< High School	da	da	da	da	8,041	7,119	720	803	7,321	6,316
High School Graduate	da	da	da	da	19,615	20,090	1,974	2,097	17,641	17,993
Some College/Associate’s Degree	da	da	da	da	23,716	23,904	2,733	2,755	20,983	21,149
College Graduate	da	da	da	da	17,947^a	19,530	837	835	17,110	18,695
EMPLOYMENT STATUS
Full-Time	da	da	da	da	27,424	29,597	2,510	2,742	24,914	26,855
Part-Time	da	da	da	da	7,894	8,218	1,351	1,541	6,544	6,676
Unemployed	da	da	da	da	3,842^b	2,991	750	634	3,092^a	2,357
Other¹	da	da	da	da	30,159	29,837	1,654	1,572	28,505	28,265
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.44B – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	26.0	26.2	13.4	12.4	27.3	27.6	18.7	18.7	28.6	29.0
GENDER
Male	24.1	24.2	11.6	11.5	25.4	25.6	16.5	15.9	26.8	27.1
Female	27.9	28.1	15.3	13.3	29.1	29.5	21.0	21.4	30.3	30.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	27.0	27.1	13.1	12.3	28.3	28.4	19.1	18.9	29.6	29.8
AIAN	33.3	33.7	*	15.7	34.3	36.9	*	*	35.3	40.7
Asian	14.7	16.8	11.8	7.0	15.0	17.8	12.2	14.4	15.4	18.4
Black or African American	29.2	28.4	14.0	15.8	30.9	29.8	21.2	19.8	32.6	31.5
NHOPI	*	24.9	*	*	*	*	*	*	*	*
White	27.7	27.7	12.9	11.9	29.0	28.9	19.0	19.1	30.2	30.2
Two or More Races	27.8	31.8	14.0	13.0	30.5	34.9	22.1	22.4	32.7	38.0
Hispanic or Latino	21.3	22.0	14.3	12.7	22.3	23.4	17.5	17.7	23.4	24.7
EDUCATION LEVEL
< High School	da	da	da	da	28.5	29.2	19.5	22.4	29.8	30.4
High School Graduate	da	da	da	da	28.3	29.1	18.7	18.1	30.0	31.3
Some College/Associate’s Degree	da	da	da	da	30.7	30.7	19.3	19.8	33.3	33.1
College Graduate	da	da	da	da	22.7	23.0	16.5	14.7	23.2	23.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	24.0	25.0	19.7	19.5	24.5	25.7
Part-Time	da	da	da	da	26.0	25.0	16.5	17.5	29.5	27.8
Unemployed	da	da	da	da	29.4	27.1	23.7	19.7	31.2	30.2
Other¹	da	da	da	da	31.4	31.7	17.6	18.0	32.9	33.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.45A – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	8,885	8,457	550	406	8,335	8,051	1,050	1,099	7,286	6,953
GENDER
Male	4,460	4,302	215	150	4,246	4,152	498	562	3,748	3,590
Female	4,425	4,155	335	256	4,090	3,900	552	537	3,537	3,363
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,319	6,780	386	296	6,932	6,484	818	818	6,115	5,666
AIAN	95	75	*	1	82	73	*	*	49	54
Asian	359	236	20	4	339	231	57	50	282	181
Black or African American	1,173	1,315	48	84	1,126	1,231	119	157	1,006	1,074
NHOPI	*	23	*	*	*	23	*	*	*	20
White	5,264	4,874	271	176	4,993	4,697	539	536	4,454	4,162
Two or More Races	357	258	35	30	322	227	60	53	262	175
Hispanic or Latino	1,566	1,677	163	110	1,403	1,567	232	281	1,171	1,287
EDUCATION LEVEL
< High School	da	da	da	da	1,289	955	172	192	1,116	763
High School Graduate	da	da	da	da	2,582	2,317	395	407	2,187	1,910
Some College/Associate’s Degree	da	da	da	da	2,695	2,926	357	378	2,338	2,548
College Graduate	da	da	da	da	1,769	1,853	125	121	1,644	1,732
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3,156	3,539	414	493	2,742	3,046
Part-Time	da	da	da	da	1,026	960	202	193	824	767
Unemployed	da	da	da	da	908	657	159	157	749	501
Other¹	da	da	da	da	3,246	2,895	275	256	2,971	2,639
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.45B – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3.2	3.0	2.1	1.6	3.3	3.1	3.1	3.2	3.3	3.1
GENDER
Male	3.3	3.1	1.6	1.1	3.4	3.3	3.0	3.2	3.5	3.3
Female	3.1	2.9	2.6	2.0	3.1	3.0	3.3	3.1	3.1	3.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.2	2.9	2.0	1.6	3.3	3.1	3.2	3.1	3.3	3.1
AIAN	5.2	5.1	*	0.6	5.0	5.9	*	*	3.8	5.2
Asian	2.2	1.4	1.4	0.3	2.3	1.5	2.9	2.2	2.2	1.4
Black or African American	3.4	3.8	1.4	2.4	3.7	4.0	2.6	3.4	3.9	4.1
NHOPI	*	1.8	*	*	*	1.9	*	*	*	1.9
White	3.1	2.8	2.1	1.4	3.2	3.0	3.0	2.9	3.2	3.0
Two or More Races	6.5	4.4	3.9	3.6	7.0	4.5	6.5	5.3	7.2	4.3
Hispanic or Latino	3.1	3.3	2.5	1.6	3.3	3.5	3.0	3.4	3.3	3.6
EDUCATION LEVEL
< High School	da	da	da	da	4.6	3.9	4.7	5.4	4.5	3.7
High School Graduate	da	da	da	da	3.7	3.4	3.7	3.5	3.7	3.3
Some College/Associate’s Degree	da	da	da	da	3.5	3.8	2.5	2.7	3.7	4.0
College Graduate	da	da	da	da	2.2	2.2	2.5	2.1	2.2	2.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.8	3.0	3.3	3.5	2.7	2.9
Part-Time	da	da	da	da	3.4	2.9	2.5	2.2	3.7	3.2
Unemployed	da	da	da	da	6.9	6.0	5.0	4.9	7.6	6.4
Other¹	da	da	da	da	3.4	3.1	2.9	2.9	3.4	3.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.46A – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	2,427	2,439	133	116	2,294	2,323	232	214	2,061	2,109
GENDER
Male	1,260	1,312	40	47	1,220	1,264	101	103	1,118	1,162
Female	1,167	1,128	93	69	1,074	1,059	131	112	943	947
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,984	2,011	87	94	1,897	1,918	166	157	1,730	1,760
AIAN	23	23	1	0	23	22	*	*	*	11
Asian	57	82	1	3	56	79	*	8	42	71
Black or African American	355	425	14	35	340	390	27	27	314	363
NHOPI	*	19	*	*	*	19	*	*	*	16
White	1,434	1,370	47	44	1,387	1,325	99	98	1,288	1,227
Two or More Races	106	93	23	11	84	82	16	10	68	72
Hispanic or Latino	443	428	46	23	397	406	66	57	331	348
EDUCATION LEVEL
< High School	da	da	da	da	371	243	45	54	326	189
High School Graduate	da	da	da	da	864	803	99	99	764	704
Some College/Associate’s Degree	da	da	da	da	629	778	63	41	566	737
College Graduate	da	da	da	da	430	498	25	19	404	479
EMPLOYMENT STATUS
Full-Time	da	da	da	da	754^a	1,199	92	109	663^a	1,090
Part-Time	da	da	da	da	254^a	127	51	27	203^a	100
Unemployed	da	da	da	da	183	172	27	30	157	142
Other¹	da	da	da	da	1,103	825	63	48	1,040	777
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.46B – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.9	0.9	0.5	0.5	0.9	0.9	0.7	0.6	0.9	1.0
GENDER
Male	0.9	0.9	0.3	0.4	1.0	1.0	0.6	0.6	1.0	1.1
Female	0.8	0.8	0.7	0.5	0.8	0.8	0.8	0.6	0.8	0.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.9	0.9	0.4	0.5	0.9	0.9	0.6	0.6	0.9	0.9
AIAN	1.3	1.6	0.5	0.1	1.4	1.8	*	*	*	1.1
Asian	0.3	0.5	0.1	0.2	0.4	0.5	*	0.3	0.3	0.5
Black or African American	1.0	1.2	0.4	1.0	1.1	1.3	0.6	0.6	1.2	1.4
NHOPI	*	1.5	*	*	*	1.5	*	*	*	1.5
White	0.8	0.8	0.4	0.3	0.9	0.8	0.6	0.5	0.9	0.9
Two or More Races	1.9	1.6	2.5	1.3	1.8	1.6	1.7	1.0	1.9	1.8
Hispanic or Latino	0.9	0.8	0.7	0.3	0.9	0.9	0.8	0.7	0.9	1.0
EDUCATION LEVEL
< High School	da	da	da	da	1.3	1.0	1.2	1.5	1.3	0.9
High School Graduate	da	da	da	da	1.2	1.2	0.9	0.9	1.3	1.2
Some College/Associate’s Degree	da	da	da	da	0.8	1.0	0.4	0.3	0.9	1.2
College Graduate	da	da	da	da	0.5	0.6	0.5	0.3	0.5	0.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.7^a	1.0	0.7	0.8	0.7^a	1.0
Part-Time	da	da	da	da	0.8^a	0.4	0.6	0.3	0.9^a	0.4
Unemployed	da	da	da	da	1.4	1.6	0.8	0.9	1.6	1.8
Other¹	da	da	da	da	1.1	0.9	0.7	0.6	1.2	0.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.47A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	16,878^b	19,674	1,829	1,845	15,049^b	17,830	3,473	3,794	11,576^b	14,035
GENDER
Male	7,865^b	9,416	1,002	993	6,863^b	8,424	1,784	1,893	5,079^b	6,531
Female	9,013^a	10,258	827	852	8,186^a	9,406	1,689	1,901	6,497^a	7,505
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14,597^b	16,826	1,544	1,503	13,053^b	15,324	2,963	3,177	10,090^b	12,147
AIAN	119	83	*	16	103	67	*	8	22	59
Asian	616	438	63	31	553	407	166	117	388	289
Black or African American	1,263^a	1,662	145	176	1,118	1,486	237	274	881	1,213
NHOPI	36	53	*	*	25	53	*	*	15	*
White	11,999^b	13,993	1,231	1,197	10,767^b	12,797	2,369	2,624	8,399^b	10,172
Two or More Races	565	597	78	83	487	514	101	148	386	366
Hispanic or Latino	2,281	2,848	285	342	1,996	2,506	510	618	1,486	1,888
EDUCATION LEVEL
< High School	da	da	da	da	1,221	1,264	290	354	931	910
High School Graduate	da	da	da	da	3,139^a	3,844	796^a	1,018	2,343	2,826
Some College/Associate’s Degree	da	da	da	da	5,822	6,292	1,684	1,703	4,138	4,589
College Graduate	da	da	da	da	4,867^b	6,430	703	720	4,164^b	5,710
EMPLOYMENT STATUS
Full-Time	da	da	da	da	7,619^b	9,473	1,464	1,645	6,155^b	7,828
Part-Time	da	da	da	da	1,969^b	2,626	906	1,031	1,063^a	1,595
Unemployed	da	da	da	da	1,087	1,119	333	311	754	808
Other¹	da	da	da	da	4,374	4,611	770	808	3,604	3,804
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.47B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	6.0^b	7.0	7.0	7.2	5.9^b	7.0	10.4	10.9	5.3^b	6.3
GENDER
Male	5.8^b	6.8	7.5	7.5	5.6^b	6.7	10.7	10.8	4.8^b	6.1
Female	6.3^a	7.1	6.5	6.8	6.3^a	7.2	10.1	11.0	5.7^a	6.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6.3^b	7.3	8.0	7.9	6.2^b	7.2	11.6	12.0	5.5^b	6.5
AIAN	6.5	5.6	*	7.1	6.3	5.4	*	3.6	1.7^a	5.7
Asian	3.8	2.6	4.3	2.0	3.7	2.6	8.5	5.2	3.0	2.2
Black or African American	3.7^a	4.8	4.1	5.0	3.7	4.8	5.2	5.9	3.4	4.6
NHOPI	3.1	4.2	*	*	2.5	4.4	*	*	1.8	*
White	7.0^b	8.2	9.4	9.3	6.8^b	8.1	13.4	14.4	6.0^b	7.3
Two or More Races	10.3	10.1	8.6	9.9	10.7	10.2	10.9	14.8	10.6	9.0
Hispanic or Latino	4.6	5.6	4.3	5.1	4.6	5.7	6.5	7.5	4.2	5.2
EDUCATION LEVEL
< High School	da	da	da	da	4.3	5.2	7.9	9.9	3.8	4.4
High School Graduate	da	da	da	da	4.5^a	5.6	7.5	8.8	4.0	4.9
Some College/Associate’s Degree	da	da	da	da	7.5	8.1	11.9	12.3	6.6	7.2
College Graduate	da	da	da	da	6.2^b	7.6	13.8	12.6	5.6^b	7.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	6.7^b	8.0	11.5	11.7	6.1^b	7.5
Part-Time	da	da	da	da	6.5^a	8.0	11.1	11.7	4.8^a	6.6
Unemployed	da	da	da	da	8.3	10.2	10.5	9.7	7.6	10.3
Other¹	da	da	da	da	4.6	4.9	8.2	9.3	4.2	4.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.48A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3,910	4,298	302	226	3,608	4,072	1,359	1,278	2,249^a	2,794
GENDER
Male	2,061	2,437	150	136	1,911	2,301	714	597	1,197^a	1,704
Female	1,849	1,861	152	90	1,697	1,771	645	681	1,052	1,090
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,391	3,575	218	178	3,173	3,396	1,206	1,039	1,967	2,358
AIAN	27	14	1	2	26	12	*	6	6	6
Asian	109	120	4	*	106	109	64	54	42	55
Black or African American	216	324	19	24	197	300	78	98	119	203
NHOPI	13	*	*	*	13	*	*	*	4	*
White	2,847	2,951	172	125	2,676	2,826	983	827	1,693	1,999
Two or More Races	178	135	23	17	155	118	53	55	103	63
Hispanic or Latino	519	723	84	47	435^a	676	153	239	282	437
EDUCATION LEVEL
< High School	da	da	da	da	173	267	70	89	104	178
High School Graduate	da	da	da	da	773	866	267	284	506	582
Some College/Associate’s Degree	da	da	da	da	1,489	1,399	654	581	836	817
College Graduate	da	da	da	da	1,172^a	1,540	368	323	804^b	1,217
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,920^a	2,450	628	661	1,292^a	1,789
Part-Time	da	da	da	da	643	658	376	325	267	333
Unemployed	da	da	da	da	315	327	112	117	203	210
Other¹	da	da	da	da	729	636	243	175	487	462
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.48B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.4	1.5	1.2	0.9	1.4	1.6	4.1	3.7	1.0^a	1.3
GENDER
Male	1.5	1.8	1.1	1.0	1.5	1.8	4.3	3.4	1.1^a	1.6
Female	1.3	1.3	1.2	0.7	1.3	1.3	3.9	3.9	0.9	1.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.5	1.5	1.1	0.9	1.5	1.6	4.7	3.9	1.1	1.3
AIAN	1.5	0.9	0.5	0.7	1.6	1.0	*	2.7	0.5	0.6
Asian	0.7	0.7	0.2	*	0.7	0.7	3.3	2.4	0.3	0.4
Black or African American	0.6	0.9	0.5	0.7	0.6	1.0	1.7	2.1	0.5	0.8
NHOPI	1.1	*	*	*	1.3	*	*	*	0.5	*
White	1.7	1.7	1.3	1.0	1.7	1.8	5.5	4.5	1.2	1.4
Two or More Races	3.3	2.3	2.5	2.1	3.4	2.3	5.7	5.5	2.8	1.6
Hispanic or Latino	1.0	1.4	1.3	0.7	1.0	1.5	2.0	2.9	0.8	1.2
EDUCATION LEVEL
< High School	da	da	da	da	0.6^a	1.1	1.9	2.5	0.4	0.9
High School Graduate	da	da	da	da	1.1	1.3	2.5	2.4	0.9	1.0
Some College/Associate’s Degree	da	da	da	da	1.9	1.8	4.6	4.2	1.3	1.3
College Graduate	da	da	da	da	1.5	1.8	7.3	5.7	1.1^a	1.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.7^a	2.1	4.9	4.7	1.3^a	1.7
Part-Time	da	da	da	da	2.1	2.0	4.6	3.7	1.2	1.4
Unemployed	da	da	da	da	2.4	3.0	3.5	3.7	2.0	2.7
Other¹	da	da	da	da	0.8	0.7	2.6	2.0	0.6	0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.49A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1,124	1,348	80^a	33	1,044	1,315	307	376	737	939
GENDER
Male	649	727	27	18	622	710	169	199	453	511
Female	475	620	53^a	15	422	605	137	177	284	428
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	996	1,122	45	28	951	1,094	292	316	660	779
AIAN	1	1	*	0	1	1	0	*	1	1
Asian	39	12	*	*	39	12	31	12	7	*
Black or African American	47	72	1	4	45	68	12	33	34	35
NHOPI	*	*	*	*	*	*	*	*	*	*
White	834	966	42	23	793	944	227	264	565	680
Two or More Races	66	44	1	0	65	44	12	7	53	37
Hispanic or Latino	127	226	35	6	92^a	220	15	60	77	160
EDUCATION LEVEL
< High School	da	da	da	da	50	80	15	28	35	52
High School Graduate	da	da	da	da	192	267	34^a	87	159	180
Some College/Associate’s Degree	da	da	da	da	435	480	167	172	268	308
College Graduate	da	da	da	da	367	488	92	89	275	398
EMPLOYMENT STATUS
Full-Time	da	da	da	da	582	781	106^a	190	476	592
Part-Time	da	da	da	da	184	170	79	74	105	96
Unemployed	da	da	da	da	111	164	47	50	64	113
Other¹	da	da	da	da	166	199	75	62	92	137
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.49B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.4	0.5	0.3^a	0.1	0.4	0.5	0.9	1.1	0.3	0.4
GENDER
Male	0.5	0.5	0.2	0.1	0.5	0.6	1.0	1.1	0.4	0.5
Female	0.3	0.4	0.4^a	0.1	0.3	0.5	0.8	1.0	0.3	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.5	0.2	0.1	0.5	0.5	1.1	1.2	0.4	0.4
AIAN	0.1	0.1	*	0.1	0.0	0.1	0.0	*	0.0	0.1
Asian	0.2	0.1	*	*	0.3	0.1	1.6	0.5	0.1	*
Black or African American	0.1	0.2	0.0	0.1	0.1	0.2	0.3	0.7	0.1	0.1
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.5	0.6	0.3	0.2	0.5	0.6	1.3	1.4	0.4	0.5
Two or More Races	1.2	0.7	0.1	0.1	1.4	0.9	1.3	0.7	1.5	0.9
Hispanic or Latino	0.3	0.4	0.5	0.1	0.2	0.5	0.2	0.7	0.2	0.4
EDUCATION LEVEL
< High School	da	da	da	da	0.2	0.3	0.4	0.8	0.1	0.3
High School Graduate	da	da	da	da	0.3	0.4	0.3^a	0.8	0.3	0.3
Some College/Associate’s Degree	da	da	da	da	0.6	0.6	1.2	1.2	0.4	0.5
College Graduate	da	da	da	da	0.5	0.6	1.8	1.6	0.4	0.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.5	0.7	0.8	1.3	0.5	0.6
Part-Time	da	da	da	da	0.6	0.5	1.0	0.8	0.5	0.4
Unemployed	da	da	da	da	0.8	1.5	1.5	1.6	0.6	1.5
Other¹	da	da	da	da	0.2	0.2	0.8	0.7	0.1	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.50A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	40,986	41,314	1,052	1,085	39,934	40,229	2,941	3,227	36,994	37,002
GENDER
Male	15,959	15,606	473	452	15,486	15,154	1,186	1,332	14,301	13,822
Female	25,027	25,708	579	633	24,448	25,076	1,755	1,896	22,693	23,180
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	36,075	36,405	717	828	35,358	35,576	2,521	2,634	32,837	32,942
AIAN	167	146	1	3	166	143	22	*	145	131
Asian	1,026	1,117	30	27	996	1,090	90	63	905	1,027
Black or African American	3,418	3,344	86	129	3,332	3,215	271	253	3,062	2,962
NHOPI	*	*	*	*	*	*	*	*	*	*
White	30,465	30,599	560	624	29,905	29,975	2,039	2,187	27,866	27,788
Two or More Races	838	995	28	42	810	954	85	108	725	846
Hispanic or Latino	4,911	4,910	335	257	4,576	4,653	420^a	593	4,156	4,060
EDUCATION LEVEL
< High School	da	da	da	da	3,358	3,184	274	334	3,084	2,850
High School Graduate	da	da	da	da	11,088^a	9,662	912	983	10,176^a	8,679
Some College/Associate’s Degree	da	da	da	da	12,426^a	13,811	1,255	1,376	11,171	12,435
College Graduate	da	da	da	da	13,062	13,572	500	534	12,563	13,038
EMPLOYMENT STATUS
Full-Time	da	da	da	da	14,916	15,521	1,205	1,335	13,711	14,186
Part-Time	da	da	da	da	4,702	5,036	650^a	859	4,052	4,178
Unemployed	da	da	da	da	1,843	1,878	351	323	1,492	1,555
Other¹	da	da	da	da	18,474	17,794	735	711	17,739	17,083
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.50B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	14.6	14.7	4.0	4.2	15.7	15.7	8.8	9.3	16.8	16.7
GENDER
Male	11.7	11.3	3.6	3.4	12.5	12.1	7.1	7.6	13.4	12.8
Female	17.5	17.9	4.6	5.0	18.8	19.1	10.5	11.0	20.0	20.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.7	15.8	3.7	4.3	16.8	16.8	9.8	9.9	17.7	17.8
AIAN	9.2	10.0	0.5	1.6	10.1	11.5	6.5	*	11.1	12.6
Asian	6.3	6.6	2.1	1.7	6.7	7.1	4.6	2.8	7.0	7.8
Black or African American	10.0	9.7	2.4	3.7	10.9	10.4	6.0	5.4	11.7	11.3
NHOPI	*	*	*	*	*	*	*	*	*	*
White	17.8	17.9	4.3	4.9	18.9	18.9	11.5	12.0	19.9	19.9
Two or More Races	15.3	16.9	3.1	5.0	17.7	18.9	9.2	10.7	19.9	20.9
Hispanic or Latino	9.9	9.6	5.0	3.9	10.6	10.5	5.4	7.2	11.8	11.3
EDUCATION LEVEL
< High School	da	da	da	da	11.9	13.1	7.4	9.3	12.6	13.7
High School Graduate	da	da	da	da	16.0^a	14.0	8.6	8.5	17.3^a	15.1
Some College/Associate’s Degree	da	da	da	da	16.1^a	17.8	8.9	9.9	17.7	19.5
College Graduate	da	da	da	da	16.5	16.0	9.8	9.4	17.0	16.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	13.0	13.1	9.5	9.5	13.5	13.6
Part-Time	da	da	da	da	15.5	15.3	8.0	9.8	18.2	17.4
Unemployed	da	da	da	da	14.1	17.0	11.1	10.1	15.0^a	19.9
Other¹	da	da	da	da	19.2	18.9	7.8	8.2	20.5	20.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.51A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	4,813	4,848	248^a	137	4,565	4,711	916	842	3,649	3,869
GENDER
Male	2,285	2,096	117	51	2,168	2,044	464	394	1,703	1,651
Female	2,528	2,752	131	85	2,397	2,667	451	449	1,946	2,218
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,137	4,088	132	94	4,005	3,994	785	695	3,220	3,299
AIAN	47	21	*	0	47	21	5	3	42	18
Asian	74	114	*	1	74	112	17	17	57	95
Black or African American	420	371	12	14	408	358	72	74	336	283
NHOPI	*	*	*	*	*	*	*	*	*	*
White	3,467	3,406	111	72	3,356	3,334	653	584	2,703	2,750
Two or More Races	120	149	8	*	113	142	31	16	82	126
Hispanic or Latino	676	760	116	43	560	717	130	147	429	569
EDUCATION LEVEL
< High School	da	da	da	da	292	475	114	91	178^a	384
High School Graduate	da	da	da	da	1,362	1,216	343	251	1,019	965
Some College/Associate’s Degree	da	da	da	da	1,468	1,660	345	364	1,123	1,296
College Graduate	da	da	da	da	1,443	1,360	113	136	1,329	1,224
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,082	2,030	396	362	1,686	1,668
Part-Time	da	da	da	da	611	715	203	207	408	508
Unemployed	da	da	da	da	371	409	106	110	266	300
Other¹	da	da	da	da	1,501	1,556	211	163	1,289	1,393
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.51B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.7	1.7	1.0	0.5	1.8	1.8	2.7	2.4	1.7	1.7
GENDER
Male	1.7	1.5	0.9	0.4	1.8	1.6	2.8	2.3	1.6	1.5
Female	1.8	1.9	1.0	0.7	1.8	2.0	2.7	2.6	1.7	1.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.8	1.8	0.7	0.5	1.9	1.9	3.1	2.6	1.7	1.8
AIAN	2.6	1.5	*	0.1	2.8	1.7	1.5	1.4	3.2	1.8
Asian	0.5	0.7	*	0.1	0.5	0.7	0.9	0.7	0.4	0.7
Black or African American	1.2	1.1	0.3	0.4	1.3	1.2	1.6	1.6	1.3	1.1
NHOPI	*	*	*	*	*	*	*	*	*	*
White	2.0	2.0	0.8	0.6	2.1	2.1	3.7	3.2	1.9	2.0
Two or More Races	2.2	2.5	0.8	*	2.5	2.8	3.4	1.6	2.2	3.1
Hispanic or Latino	1.4	1.5	1.8	0.6	1.3	1.6	1.7	1.8	1.2	1.6
EDUCATION LEVEL
< High School	da	da	da	da	1.0^a	1.9	3.1	2.5	0.7^b	1.8
High School Graduate	da	da	da	da	2.0	1.8	3.3^a	2.2	1.7	1.7
Some College/Associate’s Degree	da	da	da	da	1.9	2.1	2.4	2.6	1.8	2.0
College Graduate	da	da	da	da	1.8	1.6	2.2	2.4	1.8	1.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.8	1.7	3.1	2.6	1.7	1.6
Part-Time	da	da	da	da	2.0	2.2	2.5	2.4	1.8	2.1
Unemployed	da	da	da	da	2.8	3.7	3.3	3.4	2.7	3.8
Other¹	da	da	da	da	1.6	1.7	2.2	1.9	1.5	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.52A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1,341	1,529	52	37	1,289	1,492	156	181	1,133	1,312
GENDER
Male	621	710	9	14	612	696	86	78	526	617
Female	720	819	44	22	677	797	70	102	606	694
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,222	1,329	38	34	1,184	1,295	138	155	1,046	1,140
AIAN	9	3	*	*	9	3	*	*	6	3
Asian	41	24	*	*	41	24	1	*	41	24
Black or African American	102	91	4	11	97	80	23	17	75	63
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1,037	1,133	32	23	1,004	1,110	98	133	907	977
Two or More Races	26	53	1	0	25	53	6	5	19	48
Hispanic or Latino	120	200	15	3	105	197	18	25	86	172
EDUCATION LEVEL
< High School	da	da	da	da	87	140	30	17	57	123
High School Graduate	da	da	da	da	391	425	58	53	334	372
Some College/Associate’s Degree	da	da	da	da	312^a	527	40	88	272	440
College Graduate	da	da	da	da	498	400	29	23	469	377
EMPLOYMENT STATUS
Full-Time	da	da	da	da	393^a	629	57	82	335^a	548
Part-Time	da	da	da	da	165	251	38	43	127	208
Unemployed	da	da	da	da	98	130	28	10	70	120
Other¹	da	da	da	da	633	482	33	46	601	436
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.52B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.5	0.5	0.2	0.1	0.5	0.6	0.5	0.5	0.5	0.6
GENDER
Male	0.5	0.5	0.1	0.1	0.5	0.6	0.5	0.4	0.5	0.6
Female	0.5	0.6	0.3	0.2	0.5	0.6	0.4	0.6	0.5	0.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5	0.6	0.2	0.2	0.6	0.6	0.5	0.6	0.6	0.6
AIAN	0.5	0.2	*	*	0.5	0.2	*	*	0.4	0.2
Asian	0.3	0.1	*	*	0.3	0.2	0.0	*	0.3	0.2
Black or African American	0.3	0.3	0.1	0.3	0.3	0.3	0.5	0.4	0.3	0.2
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.6	0.7	0.2	0.2	0.6	0.7	0.6	0.7	0.6	0.7
Two or More Races	0.5	0.9	0.1	0.0	0.5	1.0	0.7	0.5	0.5	1.2
Hispanic or Latino	0.2	0.4	0.2	0.0	0.2	0.4	0.2	0.3	0.2	0.5
EDUCATION LEVEL
< High School	da	da	da	da	0.3	0.6	0.8	0.5	0.2	0.6
High School Graduate	da	da	da	da	0.6	0.6	0.5	0.5	0.6	0.6
Some College/Associate’s Degree	da	da	da	da	0.4^a	0.7	0.3	0.6	0.4	0.7
College Graduate	da	da	da	da	0.6	0.5	0.6	0.4	0.6	0.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.3^a	0.5	0.5	0.6	0.3^a	0.5
Part-Time	da	da	da	da	0.5	0.8	0.5	0.5	0.6	0.9
Unemployed	da	da	da	da	0.7	1.2	0.9	0.3	0.7	1.5
Other¹	da	da	da	da	0.7	0.5	0.3	0.5	0.7	0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.53A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	32,794	32,783	782	717	32,012	32,066	2,467	2,592	29,545	29,474
GENDER
Male	12,496	11,927	323	295	12,173	11,632	966	1,012	11,207	10,620
Female	20,299	20,856	460	422	19,839	20,433	1,501	1,580	18,338	18,853
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	28,830	28,883	515	533	28,315	28,350	2,120	2,135	26,195	26,216
AIAN	155	88	0	1	155	87	21	4	134	83
Asian	623	840	11	20	612	821	65	41	547	779
Black or African American	2,529	2,414	55	87	2,475	2,328	213	203	2,262	2,125
NHOPI	61	*	*	*	49	*	*	*	35	*
White	24,735	24,549	412	393	24,323	24,155	1,736	1,779	22,587	22,376
Two or More Races	727	835	25	31	702	803	73	95	629	708
Hispanic or Latino	3,964	3,900	267	184	3,697	3,716	347	458	3,350	3,258
EDUCATION LEVEL
< High School	da	da	da	da	2,733	2,533	226	251	2,507	2,283
High School Graduate	da	da	da	da	8,986^a	7,848	786	800	8,200	7,048
Some College/Associate’s Degree	da	da	da	da	10,246	11,059	1,034	1,095	9,212	9,964
College Graduate	da	da	da	da	10,046	10,626	421	447	9,625	10,179
EMPLOYMENT STATUS
Full-Time	da	da	da	da	11,723	12,189	1,060	1,073	10,663	11,116
Part-Time	da	da	da	da	3,986	4,008	550	697	3,436	3,311
Unemployed	da	da	da	da	1,450	1,448	274	282	1,176	1,166
Other¹	da	da	da	da	14,853	14,420	583	540	14,270	13,880
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.53B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	11.7	11.6	3.0	2.8	12.6	12.5	7.4	7.5	13.4	13.3
GENDER
Male	9.1	8.6	2.4	2.2	9.9	9.3	5.8	5.8	10.5	9.9
Female	14.2	14.5	3.6	3.4	15.2	15.6	9.0	9.1	16.1	16.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	12.5	12.5	2.7	2.8	13.4	13.4	8.3	8.0	14.2	14.1
AIAN	8.5	6.0	0.0	0.4	9.4	7.0	6.2	1.9	10.2	8.0
Asian	3.8	4.9	0.7	1.2	4.1	5.3	3.3	1.8	4.2	5.9
Black or African American	7.4	7.0	1.5	2.5	8.1	7.5	4.7	4.3	8.7	8.1
NHOPI	5.2	*	*	*	4.9	*	*	*	4.3	*
White	14.5	14.4	3.1	3.1	15.4	15.3	9.8	9.7	16.1	16.0
Two or More Races	13.3	14.2	2.8	3.8	15.4	15.9	7.8	9.5	17.3	17.5
Hispanic or Latino	8.0	7.7	4.0	2.8	8.6	8.4	4.4	5.5	9.5	9.1
EDUCATION LEVEL
< High School	da	da	da	da	9.7	10.4	6.1	7.0	10.2	11.0
High School Graduate	da	da	da	da	12.9	11.4	7.5	6.9	13.9	12.3
Some College/Associate’s Degree	da	da	da	da	13.3	14.2	7.3	7.9	14.6	15.6
College Graduate	da	da	da	da	12.7	12.5	8.3	7.8	13.0	12.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	10.3	10.3	8.3	7.6	10.5	10.7
Part-Time	da	da	da	da	13.1	12.2	6.7	7.9	15.5	13.8
Unemployed	da	da	da	da	11.1	13.1	8.6	8.8	11.9	14.9
Other¹	da	da	da	da	15.5	15.3	6.2	6.2	16.5	16.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.54A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	4,284	4,153	220	115	4,063	4,038	855	779	3,209	3,259
GENDER
Male	2,056	1,796	105^a	34	1,951	1,762	440	376	1,511	1,386
Female	2,228	2,358	115	82	2,113	2,276	415	404	1,698	1,872
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,680	3,514	110	78	3,571	3,436	739	638	2,831	2,798
AIAN	47	16	*	0	47	16	5	*	42	13
Asian	59	112	*	*	59	112	16	17	42	95
Black or African American	362	348	8	12	354	336	72	70	282	265
NHOPI	*	*	*	*	*	*	*	*	*	*
White	3,092	2,889	94	59	2,998	2,830	609	531	2,388	2,298
Two or More Races	113	121	7	*	106	115	29	16	77	99
Hispanic or Latino	603	640	111	37	493	602	115	141	377	461
EDUCATION LEVEL
< High School	da	da	da	da	258	392	114	77	144^a	314
High School Graduate	da	da	da	da	1,278	1,065	322	236	956	830
Some College/Associate’s Degree	da	da	da	da	1,325	1,384	312	341	1,012	1,043
College Graduate	da	da	da	da	1,203	1,197	107	126	1,096	1,071
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,871	1,771	373	338	1,498	1,433
Part-Time	da	da	da	da	575	636	185	191	391	445
Unemployed	da	da	da	da	345	363	95	104	250	258
Other¹	da	da	da	da	1,272	1,268	202	146	1,070	1,122
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.54B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.5	1.5	0.8	0.4	1.6	1.6	2.6	2.2	1.5	1.5
GENDER
Male	1.5	1.3	0.8^a	0.3	1.6	1.4	2.6	2.1	1.4	1.3
Female	1.6	1.6	0.9	0.6	1.6	1.7	2.5	2.3	1.5	1.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.6	1.5	0.6	0.4	1.7	1.6	2.9	2.4	1.5	1.5
AIAN	2.6	1.1	*	0.1	2.8	1.3	1.5	*	3.2	1.3
Asian	0.4	0.7	*	*	0.4	0.7	0.8	0.7	0.3	0.7
Black or African American	1.1	1.0	0.2	0.4	1.2	1.1	1.6	1.5	1.1	1.0
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1.8	1.7	0.7	0.5	1.9	1.8	3.4	2.9	1.7	1.6
Two or More Races	2.1	2.1	0.7	*	2.3	2.3	3.2	1.6	2.1	2.5
Hispanic or Latino	1.2	1.3	1.7	0.6	1.1	1.4	1.5	1.7	1.1	1.3
EDUCATION LEVEL
< High School	da	da	da	da	0.9^a	1.6	3.1	2.1	0.6^b	1.5
High School Graduate	da	da	da	da	1.8	1.5	3.1	2.0	1.6	1.4
Some College/Associate’s Degree	da	da	da	da	1.7	1.8	2.2	2.5	1.6	1.6
College Graduate	da	da	da	da	1.5	1.4	2.1	2.2	1.5	1.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.6	1.5	2.9	2.4	1.5	1.4
Part-Time	da	da	da	da	1.9	1.9	2.3	2.2	1.8	1.9
Unemployed	da	da	da	da	2.6	3.3	3.0	3.3	2.5	3.3
Other¹	da	da	da	da	1.3	1.3	2.1	1.7	1.2	1.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.55A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1,145	1,304	36	34	1,109	1,270	134	158	975	1,112
GENDER
Male	593	630	3	14	590	617	82	75	507	542
Female	552	674	32	21	519	653	52	83	468	570
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,070	1,160	25	32	1,045	1,129	118	133	928	996
AIAN	9	3	*	*	9	3	*	*	6	3
Asian	39	24	*	*	39	24	*	*	39	24
Black or African American	95	76	4	10	91	65	22	17	69	48
NHOPI	*	*	*	*	*	*	*	*	*	*
White	899	990	20	22	879	968	83	110	796	858
Two or More Races	20	43	1	0	19	43	1	5	18	38
Hispanic or Latino	75	144	11	3	64	141	17	25	47	116
EDUCATION LEVEL
< High School	da	da	da	da	80	101	26	14	54	88
High School Graduate	da	da	da	da	337	378	56	50	281	327
Some College/Associate’s Degree	da	da	da	da	285	422	24^a	71	261	351
College Graduate	da	da	da	da	407	369	28	23	379	346
EMPLOYMENT STATUS
Full-Time	da	da	da	da	338^a	544	56	71	282^a	473
Part-Time	da	da	da	da	151	206	26	35	126	171
Unemployed	da	da	da	da	82	130	27	10	55	120
Other¹	da	da	da	da	538	390	26	41	512	348
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.55B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.4	0.5	0.1	0.1	0.4	0.5	0.4	0.5	0.4	0.5
GENDER
Male	0.4	0.5	0.0	0.1	0.5	0.5	0.5	0.4	0.5	0.5
Female	0.4	0.5	0.3	0.2	0.4	0.5	0.3	0.5	0.4	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5	0.5	0.1	0.2	0.5	0.5	0.5	0.5	0.5	0.5
AIAN	0.5	0.2	*	*	0.5	0.2	*	*	0.4	0.2
Asian	0.2	0.1	*	*	0.3	0.2	*	*	0.3	0.2
Black or African American	0.3	0.2	0.1	0.3	0.3	0.2	0.5	0.4	0.3	0.2
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.5	0.6	0.2	0.2	0.6	0.6	0.5	0.6	0.6	0.6
Two or More Races	0.4	0.7	0.1	0.0	0.4	0.8	0.2	0.5	0.5	0.9
Hispanic or Latino	0.2	0.3	0.2	0.0	0.1	0.3	0.2	0.3	0.1	0.3
EDUCATION LEVEL
< High School	da	da	da	da	0.3	0.4	0.7	0.4	0.2	0.4
High School Graduate	da	da	da	da	0.5	0.5	0.5	0.4	0.5	0.6
Some College/Associate’s Degree	da	da	da	da	0.4	0.5	0.2^a	0.5	0.4	0.5
College Graduate	da	da	da	da	0.5	0.4	0.6	0.4	0.5	0.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.3^a	0.5	0.4	0.5	0.3	0.5
Part-Time	da	da	da	da	0.5	0.6	0.3	0.4	0.6	0.7
Unemployed	da	da	da	da	0.6	1.2	0.8	0.3	0.6	1.5
Other¹	da	da	da	da	0.6	0.4	0.3	0.5	0.6	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.56A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	14,602	15,399	410	521	14,192	14,878	815^a	1,082	13,376	13,797
GENDER
Male	5,807	5,982	191	244	5,616	5,738	335	451	5,281	5,287
Female	8,795	9,417	219	277	8,576	9,140	480	631	8,096	8,509
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	12,983	13,415	305	387	12,679	13,027	717	897	11,962	12,131
AIAN	58	74	1	3	57	72	*	*	49	63
Asian	538	402	19	9	518	393	40	25	478	368
Black or African American	1,369	1,465	47	59	1,322	1,406	103	92	1,219	1,313
NHOPI	*	*	*	*	*	*	*	*	*	*
White	10,657	11,054	228	292	10,429	10,762	530^a	746	9,899	10,015
Two or More Races	244	341	9	22	235	320	29	25	206	294
Hispanic or Latino	1,618	1,984	106	133	1,513	1,851	98^a	185	1,414	1,666
EDUCATION LEVEL
< High School	da	da	da	da	1,188	1,280	78	127	1,109	1,153
High School Graduate	da	da	da	da	3,699	3,515	219	320	3,480	3,195
Some College/Associate’s Degree	da	da	da	da	4,308	5,078	398	499	3,910	4,579
College Graduate	da	da	da	da	4,997	5,005	120	136	4,877	4,869
EMPLOYMENT STATUS
Full-Time	da	da	da	da	5,194	5,556	283^a	446	4,911	5,111
Part-Time	da	da	da	da	1,495	1,905	197	279	1,298	1,625
Unemployed	da	da	da	da	682	695	109	96	573	599
Other¹	da	da	da	da	6,820	6,722	226	261	6,594	6,461
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.56B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	5.2	5.5	1.6	2.0	5.6	5.8	2.4^a	3.1	6.1	6.2
GENDER
Male	4.2	4.3	1.4	1.9	4.5	4.6	2.0	2.6	4.9	4.9
Female	6.1	6.5	1.7	2.2	6.6	7.0	2.9	3.6	7.1	7.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	5.6	5.8	1.6	2.0	6.0	6.1	2.8	3.4	6.5	6.5
AIAN	3.2	5.1	0.4	1.2	3.5	5.8	*	*	3.8	6.1
Asian	3.3	2.4	1.3	0.6	3.5	2.5	2.0	1.1	3.7	2.8
Black or African American	4.0	4.3	1.3	1.7	4.3	4.5	2.3	2.0	4.7	5.0
NHOPI	*	*	*	*	*	*	*	*	*	*
White	6.2	6.5	1.7	2.3	6.6	6.8	3.0^a	4.1	7.1	7.2
Two or More Races	4.5	5.8	1.0	2.6	5.1	6.3	3.2	2.5	5.6	7.3
Hispanic or Latino	3.3	3.9	1.6	2.0	3.5	4.2	1.3	2.2	4.0	4.6
EDUCATION LEVEL
< High School	da	da	da	da	4.2	5.3	2.1	3.5	4.5	5.6
High School Graduate	da	da	da	da	5.3	5.1	2.1	2.8	5.9	5.6
Some College/Associate’s Degree	da	da	da	da	5.6	6.5	2.8	3.6	6.2	7.2
College Graduate	da	da	da	da	6.3	5.9	2.4	2.4	6.6	6.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4.5	4.7	2.2	3.2	4.8	4.9
Part-Time	da	da	da	da	4.9	5.8	2.4	3.2	5.8	6.8
Unemployed	da	da	da	da	5.2	6.3	3.4	3.0	5.8	7.7
Other¹	da	da	da	da	7.1	7.1	2.4	3.0	7.6	7.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.57A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	878	959	43	27	834	931	144	93	690	839
GENDER
Male	412	364	24	19	388	345	55	27	333	318
Female	466	595	19	9	447	586	89	66	358	520
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	763	744	28	21	735	722	126	86	609	636
AIAN	1	7	*	*	1	7	0	0	1	6
Asian	24	2	*	1	24	*	1	*	24	*
Black or African American	87	51	5	2	82	49	3	6	79	42
NHOPI	*	*	*	*	*	*	*	*	*	*
White	611	656	23	18	588	638	100	78	488	559
Two or More Races	33	29	1	0	32	29	14	1	18	28
Hispanic or Latino	114	215	15	6	99	209	18	7	81	202
EDUCATION LEVEL
< High School	da	da	da	da	80	121	22	17	58	104
High School Graduate	da	da	da	da	202	203	39	18	163	185
Some College/Associate’s Degree	da	da	da	da	234	376	66	44	168^a	332
College Graduate	da	da	da	da	318	232	18	13	301	218
EMPLOYMENT STATUS
Full-Time	da	da	da	da	354	346	50	38	304	308
Part-Time	da	da	da	da	82	110	47	23	35	88
Unemployed	da	da	da	da	78	61	16	10	61	51
Other¹	da	da	da	da	321	414	31	22	290	392
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.57B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.3	0.3	0.2	0.1	0.3	0.4	0.4	0.3	0.3	0.4
GENDER
Male	0.3	0.3	0.2	0.1	0.3	0.3	0.3	0.2	0.3	0.3
Female	0.3	0.4	0.1	0.1	0.3	0.4	0.5	0.4	0.3	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.3	0.3	0.1	0.1	0.3	0.3	0.5	0.3	0.3	0.3
AIAN	0.1	0.4	*	*	0.1	0.5	0.0	0.2	0.1	0.6
Asian	0.1	0.0	*	0.1	0.2	*	0.0	*	0.2	*
Black or African American	0.3	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.3	0.2
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.4	0.4	0.2	0.1	0.4	0.4	0.6	0.4	0.3	0.4
Two or More Races	0.6	0.5	0.1	0.0	0.7	0.6	1.6	0.1	0.5	0.7
Hispanic or Latino	0.2	0.4	0.2	0.1	0.2	0.5	0.2	0.1	0.2	0.6
EDUCATION LEVEL
< High School	da	da	da	da	0.3	0.5	0.6	0.5	0.2	0.5
High School Graduate	da	da	da	da	0.3	0.3	0.4	0.2	0.3	0.3
Some College/Associate’s Degree	da	da	da	da	0.3	0.5	0.5	0.3	0.3	0.5
College Graduate	da	da	da	da	0.4	0.3	0.3	0.2	0.4	0.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.3	0.3	0.4	0.3	0.3	0.3
Part-Time	da	da	da	da	0.3	0.3	0.6	0.3	0.2	0.4
Unemployed	da	da	da	da	0.6	0.6	0.5	0.3	0.6	0.7
Other¹	da	da	da	da	0.3	0.4	0.3	0.3	0.3	0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.58A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	225	278	20	7	205	271	32	32	173	239
GENDER
Male	40	87	6	1	34	86	4	5	30	81
Female	185	191	14	6	171	185	28	28	143	157
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	180	220	16	7	163	213	29	32	134	181
AIAN	0	*	*	*	0	*	*	*	0	*
Asian	2	*	*	*	2	*	1	*	1	*
Black or African American	7	17	1	1	6	15	0	*	6	15
NHOPI	*	*	*	*	*	*	*	*	*	*
White	156	194	16	6	140	188	16	32	124	156
Two or More Races	7	10	*	*	7	10	5	*	2	10
Hispanic or Latino	46	58	4	*	42	58	2	*	39	58
EDUCATION LEVEL
< High School	da	da	da	da	15	41	11	4	3	37
High School Graduate	da	da	da	da	65	54	3	3	62	51
Some College/Associate’s Degree	da	da	da	da	31^a	121	17	25	14^a	96
College Graduate	da	da	da	da	94	55	1	*	94	55
EMPLOYMENT STATUS
Full-Time	da	da	da	da	60	107	3	19	57	87
Part-Time	da	da	da	da	22	59	20	8	2^a	51
Unemployed	da	da	da	da	25	*	2	*	23	*
Other¹	da	da	da	da	99	105	8	5	91	100
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.58B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1
GENDER
Male	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
Female	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1
AIAN	0.0	*	*	*	0.0	*	*	*	0.0	*
Asian	0.0	*	*	*	0.0	*	0.0	*	0.0	*
Black or African American	0.0	0.0	0.0	0.0	0.0	0.0	0.0	*	0.0	0.1
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1
Two or More Races	0.1	0.2	*	*	0.2	0.2	0.5	*	0.1	0.3
Hispanic or Latino	0.1	0.1	0.1	*	0.1	0.1	0.0	*	0.1	0.2
EDUCATION LEVEL
< High School	da	da	da	da	0.1	0.2	0.3	0.1	0.0	0.2
High School Graduate	da	da	da	da	0.1	0.1	0.0	0.0	0.1	0.1
Some College/Associate’s Degree	da	da	da	da	0.0^a	0.2	0.1	0.2	0.0^a	0.1
College Graduate	da	da	da	da	0.1	0.1	0.0	*	0.1	0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.1	0.1	0.0	0.1	0.1	0.1
Part-Time	da	da	da	da	0.1	0.2	0.2	0.1	0.0^a	0.2
Unemployed	da	da	da	da	0.2	*	0.0	*	0.2	*
Other¹	da	da	da	da	0.1	0.1	0.1	0.1	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.59A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	25,735	25,703	492	480	25,244	25,223	2,162	2,178	23,082	23,045
GENDER
Male	10,127	9,309	207	201	9,920	9,108	865	864	9,055	8,243
Female	15,608	16,395	284	279	15,324	16,116	1,297	1,314	14,027	14,802
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22,489	22,792	316	368	22,172	22,423	1,865	1,803	20,308	20,620
AIAN	106	62	0	2	106	60	14	4	92	56
Asian	425	686	11	18	415	669	63	37	351	632
Black or African American	1,869	1,627	40	57	1,829	1,570	194	169	1,635	1,401
NHOPI	*	*	*	*	*	*	*	*	*	*
White	19,415	19,574	244	269	19,171	19,304	1,518	1,501	17,653	17,803
Two or More Races	538	698	20	22	518	676	61	82	457	594
Hispanic or Latino	3,247	2,912	175	112	3,072	2,800	298	375	2,774	2,425
EDUCATION LEVEL
< High School	da	da	da	da	2,238	2,117	207	214	2,032	1,904
High School Graduate	da	da	da	da	7,171	6,212	662	688	6,509	5,524
Some College/Associate’s Degree	da	da	da	da	7,802	8,614	946	908	6,857	7,707
College Graduate	da	da	da	da	8,032	8,280	348	369	7,684	7,911
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9,583	9,487	931	887	8,652	8,600
Part-Time	da	da	da	da	2,970	3,308	471	570	2,500	2,738
Unemployed	da	da	da	da	1,281	1,327	237	261	1,044	1,066
Other¹	da	da	da	da	11,410	11,101	524	460	10,886	10,641
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.59B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	9.2	9.1	1.9	1.9	9.9	9.8	6.5	6.3	10.5	10.4
GENDER
Male	7.4	6.7	1.6	1.5	8.0	7.3	5.2	4.9	8.5	7.7
Female	10.9	11.4	2.2	2.2	11.8	12.3	7.8	7.6	12.3	13.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.8	9.9	1.6	1.9	10.5	10.6	7.3	6.8	11.0	11.1
AIAN	5.8	4.2	0.1	0.7	6.5	4.8	4.3	1.9	7.0	5.4
Asian	2.6	4.0	0.7	1.1	2.8	4.3	3.2	1.6	2.7	4.8
Black or African American	5.5	4.7	1.1	1.6	6.0	5.1	4.3	3.6	6.3	5.3
NHOPI	*	*	*	*	*	*	*	*	*	*
White	11.3	11.4	1.9	2.1	12.1	12.2	8.6	8.2	12.6	12.7
Two or More Races	9.8	11.9	2.2	2.6	11.3	13.4	6.6	8.2	12.6	14.7
Hispanic or Latino	6.5	5.7	2.6	1.7	7.1	6.3	3.8	4.5	7.9	6.7
EDUCATION LEVEL
< High School	da	da	da	da	7.9	8.7	5.6	6.0	8.3	9.2
High School Graduate	da	da	da	da	10.3	9.0	6.3	5.9	11.1	9.6
Some College/Associate’s Degree	da	da	da	da	10.1	11.1	6.7	6.5	10.9	12.1
College Graduate	da	da	da	da	10.2	9.7	6.8	6.5	10.4	10.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	8.4	8.0	7.3	6.3	8.5	8.2
Part-Time	da	da	da	da	9.8	10.1	5.8	6.5	11.3	11.4
Unemployed	da	da	da	da	9.8	12.0	7.5	8.1	10.5	13.7
Other¹	da	da	da	da	11.9	11.8	5.6	5.3	12.6	12.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.60A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3,931	3,681	203	113	3,729	3,569	825	747	2,904	2,822
GENDER
Male	1,911	1,667	98^a	29	1,814	1,638	416	359	1,398	1,279
Female	2,020	2,014	105	83	1,915	1,931	409	388	1,506	1,543
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,410	3,130	111	76	3,298	3,054	699	611	2,599	2,442
AIAN	45	12	*	0	45	11	5	*	39	9
Asian	59	98	*	*	59	98	16	17	42	81
Black or African American	316	241	10	12	306	228	60	68	246	161
NHOPI	*	*	*	*	*	*	*	*	*	*
White	2,869	2,638	93	57	2,776	2,581	581	510	2,194	2,071
Two or More Races	113	116	7	*	106	109	29	14	77	95
Hispanic or Latino	522	552	91	37	430	515	126	136	305	379
EDUCATION LEVEL
< High School	da	da	da	da	248	371	114	78	134^a	294
High School Graduate	da	da	da	da	1,206	979	299	223	907	756
Some College/Associate’s Degree	da	da	da	da	1,260	1,151	309	323	951	829
College Graduate	da	da	da	da	1,015	1,067	102	123	912	944
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,753	1,606	377	322	1,376	1,284
Part-Time	da	da	da	da	498	588	173	184	324	404
Unemployed	da	da	da	da	333	350	88	99	245	252
Other¹	da	da	da	da	1,145	1,024	186	142	959	882
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.60B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.4	1.3	0.8	0.4	1.5	1.4	2.5	2.1	1.3	1.3
GENDER
Male	1.4	1.2	0.7^a	0.2	1.5	1.3	2.5	2.1	1.3	1.2
Female	1.4	1.4	0.8	0.7	1.5	1.5	2.4	2.2	1.3	1.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.5	1.4	0.6	0.4	1.6	1.4	2.7	2.3	1.4	1.3
AIAN	2.5	0.8	*	0.1	2.7	0.9	1.5	*	3.0	0.9
Asian	0.4	0.6	*	*	0.4	0.6	0.8	0.7	0.3	0.6
Black or African American	0.9	0.7	0.3	0.4	1.0	0.7	1.3	1.4	0.9	0.6
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1.7	1.5	0.7	0.4	1.8	1.6	3.3	2.8	1.6	1.5
Two or More Races	2.1	2.0	0.7	*	2.3	2.2	3.1	1.4	2.1	2.3
Hispanic or Latino	1.0	1.1	1.4	0.6	1.0	1.2	1.6	1.6	0.9	1.1
EDUCATION LEVEL
< High School	da	da	da	da	0.9^a	1.5	3.1	2.2	0.5^a	1.4
High School Graduate	da	da	da	da	1.7	1.4	2.8	1.9	1.5	1.3
Some College/Associate’s Degree	da	da	da	da	1.6	1.5	2.2	2.3	1.5	1.3
College Graduate	da	da	da	da	1.3	1.3	2.0	2.2	1.2	1.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.5	1.4	3.0	2.3	1.4	1.2
Part-Time	da	da	da	da	1.6	1.8	2.1	2.1	1.5	1.7
Unemployed	da	da	da	da	2.5	3.2	2.8	3.1	2.5	3.2
Other¹	da	da	da	da	1.2	1.1	2.0	1.6	1.1	1.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.61A – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	73,020	74,052	3,492	3,191	69,528	70,861	6,277	6,504	63,251	64,358
GENDER
Male	33,061	33,618	1,548	1,516	31,513	32,102	2,762	2,792	28,752	29,310
Female	39,959	40,434	1,944^a	1,675	38,015	38,759	3,515	3,712	34,499	35,047
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	62,430	62,839	2,543	2,344	59,887	60,494	4,909	5,039	54,978	55,455
AIAN	607	498	*	34	565	463	*	*	463	425
Asian	2,404	2,863	172	112	2,232	2,751	239	326	1,993	2,424
Black or African American	9,974	9,838	495	556	9,479	9,283	961	923	8,518	8,359
NHOPI	*	317	*	*	*	*	*	*	*	*
White	47,627	47,450	1,699	1,524	45,928	45,926	3,382	3,494	42,546	42,433
Two or More Races	1,523	1,872	126	108	1,397	1,764	204	225	1,192	1,539
Hispanic or Latino	10,590	11,214	949	847	9,641	10,367	1,368	1,465	8,272	8,902
EDUCATION LEVEL
< High School	da	da	da	da	8,119	7,218	723	813	7,396	6,406
High School Graduate	da	da	da	da	19,674	20,153	1,983	2,099	17,690	18,054
Some College/Associate’s Degree	da	da	da	da	23,786	23,932	2,733	2,756	21,053	21,176
College Graduate	da	da	da	da	17,949^a	19,558	837	836	17,112^a	18,721
EMPLOYMENT STATUS
Full-Time	da	da	da	da	27,438	29,615	2,511	2,744	24,927	26,871
Part-Time	da	da	da	da	7,962	8,236	1,356	1,541	6,606	6,695
Unemployed	da	da	da	da	3,875^b	3,025	750	636	3,125^a	2,390
Other¹	da	da	da	da	30,252	29,985	1,660	1,583	28,593	28,403
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. NOTE: For comparison of estimates between 2021 and 2022, opioid use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.61B – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	26.1	26.3	13.4	12.4	27.4	27.6	18.8	18.7	28.7	29.1
GENDER
Male	24.2	24.3	11.6	11.5	25.5	25.7	16.5	16.0	26.9	27.2
Female	27.9	28.1	15.3	13.3	29.2	29.5	21.0	21.5	30.4	30.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	27.1	27.2	13.1	12.3	28.4	28.5	19.1	19.0	29.7	29.9
AIAN	33.4	34.0	*	15.7	34.4	37.3	*	*	35.4	41.1
Asian	14.7	16.8	11.8	7.0	15.0	17.8	12.2	14.4	15.4	18.4
Black or African American	29.2	28.6	14.0	15.8	31.0	30.0	21.2	19.8	32.7	31.8
NHOPI	*	24.9	*	*	*	*	*	*	*	*
White	27.8	27.7	12.9	11.9	29.1	29.0	19.1	19.1	30.3	30.3
Two or More Races	27.9	31.8	14.0	13.0	30.6	34.9	22.1	22.5	32.7	38.0
Hispanic or Latino	21.3	22.0	14.3	12.7	22.3	23.4	17.5	17.7	23.4	24.7
EDUCATION LEVEL
< High School	da	da	da	da	28.7	29.6	19.6	22.7	30.1	30.8
High School Graduate	da	da	da	da	28.4	29.1	18.8	18.1	30.1	31.4
Some College/Associate’s Degree	da	da	da	da	30.8	30.8	19.3	19.8	33.4	33.1
College Graduate	da	da	da	da	22.7	23.0	16.5	14.7	23.2	23.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	24.0	25.0	19.8	19.5	24.5	25.8
Part-Time	da	da	da	da	26.2	25.1	16.6	17.5	29.7	27.9
Unemployed	da	da	da	da	29.6	27.5	23.7	19.8	31.5	30.6
Other¹	da	da	da	da	31.5	31.9	17.6	18.2	33.0	33.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. NOTE: For comparison of estimates between 2021 and 2022, opioid use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.62A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	9,420	8,918	550	406	8,871	8,513	1,070	1,120	7,801	7,393
GENDER
Male	4,813	4,615	215	150	4,598	4,465	502	570	4,097	3,895
Female	4,608	4,303	335	256	4,272	4,048	568	550	3,704	3,498
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,775	7,198	386	296	7,388	6,901	833	838	6,555	6,064
AIAN	97	79	*	1	84	78	*	*	51	59
Asian	371	249	20	4	351	244	57	50	294	194
Black or African American	1,209	1,421	48	84	1,161	1,338	119	157	1,042	1,180
NHOPI	*	64	*	*	*	64	*	*	*	*
White	5,667	5,117	271	176	5,396	4,941	553	554	4,843	4,387
Two or More Races	360	267	35	30	325	236	60	54	265	183
Hispanic or Latino	1,646	1,721	163	110	1,482	1,611	237	282	1,245	1,329
EDUCATION LEVEL
< High School	da	da	da	da	1,493	1,087	177	203	1,316^a	883
High School Graduate	da	da	da	da	2,751	2,482	407	413	2,343	2,070
Some College/Associate’s Degree	da	da	da	da	2,850	3,048	357	381	2,493	2,668
College Graduate	da	da	da	da	1,777	1,895	128	123	1,649	1,772
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3,244	3,607	419	497	2,824	3,110
Part-Time	da	da	da	da	1,161	999	208	193	953	806
Unemployed	da	da	da	da	984	732	159	161	825	571
Other¹	da	da	da	da	3,481	3,175	283	269	3,198	2,906
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, opioid misuse estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.62B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3.4	3.2	2.1	1.6	3.5	3.3	3.2	3.2	3.5	3.3
GENDER
Male	3.5	3.3	1.6	1.1	3.7	3.6	3.0	3.3	3.8	3.6
Female	3.2	3.0	2.6	2.0	3.3	3.1	3.4	3.2	3.3	3.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.4	3.1	2.0	1.6	3.5	3.3	3.2	3.2	3.5	3.3
AIAN	5.3	5.4	*	0.6	5.1	6.3	*	*	3.9	5.7
Asian	2.3	1.5	1.4	0.3	2.4	1.6	2.9	2.2	2.3	1.5
Black or African American	3.5	4.1	1.4	2.4	3.8	4.3	2.6	3.4	4.0	4.5
NHOPI	*	5.0	*	*	*	5.3	*	*	*	*
White	3.3	3.0	2.1	1.4	3.4	3.1	3.1	3.0	3.5	3.1
Two or More Races	6.6	4.5	3.9	3.6	7.1	4.7	6.5	5.3	7.3	4.5
Hispanic or Latino	3.3	3.4	2.5	1.6	3.4	3.6	3.0	3.4	3.5	3.7
EDUCATION LEVEL
< High School	da	da	da	da	5.3	4.5	4.8	5.7	5.4	4.3
High School Graduate	da	da	da	da	4.0	3.6	3.9	3.6	4.0	3.6
Some College/Associate’s Degree	da	da	da	da	3.7	3.9	2.5	2.7	4.0	4.2
College Graduate	da	da	da	da	2.2	2.2	2.5	2.2	2.2	2.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.8	3.0	3.3	3.5	2.8	3.0
Part-Time	da	da	da	da	3.8	3.0	2.5	2.2	4.3	3.4
Unemployed	da	da	da	da	7.5	6.6	5.0	5.0	8.3	7.3
Other¹	da	da	da	da	3.6	3.4	3.0	3.1	3.7	3.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, opioid misuse estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.63A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	2,817	2,944	133	117	2,685	2,827	239	221	2,446	2,606
GENDER
Male	1,461	1,639	40	47	1,421	1,591	105	104	1,316	1,488
Female	1,356	1,305	93	69	1,264	1,236	134	117	1,130	1,119
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,294	2,475	87	94	2,207	2,381	171	164	2,036	2,218
AIAN	34	23	1	0	34	22	*	*	29	11
Asian	69	95	1	3	68	92	*	8	55	84
Black or African American	360	533	14	35	346	498	27	27	319	471
NHOPI	*	59	*	*	*	*	*	*	*	*
White	1,716	1,668	47	45	1,668	1,623	103	104	1,565	1,519
Two or More Races	107	97	23	11	84	86	16	10	68	76
Hispanic or Latino	523	468	46	23	477	446	68	58	410	388
EDUCATION LEVEL
< High School	da	da	da	da	450	374	47	55	403	319
High School Graduate	da	da	da	da	1,007	951	103	104	904	848
Some College/Associate’s Degree	da	da	da	da	785	959	63	43	723	916
College Graduate	da	da	da	da	442	543	26	19	416	523
EMPLOYMENT STATUS
Full-Time	da	da	da	da	807^a	1,257	94	109	712^a	1,148
Part-Time	da	da	da	da	316	165	51	31	264	134
Unemployed	da	da	da	da	286	272	27	31	259	241
Other¹	da	da	da	da	1,277	1,133	66	50	1,210	1,083
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, opioid misuse estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.63B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.0	1.0	0.5	0.5	1.1	1.1	0.7	0.6	1.1	1.2
GENDER
Male	1.1	1.2	0.3	0.4	1.2	1.3	0.6	0.6	1.2	1.4
Female	0.9	0.9	0.7	0.6	1.0	0.9	0.8	0.7	1.0	1.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.0	1.1	0.4	0.5	1.0	1.1	0.7	0.6	1.1	1.2
AIAN	1.9	1.6	0.5	0.1	2.0	1.8	*	*	2.2	1.1
Asian	0.4	0.6	0.1	0.2	0.5	0.6	*	0.3	0.4	0.6
Black or African American	1.1	1.5	0.4	1.0	1.1	1.6	0.6	0.6	1.2	1.8
NHOPI	*	4.7	*	*	*	*	*	*	*	*
White	1.0	1.0	0.4	0.3	1.1	1.0	0.6	0.6	1.1	1.1
Two or More Races	2.0	1.7	2.5	1.3	1.8	1.7	1.7	1.0	1.9	1.9
Hispanic or Latino	1.1	0.9	0.7	0.3	1.1	1.0	0.9	0.7	1.2	1.1
EDUCATION LEVEL
< High School	da	da	da	da	1.6	1.5	1.3	1.5	1.6	1.5
High School Graduate	da	da	da	da	1.5	1.4	1.0	0.9	1.5	1.5
Some College/Associate’s Degree	da	da	da	da	1.0	1.2	0.4	0.3	1.1	1.4
College Graduate	da	da	da	da	0.6	0.6	0.5	0.3	0.6	0.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.7^a	1.1	0.7	0.8	0.7^a	1.1
Part-Time	da	da	da	da	1.0^a	0.5	0.6	0.3	1.2	0.6
Unemployed	da	da	da	da	2.2	2.5	0.8	1.0	2.6	3.1
Other¹	da	da	da	da	1.3	1.2	0.7	0.6	1.4	1.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, opioid misuse estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.64A – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	21,614^b	24,425	1,849	1,889	19,765^b	22,536	4,198	4,581	15,567^b	17,956
GENDER
Male	11,043^b	12,687	1,014	1,006	10,029^b	11,681	2,228	2,338	7,801^b	9,343
Female	10,570^a	11,738	835	883	9,736^a	10,855	1,969	2,243	7,766	8,613
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	18,390^b	20,680	1,559	1,535	16,832^b	19,144	3,522	3,773	13,310^b	15,371
AIAN	185	118	*	18	169	100	*	17	50	83
Asian	713	558	63	31	650	526	197	136	453	390
Black or African American	1,835	2,177	145	177	1,690	2,000	258	323	1,433	1,677
NHOPI	48	*	*	*	37	*	*	*	27	*
White	14,924^b	16,963	1,246	1,226	13,678^b	15,736	2,830	3,106	10,848^b	12,630
Two or More Races	685	742	78	83	608	660	108	170	500	490
Hispanic or Latino	3,223	3,746	290	354	2,933	3,392	676	808	2,257	2,584
EDUCATION LEVEL
< High School	da	da	da	da	1,981	1,907	401	435	1,580	1,472
High School Graduate	da	da	da	da	4,840	5,102	1,032	1,201	3,809	3,901
Some College/Associate’s Degree	da	da	da	da	7,420	8,134	1,978	1,999	5,442	6,136
College Graduate	da	da	da	da	5,524^b	7,392	788	945	4,736^b	6,447
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9,339^b	11,353	1,734	2,023	7,605^b	9,331
Part-Time	da	da	da	da	2,599^a	3,295	1,061	1,174	1,537^a	2,120
Unemployed	da	da	da	da	1,766	1,694	455	441	1,311	1,252
Other¹	da	da	da	da	6,061	6,195	948	942	5,113	5,252
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.64B – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	7.7^b	8.7	7.1	7.3	7.8^b	8.8	12.5	13.2	7.1^b	8.1
GENDER
Male	8.1^a	9.2	7.6	7.6	8.1^a	9.3	13.3	13.4	7.3^a	8.7
Female	7.4^a	8.2	6.6	7.0	7.5^a	8.3	11.8	13.0	6.8	7.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.0^b	8.9	8.0	8.0	8.0^b	9.0	13.7	14.2	7.2^b	8.3
AIAN	10.2	8.1	*	8.1	10.3	8.1	*	8.1	3.8	8.1
Asian	4.4	3.3	4.3	2.0	4.4	3.4	10.1	6.0	3.5	3.0
Black or African American	5.4	6.3	4.1	5.0	5.5	6.5	5.7	6.9	5.5	6.4
NHOPI	4.1	*	*	*	3.6	*	*	*	3.2	*
White	8.7^b	9.9	9.5	9.6	8.7^b	9.9	16.0	17.0	7.7^b	9.0
Two or More Races	12.5	12.6	8.6	9.9	13.3	13.1	11.7	16.9	13.7	12.1
Hispanic or Latino	6.5	7.4	4.4	5.3	6.8	7.7	8.6	9.8	6.4	7.2
EDUCATION LEVEL
< High School	da	da	da	da	7.0	7.8	10.9	12.1	6.4	7.1
High School Graduate	da	da	da	da	7.0	7.4	9.8	10.3	6.5	6.8
Some College/Associate’s Degree	da	da	da	da	9.6	10.5	14.0	14.4	8.6	9.6
College Graduate	da	da	da	da	7.0^b	8.7	15.5	16.6	6.4^b	8.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	8.2^b	9.6	13.6	14.4	7.5^b	8.9
Part-Time	da	da	da	da	8.6	10.0	13.0	13.4	6.9	8.8
Unemployed	da	da	da	da	13.5	15.4	14.3	13.8	13.2	16.0
Other¹	da	da	da	da	6.3	6.6	10.1	10.8	5.9	6.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.65A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	9,379	10,188	338	272	9,042	9,916	2,230	2,272	6,812	7,644
GENDER
Male	5,646	6,462	169	149	5,477	6,313	1,245	1,169	4,232^a	5,143
Female	3,733	3,726	169	123	3,565	3,603	985	1,102	2,580	2,500
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,789	8,332	248	213	7,541	8,119	1,894	1,810	5,648	6,309
AIAN	95	50	1	4	95	47	*	15	36	31
Asian	237	259	4	*	234	248	127	74	107	174
Black or African American	843	887	22	24	821	863	111	148	710	715
NHOPI	25	*	*	*	25	*	*	*	16	*
White	6,237	6,729	198	157	6,039	6,572	1,521	1,478	4,517	5,095
Two or More Races	351	292	23	17	328	275	67	78	262	197
Hispanic or Latino	1,590	1,856	90	59	1,500	1,797	337	462	1,164	1,335
EDUCATION LEVEL
< High School	da	da	da	da	1,020	983	189	201	831	782
High School Graduate	da	da	da	da	2,667	2,365	543	517	2,124	1,848
Some College/Associate’s Degree	da	da	da	da	3,336	3,760	1,021	929	2,315	2,831
College Graduate	da	da	da	da	2,020^b	2,807	478	624	1,542^b	2,183
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3,875^b	4,778	967	1,143	2,908^a	3,635
Part-Time	da	da	da	da	1,393	1,573	562	522	831	1,051
Unemployed	da	da	da	da	1,095	994	249	260	846	734
Other¹	da	da	da	da	2,678	2,572	451	347	2,227	2,224
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.65B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3.4	3.6	1.3	1.1	3.6	3.9	6.7	6.5	3.1	3.5
GENDER
Male	4.1	4.7	1.3	1.1	4.4	5.0	7.4	6.7	4.0^a	4.8
Female	2.6	2.6	1.3	1.0	2.7	2.7	5.9	6.4	2.3	2.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.4	3.6	1.3	1.1	3.6	3.8	7.4	6.8	3.1	3.4
AIAN	5.3	3.4	0.5	1.6	5.8	3.7	*	7.2	2.8	3.0
Asian	1.4	1.5	0.2	*	1.6	1.6	6.5	3.3	0.8	1.3
Black or African American	2.5	2.6	0.6	0.7	2.7	2.8	2.5	3.2	2.7	2.7
NHOPI	2.1	*	*	*	2.5	*	*	*	1.9	*
White	3.6	3.9	1.5	1.2	3.8	4.2	8.6	8.1	3.2	3.6
Two or More Races	6.4	5.0	2.5	2.1	7.2	5.4	7.2	7.8	7.2	4.9
Hispanic or Latino	3.2	3.6	1.4	0.9	3.5	4.1	4.3	5.6	3.3	3.7
EDUCATION LEVEL
< High School	da	da	da	da	3.6	4.0	5.1	5.6	3.4	3.8
High School Graduate	da	da	da	da	3.8	3.4	5.1	4.5	3.6	3.2
Some College/Associate’s Degree	da	da	da	da	4.3	4.8	7.2	6.7	3.7	4.4
College Graduate	da	da	da	da	2.6^b	3.3	9.4	11.0	2.1^a	2.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.4^a	4.0	7.6	8.1	2.9^a	3.5
Part-Time	da	da	da	da	4.6	4.8	6.9	5.9	3.7	4.4
Unemployed	da	da	da	da	8.4	9.0	7.9	8.1	8.5	9.4
Other¹	da	da	da	da	2.8	2.7	4.8	4.0	2.6	2.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.66A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	4,173	4,469	100^a	40	4,073	4,429	675	767	3,398	3,662
GENDER
Male	2,479	2,836	34	20	2,445	2,816	363	425	2,081	2,391
Female	1,695	1,632	66^a	20	1,629	1,613	312	342	1,317	1,271
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,437	3,698	63	32	3,374	3,666	583	606	2,790	3,060
AIAN	30	15	*	0	29	15	8	*	22	8
Asian	110	113	*	*	110	113	62	25	48	88
Black or African American	364	425	11	5	352	420	25	57	327	363
NHOPI	15	*	*	*	15	*	*	*	*	*
White	2,774	2,930	50	26	2,724	2,904	463	505	2,261	2,400
Two or More Races	144	123	1	0	143	123	17	11	126	112
Hispanic or Latino	736	771	37	8	700	763	92	161	608	602
EDUCATION LEVEL
< High School	da	da	da	da	545	538	75	86	470	452
High School Graduate	da	da	da	da	1,272	1,199	151	191	1,120	1,008
Some College/Associate’s Degree	da	da	da	da	1,514	1,729	312	297	1,202	1,432
College Graduate	da	da	da	da	743	963	137	192	606	770
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,501	1,851	225^a	383	1,276	1,467
Part-Time	da	da	da	da	598	645	187	152	412	493
Unemployed	da	da	da	da	553	543	97	106	456	437
Other¹	da	da	da	da	1,421	1,390	166	125	1,255	1,265
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.66B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.5	1.6	0.4^a	0.2	1.6	1.7	2.0	2.2	1.5	1.7
GENDER
Male	1.8	2.1	0.3	0.2	2.0	2.3	2.2	2.4	1.9	2.2
Female	1.2	1.1	0.5^a	0.2	1.2	1.2	1.9	2.0	1.2	1.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.5	1.6	0.3	0.2	1.6	1.7	2.3	2.3	1.5	1.6
AIAN	1.6	1.0	*	0.1	1.8	1.2	2.3	*	1.6	0.8
Asian	0.7	0.7	*	*	0.7	0.7	3.2	1.1	0.4	0.7
Black or African American	1.1	1.2	0.3	0.1	1.2	1.4	0.6	1.2	1.3	1.4
NHOPI	1.3	*	*	*	1.5	*	*	*	*	*
White	1.6	1.7	0.4	0.2	1.7	1.8	2.6	2.8	1.6	1.7
Two or More Races	2.6	2.1	0.1	0.1	3.1	2.4	1.8	1.1	3.5	2.8
Hispanic or Latino	1.5	1.5	0.6	0.1	1.6	1.7	1.2	2.0	1.7	1.7
EDUCATION LEVEL
< High School	da	da	da	da	1.9	2.2	2.0	2.4	1.9	2.2
High School Graduate	da	da	da	da	1.8	1.7	1.4	1.6	1.9	1.8
Some College/Associate’s Degree	da	da	da	da	2.0	2.2	2.2	2.1	1.9	2.2
College Graduate	da	da	da	da	0.9	1.1	2.7	3.4	0.8	1.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.3	1.6	1.8^a	2.7	1.3	1.4
Part-Time	da	da	da	da	2.0	2.0	2.3	1.7	1.9	2.0
Unemployed	da	da	da	da	4.2	4.9	3.1	3.3	4.6	5.6
Other¹	da	da	da	da	1.5	1.5	1.8	1.4	1.4	1.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.67A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	23,579	24,692	1,635^a	1,343	21,944	23,348	4,807	5,092	17,137	18,256
GENDER
Male	12,947	14,019	739	664	12,208	13,355	2,604	2,670	9,604	10,686
Female	10,632	10,673	896^a	680	9,736	9,993	2,203	2,423	7,533	7,570
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	19,497	20,175	1,158	1,043	18,339	19,132	3,929	3,961	14,410	15,171
AIAN	196	156	*	14	177	142	*	*	106	106
Asian	756	881	46	76	711	805	215	217	495	587
Black or African American	2,467	2,704	153	167	2,314	2,537	364	476	1,950	2,061
NHOPI	141	*	*	*	*	*	*	*	*	*
White	15,135	15,579	826	733	14,310	14,846	3,083	3,036	11,227	11,811
Two or More Races	801	710	84	53	716	657	179	172	537	486
Hispanic or Latino	4,082	4,516	477^a	300	3,605	4,217	878^a	1,132	2,727	3,085
EDUCATION LEVEL
< High School	da	da	da	da	2,522	2,189	471	545	2,050	1,644
High School Graduate	da	da	da	da	6,060	5,578	1,528	1,422	4,532	4,156
Some College/Associate’s Degree	da	da	da	da	7,582	8,408	2,044	2,140	5,537	6,269
College Graduate	da	da	da	da	5,780^b	7,173	763	986	5,017^b	6,187
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9,739^b	11,339	2,004^a	2,382	7,734^a	8,957
Part-Time	da	da	da	da	3,248	3,516	1,147	1,212	2,101	2,303
Unemployed	da	da	da	da	2,174	1,767	526	507	1,648	1,260
Other¹	da	da	da	da	6,783	6,727	1,129	991	5,654	5,736
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use other than marijuana estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.67B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	8.4	8.8	6.3^a	5.2	8.6	9.1	14.4	14.6	7.8	8.2
GENDER
Male	9.5	10.1	5.6	5.0	9.9	10.7	15.6	15.3	9.0	9.9
Female	7.4	7.4	7.0^a	5.4	7.5	7.6	13.2	14.0	6.6	6.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.5	8.7	6.0	5.5	8.7	9.0	15.3	14.9	7.8	8.2
AIAN	10.8	10.7	*	6.4	10.8	11.4	*	*	8.1	10.3
Asian	4.6	5.2	3.1	4.8	4.8	5.2	11.0	9.6	3.8	4.5
Black or African American	7.2	7.9	4.3	4.8	7.6	8.2	8.0	10.2	7.5	7.8
NHOPI	12.0	*	*	*	*	*	*	*	*	*
White	8.8	9.1	6.3	5.7	9.1	9.4	17.4	16.6	8.0	8.4
Two or More Races	14.6	12.1	9.3	6.3	15.7	13.0	19.4	17.1	14.7	12.0
Hispanic or Latino	8.2	8.9	7.2^a	4.5	8.4	9.5	11.2	13.7	7.7	8.6
EDUCATION LEVEL
< High School	da	da	da	da	8.9	9.0	12.8	15.2	8.3	7.9
High School Graduate	da	da	da	da	8.7	8.1	14.5^a	12.2	7.7	7.2
Some College/Associate’s Degree	da	da	da	da	9.8	10.8	14.4	15.4	8.8	9.8
College Graduate	da	da	da	da	7.3^a	8.4	15.0	17.3	6.8^a	7.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	8.5^a	9.6	15.8	16.9	7.6^a	8.6
Part-Time	da	da	da	da	10.7	10.7	14.1	13.8	9.5	9.6
Unemployed	da	da	da	da	16.6	16.0	16.6	15.8	16.6	16.1
Other¹	da	da	da	da	7.1	7.2	12.0	11.4	6.5	6.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use other than marijuana estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.68A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	9,108	9,560	527	399	8,581	9,161	1,395	1,531	7,186	7,630
GENDER
Male	5,105	5,750	245	195	4,861	5,555	751	881	4,110	4,674
Female	4,002	3,810	282	205	3,720	3,606	644	650	3,076	2,956
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,455	8,143	403	338	7,052	7,805	1,112	1,192	5,940	6,613
AIAN	93	55	*	*	75	51	15	*	61	33
Asian	256	341	14	36	241	305	98	67	144	238
Black or African American	851	1,097	78	67	773	1,030	101	114	673	916
NHOPI	36	*	*	*	34	*	*	*	*	*
White	5,935	6,256	258	213	5,677	6,043	844	951	4,833	5,092
Two or More Races	285	282	35	18	250	264	43	39	207	225
Hispanic or Latino	1,653	1,417	124^a	62	1,529	1,356	283	339	1,246	1,017
EDUCATION LEVEL
< High School	da	da	da	da	1,053	970	138	170	915	800
High School Graduate	da	da	da	da	2,575	2,429	441	453	2,134	1,976
Some College/Associate’s Degree	da	da	da	da	2,769	3,303	549	582	2,220	2,721
College Graduate	da	da	da	da	2,184	2,458	267	326	1,917	2,132
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3,347^b	4,254	579	758	2,767^a	3,496
Part-Time	da	da	da	da	1,124	1,282	324	339	801	943
Unemployed	da	da	da	da	930	800	175	183	755	617
Other¹	da	da	da	da	3,180	2,825	317	251	2,863	2,574
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use other than marijuana estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.68B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3.3	3.4	2.0	1.6	3.4	3.6	4.2	4.4	3.3	3.4
GENDER
Male	3.7	4.2	1.8	1.5	3.9	4.4	4.5	5.0	3.9	4.3
Female	2.8	2.7	2.2	1.6	2.9	2.7	3.9	3.8	2.7	2.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.2	3.5	2.1	1.8	3.3	3.7	4.3	4.5	3.2	3.6
AIAN	5.1	3.7	*	*	4.6	4.1	4.4	*	4.6	3.2
Asian	1.6	2.0	1.0	2.2	1.6	2.0	5.0	3.0	1.1	1.8
Black or African American	2.5	3.2	2.2	1.9	2.5	3.3	2.2	2.4	2.6	3.5
NHOPI	3.1	*	*	*	3.4	*	*	*	*	*
White	3.5	3.7	2.0	1.7	3.6	3.8	4.8	5.2	3.4	3.6
Two or More Races	5.2	4.8	3.8	2.1	5.5	5.2	4.6	3.9	5.7	5.6
Hispanic or Latino	3.3	2.8	1.9^a	0.9	3.5	3.1	3.6	4.1	3.5	2.8
EDUCATION LEVEL
< High School	da	da	da	da	3.7	4.0	3.7	4.7	3.7	3.9
High School Graduate	da	da	da	da	3.7	3.5	4.2	3.9	3.6	3.4
Some College/Associate’s Degree	da	da	da	da	3.6	4.2	3.9	4.2	3.5	4.3
College Graduate	da	da	da	da	2.8	2.9	5.3	5.7	2.6	2.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.9^a	3.6	4.6	5.4	2.7^a	3.4
Part-Time	da	da	da	da	3.7	3.9	4.0	3.9	3.6	3.9
Unemployed	da	da	da	da	7.1	7.3	5.5	5.7	7.6	7.9
Other¹	da	da	da	da	3.3	3.0	3.4	2.9	3.3	3.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use other than marijuana estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.69A – Any Use and Misuse of Fentanyl in Past Year and Use of Illegally Made Fentanyl (IMF) in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic	Any Fentanyl Use¹ (2021)	Any Fentanyl Use¹ (2022)	Fentanyl Misuse² (2021)	Fentanyl Misuse² (2022)	IMF Use (2021)	IMF Use (2022)
TOTAL	--	3,086	--	991	--	686
AGE GROUP
12-17	--	149	--	34	--	20
18 or Older	--	2,937	--	957	--	666
18-25	--	271	--	75	--	48
26 or Older	--	2,667	--	882	--	617
GENDER
Male	--	1,409	--	657	--	472
Female	--	1,677	--	333	--	214
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	2,673	--	854	--	654
AIAN	--	18	--	8	--	8
Asian	--	59	--	*	--	*
Black or African American	--	405	--	152	--	130
NHOPI	--	*	--	*	--	*
White	--	2,053	--	636	--	481
Two or More Races	--	96	--	58	--	35
Hispanic or Latino	--	413	--	136	--	32
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ¹ Any use of fentanyl includes use of IMF or any use of pharmaceutical fentanyl in the past year. ² Misuse of fentanyl includes use of IMF or the misuse of pharmaceutical fentanyl in the past year. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.69B – Any Use and Misuse of Fentanyl in Past Year and Use of Illegally Made Fentanyl (IMF) in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic	Any Fentanyl Use¹ (2021)	Any Fentanyl Use¹ (2022)	Fentanyl Misuse² (2021)	Fentanyl Misuse² (2022)	IMF Use (2021)	IMF Use (2022)
TOTAL	--	1.1	--	0.4	--	0.2
AGE GROUP
12-17	--	0.6	--	0.1	--	0.1
18 or Older	--	1.1	--	0.4	--	0.3
18-25	--	0.8	--	0.2	--	0.1
26 or Older	--	1.2	--	0.4	--	0.3
GENDER
Male	--	1.0	--	0.5	--	0.3
Female	--	1.2	--	0.2	--	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	1.2	--	0.4	--	0.3
AIAN	--	1.2	--	0.5	--	0.5
Asian	--	0.3	--	*	--	*
Black or African American	--	1.2	--	0.4	--	0.4
NHOPI	--	*	--	*	--	*
White	--	1.2	--	0.4	--	0.3
Two or More Races	--	1.6	--	1.0	--	0.6
Hispanic or Latino	--	0.8	--	0.3	--	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ¹ Any use of fentanyl includes use of IMF or any use of pharmaceutical fentanyl in the past year. ² Misuse of fentanyl includes use of IMF or the misuse of pharmaceutical fentanyl in the past year. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.70A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	61,995^b	70,338	3,802	3,688	58,192^b	66,650	13,036^b	14,221	45,156^b	52,429
GEOGRAPHIC REGION
Northeast	11,323^a	12,579	590	607	10,733^a	11,972	2,308	2,456	8,425	9,515
Midwest	13,242^a	14,731	847	741	12,395^b	13,989	2,969	3,076	9,425^b	10,914
South	19,945^b	23,167	1,302	1,372	18,643^b	21,794	4,300^b	4,889	14,344^b	16,906
West	17,485^b	19,862	1,063	967	16,421^b	18,895	3,460	3,800	12,962^b	15,095
COUNTY TYPE
Large Metro	34,264^b	39,876	1,978	2,049	32,287^b	37,827	6,994^a	7,962	25,293^b	29,865
Small Metro	19,617^b	22,422	1,329	1,283	18,289^b	21,139	4,345	4,802	13,944^b	16,337
Nonmetro	8,113	8,040	496^a	356	7,617	7,684	1,697	1,456	5,920	6,228
Urbanized	3,258	3,688	238	162	3,020	3,526	809	726	2,211	2,800
Less Urbanized	4,121	3,793	223^a	148	3,898	3,646	751	687	3,147	2,959
Completely Rural	734	559	35	*	699	512	138^b	44	561	469
POVERTY LEVEL¹
Less Than 100%	11,469	11,951	729	771	10,741	11,181	3,180	3,205	7,561	7,976
100-199%	13,407	14,412	875	882	12,531	13,530	3,220	3,643	9,311	9,887
200% or More	37,104^b	43,971	2,198	2,035	34,906^b	41,936	6,622^a	7,370	28,284^b	34,566
HEALTH INSURANCE²
Private	33,530^b	40,302	1,943	1,925	31,587^b	38,377	7,504^a	8,390	24,083^b	29,986
Medicaid/CHIP	16,594^a	18,399	1,753	1,642	14,841^a	16,757	3,211^a	3,728	11,630	13,029
Other³	11,344^b	13,445	154	217	11,191^b	13,228	980	1,091	10,211^b	12,136
No Coverage	7,312	7,366	190	123	7,122	7,243	1,864	1,712	5,258	5,530
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.70B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	22.2^b	24.9	14.6	14.3	22.9^b	26.0	39.0	40.9	20.5^b	23.7
GEOGRAPHIC REGION
Northeast	23.1^a	25.7	14.2	14.9	24.0	26.6	40.3	41.5	21.6	24.4
Midwest	22.8^a	25.3	15.5	13.7	23.6^b	26.5	41.8	42.1	20.7^b	24.0
South	18.7^b	21.4	12.8	13.6	19.3^b	22.2	33.9	36.6	17.1^b	20.0
West	26.4^b	29.8	17.0	15.7	27.3^b	31.2	43.6	46.2	24.9^b	28.8
COUNTY TYPE
Large Metro	22.7^b	25.6	14.1	13.8	23.6^b	26.8	39.6	41.7	21.2^b	24.5
Small Metro	22.9^b	25.1	16.6	16.1	23.5^b	26.0	39.6	41.1	20.9^b	23.5
Nonmetro	18.7^b	21.9	12.4	12.1	19.4^b	22.7	35.1	36.6	17.2^b	20.9
Urbanized	20.2^a	23.8	15.7	13.1	20.6^a	24.8	40.0	41.2	17.5^a	22.5
Less Urbanized	18.2	20.6	10.8	10.4	19.0	21.4	31.9	34.8	17.3	19.7
Completely Rural	16.1	19.6	8.8	*	16.8	19.9	29.6^a	17.6	15.2	20.1
POVERTY LEVEL¹
Less Than 100%	26.5	28.8	13.3	14.6	28.4	30.9	37.6	39.8	25.7	28.3
100-199%	23.8^a	25.9	15.6	15.2	24.7^a	27.2	40.2	42.9	21.8	23.9
200% or More	20.6^b	23.8	14.7	13.9	21.1^b	24.6	39.2	40.4	19.1^b	22.7
HEALTH INSURANCE²
Private	19.9^b	23.7	14.0	13.7	20.5^b	24.6	39.7	42.2	17.8^b	22.0
Medicaid/CHIP	28.5^b	31.3	16.2	15.4	31.3^b	34.8	36.9	40.2	30.0^a	33.6
Other³	14.8^b	17.2	11.1	14.4	14.9^b	17.2	38.5	38.9	14.0^b	16.4
No Coverage	28.0	30.4	14.3	12.2	28.7	31.2	38.8	37.0	26.3	29.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.71A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	40,564^b	46,603	1,964	1,884	38,600^b	44,719	8,648^b	9,478	29,952^b	35,241
GEOGRAPHIC REGION
Northeast	7,815	8,713	342	329	7,473	8,384	1,563	1,723	5,910	6,661
Midwest	8,877	9,695	464	366	8,413	9,329	1,969	2,009	6,445	7,320
South	12,171^b	14,785	617	728	11,553^b	14,056	2,643^b	3,175	8,910^b	10,882
West	11,702^a	13,411	541	462	11,161^b	12,950	2,473	2,571	8,688^b	10,378
COUNTY TYPE
Large Metro	22,381^b	26,425	972	1,079	21,409^b	25,347	4,697	5,265	16,712^b	20,081
Small Metro	12,876^a	14,687	709	650	12,167^a	14,037	2,812	3,261	9,355^a	10,776
Nonmetro	5,308	5,491	283^b	156	5,024	5,336	1,139	952	3,885	4,384
Urbanized	2,182	2,605	112	89	2,070	2,517	586	462	1,484^a	2,054
Less Urbanized	2,663	2,522	149^b	64	2,514	2,457	476	468	2,038	1,989
Completely Rural	463	364	22^a	2	441	362	78^a	21	363	340
POVERTY LEVEL¹
Less Than 100%	7,642	8,149	366	406	7,276	7,743	2,162	2,115	5,114	5,628
100-199%	9,276	10,144	476	424	8,800	9,720	2,139^b	2,650	6,660	7,070
200% or More	23,637^b	28,309	1,122	1,054	22,515^b	27,255	4,336	4,712	18,179^b	22,543
HEALTH INSURANCE²
Private	20,484^b	25,474	982	997	19,503^b	24,476	4,770^a	5,476	14,733^b	19,001
Medicaid/CHIP	11,545^a	13,076	964	837	10,581^b	12,238	2,275	2,597	8,306^a	9,641
Other³	7,566	8,609	47^a	92	7,519	8,517	639	693	6,881	7,824
No Coverage	5,358	5,235	99	71	5,260	5,164	1,326	1,190	3,933	3,975
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.71B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	14.5^b	16.5	7.5	7.3	15.2^b	17.4	25.8	27.2	13.6^b	15.9
GEOGRAPHIC REGION
Northeast	16.0	17.8	8.3	8.1	16.7	18.6	27.3	29.1	15.1	17.1
Midwest	15.3	16.7	8.5	6.8	16.0	17.7	27.7	27.5	14.2	16.1
South	11.4^b	13.7	6.1	7.2	12.0^b	14.3	20.8^a	23.8	10.6^b	12.9
West	17.6^a	20.1	8.7	7.5	18.6^a	21.4	31.2	31.2	16.7^b	19.8
COUNTY TYPE
Large Metro	14.8^b	16.9	6.9	7.3	15.7^b	18.0	26.6	27.5	14.0^b	16.5
Small Metro	15.0^a	16.4	8.9	8.2	15.6^a	17.3	25.7	27.9	14.0^a	15.5
Nonmetro	12.3^b	14.9	7.1	5.3	12.8^b	15.8	23.5	23.9	11.3^b	14.7
Urbanized	13.5^a	16.8	7.4	7.2	14.1^a	17.7	29.0	26.3	11.8^b	16.5
Less Urbanized	11.8	13.7	7.2	4.6	12.2	14.5	20.2	23.8	11.2	13.2
Completely Rural	10.1	12.8	5.5^a	0.9	10.6	14.0	16.7	8.5	9.8	14.6
POVERTY LEVEL¹
Less Than 100%	17.6^a	19.6	6.7	7.7	19.2	21.4	25.5	26.3	17.4^a	20.0
100-199%	16.4	18.2	8.5	7.3	17.3^a	19.5	26.7^a	31.2	15.6	17.1
200% or More	13.1^b	15.3	7.5	7.2	13.6^b	16.0	25.7	25.8	12.3^b	14.8
HEALTH INSURANCE²
Private	12.2^b	15.0	7.1	7.1	12.6^b	15.7	25.2	27.5	10.9^b	14.0
Medicaid/CHIP	19.8^a	22.3	8.9	7.8	22.3^b	25.5	26.2	28.0	21.4^b	24.8
Other³	9.9	11.0	3.4	6.1	10.0	11.1	25.1	24.7	9.5	10.6
No Coverage	20.5	21.6	7.4	7.0	21.2	22.2	27.6	25.7	19.7	21.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.72A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	53,181^b	61,901	2,845	2,947	50,337^b	58,955	12,133^b	13,299	38,204^b	45,656
GEOGRAPHIC REGION
Northeast	10,002^a	11,259	468	507	9,534^a	10,752	2,145	2,319	7,389	8,433
Midwest	11,679^b	13,147	668	606	11,011^b	12,542	2,800	2,915	8,211^b	9,626
South	16,393^b	19,783	907	1,058	15,486^b	18,726	3,902^b	4,474	11,584^b	14,251
West	15,107^b	17,712	802	776	14,305^b	16,936	3,286	3,590	11,019^b	13,345
COUNTY TYPE
Large Metro	29,312^b	35,226	1,431	1,643	27,881^b	33,583	6,550^a	7,461	21,331^b	26,122
Small Metro	16,990^b	19,704	1,034	1,042	15,956^b	18,661	4,034	4,513	11,922^b	14,149
Nonmetro	6,879	6,972	380^a	262	6,499	6,710	1,548	1,325	4,951	5,385
Urbanized	2,818	3,275	182	136	2,635	3,139	752	666	1,884	2,473
Less Urbanized	3,415	3,230	168^a	99	3,247	3,131	664	624	2,583	2,507
Completely Rural	646	467	29	*	617	440	133^b	35	484	405
POVERTY LEVEL¹
Less Than 100%	9,646	10,283	534	630	9,112	9,653	2,950	2,998	6,163	6,655
100-199%	11,641	12,661	640	702	11,001	11,959	2,983	3,442	8,017	8,517
200% or More	31,881^b	38,955	1,671	1,614	30,210^b	37,341	6,186	6,857	24,024^b	30,483
HEALTH INSURANCE²
Private	28,889^b	35,745	1,464	1,505	27,425^b	34,239	7,012^a	7,849	20,413^b	26,390
Medicaid/CHIP	13,854^b	15,906	1,336	1,372	12,518^b	14,534	2,941^a	3,481	9,577^a	11,052
Other³	9,263^b	11,215	88^a	154	9,175^b	11,060	893	1,032	8,282^b	10,028
No Coverage	6,639	6,568	142	92	6,497	6,476	1,745	1,591	4,751	4,885
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.72B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	19.0^b	22.0	10.9	11.5	19.8^b	23.0	36.3	38.2	17.3^b	20.6
GEOGRAPHIC REGION
Northeast	20.4^a	23.0	11.3	12.5	21.3	23.9	37.5	39.2	18.9	21.6
Midwest	20.1^b	22.6	12.2	11.2	21.0^b	23.8	39.4	39.9	18.1^b	21.2
South	15.4^b	18.3	8.9	10.4	16.1^b	19.1	30.7	33.5	13.8^b	16.8
West	22.8^b	26.5	12.9	12.6	23.8^b	28.0	41.4	43.6	21.1^b	25.5
COUNTY TYPE
Large Metro	19.4^b	22.6	10.2	11.1	20.4^b	23.8	37.1	39.0	17.9^b	21.4
Small Metro	19.8^b	22.1	12.9	13.1	20.5^b	22.9	36.8	38.6	17.8^b	20.3
Nonmetro	15.9^b	19.0	9.5	8.9	16.5^b	19.8	32.0	33.3	14.4^b	18.1
Urbanized	17.4^a	21.2	12.0	11.0	18.0^a	22.1	37.2	37.8	14.9^b	19.8
Less Urbanized	15.1	17.5	8.1	7.0	15.8	18.4	28.2	31.7	14.2	16.7
Completely Rural	14.2	16.3	7.3	*	14.8	17.1	28.4^b	14.1	13.1	17.4
POVERTY LEVEL¹
Less Than 100%	22.2^a	24.8	9.7	12.0	24.1^a	26.7	34.9	37.2	21.0	23.6
100-199%	20.6^a	22.8	11.4	12.1	21.7^a	24.0	37.2	40.6	18.7	20.6
200% or More	17.7^b	21.1	11.2	11.0	18.3^b	21.9	36.7	37.6	16.2^b	20.1
HEALTH INSURANCE²
Private	17.2^b	21.0	10.6	10.7	17.8^b	22.0	37.1	39.5	15.1^b	19.4
Medicaid/CHIP	23.8^b	27.1	12.3	12.8	26.4^b	30.2	33.8^a	37.6	24.7^b	28.5
Other³	12.1^b	14.3	6.3	10.2	12.2^b	14.4	35.1	36.8	11.4^b	13.6
No Coverage	25.4	27.1	10.7	9.1	26.2	27.9	36.3	34.4	23.8	26.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.73A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	36,950^b	42,317	1,586	1,647	35,364^b	40,670	8,236^a	9,013	27,128^b	31,657
GEOGRAPHIC REGION
Northeast	7,141	7,932	259	303	6,882	7,629	1,498	1,652	5,384	5,977
Midwest	8,245	8,831	413	327	7,833	8,504	1,903	1,902	5,929	6,602
South	10,890^b	13,183	475	604	10,415^b	12,579	2,546^b	2,995	7,869^b	9,584
West	10,673^a	12,371	439	413	10,234^b	11,958	2,289	2,464	7,945^b	9,494
COUNTY TYPE
Large Metro	20,396^b	23,936	761	944	19,635^b	22,992	4,491	5,039	15,144^b	17,954
Small Metro	11,697^a	13,426	595	577	11,102^b	12,849	2,651	3,093	8,450^a	9,756
Nonmetro	4,857	4,954	229^b	126	4,628	4,828	1,094	881	3,534	3,947
Urbanized	1,985	2,332	89	76	1,896	2,256	554	435	1,343	1,822
Less Urbanized	2,434	2,281	122^b	48	2,312	2,233	463	428	1,849	1,805
Completely Rural	438	341	18^a	2	419	339	77^a	19	342	320
POVERTY LEVEL¹
Less Than 100%	6,807	7,133	294	344	6,513	6,790	2,008	2,024	4,504	4,765
100-199%	8,524	9,221	368	379	8,157	8,842	2,033^a	2,521	6,124	6,321
200% or More	21,608^b	25,962	924	924	20,684^b	25,038	4,183	4,467	16,500^b	20,571
HEALTH INSURANCE²
Private	18,937^b	23,479	815	871	18,122^b	22,608	4,574^a	5,227	13,548^b	17,380
Medicaid/CHIP	10,231^a	11,425	775	751	9,456^a	10,674	2,126	2,462	7,330	8,212
Other³	6,586	7,562	26^b	81	6,560	7,482	605	666	5,956	6,815
No Coverage	4,986	4,836	82	51	4,904	4,786	1,273	1,110	3,632	3,675
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.73B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	13.2^b	15.0	6.1	6.4	13.9^b	15.9	24.6	25.9	12.3^b	14.3
GEOGRAPHIC REGION
Northeast	14.6	16.2	6.2	7.5	15.4	17.0	26.2	27.9	13.8	15.3
Midwest	14.2	15.2	7.5	6.1	14.9	16.1	26.8	26.1	13.0	14.5
South	10.2^b	12.2	4.7	6.0	10.8^b	12.8	20.1	22.4	9.4^b	11.3
West	16.1^a	18.5	7.0	6.7	17.0^a	19.7	28.8	29.9	15.2^b	18.1
COUNTY TYPE
Large Metro	13.5^b	15.3	5.4	6.4	14.4^b	16.3	25.4	26.4	12.7^b	14.7
Small Metro	13.6^a	15.0	7.4	7.2	14.3^a	15.8	24.2	26.5	12.6	14.0
Nonmetro	11.2^b	13.5	5.7	4.3	11.8^b	14.3	22.6	22.1	10.2^b	13.2
Urbanized	12.3	15.1	5.9	6.1	13.0	15.9	27.4	24.7	10.6^a	14.6
Less Urbanized	10.8	12.4	5.9	3.4	11.3	13.1	19.7	21.7	10.2	12.0
Completely Rural	9.6	12.0	4.6^a	0.9	10.1	13.2	16.6	7.4	9.2	13.8
POVERTY LEVEL¹
Less Than 100%	15.7	17.2	5.4	6.5	17.2	18.8	23.7	25.1	15.3	16.9
100-199%	15.1	16.6	6.5	6.5	16.1	17.7	25.4^a	29.7	14.3	15.3
200% or More	12.0^b	14.0	6.2	6.3	12.5^b	14.7	24.8	24.5	11.1^b	13.5
HEALTH INSURANCE²
Private	11.3^b	13.8	5.9	6.2	11.7^b	14.5	24.2	26.3	10.0^b	12.8
Medicaid/CHIP	17.6^a	19.4	7.1	7.0	19.9^a	22.2	24.4	26.6	18.9	21.2
Other³	8.6	9.7	1.9^b	5.3	8.7	9.8	23.8	23.7	8.2	9.2
No Coverage	19.1	19.9	6.1	5.0	19.8	20.6	26.5	24.0	18.2	19.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.74A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	4,760	5,274	35	40	4,725	5,235	1,225	1,295	3,500	3,939
GEOGRAPHIC REGION
Northeast	993	1,083	4	10	990	1,073	220	212	770	860
Midwest	920	1,011	6	3	914	1,008	189^a	303	725	705
South	1,533	1,606	12	11	1,522	1,596	351	376	1,170	1,220
West	1,314	1,575	13	16	1,301	1,558	465	404	835	1,154
COUNTY TYPE
Large Metro	2,836	3,236	21	31	2,814	3,205	691	775	2,123	2,430
Small Metro	1,422	1,577	6	4	1,416	1,573	413	394	1,003	1,179
Nonmetro	503	461	7	5	495	457	121	126	375	330
Urbanized	211	208	2	2	209	206	55	63	154	143
Less Urbanized	211	252	6	2	205	250	56	63	149	187
Completely Rural	81	1	*	*	81	1	10	1	71	0
POVERTY LEVEL¹
Less Than 100%	1,174	1,000	1	4	1,173	996	313	300	860	696
100-199%	1,003	1,103	8	4	995	1,099	235	282	760	817
200% or More	2,583^a	3,171	26	32	2,558^a	3,139	677	713	1,881^a	2,426
HEALTH INSURANCE²
Private	2,040^b	2,732	6	24	2,033^b	2,708	732	848	1,302^a	1,860
Medicaid/CHIP	1,624	1,762	15	15	1,609	1,746	190	263	1,419	1,484
Other³	812	839	6	1	806	838	104	93	702	746
No Coverage	806	593	8	1	798	592	221	126	577	466
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.74B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.7	1.9	0.1	0.2	1.9	2.0	3.7	3.7	1.6	1.8
GEOGRAPHIC REGION
Northeast	2.0	2.2	0.1	0.2	2.2	2.4	3.8	3.6	2.0	2.2
Midwest	1.6	1.7	0.1	0.1	1.7	1.9	2.7^a	4.2	1.6	1.6
South	1.4	1.5	0.1	0.1	1.6	1.6	2.8	2.8	1.4	1.4
West	2.0	2.4	0.2	0.3	2.2	2.6	5.9	4.9	1.6	2.2
COUNTY TYPE
Large Metro	1.9	2.1	0.2	0.2	2.1	2.3	3.9	4.1	1.8	2.0
Small Metro	1.7	1.8	0.1	0.0	1.8	1.9	3.8	3.4	1.5	1.7
Nonmetro	1.2	1.3	0.2	0.2	1.3	1.4	2.5	3.2	1.1	1.1
Urbanized	1.3	1.3	0.1	0.2	1.4	1.4	2.7	3.6	1.2	1.1
Less Urbanized	0.9	1.4	0.3	0.2	1.0	1.5	2.4	3.2	0.8	1.2
Completely Rural	1.8^a	0.0	*	*	1.9^a	0.0	2.1	0.3	1.9	0.0
POVERTY LEVEL¹
Less Than 100%	2.7	2.4	0.0	0.1	3.1	2.8	3.7	3.7	2.9	2.5
100-199%	1.8	2.0	0.1	0.1	2.0	2.2	2.9	3.3	1.8	2.0
200% or More	1.4	1.7	0.2	0.2	1.5	1.8	4.0	3.9	1.3	1.6
HEALTH INSURANCE²
Private	1.2^b	1.6	0.0	0.2	1.3^b	1.7	3.9	4.3	1.0^a	1.4
Medicaid/CHIP	2.8	3.0	0.1	0.1	3.4	3.6	2.2	2.8	3.7	3.8
Other³	1.1	1.1	0.4	0.1	1.1	1.1	4.1	3.3	1.0	1.0
No Coverage	3.1	2.4	0.6	0.1	3.2	2.5	4.6	2.7	2.9	2.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.75A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1,846	2,015	5	5	1,841	2,010	363	403	1,478	1,607
GEOGRAPHIC REGION
Northeast	547	426	3	*	543	426	92	51	452	375
Midwest	267	407	0	0	267	407	48	104	218	303
South	594	566	*	4	594	563	71^a	145	523	418
West	439	616	1	1	438	615	153	103	285	512
COUNTY TYPE
Large Metro	1,105	1,326	4	5	1,101	1,321	215	261	886	1,060
Small Metro	586	496	1	*	585	496	110	107	474	389
Nonmetro	155	193	*	1	155	193	38	35	117	158
Urbanized	75	77	*	0	75	77	10	12	65	65
Less Urbanized	47	116	*	0	47	116	22	*	25	93
Completely Rural	33	*	*	*	33	*	5	*	28	*
POVERTY LEVEL¹
Less Than 100%	425	489	*	1	425	487	95	84	330	404
100-199%	402	453	4	*	398	453	83	85	315	368
200% or More	1,020	1,073	1	4	1,019	1,070	186	234	833	836
HEALTH INSURANCE²
Private	616	836	*	2	616	834	200	252	416	582
Medicaid/CHIP	733	922	4	3	728	920	63	86	665	833
Other³	386	398	*	1	386	397	28	16	358	381
No Coverage	347^a	206	*	1	347^a	205	78	59	269	146
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.75B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.7	0.7	0.0	0.0	0.7	0.8	1.1	1.2	0.7	0.7
GEOGRAPHIC REGION
Northeast	1.1	0.9	0.1	*	1.2	0.9	1.6	0.9	1.2	1.0
Midwest	0.5	0.7	0.0	0.0	0.5	0.8	0.7	1.4	0.5	0.7
South	0.6	0.5	*	0.0	0.6	0.6	0.6	1.1	0.6	0.5
West	0.7	0.9	0.0	0.0	0.7	1.0	1.9	1.2	0.5	1.0
COUNTY TYPE
Large Metro	0.7	0.9	0.0	0.0	0.8	0.9	1.2	1.4	0.7	0.9
Small Metro	0.7	0.6	0.0	*	0.8	0.6	1.0	0.9	0.7	0.6
Nonmetro	0.4	0.5	*	0.0	0.4	0.6	0.8	0.9	0.3	0.5
Urbanized	0.5	0.5	*	0.0	0.5	0.5	0.5	0.7	0.5	0.5
Less Urbanized	0.2	0.6	*	0.0	0.2	0.7	0.9	*	0.1	0.6
Completely Rural	0.7	*	*	*	0.8	*	1.2	*	0.8	*
POVERTY LEVEL¹
Less Than 100%	1.0	1.2	*	0.0	1.1	1.3	1.1	1.0	1.1	1.4
100-199%	0.7	0.8	0.1	*	0.8	0.9	1.0	1.0	0.7	0.9
200% or More	0.6	0.6	0.0	0.0	0.6	0.6	1.1	1.3	0.6	0.5
HEALTH INSURANCE²
Private	0.4	0.5	*	0.0	0.4	0.5	1.1	1.3	0.3	0.4
Medicaid/CHIP	1.3	1.6	0.0	0.0	1.5	1.9	0.7	0.9	1.7	2.1
Other³	0.5	0.5	*	0.1	0.5	0.5	1.1	0.6	0.5	0.5
No Coverage	1.3	0.8	*	0.1	1.4	0.9	1.6	1.3	1.3	0.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.76A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	10,625	10,167	1,003	918	519	573
GEOGRAPHIC REGION
Northeast	1,721	1,871	288	313	182	194
Midwest	2,463	2,017	172	208	66	168
South	3,559	3,565	444	292	244	167
West	2,882	2,714	98	105	27	44
COUNTY TYPE
Large Metro	5,410	4,934	557	561	310	394
Small Metro	3,597	3,692	328	258	172	104
Nonmetro	1,617	1,540	117	99	36	75
Urbanized	592	666	32	38	26	31
Less Urbanized	812	735	43	60	6	44
Completely Rural	214	140	42	0	5	*
POVERTY LEVEL¹
Less Than 100%	2,944	2,659	391	358	199	246
100-199%	3,015	2,627	353	359	193	225
200% or More	4,666	4,881	258	200	127	102
HEALTH INSURANCE²
Private	3,906	3,839	114	169	31	84
Medicaid/CHIP	4,171	4,138	601	642	324	418
Other³	2,731	2,690	334	381	221	248
No Coverage	1,649	1,218	184^a	60	98^a	21
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.76B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	3.8	3.6	0.4	0.3	0.2	0.2
GEOGRAPHIC REGION
Northeast	3.5	3.8	0.6	0.6	0.4	0.4
Midwest	4.2	3.5	0.3	0.4	0.1	0.3
South	3.3	3.3	0.4	0.3	0.2	0.2
West	4.3	4.1	0.1	0.2	0.0	0.1
COUNTY TYPE
Large Metro	3.6	3.2	0.4	0.4	0.2	0.3
Small Metro	4.2	4.1	0.4	0.3	0.2	0.1
Nonmetro	3.7	4.2	0.3	0.3	0.1	0.2
Urbanized	3.7	4.3	0.2	0.2	0.2	0.2
Less Urbanized	3.6	4.0	0.2	0.3	0.0	0.2
Completely Rural	4.7	4.9	0.9	0.0	0.1	*
POVERTY LEVEL¹
Less Than 100%	6.8	6.4	0.9	0.9	0.5	0.6
100-199%	5.3	4.7	0.6	0.6	0.3	0.4
200% or More	2.6	2.6	0.1	0.1	0.1	0.1
HEALTH INSURANCE²
Private	2.3	2.3	0.1	0.1	0.0	0.0
Medicaid/CHIP	7.2	7.0	1.0	1.1	0.6	0.7
Other³	3.6	3.4	0.4	0.5	0.3	0.3
No Coverage	6.3	5.0	0.7^a	0.2	0.4^a	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.77A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	46,474	48,850	7,572^a	8,509	2,301	2,289
GEOGRAPHIC REGION
Northeast	8,220	7,852	1,146	1,348	365	412
Midwest	9,745	9,928	1,716	1,461	548^a	327
South	14,094^a	15,532	2,035^a	2,504	506	746
West	14,415	15,537	2,675	3,195	882	805
COUNTY TYPE
Large Metro	25,980	26,684	4,536	5,074	1,375	1,446
Small Metro	14,648	16,175	2,011^b	2,639	577	626
Nonmetro	5,846	5,991	1,024	795	349	217
Urbanized	2,428	2,967	563	452	189	112
Less Urbanized	2,791	2,578	397	315	128	83
Completely Rural	627	446	64	28	32	22
POVERTY LEVEL¹
Less Than 100%	6,734	6,527	1,426	1,219	521	324
100-199%	8,995	8,943	1,683	1,669	550	402
200% or More	30,736^a	33,379	4,463^b	5,620	1,230	1,562
HEALTH INSURANCE²
Private	27,320^a	29,765	3,887^b	4,972	1,078	1,236
Medicaid/CHIP	10,052	10,534	2,225	2,213	783	718
Other³	10,105	11,097	746	831	166	303
No Coverage	4,944	4,688	1,098	1,073	383	269
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.77B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Lifetime (2021)	Lifetime (2022)	Past Year (2021)	Past Year (2022)	Past Month (2021)	Past Month (2022)
TOTAL	16.6	17.3	2.7	3.0	0.8	0.8
GEOGRAPHIC REGION
Northeast	16.8	16.0	2.3	2.7	0.7	0.8
Midwest	16.8	17.1	3.0	2.5	0.9^a	0.6
South	13.2^a	14.4	1.9	2.3	0.5	0.7
West	21.7	23.3	4.0	4.8	1.3	1.2
COUNTY TYPE
Large Metro	17.2	17.1	3.0	3.3	0.9	0.9
Small Metro	17.1	18.1	2.3^a	3.0	0.7	0.7
Nonmetro	13.5^a	16.3	2.4	2.2	0.8	0.6
Urbanized	15.0^a	19.2	3.5	2.9	1.2	0.7
Less Urbanized	12.4	14.0	1.8	1.7	0.6	0.5
Completely Rural	13.7	15.6	1.4	1.0	0.7	0.8
POVERTY LEVEL¹
Less Than 100%	15.5	15.7	3.3	2.9	1.2	0.8
100-199%	15.9	16.1	3.0	3.0	1.0	0.7
200% or More	17.1	18.1	2.5^b	3.0	0.7	0.8
HEALTH INSURANCE²
Private	16.2^a	17.5	2.3^b	2.9	0.6	0.7
Medicaid/CHIP	17.2	17.9	3.8	3.8	1.3	1.2
Other³	13.2	14.2	1.0	1.1	0.2	0.4
No Coverage	18.9	19.3	4.2	4.4	1.5	1.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.78A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	2,119	2,254	643	554	1,475	1,700	507	647	968	1,053
GEOGRAPHIC REGION
Northeast	452	432	89	64	363	368	98	159	265	209
Midwest	346	410	106	110	240	301	78	90	162	210
South	736	687	220	221	516	467	176	174	340	293
West	584	724	228	159	356	565	155	224	201	341
COUNTY TYPE
Large Metro	1,323	1,373	403	309	921	1,064	264	390	657	674
Small Metro	622	582	174	164	448	418	197	185	251	233
Nonmetro	173	299	67	81	106	219	47	72	60	147
Urbanized	67	97	26	26	41	71	16	47	25	24
Less Urbanized	101	139	36	41	65	98	30	25	35	73
Completely Rural	6	64	5	*	1	50	1	*	*	50
POVERTY LEVEL¹
Less Than 100%	312	307	96	116	217	191	125	106	92	85
100-199%	405	458	120	117	285	341	169	164	116	177
200% or More	1,401	1,489	428	321	974	1,168	213^b	377	761	791
HEALTH INSURANCE²
Private	1,199	1,409	347	313	853	1,096	314	414	539	682
Medicaid/CHIP	624	544	269	201	355	343	105	143	251	200
Other³	214	237	38	33	175	204	33	51	143	153
No Coverage	245	226	16	29	230	197	77	63	152	134
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.78B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.8	0.8	2.5	2.2	0.6	0.7	1.5	1.9	0.4	0.5
GEOGRAPHIC REGION
Northeast	0.9	0.9	2.1	1.6	0.8	0.8	1.7	2.7	0.7	0.5
Midwest	0.6	0.7	1.9	2.0	0.5	0.6	1.1	1.2	0.4	0.5
South	0.7	0.6	2.2	2.2	0.5	0.5	1.4	1.3	0.4	0.3
West	0.9	1.1	3.7	2.6	0.6	0.9	2.0	2.7	0.4	0.7
COUNTY TYPE
Large Metro	0.9	0.9	2.9	2.1	0.7	0.8	1.5	2.0	0.6	0.6
Small Metro	0.7	0.7	2.2	2.1	0.6	0.5	1.8	1.6	0.4	0.3
Nonmetro	0.4^a	0.8	1.7	2.8	0.3^a	0.6	1.0	1.8	0.2	0.5
Urbanized	0.4	0.6	1.7	2.1	0.3	0.5	0.8^a	2.7	0.2	0.2
Less Urbanized	0.4	0.8	1.7	2.9	0.3	0.6	1.3	1.3	0.2	0.5
Completely Rural	0.1	2.2	1.2	*	0.0	1.9	0.2	*	*	2.2
POVERTY LEVEL¹
Less Than 100%	0.7	0.7	1.7	2.2	0.6	0.5	1.5	1.3	0.3	0.3
100-199%	0.7	0.8	2.1	2.0	0.6	0.7	2.1	1.9	0.3	0.4
200% or More	0.8	0.8	2.9	2.2	0.6	0.7	1.3^a	2.1	0.5	0.5
HEALTH INSURANCE²
Private	0.7	0.8	2.5	2.2	0.6	0.7	1.7	2.1	0.4	0.5
Medicaid/CHIP	1.1	0.9	2.5	1.9	0.7	0.7	1.2	1.5	0.6	0.5
Other³	0.3	0.3	2.8	2.2	0.2	0.3	1.3	1.8	0.2	0.2
No Coverage	0.9	0.9	1.2	2.9	0.9	0.8	1.6	1.4	0.8	0.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.79A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	787	842	222	170	565	672	119	193	446	479
GEOGRAPHIC REGION
Northeast	161	196	28	22	133	174	25	48	109	127
Midwest	119	198	31	32	88	166	17	31	71	134
South	302	279	76	70	226	209	49	71	178	138
West	205	169	88	46	117	123	29	43	88	80
COUNTY TYPE
Large Metro	496	528	142	100	354	428	49	103	304	324
Small Metro	242	216	56	44	186	171	54	70	132	101
Nonmetro	50	98	24	25	26	73	16	20	10	53
Urbanized	15	41	7	13	9	28	0^a	17	8	11
Less Urbanized	31	29	14	12	17	17	15	3	2	14
Completely Rural	3	*	3	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	97	140	28	43	69	97	43	42	25	55
100-199%	188	152	52	22	136	130	47	44	90	86
200% or More	502	549	142	104	360	445	29^b	107	331	338
HEALTH INSURANCE²
Private	461	531	119	86	342	445	68	123	274	322
Medicaid/CHIP	231	171	104	53	126	118	33	33	93	85
Other³	82	137	7	17	75	121	2	14	72	107
No Coverage	121	90	2	19	118	71	17	28	101	42
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.79B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.3	0.3	0.9	0.7	0.2	0.3	0.4	0.6	0.2	0.2
GEOGRAPHIC REGION
Northeast	0.3	0.4	0.7	0.5	0.3	0.4	0.4	0.8	0.3	0.3
Midwest	0.2	0.3	0.6	0.6	0.2	0.3	0.2	0.4	0.2	0.3
South	0.3	0.3	0.7	0.7	0.2	0.2	0.4	0.5	0.2	0.2
West	0.3	0.3	1.4	0.7	0.2	0.2	0.4	0.5	0.2	0.2
COUNTY TYPE
Large Metro	0.3	0.3	1.0	0.7	0.3	0.3	0.3	0.5	0.3	0.3
Small Metro	0.3	0.2	0.7	0.6	0.2	0.2	0.5	0.6	0.2	0.1
Nonmetro	0.1	0.3	0.6	0.9	0.1	0.2	0.3	0.5	0.0	0.2
Urbanized	0.1	0.3	0.4	1.0	0.1	0.2	0.0^a	0.9	0.1	0.1
Less Urbanized	0.1	0.2	0.7	0.9	0.1	0.1	0.7	0.2	0.0	0.1
Completely Rural	0.1	*	0.8	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.2	0.3	0.5	0.8	0.2	0.3	0.5	0.5	0.1	0.2
100-199%	0.3	0.3	0.9	0.4	0.3	0.3	0.6	0.5	0.2	0.2
200% or More	0.3	0.3	1.0	0.7	0.2	0.3	0.2^b	0.6	0.2	0.2
HEALTH INSURANCE²
Private	0.3	0.3	0.9	0.6	0.2	0.3	0.4	0.6	0.2	0.2
Medicaid/CHIP	0.4	0.3	1.0	0.5	0.3	0.2	0.4	0.4	0.2	0.2
Other³	0.1	0.2	0.5	1.1	0.1	0.2	0.1	0.5	0.1	0.1
No Coverage	0.5	0.4	0.2	1.9	0.5	0.3	0.4	0.6	0.5	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.80A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	2,640	2,705	35	18	2,605	2,687	183	161	2,422	2,526
GEOGRAPHIC REGION
Northeast	345^a	139	1	5	344^a	134	48	7	296^a	127
Midwest	468	697	9	5	459	693	10^b	83	448	610
South	962	867	12	3	950	864	60	45	890	819
West	865	1,002	14	5	852	997	64	27	788	970
COUNTY TYPE
Large Metro	1,216	1,215	19	5	1,197	1,209	51	79	1,146	1,131
Small Metro	757	916	3	5	754	912	91	55	663	856
Nonmetro	667	574	13	8	654	566	41	27	613	539
Urbanized	214	230	8	4	206	226	7	11	199	215
Less Urbanized	391	286	6	4	385	282	31	14	355	268
Completely Rural	62	58	*	*	62	58	*	*	59	*
POVERTY LEVEL¹
Less Than 100%	891	926	8	1	883	925	59	59	824	866
100-199%	918	866	4	9	914	857	44	29	869	827
200% or More	831	913	23	8	808	905	79	73	729	832
HEALTH INSURANCE²
Private	375	494	8	9	367	485	54	51	312	434
Medicaid/CHIP	1,436	1,491	24	12	1,412	1,479	94	85	1,318	1,394
Other³	555	711	2	*	552	711	8	7	544	704
No Coverage	513	389	2	*	511	389	32	23	479	365
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.80B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.9	1.0	0.1	0.1	1.0	1.0	0.5	0.5	1.1	1.1
GEOGRAPHIC REGION
Northeast	0.7^a	0.3	0.0	0.1	0.8^a	0.3	0.8	0.1	0.8^a	0.3
Midwest	0.8	1.2	0.2	0.1	0.9	1.3	0.1^b	1.1	1.0	1.3
South	0.9	0.8	0.1	0.0	1.0	0.9	0.5	0.3	1.1	1.0
West	1.3	1.5	0.2	0.1	1.4	1.6	0.8	0.3	1.5	1.9
COUNTY TYPE
Large Metro	0.8	0.8	0.1	0.0	0.9	0.9	0.3	0.4	1.0	0.9
Small Metro	0.9	1.0	0.0	0.1	1.0	1.1	0.8	0.5	1.0	1.2
Nonmetro	1.5	1.6	0.3	0.3	1.7	1.7	0.8	0.7	1.8	1.8
Urbanized	1.3	1.5	0.5	0.3	1.4	1.6	0.3	0.6	1.6	1.7
Less Urbanized	1.7	1.6	0.3	0.3	1.9	1.7	1.3	0.7	2.0	1.8
Completely Rural	1.4	2.0	*	*	1.5	2.3	*	*	1.6	*
POVERTY LEVEL¹
Less Than 100%	2.1	2.2	0.1	0.0	2.3	2.6	0.7	0.7	2.8	3.1
100-199%	1.6	1.6	0.1	0.2	1.8	1.7	0.6	0.3	2.0	2.0
200% or More	0.5	0.5	0.2	0.1	0.5	0.5	0.5	0.4	0.5	0.5
HEALTH INSURANCE²
Private	0.2	0.3	0.1	0.1	0.2	0.3	0.3	0.3	0.2	0.3
Medicaid/CHIP	2.5	2.5	0.2	0.1	3.0	3.1	1.1	0.9	3.4	3.6
Other³	0.7	0.9	0.2	*	0.7	0.9	0.3	0.2	0.7	1.0
No Coverage	2.0	1.6	0.1	*	2.1	1.7	0.7	0.5	2.4	2.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.81A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1,630	1,685	16	3	1,614	1,682	103	54	1,511	1,628
GEOGRAPHIC REGION
Northeast	112	96	*	*	112	96	26	3	86	93
Midwest	335	312	*	1	335	311	1^a	16	334	295
South	494	580	10	1	485	579	33	18	452	561
West	689	697	6	1	682	697	43	18	639	679
COUNTY TYPE
Large Metro	806	780	8	1	798	779	21	10	777	769
Small Metro	389	531	3	1	386	530	58	34	329^a	497
Nonmetro	436	374	6	1	430	373	25	11	405	362
Urbanized	140	151	1	0	139	151	3	6	137	145
Less Urbanized	238	178	5	1	233	177	22	5	211	173
Completely Rural	57	*	*	*	57	*	*	*	57	*
POVERTY LEVEL¹
Less Than 100%	566	551	8	*	559	551	38	27	521	524
100-199%	554	538	2	1	552	538	21	12	531	526
200% or More	510	596	6	2	503	594	44	16	459	578
HEALTH INSURANCE²
Private	172	277	6	3	166	274	7	20	159	255
Medicaid/CHIP	933	950	10	1	922	950	66	23	857	927
Other³	334	466	*	*	334	466	7	5	326	461
No Coverage	339	238	*	*	339	238	27	11	312	226
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.81B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.6	0.6	0.1	0.0	0.6	0.7	0.3	0.2	0.7	0.7
GEOGRAPHIC REGION
Northeast	0.2	0.2	*	*	0.3	0.2	0.5	0.0	0.2	0.2
Midwest	0.6	0.5	*	0.0	0.6	0.6	0.0^a	0.2	0.7	0.6
South	0.5	0.5	0.1	0.0	0.5	0.6	0.3	0.1	0.5	0.7
West	1.0	1.0	0.1	0.0	1.1	1.1	0.5	0.2	1.2	1.3
COUNTY TYPE
Large Metro	0.5	0.5	0.1	0.0	0.6	0.6	0.1	0.1	0.7	0.6
Small Metro	0.5	0.6	0.0	0.0	0.5	0.7	0.5	0.3	0.5	0.7
Nonmetro	1.0	1.0	0.1	0.0	1.1	1.1	0.5	0.3	1.2	1.2
Urbanized	0.9	1.0	0.0	0.0	1.0	1.1	0.1	0.3	1.1	1.2
Less Urbanized	1.1	1.0	0.3	0.0	1.1	1.0	0.9	0.2	1.2	1.1
Completely Rural	1.2	*	*	*	1.4	*	*	*	1.5	*
POVERTY LEVEL¹
Less Than 100%	1.3	1.3	0.1	*	1.5	1.5	0.5	0.3	1.8	1.9
100-199%	1.0	1.0	0.0	0.0	1.1	1.1	0.3	0.1	1.2	1.3
200% or More	0.3	0.3	0.0	0.0	0.3	0.3	0.3	0.1	0.3	0.4
HEALTH INSURANCE²
Private	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.2
Medicaid/CHIP	1.6	1.6	0.1	0.0	1.9	2.0	0.8	0.2	2.2	2.4
Other³	0.4	0.6	*	*	0.4	0.6	0.3	0.2	0.4	0.6
No Coverage	1.3	1.0	*	*	1.4	1.0	0.6	0.2	1.6	1.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.82A – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	72,811	73,833	3,492	3,191	69,319	70,642	6,265	6,489	63,054	64,153
GEOGRAPHIC REGION
Northeast	10,490	10,781	539^a	395	9,952	10,386	889	891	9,062	9,495
Midwest	15,585	15,978	742	684	14,843	15,294	1,391	1,452	13,452	13,842
South	29,598	30,013	1,326	1,366	28,272	28,647	2,536	2,690	25,736	25,957
West	17,138	17,062	885	746	16,253	16,315	1,449	1,457	14,804	14,858
COUNTY TYPE
Large Metro	36,910	38,843	1,729	1,624	35,181	37,219	3,068	3,475	32,114	33,744
Small Metro	23,126	23,863	1,166	1,139	21,960	22,723	2,236	2,220	19,724	20,503
Nonmetro	12,776	11,128	597^a	428	12,178	10,700	961	794	11,217	9,906
Urbanized	4,693	4,563	224	176	4,469	4,386	372	369	4,097	4,017
Less Urbanized	6,628	5,600	320^a	213	6,308	5,386	460	374	5,848	5,013
Completely Rural	1,455	965	53	38	1,401	928	130	*	1,272	877
POVERTY LEVEL¹
Less Than 100%	12,801	11,508	819	682	11,982	10,826	1,588	1,455	10,394	9,371
100-199%	15,679	15,866	861	782	14,818	15,084	1,583	1,680	13,235	13,405
200% or More	44,328	46,458	1,812	1,726	42,516	44,731	3,091	3,354	39,426	41,378
HEALTH INSURANCE²
Private	40,063	41,440	1,720	1,622	38,343	39,819	3,282	3,693	35,061	36,126
Medicaid/CHIP	18,666	18,027	1,609	1,484	17,056	16,542	1,898	1,949	15,158	14,593
Other³	24,948	25,880	141	209	24,806	25,671	526	496	24,280	25,175
No Coverage	5,590	5,030	173	134	5,417	4,896	886	747	4,531	4,149
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.82B – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	26.0	26.2	13.4	12.4	27.3	27.6	18.7	18.7	28.6	29.0
GEOGRAPHIC REGION
Northeast	21.4	22.0	13.0^a	9.7	22.2	23.1	15.5	15.1	23.2	24.3
Midwest	26.9	27.5	13.5	12.7	28.3	29.0	19.6	19.9	29.6	30.5
South	27.8	27.8	13.1	13.5	29.3	29.2	20.0	20.2	30.7	30.7
West	25.8	25.6	14.2	12.2	27.1	26.9	18.3	17.7	28.4	28.4
COUNTY TYPE
Large Metro	24.5	24.9	12.3	11.0	25.7	26.4	17.4	18.2	27.0	27.7
Small Metro	27.0	26.7	14.6	14.3	28.2	27.9	20.4	19.0	29.5	29.4
Nonmetro	29.5	30.3	15.0	14.6	31.0	31.6	19.9	19.9	32.5	33.2
Urbanized	29.0	29.5	14.8	14.2	30.5	30.8	18.4	21.0	32.5	32.2
Less Urbanized	29.3	30.4	15.4	15.1	30.7	31.7	19.5	19.0	32.2	33.3
Completely Rural	31.9	33.8	13.3	13.6	33.7	36.0	27.8	*	34.4	37.7
POVERTY LEVEL¹
Less Than 100%	29.5	27.7	14.9	12.9	31.6	29.9	18.8	18.1	35.4	33.3
100-199%	27.8	28.5	15.3	13.5	29.2	30.3	19.7	19.8	30.9	32.4
200% or More	24.6	25.1	12.1	11.8	25.8	26.3	18.3	18.4	26.6	27.2
HEALTH INSURANCE²
Private	23.8	24.4	12.4	11.5	24.8	25.5	17.4	18.6	25.9	26.6
Medicaid/CHIP	32.0	30.7	14.8	13.9	36.0	34.4	21.8	21.0	39.1	37.6
Other³	32.5	33.1	10.2	13.9	32.9	33.5	20.7	17.7	33.4	34.1
No Coverage	21.4	20.7	13.0	13.3	21.8	21.1	18.4	16.1	22.7	22.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.83A – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	8,885	8,457	550	406	8,335	8,051	1,050	1,099	7,286	6,953
GEOGRAPHIC REGION
Northeast	1,534	1,265	100	49	1,434	1,216	170	144	1,264	1,072
Midwest	1,761	1,628	137^a	65	1,624	1,563	189	239	1,435	1,324
South	3,431	3,428	206	189	3,225	3,239	397	448	2,828	2,791
West	2,160	2,137	108	103	2,052	2,034	294	269	1,758	1,765
COUNTY TYPE
Large Metro	4,541	4,625	301^a	203	4,240	4,422	520	587	3,720	3,835
Small Metro	2,935	2,764	182	165	2,752	2,600	381	399	2,372	2,200
Nonmetro	1,410	1,067	66	38	1,343	1,030	149	112	1,194	917
Urbanized	523	441	36^a	12	487	429	61	47	427	382
Less Urbanized	747	544	29	21	719	524	75	57	643	467
Completely Rural	139	82	2	*	138	77	13	8	124	69
POVERTY LEVEL¹
Less Than 100%	2,149	1,946	125	92	2,024	1,853	256	245	1,768	1,608
100-199%	2,034	1,901	138	110	1,896	1,791	311	269	1,585	1,522
200% or More	4,702	4,610	287	203	4,416	4,407	483	584	3,933	3,823
HEALTH INSURANCE²
Private	4,000	3,992	233	211	3,767	3,781	478	570	3,289	3,211
Medicaid/CHIP	3,136	3,122	270	187	2,866	2,935	312	347	2,555	2,587
Other³	1,958	2,059	40	23	1,918	2,036	100	78	1,818	1,958
No Coverage	1,091	859	37	8	1,054	851	196	162	859	689
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.83B – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3.2	3.0	2.1	1.6	3.3	3.1	3.1	3.2	3.3	3.1
GEOGRAPHIC REGION
Northeast	3.1	2.6	2.4	1.2	3.2	2.7	3.0	2.4	3.2	2.7
Midwest	3.0	2.8	2.5^a	1.2	3.1	3.0	2.7	3.3	3.2	2.9
South	3.2	3.2	2.0	1.9	3.3	3.3	3.1	3.4	3.4	3.3
West	3.3	3.2	1.7	1.7	3.4	3.4	3.7	3.3	3.4	3.4
COUNTY TYPE
Large Metro	3.0	3.0	2.1^a	1.4	3.1	3.1	2.9	3.1	3.1	3.1
Small Metro	3.4	3.1	2.3	2.1	3.5	3.2	3.5	3.4	3.6	3.2
Nonmetro	3.3	2.9	1.7	1.3	3.4	3.0	3.1	2.8	3.5	3.1
Urbanized	3.2	2.8	2.4	0.9	3.3	3.0	3.0	2.7	3.4	3.1
Less Urbanized	3.3	3.0	1.4	1.5	3.5	3.1	3.2	2.9	3.5	3.1
Completely Rural	3.1	2.9	0.5	*	3.3	3.0	2.9	3.3	3.4	3.0
POVERTY LEVEL¹
Less Than 100%	5.0	4.7	2.3	1.8	5.3	5.1	3.0	3.0	6.0	5.7
100-199%	3.6	3.4	2.5	1.9	3.7	3.6	3.9	3.2	3.7	3.7
200% or More	2.6	2.5	1.9	1.4	2.7	2.6	2.9	3.2	2.7	2.5
HEALTH INSURANCE²
Private	2.4	2.3	1.7	1.5	2.4	2.4	2.5	2.9	2.4	2.4
Medicaid/CHIP	5.4	5.3	2.5	1.8	6.0	6.1	3.6	3.7	6.6	6.7
Other³	2.6	2.6	2.9	1.5	2.5	2.7	3.9	2.8	2.5	2.6
No Coverage	4.2	3.5	2.8	0.8	4.3	3.7	4.1	3.5	4.3	3.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.84A – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	2,427	2,439	133	116	2,294	2,323	232	214	2,061	2,109
GEOGRAPHIC REGION
Northeast	532	419	46	10	486	409	31	22	454	387
Midwest	406	463	16	14	390	449	40	45	350	404
South	947	1,007	55	60	892	947	75	113	818	835
West	541	550	15	31	526	518	87	35	439	483
COUNTY TYPE
Large Metro	1,214	1,293	68	68	1,146	1,225	104	93	1,042	1,132
Small Metro	910	795	41	39	869	757	101	86	768	670
Nonmetro	302	351	24	10	278	342	27	35	252	306
Urbanized	111	138	13^a	1	99	137	8	11	91	126
Less Urbanized	168	191	11	9	157	182	18	22	139	160
Completely Rural	22	23	*	*	22	*	1	*	21	*
POVERTY LEVEL¹
Less Than 100%	707	610	41	41	666	569	49	52	618	518
100-199%	588	559	56^a	17	532	543	91	72	441	471
200% or More	1,131	1,269	36	58	1,095	1,211	93	91	1,002	1,120
HEALTH INSURANCE²
Private	854	1,008	39	61	815	947	91	99	724	848
Medicaid/CHIP	1,064	1,074	70	50	993	1,024	101	54	892	970
Other³	725	574	13	5	712	569	15	20	698	549
No Coverage	292	245	15	6	277	239	38	46	239	193
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.84B – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.9	0.9	0.5	0.5	0.9	0.9	0.7	0.6	0.9	1.0
GEOGRAPHIC REGION
Northeast	1.1	0.9	1.1	0.3	1.1	0.9	0.5	0.4	1.2	1.0
Midwest	0.7	0.8	0.3	0.3	0.7	0.9	0.6	0.6	0.8	0.9
South	0.9	0.9	0.5	0.6	0.9	1.0	0.6	0.8	1.0	1.0
West	0.8	0.8	0.2	0.5	0.9	0.9	1.1	0.4	0.8	0.9
COUNTY TYPE
Large Metro	0.8	0.8	0.5	0.5	0.8	0.9	0.6	0.5	0.9	0.9
Small Metro	1.1	0.9	0.5	0.5	1.1	0.9	0.9	0.7	1.1	1.0
Nonmetro	0.7	1.0	0.6	0.3	0.7	1.0	0.6	0.9	0.7	1.0
Urbanized	0.7	0.9	0.9	0.1	0.7	1.0	0.4	0.6	0.7	1.0
Less Urbanized	0.7	1.0	0.5	0.6	0.8	1.1	0.8	1.1	0.8	1.1
Completely Rural	0.5	0.8	*	*	0.5	*	0.2	*	0.6	*
POVERTY LEVEL¹
Less Than 100%	1.6	1.5	0.7	0.8	1.8	1.6	0.6	0.6	2.1	1.8
100-199%	1.0	1.0	1.0^a	0.3	1.0	1.1	1.1	0.8	1.0	1.1
200% or More	0.6	0.7	0.2	0.4	0.7	0.7	0.6	0.5	0.7	0.7
HEALTH INSURANCE²
Private	0.5	0.6	0.3	0.4	0.5	0.6	0.5	0.5	0.5	0.6
Medicaid/CHIP	1.8	1.8	0.6	0.5	2.1	2.1	1.2	0.6	2.3	2.5
Other³	0.9	0.7	0.9	0.3	0.9	0.7	0.6	0.7	1.0	0.7
No Coverage	1.1	1.0	1.1	0.6	1.1	1.0	0.8	1.0	1.2	1.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.85A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	16,878^b	19,674	1,829	1,845	15,049^b	17,830	3,473	3,794	11,576^b	14,035
GEOGRAPHIC REGION
Northeast	3,071	3,046	255	215	2,816	2,832	680	637	2,136	2,194
Midwest	3,673^b	4,681	484	429	3,189^b	4,252	701^b	1,039	2,488^b	3,214
South	6,296^b	7,730	690	826	5,606^b	6,905	1,260	1,338	4,346^b	5,567
West	3,839	4,217	400	376	3,438	3,841	832	780	2,606	3,061
COUNTY TYPE
Large Metro	9,285^a	10,622	940	1,038	8,345^a	9,584	1,863	1,995	6,482	7,589
Small Metro	5,434^b	6,700	571	596	4,863^b	6,105	1,155	1,371	3,708^b	4,733
Nonmetro	2,159	2,352	318^a	211	1,841	2,141	455	428	1,386	1,713
Urbanized	840	1,055	143	97	698	957	179	225	519	732
Less Urbanized	1,110	1,137	152	95	958	1,043	232	176	726	866
Completely Rural	209	160	24	19	186	141	44	27	141	114
POVERTY LEVEL¹
Less Than 100%	3,003	2,649	355^a	233	2,648	2,416	814	742	1,834	1,675
100-199%	3,124	3,569	381	423	2,743	3,146	643	777	2,100	2,369
200% or More	10,746^b	13,453	1,093	1,189	9,653^b	12,264	2,011	2,273	7,642^b	9,992
HEALTH INSURANCE²
Private	10,384^b	12,457	1,009	1,139	9,375^b	11,318	2,437	2,611	6,938^b	8,707
Medicaid/CHIP	4,508	4,738	800	666	3,707	4,072	650^a	879	3,058	3,194
Other³	2,704^a	3,394	102	144	2,602	3,250	258	278	2,344	2,971
No Coverage	1,246	1,451	75	29	1,171	1,422	298	222	873	1,199
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.85B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	6.0^b	7.0	7.0	7.2	5.9^b	7.0	10.4	10.9	5.3^b	6.3
GEOGRAPHIC REGION
Northeast	6.3	6.2	6.1	5.3	6.3	6.3	11.9	10.8	5.5	5.6
Midwest	6.3^b	8.0	8.8	7.9	6.1^b	8.1	9.9^b	14.2	5.5^b	7.1
South	5.9^b	7.2	6.8	8.2	5.8^b	7.0	9.9	10.0	5.2^b	6.6
West	5.8	6.3	6.4	6.1	5.7	6.3	10.5	9.5	5.0	5.8
COUNTY TYPE
Large Metro	6.2	6.8	6.7	7.0	6.1	6.8	10.6	10.4	5.4	6.2
Small Metro	6.3^b	7.5	7.1	7.5	6.3^b	7.5	10.5	11.7	5.5^a	6.8
Nonmetro	5.0^b	6.4	8.0	7.2	4.7^b	6.3	9.4	10.8	4.0^b	5.7
Urbanized	5.2^a	6.8	9.4	7.9	4.8^a	6.7	8.9^a	12.8	4.1	5.9
Less Urbanized	4.9	6.2	7.3	6.7	4.7	6.1	9.9	8.9	4.0^a	5.8
Completely Rural	4.6	5.6	5.9	6.7	4.5	5.5	9.5	10.9	3.8	4.9
POVERTY LEVEL¹
Less Than 100%	6.9	6.4	6.5^a	4.4	7.0	6.7	9.6	9.2	6.2	5.9
100-199%	5.5	6.4	6.8	7.3	5.4	6.3	8.0	9.2	4.9	5.7
200% or More	6.0^b	7.3	7.3	8.1	5.8^b	7.2	11.9	12.5	5.2^b	6.6
HEALTH INSURANCE²
Private	6.2^b	7.3	7.3	8.1	6.1^b	7.3	12.9	13.1	5.1^b	6.4
Medicaid/CHIP	7.7	8.1	7.4	6.2	7.8	8.5	7.5^a	9.5	7.9	8.2
Other³	3.5	4.3	7.4	9.6	3.5	4.2	10.1	9.9	3.2	4.0
No Coverage	4.8	6.0	5.7	2.9	4.7	6.1	6.2	4.8	4.4^a	6.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.86A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3,910	4,298	302	226	3,608	4,072	1,359	1,278	2,249^a	2,794
GEOGRAPHIC REGION
Northeast	855	718	58	42	797	676	296	224	501	452
Midwest	955	997	79^a	31	875	967	295	352	581	614
South	1,175^a	1,552	86	84	1,088^a	1,469	411	427	677^b	1,042
West	926	1,031	79	70	847	961	357	274	490	687
COUNTY TYPE
Large Metro	2,229	2,563	193	114	2,037	2,449	719	727	1,318	1,722
Small Metro	1,217	1,332	84	97	1,134	1,234	466	456	668	778
Nonmetro	463	403	26	14	437	389	174^a	95	263	294
Urbanized	195	158	16^a	1	179	157	76	50	103	107
Less Urbanized	248	211	8	7	240	205	90	38	150	166
Completely Rural	21	33	2	*	19	27	8	*	11	*
POVERTY LEVEL¹
Less Than 100%	768	563	51	17	717	546	329	252	388	294
100-199%	680	760	69	63	610	697	225	249	386	448
200% or More	2,462^a	2,972	182	146	2,280^a	2,826	805	773	1,476^b	2,053
HEALTH INSURANCE²
Private	2,392	2,733	189	144	2,202	2,589	1,005	920	1,197^a	1,669
Medicaid/CHIP	965	1,002	91	70	874	933	205	225	668	707
Other³	346	450	10	25	336	425	106	113	231	312
No Coverage	484	366	30	4	454	362	116	73	337	290
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.86B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.4	1.5	1.2	0.9	1.4	1.6	4.1	3.7	1.0^a	1.3
GEOGRAPHIC REGION
Northeast	1.7	1.5	1.4	1.0	1.8	1.5	5.2	3.8	1.3	1.2
Midwest	1.6	1.7	1.4^a	0.6	1.7	1.8	4.1	4.8	1.3	1.4
South	1.1^a	1.4	0.9	0.8	1.1^a	1.5	3.2	3.2	0.8^b	1.2
West	1.4	1.5	1.3	1.1	1.4	1.6	4.5	3.3	0.9	1.3
COUNTY TYPE
Large Metro	1.5	1.6	1.4^a	0.8	1.5	1.7	4.1	3.8	1.1	1.4
Small Metro	1.4	1.5	1.0	1.2	1.5	1.5	4.3	3.9	1.0	1.1
Nonmetro	1.1	1.1	0.7	0.5	1.1	1.2	3.6	2.4	0.8	1.0
Urbanized	1.2	1.0	1.1^a	0.1	1.2	1.1	3.7	2.8	0.8	0.9
Less Urbanized	1.1	1.1	0.4	0.5	1.2	1.2	3.8	1.9	0.8	1.1
Completely Rural	0.4	1.2	0.4	*	0.5	1.1	1.7	*	0.3	*
POVERTY LEVEL¹
Less Than 100%	1.8	1.4	0.9	0.3	1.9	1.5	3.9	3.1	1.3	1.0
100-199%	1.2	1.4	1.2	1.1	1.2	1.4	2.8	2.9	0.9	1.1
200% or More	1.4	1.6	1.2	1.0	1.4	1.7	4.8	4.2	1.0^a	1.4
HEALTH INSURANCE²
Private	1.4	1.6	1.4	1.0	1.4	1.7	5.3	4.6	0.9^a	1.2
Medicaid/CHIP	1.7	1.7	0.8	0.7	1.8	1.9	2.4	2.4	1.7	1.8
Other³	0.5	0.6	0.7	1.7	0.4	0.6	4.1	4.0	0.3	0.4
No Coverage	1.9	1.5	2.3	0.4	1.8	1.6	2.4	1.6	1.7	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.87A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1,124	1,348	80^a	33	1,044	1,315	307	376	737	939
GEOGRAPHIC REGION
Northeast	274	286	24	7	250	279	61	92	189	186
Midwest	363	315	14	6	348	309	89	103	259	205
South	267^b	502	17	12	250^b	490	84	130	166^b	360
West	221	245	25	8	196	237	72	50	124	187
COUNTY TYPE
Large Metro	666	835	56^a	14	610	821	174	207	436	614
Small Metro	326	403	14	18	311	385	99	142	212	243
Nonmetro	133	110	10^a	1	123	109	34	27	89	82
Urbanized	70	48	*	*	65	48	25	14	40	34
Less Urbanized	58	61	5	1	54	60	9	12	45	48
Completely Rural	4	0	*	*	4	0	0	*	4	0
POVERTY LEVEL¹
Less Than 100%	236	155	6	1	229	154	91	77	138	78
100-199%	202	265	27	8	175	257	44	92	131	165
200% or More	687	927	47	24	640	903	172	207	468	696
HEALTH INSURANCE²
Private	622^a	871	46	21	576^a	849	229	270	346^a	580
Medicaid/CHIP	258	313	21	14	236	299	42	74	195	225
Other³	116	138	2	0	114	137	25	29	89	108
No Coverage	184	116	*	*	172	116	17	11	155	105
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.87B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.4	0.5	0.3^a	0.1	0.4	0.5	0.9	1.1	0.3	0.4
GEOGRAPHIC REGION
Northeast	0.6	0.6	0.6	0.2	0.6	0.6	1.1	1.6	0.5	0.5
Midwest	0.6	0.5	0.3	0.1	0.7	0.6	1.3	1.4	0.6	0.5
South	0.3^b	0.5	0.2	0.1	0.3^b	0.5	0.7	1.0	0.2^b	0.4
West	0.3	0.4	0.4	0.1	0.3	0.4	0.9	0.6	0.2	0.4
COUNTY TYPE
Large Metro	0.4	0.5	0.4^a	0.1	0.4	0.6	1.0	1.1	0.4	0.5
Small Metro	0.4	0.5	0.2	0.2	0.4	0.5	0.9	1.2	0.3	0.3
Nonmetro	0.3	0.3	0.2	0.0	0.3	0.3	0.7	0.7	0.3	0.3
Urbanized	0.4	0.3	*	*	0.4	0.3	1.2	0.8	0.3	0.3
Less Urbanized	0.3	0.3	0.2	0.1	0.3	0.4	0.4	0.6	0.2	0.3
Completely Rural	0.1	0.0	*	*	0.1	0.0	0.0	*	0.1	0.0
POVERTY LEVEL¹
Less Than 100%	0.5	0.4	0.1	0.0	0.6	0.4	1.1	1.0	0.5	0.3
100-199%	0.4	0.5	0.5	0.1	0.3	0.5	0.5	1.1	0.3	0.4
200% or More	0.4	0.5	0.3	0.2	0.4	0.5	1.0	1.1	0.3	0.5
HEALTH INSURANCE²
Private	0.4	0.5	0.3	0.2	0.4^a	0.5	1.2	1.4	0.3^a	0.4
Medicaid/CHIP	0.4	0.5	0.2	0.1	0.5	0.6	0.5	0.8	0.5	0.6
Other³	0.2	0.2	0.2	0.0	0.2	0.2	1.0	1.0	0.1	0.1
No Coverage	0.7	0.5	*	*	0.7	0.5	0.4	0.2	0.8	0.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.88A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	40,986	41,314	1,052	1,085	39,934	40,229	2,941	3,227	36,994	37,002
GEOGRAPHIC REGION
Northeast	6,485	6,740	81	101	6,404	6,639	461	547	5,943	6,092
Midwest	8,923	9,125	267	235	8,656	8,890	695	787	7,961	8,103
South	16,514	16,631	411	452	16,103	16,179	1,132	1,295	14,971	14,883
West	9,065	8,818	293	296	8,771	8,522	653	598	8,118	7,923
COUNTY TYPE
Large Metro	20,941	21,376	508	584	20,433	20,792	1,476	1,665	18,957	19,126
Small Metro	13,251	13,876	401	361	12,850	13,515	985	1,143	11,865	12,372
Nonmetro	6,794	6,063	143	140	6,651	5,923	480	419	6,172	5,504
Urbanized	2,447	2,530	76	53	2,370	2,477	214	185	2,156	2,292
Less Urbanized	3,777	3,078	61	74	3,716	3,005	223	214	3,493	2,791
Completely Rural	571	455	5	*	565	441	43	20	523	421
POVERTY LEVEL¹
Less Than 100%	6,212	5,514	204	213	6,008	5,302	624	725	5,384	4,577
100-199%	8,244	7,920	260	235	7,984	7,685	720	777	7,264	6,907
200% or More	26,530	27,879	589	637	25,942	27,242	1,596	1,724	24,346	25,518
HEALTH INSURANCE²
Private	24,354	25,467	547	588	23,807	24,879	1,821	2,029	21,985	22,850
Medicaid/CHIP	9,305	9,180	506	458	8,799	8,722	706	859	8,093	7,862
Other³	14,871	15,664	37	77	14,835	15,587	233	290	14,602	15,298
No Coverage	2,554^a	1,989	44	29	2,510^a	1,959	307	278	2,203	1,682
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.88B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	14.6	14.7	4.0	4.2	15.7	15.7	8.8	9.3	16.8	16.7
GEOGRAPHIC REGION
Northeast	13.3	13.7	2.0	2.5	14.3	14.8	8.1	9.2	15.2	15.6
Midwest	15.4	15.7	4.9	4.3	16.5	16.9	9.8	10.8	17.5	17.8
South	15.5	15.4	4.0	4.5	16.7	16.5	8.9	9.7	17.9	17.6
West	13.7	13.2	4.7	4.8	14.6	14.1	8.2	7.3	15.6	15.1
COUNTY TYPE
Large Metro	13.9	13.7	3.6	3.9	14.9	14.7	8.4	8.7	15.9	15.7
Small Metro	15.4	15.5	5.0	4.5	16.5	16.6	9.0	9.8	17.8	17.8
Nonmetro	15.7	16.5	3.6	4.8	16.9	17.5	9.9	10.5	17.9	18.5
Urbanized	15.1	16.4	5.0	4.3	16.2	17.4	10.6	10.5	17.1	18.4
Less Urbanized	16.7	16.7	3.0	5.2	18.1	17.7	9.5	10.9	19.2	18.6
Completely Rural	12.5	15.9	1.3	*	13.6	17.1	9.1	8.0	14.1	18.1
POVERTY LEVEL¹
Less Than 100%	14.3	13.3	3.7	4.0	15.9	14.6	7.4	9.0	18.3	16.3
100-199%	14.6	14.2	4.6	4.1	15.7	15.4	9.0	9.2	17.0	16.7
200% or More	14.7	15.1	3.9	4.3	15.7	16.0	9.5	9.5	16.4	16.8
HEALTH INSURANCE²
Private	14.5	15.0	3.9	4.2	15.4	16.0	9.6	10.2	16.2	16.8
Medicaid/CHIP	16.0	15.6	4.7	4.3	18.5	18.1	8.1	9.3	20.9	20.3
Other³	19.4	20.0	2.7	5.1	19.7	20.3	9.1	10.3	20.1	20.7
No Coverage	9.8	8.2	3.3	2.9	10.1	8.4	6.4	6.0	11.0	9.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.89A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	4,813	4,848	248^a	137	4,565	4,711	916	842	3,649	3,869
GEOGRAPHIC REGION
Northeast	835	785	17	9	818	776	173	121	645	655
Midwest	856	941	42	26	814	915	199	207	615	708
South	1,879	2,031	89	62	1,790	1,968	348	333	1,442	1,635
West	1,244	1,091	101	39	1,143	1,052	196	180	947	871
COUNTY TYPE
Large Metro	2,724	2,546	94	71	2,630	2,474	470	433	2,160	2,041
Small Metro	1,444	1,582	124	50	1,320	1,532	278	310	1,041	1,222
Nonmetro	646	720	31	15	615	705	167	100	448	605
Urbanized	270	336	17	8	253	328	79	42	174	287
Less Urbanized	343	329	14	8	330	322	81	54	249	268
Completely Rural	33	55	*	*	33	55	7	*	26	51
POVERTY LEVEL¹
Less Than 100%	692	890	38	28	654	862	149	203	505	659
100-199%	1,112	1,065	89	42	1,023	1,022	272	193	751	830
200% or More	3,009	2,893	121	66	2,888	2,826	495	446	2,393	2,380
HEALTH INSURANCE²
Private	2,392	2,601	91	71	2,301	2,529	504	505	1,797	2,025
Medicaid/CHIP	1,520	1,575	160	66	1,360	1,509	267	226	1,092	1,283
Other³	995	1,182	14	5	981	1,177	37	76	944	1,102
No Coverage	460	404	*	*	449	404	128^a	72	320	331
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.89B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.7	1.7	1.0	0.5	1.8	1.8	2.7	2.4	1.7	1.7
GEOGRAPHIC REGION
Northeast	1.7	1.6	0.4	0.2	1.8	1.7	3.0	2.0	1.7	1.7
Midwest	1.5	1.6	0.8	0.5	1.6	1.7	2.8	2.8	1.4	1.6
South	1.8	1.9	0.9	0.6	1.9	2.0	2.7	2.5	1.7	1.9
West	1.9	1.6	1.6	0.6	1.9	1.7	2.5	2.2	1.8	1.7
COUNTY TYPE
Large Metro	1.8	1.6	0.7	0.5	1.9	1.8	2.7	2.3	1.8	1.7
Small Metro	1.7	1.8	1.5	0.6	1.7	1.9	2.5	2.6	1.6	1.8
Nonmetro	1.5	2.0	0.8	0.5	1.6	2.1	3.5	2.5	1.3	2.0
Urbanized	1.7	2.2	1.1	0.6	1.7	2.3	3.9	2.4	1.4	2.3
Less Urbanized	1.5	1.8	0.7	0.5	1.6	1.9	3.4	2.7	1.4	1.8
Completely Rural	0.7	1.9	*	*	0.8	2.1	1.5	*	0.7	2.2
POVERTY LEVEL¹
Less Than 100%	1.6	2.1	0.7	0.5	1.7	2.4	1.8	2.5	1.7	2.3
100-199%	2.0	1.9	1.6	0.7	2.0	2.1	3.4	2.3	1.8	2.0
200% or More	1.7	1.6	0.8	0.5	1.7	1.7	2.9	2.4	1.6	1.6
HEALTH INSURANCE²
Private	1.4	1.5	0.7	0.5	1.5	1.6	2.7	2.5	1.3	1.5
Medicaid/CHIP	2.6	2.7	1.5	0.6	2.9	3.1	3.1	2.4	2.8	3.3
Other³	1.3	1.5	1.0	0.3	1.3	1.5	1.4	2.7	1.3	1.5
No Coverage	1.8	1.7	*	*	1.8	1.7	2.7^a	1.6	1.6	1.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.90A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1,341	1,529	52	37	1,289	1,492	156	181	1,133	1,312
GEOGRAPHIC REGION
Northeast	213	203	11	2	202	201	33	35	169	166
Midwest	309	281	15	8	294	273	30	47	264	225
South	427^a	697	16	18	411^a	679	58	75	353^a	604
West	393	348	11	8	381	339	34	23	347	316
COUNTY TYPE
Large Metro	790	794	19	19	771	775	55	64	716	711
Small Metro	412	450	25	11	387	439	81	90	306	348
Nonmetro	139	285	9	7	131	279	21	26	110^a	252
Urbanized	73	173	9	4	64	168	8	6	57	162
Less Urbanized	63	85	*	2	63	83	12	20	50	63
Completely Rural	3	*	*	*	3	*	0	*	3	*
POVERTY LEVEL¹
Less Than 100%	212	268	0	11	212	257	43	47	168	211
100-199%	262	399	19	9	242	390	44	40	199	350
200% or More	868	862	32	17	835	846	69	94	766	751
HEALTH INSURANCE²
Private	582	716	13	15	568	702	59^a	119	509	583
Medicaid/CHIP	397	505	28	27	369	478	74	40	295	438
Other³	426	415	1	0	426	414	9	13	417	401
No Coverage	196	163	*	*	185	163	19	15	167	148
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.90B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.5	0.5	0.2	0.1	0.5	0.6	0.5	0.5	0.5	0.6
GEOGRAPHIC REGION
Northeast	0.4	0.4	0.3	0.1	0.5	0.4	0.6	0.6	0.4	0.4
Midwest	0.5	0.5	0.3	0.2	0.6	0.5	0.4	0.7	0.6	0.5
South	0.4^a	0.6	0.2	0.2	0.4^a	0.7	0.5	0.6	0.4^a	0.7
West	0.6	0.5	0.2	0.1	0.6	0.6	0.4	0.3	0.7	0.6
COUNTY TYPE
Large Metro	0.5	0.5	0.1	0.1	0.6	0.5	0.3	0.3	0.6	0.6
Small Metro	0.5	0.5	0.3	0.1	0.5	0.5	0.7	0.8	0.5	0.5
Nonmetro	0.3^a	0.8	0.2	0.2	0.3^a	0.8	0.4	0.7	0.3^a	0.8
Urbanized	0.5	1.1	0.6	0.4	0.4	1.2	0.4	0.3	0.4	1.3
Less Urbanized	0.3	0.5	*	0.2	0.3	0.5	0.5	1.0	0.3	0.4
Completely Rural	0.1	*	*	*	0.1	*	0.1	*	0.1	*
POVERTY LEVEL¹
Less Than 100%	0.5	0.6	0.0	0.2	0.6	0.7	0.5	0.6	0.6	0.7
100-199%	0.5	0.7	0.3	0.2	0.5	0.8	0.5	0.5	0.5	0.8
200% or More	0.5	0.5	0.2	0.1	0.5	0.5	0.4	0.5	0.5	0.5
HEALTH INSURANCE²
Private	0.3	0.4	0.1	0.1	0.4	0.5	0.3	0.6	0.4	0.4
Medicaid/CHIP	0.7	0.9	0.3	0.3	0.8	1.0	0.9	0.4	0.8	1.1
Other³	0.6	0.5	0.0	0.0	0.6	0.5	0.4	0.5	0.6	0.5
No Coverage	0.8	0.7	*	*	0.7	0.7	0.4	0.3	0.8	0.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.91A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	32,794	32,783	782	717	32,012	32,066	2,467	2,592	29,545	29,474
GEOGRAPHIC REGION
Northeast	5,224	5,455	64	59	5,160	5,396	412	424	4,748	4,972
Midwest	7,312	7,341	181	149	7,131	7,193	574	672	6,556	6,521
South	13,163	13,313	303	308	12,861	13,005	965	1,044	11,895	11,960
West	7,095	6,674	234	201	6,861	6,473	516	452	6,345	6,020
COUNTY TYPE
Large Metro	16,509	16,335	383	388	16,127	15,947	1,270	1,265	14,857	14,682
Small Metro	10,883	11,433	300	235	10,583	11,197	794	991	9,789	10,206
Nonmetro	5,401	5,015	99	94	5,302	4,921	403	336	4,899	4,585
Urbanized	1,851	2,023	52	40	1,799	1,983	197	148	1,602	1,836
Less Urbanized	3,040	2,616	46	52	2,994	2,564	174	172	2,820	2,392
Completely Rural	510	375	2	*	509	373	33	16	476	357
POVERTY LEVEL¹
Less Than 100%	5,108	4,474	119	149	4,989	4,325	480	581	4,509	3,744
100-199%	6,793	6,413	214	148	6,579	6,265	638	653	5,941	5,612
200% or More	20,893	21,895	449	420	20,444	21,475	1,349	1,357	19,095	20,118
HEALTH INSURANCE²
Private	19,233	20,049	415	393	18,818	19,656	1,512	1,597	17,306	18,058
Medicaid/CHIP	7,672	7,749	367	290	7,306	7,459	590	717	6,716	6,742
Other³	11,770	12,054	35	54	11,735	12,000	212	219	11,523	11,781
No Coverage	2,176^a	1,592	37	22	2,138^a	1,569	260	238	1,878^a	1,332
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.91B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	11.7	11.6	3.0	2.8	12.6	12.5	7.4	7.5	13.4	13.3
GEOGRAPHIC REGION
Northeast	10.7	11.1	1.5	1.5	11.5	12.0	7.2	7.2	12.2	12.7
Midwest	12.6	12.6	3.3	2.8	13.6	13.6	8.1	9.2	14.4	14.3
South	12.3	12.3	3.0	3.0	13.3	13.3	7.6	7.8	14.2	14.1
West	10.7	10.0	3.8	3.3	11.4	10.7	6.5	5.5	12.2	11.5
COUNTY TYPE
Large Metro	11.0	10.5	2.7	2.6	11.8	11.3	7.2	6.6	12.5	12.0
Small Metro	12.7	12.8	3.8	3.0	13.6	13.8	7.2	8.5	14.7	14.7
Nonmetro	12.5	13.6	2.5	3.2	13.5	14.6	8.3	8.4	14.2	15.4
Urbanized	11.5	13.1	3.4	3.2	12.3	13.9	9.7	8.4	12.7	14.7
Less Urbanized	13.5	14.2	2.2	3.7	14.6	15.1	7.4	8.7	15.5	15.9
Completely Rural	11.2	13.2	0.4	*	12.2	14.5	7.0	6.5	12.9	15.4
POVERTY LEVEL¹
Less Than 100%	11.8	10.8	2.2	2.8	13.2	11.9	5.7	7.2	15.3	13.3
100-199%	12.0	11.5	3.8	2.6	13.0	12.6	7.9	7.7	13.9	13.6
200% or More	11.6	11.8	3.0	2.9	12.4	12.6	8.0	7.4	12.9	13.2
HEALTH INSURANCE²
Private	11.4	11.8	3.0	2.8	12.2	12.6	8.0	8.0	12.8	13.3
Medicaid/CHIP	13.2	13.2	3.4	2.7	15.4	15.5	6.8	7.7	17.3	17.4
Other³	15.4	15.4	2.5	3.5	15.6	15.6	8.3	7.8	15.8	15.9
No Coverage	8.3	6.6	2.8	2.2	8.6^a	6.8	5.4	5.1	9.4	7.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.92A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	4,284	4,153	220	115	4,063	4,038	855	779	3,209	3,259
GEOGRAPHIC REGION
Northeast	776	738	17	5	759	733	171	111	588	622
Midwest	819	777	38	24	781	753	179	191	602	562
South	1,587	1,682	73	49	1,514	1,633	329	307	1,184	1,326
West	1,102	957	93	38	1,009	919	175	169	834	750
COUNTY TYPE
Large Metro	2,421	2,158	91	55	2,330	2,103	445	400	1,885	1,703
Small Metro	1,287	1,400	106	46	1,181	1,353	253	290	928	1,063
Nonmetro	575	595	23	13	552	582	157	90	395	492
Urbanized	241	307	12	8	229	299	72	41	158	258
Less Urbanized	302	258	11	6	290	252	78	45	212	208
Completely Rural	33	30	*	*	33	30	7	*	26	26
POVERTY LEVEL¹
Less Than 100%	642	798	35	25	607	773	134	188	473	585
100-199%	1,041	936	86	39	955	897	245	185	710	712
200% or More	2,601	2,419	100	51	2,501	2,367	476	406	2,025	1,961
HEALTH INSURANCE²
Private	2,078	2,178	80	57	1,998	2,122	478	469	1,520	1,653
Medicaid/CHIP	1,416	1,429	142	58	1,275	1,371	238	208	1,037	1,163
Other³	824	918	14	5	811	913	36	61	775	852
No Coverage	444	376	*	*	433	376	124^a	69	309	307
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.92B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.5	1.5	0.8	0.4	1.6	1.6	2.6	2.2	1.5	1.5
GEOGRAPHIC REGION
Northeast	1.6	1.5	0.4	0.1	1.7	1.6	3.0	1.9	1.5	1.6
Midwest	1.4	1.3	0.7	0.4	1.5	1.4	2.5	2.6	1.3	1.2
South	1.5	1.6	0.7	0.5	1.6	1.7	2.6	2.3	1.4	1.6
West	1.7	1.4	1.5	0.6	1.7	1.5	2.2	2.1	1.6	1.4
COUNTY TYPE
Large Metro	1.6	1.4	0.6	0.4	1.7	1.5	2.5	2.1	1.6	1.4
Small Metro	1.5	1.6	1.3	0.6	1.5	1.7	2.3	2.5	1.4	1.5
Nonmetro	1.3	1.6	0.6	0.5	1.4	1.7	3.2	2.3	1.1	1.6
Urbanized	1.5	2.0	0.8	0.6	1.6	2.1	3.5	2.3	1.2	2.1
Less Urbanized	1.3	1.4	0.5	0.4	1.4	1.5	3.3	2.3	1.2	1.4
Completely Rural	0.7	1.1	*	*	0.8	1.2	1.5	*	0.7	1.1
POVERTY LEVEL¹
Less Than 100%	1.5	1.9	0.6	0.5	1.6	2.1	1.6	2.3	1.6	2.1
100-199%	1.8	1.7	1.5	0.7	1.9	1.8	3.1	2.2	1.7	1.7
200% or More	1.4	1.3	0.7	0.3	1.5	1.4	2.8	2.2	1.4	1.3
HEALTH INSURANCE²
Private	1.2	1.3	0.6	0.4	1.3	1.4	2.5	2.4	1.1	1.2
Medicaid/CHIP	2.4	2.4	1.3	0.5	2.7	2.9	2.7	2.2	2.7	3.0
Other³	1.1	1.2	1.0	0.3	1.1	1.2	1.4	2.2	1.1	1.2
No Coverage	1.7	1.6	*	*	1.7	1.6	2.6^a	1.5	1.5	1.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.93A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1,145	1,304	36	34	1,109	1,270	134	158	975	1,112
GEOGRAPHIC REGION
Northeast	182	179	11	2	171	177	27	34	145	143
Midwest	285	249	14	8	270	240	21	43	249	198
South	372	569	9	16	363	554	54	61	309	492
West	306	307	2	8	304	299	32	20	272	279
COUNTY TYPE
Large Metro	669	700	16	18	653	682	48	61	605	621
Small Metro	359	368	16	11	343	357	67	73	276	285
Nonmetro	116	236	3	6	113	230	20	24	93	206
Urbanized	53	153	3	4	50	148	7	6	43	142
Less Urbanized	60	81	*	2	60	79	12	18	47	61
Completely Rural	3	2	*	*	3	2	0	*	3	2
POVERTY LEVEL¹
Less Than 100%	185	237	0	10	184	227	28	36	156	191
100-199%	249	347	15	9	234	338	43	38	191	300
200% or More	711	721	20	15	691	705	63	84	628	622
HEALTH INSURANCE²
Private	469	601	10	13	458	588	57	106	401	481
Medicaid/CHIP	326	457	14	25	312	432	58	31	253	400
Other³	383	327	1	0	383	326	9	9	374	317
No Coverage	189	145	*	*	178	145	15	12	163	132
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.93B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.4	0.5	0.1	0.1	0.4	0.5	0.4	0.5	0.4	0.5
GEOGRAPHIC REGION
Northeast	0.4	0.4	0.3	0.1	0.4	0.4	0.5	0.6	0.4	0.4
Midwest	0.5	0.4	0.3	0.2	0.5	0.5	0.3	0.6	0.5	0.4
South	0.3	0.5	0.1	0.2	0.4	0.6	0.4	0.5	0.4	0.6
West	0.5	0.5	0.0	0.1	0.5	0.5	0.4	0.2	0.5	0.5
COUNTY TYPE
Large Metro	0.4	0.4	0.1	0.1	0.5	0.5	0.3	0.3	0.5	0.5
Small Metro	0.4	0.4	0.2	0.1	0.4	0.4	0.6	0.6	0.4	0.4
Nonmetro	0.3^a	0.6	0.1	0.2	0.3^a	0.7	0.4	0.6	0.3^a	0.7
Urbanized	0.3	1.0	0.2	0.4	0.3	1.0	0.3	0.3	0.3	1.1
Less Urbanized	0.3	0.4	*	0.1	0.3	0.5	0.5	0.9	0.3	0.4
Completely Rural	0.1	0.1	*	*	0.1	0.1	0.1	*	0.1	0.1
POVERTY LEVEL¹
Less Than 100%	0.4	0.6	0.0	0.2	0.5	0.6	0.3	0.4	0.5	0.7
100-199%	0.4	0.6	0.3	0.2	0.5	0.7	0.5	0.4	0.4	0.7
200% or More	0.4	0.4	0.1	0.1	0.4	0.4	0.4	0.5	0.4	0.4
HEALTH INSURANCE²
Private	0.3	0.4	0.1	0.1	0.3	0.4	0.3	0.5	0.3	0.4
Medicaid/CHIP	0.6	0.8	0.1	0.2	0.7	0.9	0.7	0.3	0.7	1.0
Other³	0.5	0.4	0.0	0.0	0.5	0.4	0.4	0.3	0.5	0.4
No Coverage	0.7	0.6	*	*	0.7	0.6	0.3	0.3	0.8	0.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.94A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	14,602	15,399	410	521	14,192	14,878	815^a	1,082	13,376	13,797
GEOGRAPHIC REGION
Northeast	2,375	2,269	38	52	2,337	2,217	95^b	228	2,242	1,989
Midwest	2,804	3,036	114	96	2,690	2,940	185	204	2,505	2,736
South	5,977	6,427	177	232	5,800	6,195	313	454	5,486	5,741
West	3,447	3,667	82	141	3,365	3,527	222	196	3,144	3,331
COUNTY TYPE
Large Metro	8,061	8,402	211	260	7,850	8,141	381^a	581	7,469	7,561
Small Metro	4,331	4,970	141	187	4,190	4,783	310	355	3,880	4,428
Nonmetro	2,210	2,028	59	74	2,151	1,954	124	146	2,027	1,808
Urbanized	880	873	32	19	848	854	56	65	792	788
Less Urbanized	1,200	989	23	43	1,177	946	58	73	1,119	874
Completely Rural	130	165	4	*	126	154	10	*	116	146
POVERTY LEVEL¹
Less Than 100%	2,261	2,091	122	108	2,139	1,983	212	250	1,927	1,734
100-199%	2,782	2,950	77^a	144	2,705	2,806	170	248	2,535	2,558
200% or More	9,559	10,358	211	269	9,348	10,089	433	584	8,914	9,505
HEALTH INSURANCE²
Private	8,898	9,365	206	256	8,692	9,109	530	718	8,162	8,390
Medicaid/CHIP	3,418	3,297	207	257	3,211	3,039	193	290	3,018	2,750
Other³	5,574	6,256	10	32	5,565	6,224	38^b	103	5,527	6,121
No Coverage	751	730	20	9	732	721	80	83	651	638
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.94B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	5.2	5.5	1.6	2.0	5.6	5.8	2.4^a	3.1	6.1	6.2
GEOGRAPHIC REGION
Northeast	4.9	4.6	0.9	1.3	5.2	4.9	1.7^b	3.8	5.7	5.1
Midwest	4.8	5.2	2.1	1.8	5.1	5.6	2.6	2.8	5.5	6.0
South	5.6	5.9	1.7	2.3	6.0	6.3	2.5	3.4	6.6	6.8
West	5.2	5.5	1.3	2.3	5.6	5.8	2.8	2.4	6.0	6.4
COUNTY TYPE
Large Metro	5.3	5.4	1.5	1.8	5.7	5.8	2.2	3.0	6.3	6.2
Small Metro	5.0	5.6	1.8	2.3	5.4	5.9	2.8	3.0	5.8	6.4
Nonmetro	5.1	5.5	1.5	2.5	5.5	5.8	2.6	3.7	5.9	6.1
Urbanized	5.4	5.6	2.1	1.5	5.8	6.0	2.8	3.7	6.3	6.3
Less Urbanized	5.3	5.4	1.1	3.0	5.7	5.6	2.4	3.7	6.2	5.8
Completely Rural	2.8	5.8	0.9	*	3.0	6.0	2.2	*	3.1	6.3
POVERTY LEVEL¹
Less Than 100%	5.2	5.0	2.2	2.0	5.6	5.5	2.5	3.1	6.6	6.2
100-199%	4.9	5.3	1.4	2.5	5.3	5.6	2.1	2.9	5.9	6.2
200% or More	5.3	5.6	1.4	1.8	5.7	5.9	2.6	3.2	6.0	6.3
HEALTH INSURANCE²
Private	5.3	5.5	1.5	1.8	5.6	5.8	2.8	3.6	6.0	6.2
Medicaid/CHIP	5.9	5.6	1.9	2.4	6.8	6.3	2.2	3.1	7.8	7.1
Other³	7.3	8.0	0.7	2.1	7.4	8.1	1.5^a	3.7	7.6	8.3
No Coverage	2.9	3.0	1.5	0.9	3.0	3.1	1.7	1.8	3.3	3.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.95A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	878	959	43	27	834	931	144	93	690	839
GEOGRAPHIC REGION
Northeast	122	102	0	4	122	98	24	21	98	77
Midwest	97^a	213	5	3	92^a	210	35	20	57^a	190
South	418	466	18	15	399	451	49	36	350	415
West	241	177	20	6	222	172	37	16	185	156
COUNTY TYPE
Large Metro	490	515	15	16	475	498	53	44	422	455
Small Metro	262	274	20	9	242	265	58	39	184	226
Nonmetro	126	170	9	2	117	168	34	10	84	158
Urbanized	66	40	7	*	59	40	31^a	1	29	40
Less Urbanized	55	104	2	2	53	102	3	9	50	93
Completely Rural	5	*	*	*	5	*	0	*	5	*
POVERTY LEVEL¹
Less Than 100%	132	167	4	7	128	160	44	25	84	134
100-199%	156	170	5	4	151	166	52^a	9	99	157
200% or More	590	622	34	16	556	606	49	58	507	548
HEALTH INSURANCE²
Private	476	521	24	16	452	505	68	61	383	443
Medicaid/CHIP	249	258	21	13	228	245	52	19	176	226
Other³	226	330	*	*	226	330	6	15	220	315
No Coverage	43	51	*	*	43	51	19	7	24	44
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.95B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.3	0.3	0.2	0.1	0.3	0.4	0.4	0.3	0.3	0.4
GEOGRAPHIC REGION
Northeast	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.4	0.2	0.2
Midwest	0.2^a	0.4	0.1	0.0	0.2^a	0.4	0.5	0.3	0.1^a	0.4
South	0.4	0.4	0.2	0.1	0.4	0.5	0.4	0.3	0.4	0.5
West	0.4	0.3	0.3	0.1	0.4	0.3	0.5	0.2	0.4	0.3
COUNTY TYPE
Large Metro	0.3	0.3	0.1	0.1	0.3	0.4	0.3	0.2	0.4	0.4
Small Metro	0.3	0.3	0.2	0.1	0.3	0.3	0.5	0.3	0.3	0.3
Nonmetro	0.3	0.5	0.2	0.1	0.3	0.5	0.7	0.2	0.2	0.5
Urbanized	0.4	0.3	0.4	*	0.4	0.3	1.5^a	0.0	0.2	0.3
Less Urbanized	0.2	0.6	0.1	0.1	0.3	0.6	0.1	0.5	0.3	0.6
Completely Rural	0.1	*	*	*	0.1	*	0.0	*	0.1	*
POVERTY LEVEL¹
Less Than 100%	0.3	0.4	0.1	0.1	0.3	0.4	0.5	0.3	0.3	0.5
100-199%	0.3	0.3	0.1	0.1	0.3	0.3	0.6^a	0.1	0.2	0.4
200% or More	0.3	0.3	0.2	0.1	0.3	0.4	0.3	0.3	0.3	0.4
HEALTH INSURANCE²
Private	0.3	0.3	0.2	0.1	0.3	0.3	0.4	0.3	0.3	0.3
Medicaid/CHIP	0.4	0.4	0.2	0.1	0.5	0.5	0.6	0.2	0.5	0.6
Other³	0.3	0.4	*	*	0.3	0.4	0.2	0.5	0.3	0.4
No Coverage	0.2	0.2	*	*	0.2	0.2	0.4	0.1	0.1	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.96A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	225	278	20	7	205	271	32	32	173	239
GEOGRAPHIC REGION
Northeast	45	36	*	*	45	36	14	11	30	25
Midwest	28	42	1	*	27	41	10	5	16	37
South	60	131	10	3	50	128	5	14	45	115
West	93	69	10	4	84	65	2	3	81	62
COUNTY TYPE
Large Metro	129	124	5	1	123	122	8	4	115	118
Small Metro	71	105	9	5	62	100	23	26	39	74
Nonmetro	25	49	5	1	20	49	1	2	19	47
Urbanized	20	20	5	*	14	20	1	*	14	20
Less Urbanized	5	4	*	1	5	4	0	2	5	2
Completely Rural	0	*	*	*	0	*	*	*	0	*
POVERTY LEVEL¹
Less Than 100%	40	41	*	5	40	37	23	11	17	26
100-199%	17	55	4	1	12	55	1	2	11	53
200% or More	169	182	16	2	154	180	8	20	145	160
HEALTH INSURANCE²
Private	120	146	6	2	113	144	4	21	109	122
Medicaid/CHIP	88	60	14	6	74	54	23	9	51	45
Other³	50	98	*	*	50	98	*	4	50	94
No Coverage	12	21	*	*	12	21	4	2	8	19
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.96B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1
GEOGRAPHIC REGION
Northeast	0.1	0.1	*	*	0.1	0.1	0.2	0.2	0.1	0.1
Midwest	0.0	0.1	0.0	*	0.1	0.1	0.1	0.1	0.0	0.1
South	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1
West	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1
COUNTY TYPE
Large Metro	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1
Small Metro	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1
Nonmetro	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.2
Urbanized	0.1	0.1	0.4	*	0.1	0.1	0.0	*	0.1	0.2
Less Urbanized	0.0	0.0	*	0.0	0.0	0.0	0.0	0.1	0.0	0.0
Completely Rural	0.0	*	*	*	0.0	*	*	*	0.0	*
POVERTY LEVEL¹
Less Than 100%	0.1	0.1	*	0.1	0.1	0.1	0.3	0.1	0.1	0.1
100-199%	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1
200% or More	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1
HEALTH INSURANCE²
Private	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1
Medicaid/CHIP	0.2	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1
Other³	0.1	0.1	*	*	0.1	0.1	*	0.1	0.1	0.1
No Coverage	0.0	0.1	*	*	0.1	0.1	0.1	0.0	0.0	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.97A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	25,735	25,703	492	480	25,244	25,223	2,162	2,178	23,082	23,045
GEOGRAPHIC REGION
Northeast	4,110	4,373	51	34	4,059	4,339	390	342	3,669	3,997
Midwest	5,551	5,853	127	92	5,424	5,761	512	582	4,912	5,178
South	10,198	10,308	181	186	10,017	10,121	825	869	9,192	9,252
West	5,877	5,170	132	168	5,744	5,002	435	385	5,309	4,617
COUNTY TYPE
Large Metro	13,315	12,943	238	265	13,077	12,678	1,094	1,066	11,983	11,612
Small Metro	8,283	8,956	187	171	8,096	8,785	702	824	7,394	7,962
Nonmetro	4,137	3,805	66	45	4,071	3,760	366	289	3,705	3,472
Urbanized	1,441	1,535	27	30	1,414	1,505	177	132	1,237	1,373
Less Urbanized	2,364	1,920	38	13	2,326	1,907	168	148	2,157	1,759
Completely Rural	332	350	1	*	331	348	20	9	311	339
POVERTY LEVEL¹
Less Than 100%	4,031	3,543	83	87	3,948	3,456	431	470	3,517	2,986
100-199%	5,440	5,076	154	112	5,286	4,964	574	568	4,712	4,396
200% or More	16,264	17,084	254	281	16,010	16,803	1,157	1,139	14,853	15,664
HEALTH INSURANCE²
Private	14,871	15,965	237	268	14,634	15,697	1,287	1,322	13,347	14,375
Medicaid/CHIP	6,230	5,829	253	188	5,977	5,641	530	613	5,447	5,027
Other³	8,601	9,288	27	33	8,574	9,255	197	187	8,377	9,067
No Coverage	1,776^a	1,326	28	16	1,748^a	1,310	230	206	1,518^a	1,103
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.97B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	9.2	9.1	1.9	1.9	9.9	9.8	6.5	6.3	10.5	10.4
GEOGRAPHIC REGION
Northeast	8.4	8.9	1.2	0.8	9.1	9.7	6.8	5.8	9.4	10.2
Midwest	9.6	10.1	2.3	1.7	10.3	10.9	7.2	8.0	10.8	11.4
South	9.6	9.5	1.8	1.8	10.4	10.3	6.5	6.5	11.0	10.9
West	8.9	7.7	2.1	2.7	9.6	8.3	5.5	4.7	10.2	8.8
COUNTY TYPE
Large Metro	8.8	8.3	1.7	1.8	9.6	9.0	6.2	5.6	10.1	9.5
Small Metro	9.7	10.0	2.3	2.1	10.4	10.8	6.4	7.0	11.1	11.4
Nonmetro	9.5	10.4	1.7	1.5	10.4	11.1	7.6	7.3	10.7	11.6
Urbanized	8.9	9.9	1.8	2.4	9.7	10.6	8.8	7.5	9.8	11.0
Less Urbanized	10.5	10.4	1.8	0.9	11.3	11.2	7.2	7.5	11.9	11.7
Completely Rural	7.3^a	12.3	0.2	*	8.0^a	13.5	4.2	3.5	8.4^a	14.6
POVERTY LEVEL¹
Less Than 100%	9.3	8.5	1.5	1.7	10.4	9.5	5.1	5.8	12.0	10.6
100-199%	9.6	9.1	2.7	1.9	10.4	10.0	7.2	6.7	11.0	10.6
200% or More	9.0	9.2	1.7	1.9	9.7	9.9	6.9	6.2	10.0	10.3
HEALTH INSURANCE²
Private	8.8	9.4	1.7	1.9	9.5	10.1	6.8	6.6	9.8	10.6
Medicaid/CHIP	10.7	9.9	2.3	1.8	12.6	11.7	6.1	6.6	14.1	13.0
Other³	11.2	11.9	2.0	2.2	11.4	12.1	7.7	6.7	11.5	12.3
No Coverage	6.8	5.5	2.1	1.6	7.1	5.6	4.8	4.5	7.6	5.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.98A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3,931	3,681	203	113	3,729	3,569	825	747	2,904	2,822
GEOGRAPHIC REGION
Northeast	732	672	6	5	725	667	163	106	562	560
Midwest	766	714	38	23	728	690	171	184	558	506
South	1,483	1,481	75	48	1,408	1,434	311	295	1,098	1,139
West	951	814	84	36	867	778	180	161	687	617
COUNTY TYPE
Large Metro	2,256	1,971	71	53	2,185	1,918	433	381	1,753	1,537
Small Metro	1,126	1,156	108	45	1,019	1,111	238	276	781	834
Nonmetro	549	554	24	14	525	540	155	90	370	451
Urbanized	223	279	13	8	210	271	72	38	138	233
Less Urbanized	295	246	11	6	284	239	76	47	208	192
Completely Rural	31	30	*	*	31	30	7	*	24	26
POVERTY LEVEL¹
Less Than 100%	599	710	36	25	563	684	126	176	438	509
100-199%	991	842	75	37	916	804	247	181	669	624
200% or More	2,341	2,130	91	50	2,250	2,080	452	390	1,798	1,689
HEALTH INSURANCE²
Private	1,902	1,923	73	54	1,829	1,869	459	448	1,370	1,421
Medicaid/CHIP	1,327	1,204	143	60	1,184	1,143	228	196	956	947
Other³	717	726	14	3	704	724	36	53	668	671
No Coverage	415	366	1	*	415	366	122^a	66	293	300
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.98B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.4	1.3	0.8	0.4	1.5	1.4	2.5	2.1	1.3	1.3
GEOGRAPHIC REGION
Northeast	1.5	1.4	0.2	0.1	1.6	1.5	2.9	1.8	1.4	1.4
Midwest	1.3	1.2	0.7	0.4	1.4	1.3	2.4	2.5	1.2	1.1
South	1.4	1.4	0.7	0.5	1.5	1.5	2.4	2.2	1.3	1.3
West	1.4	1.2	1.3	0.6	1.4	1.3	2.3	2.0	1.3	1.2
COUNTY TYPE
Large Metro	1.5	1.3	0.5	0.4	1.6	1.4	2.5	2.0	1.5	1.3
Small Metro	1.3	1.3	1.3	0.6	1.3	1.4	2.2	2.4	1.2	1.2
Nonmetro	1.3	1.5	0.6	0.5	1.3	1.6	3.2	2.2	1.1	1.5
Urbanized	1.4	1.8	0.9	0.6	1.4	1.9	3.5	2.2	1.1	1.9
Less Urbanized	1.3	1.3	0.5	0.4	1.4	1.4	3.2	2.4	1.1	1.3
Completely Rural	0.7	1.1	*	*	0.8	1.2	1.5	*	0.7	1.1
POVERTY LEVEL¹
Less Than 100%	1.4	1.7	0.7	0.5	1.5	1.9	1.5	2.2	1.5	1.8
100-199%	1.8	1.5	1.3	0.6	1.8	1.6	3.1	2.1	1.6	1.5
200% or More	1.3	1.2	0.6	0.3	1.4	1.2	2.7	2.1	1.2	1.1
HEALTH INSURANCE²
Private	1.1	1.1	0.5	0.4	1.2	1.2	2.4	2.3	1.0	1.0
Medicaid/CHIP	2.3	2.0	1.3	0.6	2.5	2.4	2.6	2.1	2.5	2.4
Other³	0.9	0.9	1.0	0.2	0.9	0.9	1.4	1.9	0.9	0.9
No Coverage	1.6	1.5	0.0	*	1.7	1.6	2.5^a	1.4	1.5	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.99A – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	73,020	74,052	3,492	3,191	69,528	70,861	6,277	6,504	63,251	64,358
GEOGRAPHIC REGION
Northeast	10,526	10,866	539^a	395	9,987	10,471	892	892	9,095	9,579
Midwest	15,598	16,018	742	684	14,856	15,335	1,391	1,465	13,464	13,870
South	29,753	30,086	1,326	1,366	28,426	28,720	2,542	2,690	25,884	26,030
West	17,143	17,083	885	746	16,259	16,336	1,452	1,457	14,807	14,879
COUNTY TYPE
Large Metro	37,076	38,987	1,729	1,624	35,347	37,364	3,068	3,483	32,279	33,880
Small Metro	23,159	23,923	1,166	1,139	21,993	22,784	2,245	2,222	19,748	20,562
Nonmetro	12,785	11,141	597^a	428	12,188	10,714	964	799	11,224	9,915
Urbanized	4,694	4,563	224	176	4,470	4,386	372	369	4,098	4,017
Less Urbanized	6,635	5,613	320^a	213	6,315	5,400	463	379	5,852	5,021
Completely Rural	1,457	965	53	38	1,404	928	130	*	1,274	877
POVERTY LEVEL¹
Less Than 100%	12,854	11,663	819	682	12,035	10,981	1,597	1,461	10,438	9,520
100-199%	15,719	15,878	861	782	14,858	15,095	1,586	1,680	13,272	13,415
200% or More	44,444	46,511	1,812	1,726	42,632	44,785	3,091	3,362	39,541	41,423
HEALTH INSURANCE²
Private	40,075	41,461	1,720	1,622	38,355	39,840	3,283	3,700	35,072	36,139
Medicaid/CHIP	18,730	18,171	1,609	1,484	17,121	16,686	1,903	1,954	15,218	14,732
Other³	25,073	25,912	141	209	24,932	25,703	526	496	24,405	25,207
No Coverage	5,621	5,077	173	134	5,448	4,943	892	749	4,556	4,194
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. NOTE: For comparison of estimates between 2021 and 2022, opioid use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.99B – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	26.1	26.3	13.4	12.4	27.4	27.6	18.8	18.7	28.7	29.1
GEOGRAPHIC REGION
Northeast	21.5	22.2	13.0^a	9.7	22.3	23.3	15.6	15.1	23.3	24.5
Midwest	26.9	27.5	13.5	12.7	28.3	29.1	19.6	20.1	29.6	30.5
South	27.9	27.8	13.1	13.5	29.5	29.3	20.0	20.2	30.9	30.8
West	25.9	25.6	14.2	12.2	27.1	27.0	18.3	17.7	28.4	28.4
COUNTY TYPE
Large Metro	24.6	25.0	12.3	11.0	25.9	26.5	17.4	18.2	27.1	27.8
Small Metro	27.0	26.8	14.6	14.3	28.3	28.0	20.5	19.0	29.6	29.5
Nonmetro	29.5	30.3	15.0	14.6	31.0	31.7	19.9	20.1	32.5	33.2
Urbanized	29.0	29.5	14.8	14.2	30.5	30.8	18.4	21.0	32.5	32.2
Less Urbanized	29.4	30.5	15.4	15.1	30.8	31.8	19.7	19.2	32.2	33.4
Completely Rural	31.9	33.8	13.3	13.6	33.7	36.0	27.8	*	34.5	37.7
POVERTY LEVEL¹
Less Than 100%	29.6	28.1	14.9	12.9	31.8	30.3	18.9	18.1	35.5	33.8
100-199%	27.9	28.5	15.3	13.5	29.3	30.3	19.8	19.8	31.0	32.4
200% or More	24.7	25.2	12.1	11.8	25.8	26.3	18.3	18.4	26.7	27.3
HEALTH INSURANCE²
Private	23.8	24.4	12.4	11.5	24.8	25.6	17.4	18.6	25.9	26.6
Medicaid/CHIP	32.1	30.9	14.8	13.9	36.1	34.7	21.9	21.1	39.3	38.0
Other³	32.7	33.1	10.2	13.9	33.1	33.5	20.7	17.7	33.5	34.1
No Coverage	21.5	20.9	13.0	13.3	22.0	21.3	18.6	16.2	22.8	22.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. NOTE: For comparison of estimates between 2021 and 2022, opioid use estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.100A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	9,420	8,918	550	406	8,871	8,513	1,070	1,120	7,801	7,393
GEOGRAPHIC REGION
Northeast	1,606	1,457	100	49	1,506	1,408	176	145	1,331	1,264
Midwest	1,828	1,701	137^a	65	1,691	1,636	189	256	1,502	1,380
South	3,688	3,590	206	189	3,482	3,401	408	451	3,074	2,951
West	2,298	2,170	108	103	2,190	2,067	297	269	1,894	1,798
COUNTY TYPE
Large Metro	4,841	4,929	301^a	203	4,539	4,726	524	598	4,015	4,127
Small Metro	3,119	2,879	182	165	2,937	2,714	393	404	2,545	2,310
Nonmetro	1,460	1,111	66	38	1,394	1,073	153	117	1,241	956
Urbanized	524	454	36^a	12	488	442	61	47	427	395
Less Urbanized	793	572	29	21	765	552	79	62	686	490
Completely Rural	143	85	2	*	141	79	13	8	128	71
POVERTY LEVEL¹
Less Than 100%	2,347	2,233	125	92	2,221	2,140	268	255	1,954	1,885
100-199%	2,138	1,993	138	110	2,000	1,883	316	270	1,684	1,613
200% or More	4,936	4,692	287	203	4,649	4,489	486	594	4,163	3,895
HEALTH INSURANCE²
Private	4,051	4,022	233	211	3,818	3,811	482	580	3,336	3,231
Medicaid/CHIP	3,344	3,431	270	187	3,074	3,243	320	358	2,754	2,885
Other³	2,129	2,168	40	23	2,089	2,145	100	78	1,989	2,067
No Coverage	1,274	947	37	8	1,237	939	204	163	1,033	776
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, opioid misuse estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.100B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3.4	3.2	2.1	1.6	3.5	3.3	3.2	3.2	3.5	3.3
GEOGRAPHIC REGION
Northeast	3.3	3.0	2.4	1.2	3.4	3.1	3.1	2.4	3.4	3.2
Midwest	3.2	2.9	2.5^a	1.2	3.2	3.1	2.7	3.5	3.3	3.0
South	3.5	3.3	2.0	1.9	3.6	3.5	3.2	3.4	3.7	3.5
West	3.5	3.3	1.7	1.7	3.6	3.4	3.7	3.3	3.6	3.4
COUNTY TYPE
Large Metro	3.2	3.2	2.1^a	1.4	3.3	3.3	3.0	3.1	3.4	3.4
Small Metro	3.6	3.2	2.3	2.1	3.8	3.3	3.6	3.5	3.8	3.3
Nonmetro	3.4	3.0	1.7	1.3	3.5	3.2	3.2	2.9	3.6	3.2
Urbanized	3.2	2.9	2.4	0.9	3.3	3.1	3.0	2.7	3.4	3.2
Less Urbanized	3.5	3.1	1.4	1.5	3.7	3.2	3.4	3.2	3.8	3.3
Completely Rural	3.1	3.0	0.5	*	3.4	3.1	2.9	3.3	3.5	3.1
POVERTY LEVEL¹
Less Than 100%	5.4	5.4	2.3	1.8	5.9	5.9	3.2	3.2	6.6	6.7
100-199%	3.8	3.6	2.5	1.9	3.9	3.8	3.9	3.2	3.9	3.9
200% or More	2.7	2.5	1.9	1.4	2.8	2.6	2.9	3.3	2.8	2.6
HEALTH INSURANCE²
Private	2.4	2.4	1.7	1.5	2.5	2.4	2.5	2.9	2.5	2.4
Medicaid/CHIP	5.7	5.8	2.5	1.8	6.5	6.7	3.7	3.9	7.1	7.4
Other³	2.8	2.8	2.9	1.5	2.8	2.8	3.9	2.8	2.7	2.8
No Coverage	4.9	3.9	2.8	0.8	5.0	4.0	4.2	3.5	5.2	4.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, opioid misuse estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.101A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	2,817	2,944	133	117	2,685	2,827	239	221	2,446	2,606
GEOGRAPHIC REGION
Northeast	642	615	46	10	596	605	32	22	564	582
Midwest	486	530	16	15	470	515	40	47	430	468
South	998	1,176	55	60	943	1,115	77	113	866	1,003
West	691	623	15	31	676	592	90	39	586	553
COUNTY TYPE
Large Metro	1,428	1,626	68	68	1,360	1,558	106	94	1,254	1,464
Small Metro	1,044	905	41	39	1,003	867	105	92	898	775
Nonmetro	345	413	24	10	322	402	28	35	294	367
Urbanized	119	156	13^a	1	106	155	8	11	99	145
Less Urbanized	204	231	11	9	193	222	19	22	174	200
Completely Rural	22	25	*	*	22	25	1	*	21	*
POVERTY LEVEL¹
Less Than 100%	843	886	41	42	803	844	52	57	751	787
100-199%	690	690	56^a	17	634	673	93	72	541	601
200% or More	1,284	1,368	36	58	1,248	1,310	93	92	1,155	1,218
HEALTH INSURANCE²
Private	897	1,039	39	61	858	978	93	100	765	877
Medicaid/CHIP	1,295	1,428	70	50	1,225	1,378	104	58	1,121	1,320
Other³	765	709	13	5	752	704	15	20	738	684
No Coverage	405	313	15	6	391	307	41	47	350	260
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, opioid misuse estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.101B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.0	1.0	0.5	0.5	1.1	1.1	0.7	0.6	1.1	1.2
GEOGRAPHIC REGION
Northeast	1.3	1.3	1.1	0.3	1.3	1.3	0.6	0.4	1.4	1.5
Midwest	0.8	0.9	0.3	0.3	0.9	1.0	0.6	0.6	0.9	1.0
South	0.9	1.1	0.5	0.6	1.0	1.1	0.6	0.8	1.0	1.2
West	1.0	0.9	0.2	0.5	1.1	1.0	1.1	0.5	1.1	1.1
COUNTY TYPE
Large Metro	0.9	1.0	0.5	0.5	1.0	1.1	0.6	0.5	1.1	1.2
Small Metro	1.2	1.0	0.5	0.5	1.3	1.1	1.0	0.8	1.3	1.1
Nonmetro	0.8	1.1	0.6	0.3	0.8	1.2	0.6	0.9	0.9	1.2
Urbanized	0.7	1.0	0.9	0.1	0.7	1.1	0.4	0.6	0.8	1.2
Less Urbanized	0.9	1.3	0.5	0.6	0.9	1.3	0.8	1.1	1.0	1.3
Completely Rural	0.5	0.9	*	*	0.5	1.0	0.2	*	0.6	*
POVERTY LEVEL¹
Less Than 100%	1.9	2.1	0.7	0.8	2.1	2.3	0.6	0.7	2.6	2.8
100-199%	1.2	1.2	1.0^a	0.3	1.2	1.4	1.2	0.8	1.3	1.5
200% or More	0.7	0.7	0.2	0.4	0.8	0.8	0.6	0.5	0.8	0.8
HEALTH INSURANCE²
Private	0.5	0.6	0.3	0.4	0.6	0.6	0.5	0.5	0.6	0.6
Medicaid/CHIP	2.2	2.4	0.6	0.5	2.6	2.9	1.2	0.6	2.9	3.4
Other³	1.0	0.9	0.9	0.3	1.0	0.9	0.6	0.7	1.0	0.9
No Coverage	1.6	1.3	1.1	0.6	1.6	1.3	0.9	1.0	1.7	1.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For comparison of estimates between 2021 and 2022, opioid misuse estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.102A – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	21,614^b	24,425	1,849	1,889	19,765^b	22,536	4,198	4,581	15,567^b	17,956
GEOGRAPHIC REGION
Northeast	3,919	3,822	258	227	3,661	3,595	787	769	2,874	2,826
Midwest	4,519^b	5,595	484	435	4,035^b	5,161	812^b	1,181	3,223^a	3,980
South	7,946^a	9,034	695	836	7,251^a	8,198	1,485	1,566	5,766	6,632
West	5,229	5,975	411	392	4,818	5,583	1,113	1,065	3,705	4,517
COUNTY TYPE
Large Metro	11,910	13,321	950	1,071	10,960	12,251	2,220	2,443	8,739	9,808
Small Metro	6,749^b	8,189	575	600	6,174^b	7,589	1,435	1,622	4,739^b	5,967
Nonmetro	2,955	2,915	323^a	219	2,632	2,697	543	516	2,089	2,181
Urbanized	1,120	1,303	143	103	977	1,200	215	264	762	936
Less Urbanized	1,517	1,404	157	96	1,360	1,308	277	224	1,083	1,084
Completely Rural	318	208	24	19	294	189	51	28	244	162
POVERTY LEVEL¹
Less Than 100%	4,272	3,911	355^a	237	3,917	3,674	1,007	963	2,910	2,711
100-199%	4,438	4,773	386	431	4,052	4,342	786	959	3,266	3,383
200% or More	12,898^b	15,739	1,108	1,221	11,790^b	14,518	2,399	2,656	9,391^b	11,862
HEALTH INSURANCE²
Private	11,904^b	14,210	1,013	1,164	10,891^b	13,046	2,761	3,059	8,130^b	9,987
Medicaid/CHIP	6,430	6,759	810	685	5,620	6,074	829^a	1,085	4,791	4,988
Other³	3,653	4,264	102	144	3,551	4,120	323	340	3,228	3,781
No Coverage	2,105	2,072	81	30	2,024	2,042	473^a	313	1,551	1,729
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.102B – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	7.7^b	8.7	7.1	7.3	7.8^b	8.8	12.5	13.2	7.1^b	8.1
GEOGRAPHIC REGION
Northeast	8.0	7.8	6.2	5.6	8.2	8.0	13.8	13.0	7.4	7.2
Midwest	7.8^b	9.6	8.8	8.1	7.7^b	9.8	11.4^b	16.2	7.1^a	8.8
South	7.5^a	8.4	6.8	8.3	7.5	8.4	11.7	11.7	6.9	7.8
West	7.9	9.0	6.6	6.4	8.0	9.2	14.0	12.9	7.1	8.6
COUNTY TYPE
Large Metro	7.9	8.5	6.8	7.2	8.0	8.7	12.6	12.8	7.3	8.0
Small Metro	7.9^b	9.2	7.2	7.5	7.9^b	9.3	13.1	13.9	7.1^b	8.6
Nonmetro	6.8	7.9	8.1	7.5	6.7	8.0	11.2	13.0	6.1	7.3
Urbanized	6.9	8.4	9.4	8.3	6.7	8.4	10.6^a	15.0	6.0	7.5
Less Urbanized	6.7	7.6	7.6	6.8	6.6	7.7	11.8	11.4	6.0	7.2
Completely Rural	7.0	7.3	5.9	6.7	7.1	7.4	10.9	11.1	6.6	6.9
POVERTY LEVEL¹
Less Than 100%	9.9	9.4	6.5^a	4.5	10.3	10.1	11.9	12.0	9.9	9.6
100-199%	7.9	8.6	6.9	7.4	8.0	8.7	9.8	11.3	7.6	8.2
200% or More	7.2^b	8.5	7.4	8.3	7.1^b	8.5	14.2	14.6	6.3^b	7.8
HEALTH INSURANCE²
Private	7.1^b	8.4	7.3	8.3	7.1^b	8.4	14.6	15.4	6.0^b	7.3
Medicaid/CHIP	11.0	11.5	7.5	6.4	11.8	12.6	9.5	11.7	12.4	12.9
Other³	4.8	5.5	7.4	9.6	4.7	5.4	12.7	12.1	4.4	5.1
No Coverage	8.1	8.5	6.1	3.0	8.2	8.8	9.8^a	6.8	7.8	9.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.103A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	9,379	10,188	338	272	9,042	9,916	2,230	2,272	6,812	7,644
GEOGRAPHIC REGION
Northeast	1,800	1,623	61	54	1,739	1,569	425	373	1,314	1,196
Midwest	1,915	2,209	81^a	38	1,834	2,171	420	577	1,414	1,594
South	3,128	3,268	99	94	3,029	3,174	693	716	2,336	2,458
West	2,535	3,088	96	86	2,439	3,002	692	606	1,747^a	2,396
COUNTY TYPE
Large Metro	5,221	5,918	209	148	5,013	5,770	1,163	1,306	3,849	4,464
Small Metro	2,805	3,184	91	102	2,714	3,082	793	764	1,921	2,318
Nonmetro	1,353	1,086	38	22	1,315	1,064	274	202	1,041	862
Urbanized	516	459	17	7	499	452	119	106	380	346
Less Urbanized	707	535	19	9	688	526	141	88	548	438
Completely Rural	129	92	2	*	128	86	14	9	113	77
POVERTY LEVEL¹
Less Than 100%	2,261	2,039	53	22	2,208	2,018	549	513	1,659	1,505
100-199%	2,211	2,265	76	71	2,135	2,194	448	475	1,687	1,719
200% or More	4,906^a	5,881	208	180	4,698^a	5,701	1,233	1,281	3,465^b	4,421
HEALTH INSURANCE²
Private	4,127^b	5,041	201	171	3,926^b	4,870	1,414	1,496	2,512^b	3,374
Medicaid/CHIP	3,179	3,407	109	89	3,070	3,318	421	496	2,649	2,822
Other³	1,431	1,618	10	25	1,421	1,592	187	177	1,234	1,416
No Coverage	1,489^a	1,118	36	5	1,453	1,113	306^a	181	1,147	932
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.103B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3.4	3.6	1.3	1.1	3.6	3.9	6.7	6.5	3.1	3.5
GEOGRAPHIC REGION
Northeast	3.7	3.3	1.5	1.3	3.9	3.5	7.4	6.3	3.4	3.1
Midwest	3.3	3.8	1.5^a	0.7	3.5	4.1	5.9	7.9	3.1	3.5
South	2.9	3.0	1.0	0.9	3.1	3.2	5.5	5.4	2.8	2.9
West	3.8	4.6	1.5	1.4	4.1	5.0	8.7	7.4	3.4^a	4.6
COUNTY TYPE
Large Metro	3.5	3.8	1.5	1.0	3.7	4.1	6.6	6.8	3.2	3.7
Small Metro	3.3	3.6	1.1	1.3	3.5	3.8	7.2	6.5	2.9	3.3
Nonmetro	3.1	3.0	0.9	0.8	3.3	3.1	5.7	5.1	3.0	2.9
Urbanized	3.2	3.0	1.1	0.6	3.4	3.2	5.9	6.0	3.0	2.8
Less Urbanized	3.1	2.9	0.9	0.6	3.4	3.1	6.0	4.4	3.0	2.9
Completely Rural	2.8	3.2	0.4	*	3.1	3.4	3.0	3.6	3.1	3.3
POVERTY LEVEL¹
Less Than 100%	5.2	4.9	1.0	0.4	5.8	5.6	6.5	6.4	5.6	5.3
100-199%	3.9	4.1	1.4	1.2	4.2	4.4	5.6	5.6	3.9	4.2
200% or More	2.7^a	3.2	1.4	1.2	2.8^a	3.3	7.3	7.0	2.3^a	2.9
HEALTH INSURANCE²
Private	2.5^b	3.0	1.4	1.2	2.5^b	3.1	7.5	7.5	1.9^b	2.5
Medicaid/CHIP	5.5	5.8	1.0	0.8	6.5	6.9	4.8	5.4	6.8	7.3
Other³	1.9	2.1	0.7	1.7	1.9	2.1	7.3	6.3	1.7	1.9
No Coverage	5.7	4.6	2.7	0.5	5.9	4.8	6.4^a	3.9	5.7	5.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.104A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	4,173	4,469	100^a	40	4,073	4,429	675	767	3,398	3,662
GEOGRAPHIC REGION
Northeast	851	702	27	7	823	695	157	142	667	553
Midwest	827	936	15	8	813	928	125	193	688	736
South	1,240	1,430	26	16	1,213	1,414	152^a	276	1,061	1,138
West	1,255	1,400	32	9	1,224	1,391	241	156	983	1,235
COUNTY TYPE
Large Metro	2,383	2,676	67^a	20	2,316	2,656	368	449	1,948	2,207
Small Metro	1,145	1,253	17	19	1,127	1,234	232	252	896	983
Nonmetro	646	540	16^a	2	630	538	76	67	554	472
Urbanized	266	252	6	0	260	251	38	32	223	219
Less Urbanized	308	244	10	1	299	243	33	35	266	208
Completely Rural	71	*	*	*	71	*	6	*	65	*
POVERTY LEVEL¹
Less Than 100%	1,067	1,046	14	3	1,053	1,043	186	165	868	878
100-199%	1,042	1,113	33	8	1,009	1,104	139	181	871	923
200% or More	2,064	2,309	53	29	2,011	2,280	351	420	1,660	1,861
HEALTH INSURANCE²
Private	1,330^a	1,762	52	24	1,278^a	1,737	391	496	888^a	1,241
Medicaid/CHIP	1,717	1,903	36	17	1,681	1,886	151	171	1,530	1,715
Other³	776	838	2	1	773	837	52	39	721	797
No Coverage	745	512	*	1	733	511	97	76	636	435
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.104B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	1.5	1.6	0.4^a	0.2	1.6	1.7	2.0	2.2	1.5	1.7
GEOGRAPHIC REGION
Northeast	1.7	1.4	0.7	0.2	1.8	1.5	2.7	2.4	1.7	1.4
Midwest	1.4	1.6	0.3	0.1	1.5	1.8	1.8	2.6	1.5	1.6
South	1.2	1.3	0.3	0.2	1.3	1.4	1.2^a	2.1	1.3	1.3
West	1.9	2.1	0.5	0.2	2.0	2.3	3.0	1.9	1.9	2.4
COUNTY TYPE
Large Metro	1.6	1.7	0.5^a	0.1	1.7	1.9	2.1	2.3	1.6	1.8
Small Metro	1.3	1.4	0.2	0.2	1.4	1.5	2.1	2.2	1.3	1.4
Nonmetro	1.5	1.5	0.4^a	0.1	1.6	1.6	1.6	1.7	1.6	1.6
Urbanized	1.6	1.6	0.4	0.0	1.8	1.8	1.9	1.8	1.8	1.8
Less Urbanized	1.4	1.3	0.5	0.1	1.5	1.4	1.4	1.8	1.5	1.4
Completely Rural	1.6	*	*	*	1.7	*	1.2	*	1.8	*
POVERTY LEVEL¹
Less Than 100%	2.5	2.5	0.3	0.0	2.8	2.9	2.2	2.0	3.0	3.1
100-199%	1.8	2.0	0.6	0.1	2.0	2.2	1.7	2.1	2.0	2.2
200% or More	1.1	1.2	0.4	0.2	1.2	1.3	2.1	2.3	1.1	1.2
HEALTH INSURANCE²
Private	0.8^a	1.0	0.4	0.2	0.8^a	1.1	2.1	2.5	0.7^a	0.9
Medicaid/CHIP	2.9	3.2	0.3	0.2	3.5	3.9	1.7	1.8	3.9	4.4
Other³	1.0	1.1	0.2	0.1	1.0	1.1	2.0	1.4	1.0	1.1
No Coverage	2.9	2.1	*	0.1	3.0	2.2	2.0	1.7	3.2	2.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.105A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	23,579	24,692	1,635^a	1,343	21,944	23,348	4,807	5,092	17,137	18,256
GEOGRAPHIC REGION
Northeast	4,011	4,006	205	171	3,806	3,835	781	797	3,025	3,037
Midwest	4,533	4,870	355^a	242	4,178	4,628	1,070	1,122	3,108	3,506
South	8,295	8,592	595	555	7,700	8,038	1,622	1,704	6,078	6,334
West	6,740	7,223	480	375	6,261	6,848	1,334	1,469	4,926	5,379
COUNTY TYPE
Large Metro	13,166	13,991	868	744	12,298	13,247	2,548	2,840	9,750	10,407
Small Metro	7,134	7,816	578	445	6,556	7,371	1,591	1,702	4,965	5,669
Nonmetro	3,279	2,884	189	155	3,090	2,730	668	550	2,422	2,179
Urbanized	1,356	1,248	96	57	1,260	1,192	327	266	933	925
Less Urbanized	1,639	1,382	85	72	1,554	1,310	302	270	1,252	1,040
Completely Rural	284	255	8	*	276	228	38	15	238	214
POVERTY LEVEL¹
Less Than 100%	4,876	4,660	296	231	4,581	4,429	1,141	1,092	3,439	3,338
100-199%	5,306	5,060	373	347	4,933	4,713	1,245	1,175	3,688	3,538
200% or More	13,397^a	14,968	966^a	765	12,430^b	14,203	2,421^a	2,823	10,010^a	11,380
HEALTH INSURANCE²
Private	11,736^a	13,282	863	764	10,874^b	12,517	2,819	3,178	8,055^a	9,339
Medicaid/CHIP	7,322	7,321	745^a	523	6,577	6,798	1,064	1,213	5,513	5,585
Other³	4,092	4,589	77	90	4,015	4,500	392	364	3,623	4,136
No Coverage	3,004	2,722	74	48	2,930	2,674	713	558	2,216	2,116
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use other than marijuana estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.105B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	8.4	8.8	6.3^a	5.2	8.6	9.1	14.4	14.6	7.8	8.2
GEOGRAPHIC REGION
Northeast	8.2	8.2	4.9	4.2	8.5	8.5	13.6	13.5	7.7	7.8
Midwest	7.8	8.4	6.5^a	4.5	8.0	8.8	15.1	15.4	6.8	7.7
South	7.8	7.9	5.9	5.5	8.0	8.2	12.8	12.8	7.3	7.5
West	10.2	10.8	7.7	6.1	10.4	11.3	16.8	17.8	9.5	10.3
COUNTY TYPE
Large Metro	8.7	9.0	6.2	5.0	9.0	9.4	14.4	14.9	8.2	8.5
Small Metro	8.3	8.8	7.2	5.6	8.4	9.1	14.5	14.6	7.4	8.1
Nonmetro	7.6	7.9	4.7	5.3	7.9	8.1	13.8	13.8	7.0	7.3
Urbanized	8.4	8.1	6.3	4.6	8.6	8.4	16.2	15.1	7.4	7.4
Less Urbanized	7.3	7.5	4.1	5.1	7.6	7.7	12.8	13.7	6.9	6.9
Completely Rural	6.2	8.9	2.0	*	6.6	8.9	8.2	5.8	6.4	9.2
POVERTY LEVEL¹
Less Than 100%	11.2	11.2	5.4	4.4	12.1	12.2	13.5	13.6	11.7	11.9
100-199%	9.4	9.1	6.6	6.0	9.7	9.5	15.5	13.9	8.6	8.6
200% or More	7.4	8.1	6.5^a	5.2	7.5^a	8.3	14.3	15.5	6.8	7.5
HEALTH INSURANCE²
Private	7.0^a	7.8	6.2	5.4	7.0^b	8.0	14.9	16.0	5.9^a	6.9
Medicaid/CHIP	12.6	12.5	6.9^a	4.9	13.9	14.1	12.2	13.1	14.2	14.4
Other³	5.3	5.9	5.6	5.9	5.3	5.9	15.4	13.0	5.0	5.6
No Coverage	11.5	11.2	5.6	4.8	11.8	11.5	14.9	12.1	11.1	11.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use other than marijuana estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.106A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	9,108	9,560	527	399	8,581	9,161	1,395	1,531	7,186	7,630
GEOGRAPHIC REGION
Northeast	1,740	1,683	88	54	1,652	1,629	263	281	1,389	1,347
Midwest	1,746	1,933	110	69	1,636	1,865	293	325	1,343	1,539
South	2,909	3,321	177	174	2,732	3,147	378^a	575	2,354	2,572
West	2,713	2,623	152	103	2,561	2,520	460	349	2,100	2,171
COUNTY TYPE
Large Metro	5,102	5,598	267	248	4,835	5,350	745	834	4,090	4,517
Small Metro	2,812	2,707	181	106	2,631	2,601	490	540	2,141	2,060
Nonmetro	1,194	1,255	79	46	1,115	1,210	160	157	955	1,053
Urbanized	540	605	41	22	499	583	86	85	413	498
Less Urbanized	528	510	35	23	493	487	62	70	431	417
Completely Rural	126	140	3	*	123	140	12	*	110	*
POVERTY LEVEL¹
Less Than 100%	2,019	2,002	84	88	1,935	1,914	350	307	1,585	1,607
100-199%	2,082	2,093	140^a	76	1,942	2,017	378	394	1,564	1,624
200% or More	5,007	5,464	303	235	4,704	5,229	667	830	4,037	4,399
HEALTH INSURANCE²
Private	3,730^a	4,386	261	221	3,469^a	4,165	781	944	2,688	3,221
Medicaid/CHIP	3,284	3,523	260^a	146	3,024	3,377	366	357	2,659	3,020
Other³	1,798	1,918	21	23	1,777	1,896	95	82	1,682	1,814
No Coverage	1,397	1,040	23	29	1,374	1,011	194	190	1,180	821
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use other than marijuana estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.106B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
TOTAL	3.3	3.4	2.0	1.6	3.4	3.6	4.2	4.4	3.3	3.4
GEOGRAPHIC REGION
Northeast	3.6	3.4	2.1	1.3	3.7	3.6	4.6	4.8	3.6	3.5
Midwest	3.0	3.3	2.0	1.3	3.1	3.5	4.1	4.5	3.0	3.4
South	2.7	3.1	1.7	1.7	2.8	3.2	3.0^a	4.3	2.8	3.0
West	4.1	3.9	2.4	1.7	4.3	4.2	5.8	4.2	4.0	4.1
COUNTY TYPE
Large Metro	3.4	3.6	1.9	1.7	3.5	3.8	4.2	4.4	3.4	3.7
Small Metro	3.3	3.0	2.3	1.3	3.4	3.2	4.5	4.6	3.2	3.0
Nonmetro	2.8	3.4	2.0	1.6	2.8	3.6	3.3	3.9	2.8	3.5
Urbanized	3.3	3.9	2.7	1.8	3.4	4.1	4.2	4.8	3.3	4.0
Less Urbanized	2.3	2.8	1.7	1.7	2.4	2.9	2.6	3.5	2.4	2.8
Completely Rural	2.8	4.9	0.8	*	2.9	5.4	2.6	*	3.0	*
POVERTY LEVEL¹
Less Than 100%	4.7	4.8	1.5	1.7	5.1	5.3	4.1	3.8	5.4	5.7
100-199%	3.7	3.8	2.5^a	1.3	3.8	4.0	4.7	4.6	3.7	3.9
200% or More	2.8	3.0	2.0	1.6	2.8	3.1	4.0	4.5	2.7	2.9
HEALTH INSURANCE²
Private	2.2	2.6	1.9	1.6	2.2^a	2.7	4.1	4.7	2.0	2.4
Medicaid/CHIP	5.6	6.0	2.4^a	1.4	6.4	7.0	4.2	3.9	6.9	7.8
Other³	2.3	2.5	1.5	1.5	2.4	2.5	3.7	2.9	2.3	2.5
No Coverage	5.3	4.3	1.7	2.8	5.5	4.4	4.0	4.1	5.9	4.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: For comparison of estimates between 2021 and 2022, illicit drug use other than marijuana estimates do not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.107A – Any Use and Misuse of Fentanyl in Past Year and Use of Illegally Made Fentanyl (IMF) in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic	Any Fentanyl Use¹ (2021)	Any Fentanyl Use¹ (2022)	Fentanyl Misuse² (2021)	Fentanyl Misuse² (2022)	IMF Use (2021)	IMF Use (2022)
TOTAL	--	3,086	--	991	--	686
GEOGRAPHIC REGION
Northeast	--	566	--	181	--	136
Midwest	--	630	--	169	--	111
South	--	1,034	--	384	--	293
West	--	856	--	257	--	146
COUNTY TYPE
Large Metro	--	1,359	--	522	--	320
Small Metro	--	1,199	--	304	--	231
Nonmetro	--	529	--	164	--	136
Urbanized	--	248	--	50	--	37
Less Urbanized	--	247	--	96	--	80
Completely Rural	--	34	--	*	--	*
POVERTY LEVEL³
Less Than 100%	--	666	--	370	--	239
100-199%	--	783	--	291	--	212
200% or More	--	1,638	--	330	--	235
HEALTH INSURANCE⁴
Private	--	1,348	--	215	--	150
Medicaid/CHIP	--	1,283	--	678	--	458
Other⁵	--	1,116	--	228	--	192
No Coverage	--	201	--	114	--	96
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ¹ Any use of fentanyl includes use of IMF or any use of pharmaceutical fentanyl in the past year. ² Misuse of fentanyl includes use of IMF or the misuse of pharmaceutical fentanyl in the past year. ³ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ⁴ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁵ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.107B – Any Use and Misuse of Fentanyl in Past Year and Use of Illegally Made Fentanyl (IMF) in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic	Any Fentanyl Use¹ (2021)	Any Fentanyl Use¹ (2022)	Fentanyl Misuse² (2021)	Fentanyl Misuse² (2022)	IMF Use (2021)	IMF Use (2022)
TOTAL	--	1.1	--	0.4	--	0.2
GEOGRAPHIC REGION
Northeast	--	1.2	--	0.4	--	0.3
Midwest	--	1.1	--	0.3	--	0.2
South	--	1.0	--	0.4	--	0.3
West	--	1.3	--	0.4	--	0.2
COUNTY TYPE
Large Metro	--	0.9	--	0.3	--	0.2
Small Metro	--	1.3	--	0.3	--	0.3
Nonmetro	--	1.4	--	0.4	--	0.4
Urbanized	--	1.6	--	0.3	--	0.2
Less Urbanized	--	1.3	--	0.5	--	0.4
Completely Rural	--	1.2	--	*	--	*
POVERTY LEVEL³
Less Than 100%	--	1.6	--	0.9	--	0.6
100-199%	--	1.4	--	0.5	--	0.4
200% or More	--	0.9	--	0.2	--	0.1
HEALTH INSURANCE⁴
Private	--	0.8	--	0.1	--	0.1
Medicaid/CHIP	--	2.2	--	1.2	--	0.8
Other⁵	--	1.4	--	0.3	--	0.2
No Coverage	--	0.8	--	0.5	--	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ¹ Any use of fentanyl includes use of IMF or any use of pharmaceutical fentanyl in the past year. ² Misuse of fentanyl includes use of IMF or the misuse of pharmaceutical fentanyl in the past year. ³ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ⁴ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁵ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.108A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2021 and 2022
Drug or Method of Administration	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
HALLUCINOGENS	46,474	48,850	626	533	45,848	48,316	5,349^a	5,889	40,499	42,427
PCP	6,570	6,394	32	28	6,538	6,366	226	180	6,312	6,186
LSD	30,114	31,074	451^b	283	29,663	30,791	3,317	3,583	26,346	27,207
Peyote¹	5,326	5,604	21	3	5,305	5,601	125	173	5,180	5,428
Mescaline¹	6,957	7,796	17	11	6,940	7,785	87	133	6,853	7,652
Psilocybin/Mushrooms¹	29,105^a	31,825	282	345	28,823^a	31,480	3,588^b	4,229	25,234	27,252
Ecstasy	21,436	22,103	155	124	21,281	21,979	2,756	2,628	18,524	19,351
Ketamine	4,667	4,702	52	36	4,615	4,666	524	649	4,091	4,016
DMT, AMT, or 5-MeO-DIPT/Foxy	3,618	3,943	53	39	3,564	3,904	483^a	656	3,082	3,248
Salvia divinorum	5,024	5,515	22	23	5,003	5,492	391	372	4,611	5,120
INHALANTS	25,436	27,242	2,356^b	1,940	23,080^a	25,302	2,754	3,073	20,326^a	22,229
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush¹	7,836	8,829	175^a	81	7,661	8,749	570	743	7,091	8,006
Correction Fluid, Degreaser, or Cleaning Fluid¹	1,367	1,739	252	204	1,115^a	1,534	105	164	1,010	1,370
Gasoline or Lighter Fluid¹	2,831	3,024	573^a	397	2,258	2,627	297	326	1,961	2,300
Glue, Shoe Polish, or Toluene¹	3,167	2,856	524	420	2,643	2,436	327	325	2,316	2,111
Halothane, Ether, or Other Anesthetics¹	616^b	1,197	47^a	13	569^b	1,185	29^a	82	540^b	1,103
Lacquer Thinner or Other Paint Solvents¹	1,206	1,577	181	106	1,025^a	1,471	147	147	878^a	1,323
Lighter Gases¹	720	844	155	95	565	749	57^a	129	507	621
Nitrous Oxide or Whippits¹	12,387^a	13,915	154	111	12,233^a	13,804	926^a	1,177	11,307	12,627
Felt-Tip Pens or Felt-Tip/Magic Markers¹	6,860	6,894	1,760^a	1,453	5,100	5,441	1,408	1,357	3,692	4,084
Spray Paints¹	1,969	1,910	486	362	1,483	1,548	294	230	1,189	1,318
Computer Cleaner/Air Duster¹	2,675	3,081	171	172	2,504	2,910	270	290	2,234	2,619
Other Aerosol Sprays¹	1,127	1,429	149	113	979	1,316	109	141	870	1,175
NEEDLE USE^1,2	--	5,691	--	30	--	5,661	--	193	--	5,468
Heroin Needle Use¹	3,236	3,274	3	1	3,234	3,272	123	84	3,111	3,188
Cocaine Needle Use¹	2,597	2,897	2	6	2,595	2,891	45	34	2,550	2,857
Methamphetamine Needle Use¹	3,215	2,978	3	*	3,212	2,978	81	94	3,131	2,884
Illegally Made Fentanyl Needle Use^1,2	--	619	--	15	--	604	--	47	--	557
HEROIN	6,684	6,558	7	10	6,677	6,549	349^a	218	6,328	6,331
Smoke Heroin¹	3,222	2,998	3	2	3,219	2,996	205^a	111	3,014	2,885
Sniff or Snort Heroin¹	4,510	4,644	*	6	4,509	4,638	233	169	4,276	4,469
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.108B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Percentages, 2021 and 2022
Drug or Method of Administration	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
HALLUCINOGENS	16.6	17.3	2.4	2.1	18.1	18.9	16.0	16.9	18.4	19.2
PCP	2.3	2.3	0.1	0.1	2.6	2.5	0.7	0.5	2.9	2.8
LSD	10.8	11.0	1.7^a	1.1	11.7	12.0	9.9	10.3	12.0	12.3
Peyote¹	1.9	2.0	0.1	0.0	2.1	2.2	0.4	0.5	2.4	2.5
Mescaline¹	2.5	2.8	0.1	0.0	2.7	3.0	0.3	0.4	3.1	3.5
Psilocybin/Mushrooms¹	10.4^a	11.3	1.1	1.3	11.4^a	12.3	10.7^a	12.2	11.5	12.3
Ecstasy	7.7	7.8	0.6	0.5	8.4	8.6	8.2	7.6	8.4	8.7
Ketamine	1.7	1.7	0.2	0.1	1.8	1.8	1.6	1.9	1.9	1.8
DMT, AMT, or 5-MeO-DIPT/Foxy	1.3	1.4	0.2	0.2	1.4	1.5	1.4^a	1.9	1.4	1.5
Salvia divinorum	1.8	2.0	0.1	0.1	2.0	2.1	1.2	1.1	2.1	2.3
INHALANTS	9.1	9.7	9.1^b	7.5	9.1^a	9.9	8.2	8.8	9.2	10.0
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush¹	2.8	3.1	0.7^a	0.3	3.0	3.4	1.7	2.1	3.2	3.6
Correction Fluid, Degreaser, or Cleaning Fluid¹	0.5	0.6	1.0	0.8	0.4^a	0.6	0.3	0.5	0.5	0.6
Gasoline or Lighter Fluid¹	1.0	1.1	2.2^a	1.5	0.9	1.0	0.9	0.9	0.9	1.0
Glue, Shoe Polish, or Toluene¹	1.1	1.0	2.0	1.6	1.0	1.0	1.0	0.9	1.1	1.0
Halothane, Ether, or Other Anesthetics¹	0.2^b	0.4	0.2^a	0.0	0.2^b	0.5	0.1	0.2	0.2^b	0.5
Lacquer Thinner or Other Paint Solvents¹	0.4	0.6	0.7	0.4	0.4^a	0.6	0.4	0.4	0.4^a	0.6
Lighter Gases¹	0.3	0.3	0.6	0.4	0.2	0.3	0.2^a	0.4	0.2	0.3
Nitrous Oxide or Whippits¹	4.4	4.9	0.6	0.4	4.8^a	5.4	2.8	3.4	5.1	5.7
Felt-Tip Pens or Felt-Tip/Magic Markers¹	2.5	2.4	6.8^a	5.7	2.0	2.1	4.2	3.9	1.7	1.8
Spray Paints¹	0.7	0.7	1.9	1.4	0.6	0.6	0.9	0.7	0.5	0.6
Computer Cleaner/Air Duster¹	1.0	1.1	0.7	0.7	1.0	1.1	0.8	0.8	1.0	1.2
Other Aerosol Sprays¹	0.4	0.5	0.6	0.4	0.4	0.5	0.3	0.4	0.4	0.5
NEEDLE USE^1,2	--	2.0	--	0.1	--	2.2	--	0.6	--	2.5
Heroin Needle Use¹	1.2	1.2	0.0	0.0	1.3	1.3	0.4	0.2	1.4	1.4
Cocaine Needle Use¹	0.9	1.0	0.0	0.0	1.0	1.1	0.1	0.1	1.2	1.3
Methamphetamine Needle Use¹	1.1	1.1	0.0	*	1.3	1.2	0.2	0.3	1.4	1.3
Illegally Made Fentanyl Needle Use^1,2	--	0.2	--	0.1	--	0.2	--	0.1	--	0.3
HEROIN	2.4	2.3	0.0	0.0	2.6	2.6	1.0^a	0.6	2.9	2.9
Smoke Heroin¹	1.2	1.1	0.0	0.0	1.3	1.2	0.6^a	0.3	1.4	1.3
Sniff or Snort Heroin¹	1.6	1.6	*	0.0	1.8	1.8	0.7	0.5	1.9	2.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.109A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2021 and 2022
Drug or Method of Administration	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
HALLUCINOGENS	7,572^a	8,509	377	358	7,195^a	8,151	2,462	2,676	4,733	5,475
PCP	198	204	22	15	175	190	54	13	121	177
LSD	2,579	2,322	272^a	169	2,307	2,154	1,077	894	1,230	1,259
Ecstasy	2,228	2,109	96	63	2,132	2,046	709	639	1,423	1,407
Ketamine	570	762	7	18	563	744	131	210	432	534
DMT, AMT, or 5-MeO-DIPT/Foxy	581	678	13	13	567	665	155	127	412	539
Salvia divinorum	74	140	11	7	63	133	16^a	70	46	63
INHALANTS	2,119	2,254	643	554	1,475	1,700	507	647	968	1,053
NEEDLE USE^1,2	--	1,054	--	12	--	1,042	--	69	--	973
Heroin Needle Use¹	453	438	*	*	453	438	31	16	422	422
Cocaine Needle Use¹	129	184	*	*	129	184	9	*	120	184
Methamphetamine Needle Use¹	597	620	3	*	595	620	23	24	572	597
Illegally Made Fentanyl Needle Use^1,2	--	243	--	10	--	233	--	20	--	213
HEROIN	1,089	1,049	*	3	1,088	1,046	71	55	1,018	991
Smoke Heroin¹	286	381	*	*	285	381	37	21	248	360
Sniff or Snort Heroin¹	685	741	*	*	684	741	36	32	648	709
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.109B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2021 and 2022
Drug or Method of Administration	Aged 12+ (2021)	Aged 12+ (2022)	Aged 12-17 (2021)	Aged 12-17 (2022)	Aged 18+ (2021)	Aged 18+ (2022)	Aged 18-25 (2021)	Aged 18-25 (2022)	Aged 26+ (2021)	Aged 26+ (2022)
HALLUCINOGENS	2.7	3.0	1.4	1.4	2.8	3.2	7.4	7.7	2.1	2.5
PCP	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1
LSD	0.9	0.8	1.0^a	0.7	0.9	0.8	3.2	2.6	0.6	0.6
Ecstasy	0.8	0.7	0.4	0.2	0.8	0.8	2.1	1.8	0.6	0.6
Ketamine	0.2	0.3	0.0	0.1	0.2	0.3	0.4	0.6	0.2	0.2
DMT, AMT, or 5-MeO-DIPT/Foxy	0.2	0.2	0.1	0.1	0.2	0.3	0.5	0.4	0.2	0.2
Salvia divinorum	0.0	0.0	0.0	0.0	0.0	0.1	0.0^a	0.2	0.0	0.0
INHALANTS	0.8	0.8	2.5	2.2	0.6	0.7	1.5	1.9	0.4	0.5
NEEDLE USE^1,2	--	0.4	--	0.0	--	0.4	--	0.2	--	0.4
Heroin Needle Use¹	0.2	0.2	*	*	0.2	0.2	0.1	0.0	0.2	0.2
Cocaine Needle Use¹	0.0	0.1	*	*	0.1	0.1	0.0	*	0.1	0.1
Methamphetamine Needle Use¹	0.2	0.2	0.0	*	0.2	0.2	0.1	0.1	0.3	0.3
Illegally Made Fentanyl Needle Use^1,2	--	0.1	--	0.0	--	0.1	--	0.1	--	0.1
HEROIN	0.4	0.4	*	0.0	0.4	0.4	0.2	0.2	0.5	0.4
Smoke Heroin¹	0.1	0.1	*	*	0.1	0.1	0.1	0.1	0.1	0.2
Sniff or Snort Heroin¹	0.2	0.3	*	*	0.3	0.3	0.1	0.1	0.3	0.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.110A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Pain Reliever Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)
ANY PRESCRIPTION PAIN RELIEVER	72,811	73,833	8,885	8,457	12.2	11.5
Hydrocodone Products¹	36,296	36,598	4,174	3,735	11.5	10.2
Oxycodone Products¹	21,120	20,773	2,761	2,547	13.1	12.3
OxyContin^®	6,982	7,793	926	984	13.3	12.6
Tramadol Products¹	14,327	14,658	1,384	1,379	9.7	9.4
Codeine Products¹	19,994	19,839	2,280	1,850	11.4	9.3
Morphine Products¹	4,905	5,230	438	375	8.9	7.2
Pharmaceutical Fentanyl Products²	2,581	2,665	526	507	20.4	19.0
Buprenorphine Products¹	3,451	3,505	771	679	22.4	19.5
Oxymorphone Products¹	968	1,068	162	113	*	10.7
Demerol^®1	507	644	51	53	*	*
Hydromorphone Products¹	1,686	1,268	199	99	11.9	7.9
Methadone¹	1,708	1,405	301	206	*	14.8
Any Other Prescription Pain Reliever^1,3	20,838	21,512	542	660	2.6	3.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² These estimates include fentanyl products that are available by prescription in the United States. Estimates do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.110B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 or Older; Percentages, 2021 and 2022
Pain Reliever Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)
ANY PRESCRIPTION PAIN RELIEVER	26.0	26.2	3.2	3.0	12.2	11.5
Hydrocodone Products¹	13.0	13.0	1.5	1.3	11.5	10.2
Oxycodone Products¹	7.6	7.4	1.0	0.9	13.1	12.3
OxyContin^®	2.5	2.8	0.3	0.3	13.3	12.6
Tramadol Products¹	5.1	5.2	0.5	0.5	9.7	9.4
Codeine Products¹	7.2	7.1	0.8	0.7	11.4	9.3
Morphine Products¹	1.8	1.9	0.2	0.1	8.9	7.2
Pharmaceutical Fentanyl Products²	0.9	0.9	0.2	0.2	20.4	19.0
Buprenorphine Products¹	1.2	1.2	0.3	0.2	22.4	19.5
Oxymorphone Products¹	0.3	0.4	0.1	0.0	*	10.7
Demerol^®1	0.2	0.2	0.0	0.0	*	*
Hydromorphone Products¹	0.6	0.5	0.1	0.0	11.9	7.9
Methadone¹	0.6	0.5	0.1	0.1	*	14.8
Any Other Prescription Pain Reliever^1,3	7.5	7.6	0.2	0.2	2.6	3.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² These estimates include fentanyl products that are available by prescription in the United States. Estimates do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.111A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2021 and 2022
Pain Reliever Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)
ANY PRESCRIPTION PAIN RELIEVER	3,492	3,191	550	406	15.7	12.7
Hydrocodone Products¹	701	633	95	70	13.6	11.1
Oxycodone Products¹	628	522	129	89	20.7	17.1
OxyContin^®	232	229	54	53	*	23.2
Tramadol Products¹	295	250	32	33	*	*
Codeine Products¹	1,334	1,207	300^b	147	22.5^b	12.3
Morphine Products¹	291	251	5	18	1.6	7.2
Pharmaceutical Fentanyl Products²	64^a	129	15	14	*	*
Buprenorphine Products¹	75	107	8	3	*	*
Oxymorphone Products¹	52	91	2	2	*	*
Demerol^®1	11	32	*	*	*	*
Hydromorphone Products¹	54	31	23	2	*	*
Methadone¹	42	59	2	2	*	*
Any Other Prescription Pain Reliever^1,3	1,512	1,385	56	36	3.8	2.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² These estimates include fentanyl products that are available by prescription in the United States. Estimates do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.111B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 to 17; Percentages, 2021 and 2022
Pain Reliever Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)
ANY PRESCRIPTION PAIN RELIEVER	13.4	12.4	2.1	1.6	15.7	12.7
Hydrocodone Products¹	2.7	2.5	0.4	0.3	13.6	11.1
Oxycodone Products¹	2.4	2.0	0.5	0.3	20.7	17.1
OxyContin^®	0.9	0.9	0.2	0.2	*	23.2
Tramadol Products¹	1.1	1.0	0.1	0.1	*	*
Codeine Products¹	5.2	4.7	1.2^b	0.6	22.5^b	12.3
Morphine Products¹	1.1	1.0	0.0	0.1	1.6	7.2
Pharmaceutical Fentanyl Products²	0.2^a	0.5	0.1	0.1	*	*
Buprenorphine Products¹	0.3	0.4	0.0	0.0	*	*
Oxymorphone Products¹	0.2	0.4	0.0	0.0	*	*
Demerol^®1	0.0	0.1	*	*	*	*
Hydromorphone Products¹	0.2	0.1	0.1	0.0	*	*
Methadone¹	0.2	0.2	0.0	0.0	*	*
Any Other Prescription Pain Reliever^1,3	5.8	5.4	0.2	0.1	3.8	2.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² These estimates include fentanyl products that are available by prescription in the United States. Estimates do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.112A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Pain Reliever Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)
ANY PRESCRIPTION PAIN RELIEVER	69,319	70,642	8,335	8,051	12.0	11.4
Hydrocodone Products¹	35,595	35,965	4,079	3,665	11.5	10.2
Oxycodone Products¹	20,492	20,252	2,632	2,457	12.9	12.2
OxyContin^®	6,750	7,565	873	931	12.9	12.3
Tramadol Products¹	14,032	14,408	1,352	1,346	9.7	9.4
Codeine Products¹	18,660	18,632	1,979	1,703	10.6	9.2
Morphine Products¹	4,614	4,979	433	358	9.4	7.2
Pharmaceutical Fentanyl Products²	2,517	2,535	510	494	20.3	19.5
Buprenorphine Products¹	3,376	3,398	763	676	22.7	20.0
Oxymorphone Products¹	916	977	160	112	*	11.6
Demerol^®1	496	612	51	53	*	*
Hydromorphone Products¹	1,632	1,237	176	97	10.9	7.9
Methadone¹	1,667	1,346	300	203	*	15.2
Any Other Prescription Pain Reliever^1,3	19,325	20,127	486	624	2.6	3.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² These estimates include fentanyl products that are available by prescription in the United States. Estimates do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.112B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 or Older; Percentages, 2021 and 2022
Pain Reliever Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)
ANY PRESCRIPTION PAIN RELIEVER	27.3	27.6	3.3	3.1	12.0	11.4
Hydrocodone Products¹	14.0	14.1	1.6	1.4	11.5	10.2
Oxycodone Products¹	8.1	7.9	1.0	1.0	12.9	12.2
OxyContin^®	2.7	3.0	0.3	0.4	12.9	12.3
Tramadol Products¹	5.5	5.6	0.5	0.5	9.7	9.4
Codeine Products¹	7.4	7.3	0.8	0.7	10.6	9.2
Morphine Products¹	1.8	1.9	0.2	0.1	9.4	7.2
Pharmaceutical Fentanyl Products²	1.0	1.0	0.2	0.2	20.3	19.5
Buprenorphine Products¹	1.3	1.3	0.3	0.3	22.7	20.0
Oxymorphone Products¹	0.4	0.4	0.1	0.0	*	11.6
Demerol^®1	0.2	0.2	0.0	0.0	*	*
Hydromorphone Products¹	0.6	0.5	0.1	0.0	10.9	7.9
Methadone¹	0.7	0.5	0.1	0.1	*	15.2
Any Other Prescription Pain Reliever^1,3	7.6	7.9	0.2	0.2	2.6	3.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² These estimates include fentanyl products that are available by prescription in the United States. Estimates do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.113A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2021 and 2022
Pain Reliever Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)
ANY PRESCRIPTION PAIN RELIEVER	6,265	6,489	1,050	1,099	16.8	16.9
Hydrocodone Products¹	2,461	2,403	402	531	16.3^a	22.2
Oxycodone Products¹	1,886	1,818	479	401	25.5	22.3
OxyContin^®	661	593	141	119	21.3	20.0
Tramadol Products¹	850	829	147	152	17.3	18.5
Codeine Products¹	1,763	1,779	220	233	12.5	13.2
Morphine Products¹	550	497	90^a	38	16.4	7.8
Pharmaceutical Fentanyl Products²	316	237	76	41	*	*
Buprenorphine Products¹	211	238	62	65	*	*
Oxymorphone Products¹	102	108	22	23	*	*
Demerol^®1	44	41	7	12	*	*
Hydromorphone Products¹	88	79	29	15	*	*
Methadone¹	66	72	22	8	*	*
Any Other Prescription Pain Reliever^1,3	2,026	2,307	71	106	3.6	4.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² These estimates include fentanyl products that are available by prescription in the United States. Estimates do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.113B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 to 25; Percentages, 2021 and 2022
Pain Reliever Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)
ANY PRESCRIPTION PAIN RELIEVER	18.7	18.7	3.1	3.2	16.8	16.9
Hydrocodone Products¹	7.4	6.9	1.2	1.5	16.3^a	22.2
Oxycodone Products¹	5.6	5.2	1.4	1.2	25.5	22.3
OxyContin^®	2.0	1.7	0.4	0.3	21.3	20.0
Tramadol Products¹	2.5	2.4	0.4	0.4	17.3	18.5
Codeine Products¹	5.3	5.1	0.7	0.7	12.5	13.2
Morphine Products¹	1.6	1.4	0.3^a	0.1	16.4	7.8
Pharmaceutical Fentanyl Products²	0.9	0.7	0.2	0.1	*	*
Buprenorphine Products¹	0.6	0.7	0.2	0.2	*	*
Oxymorphone Products¹	0.3	0.3	0.1	0.1	*	*
Demerol^®1	0.1	0.1	0.0	0.0	*	*
Hydromorphone Products¹	0.3	0.2	0.1	0.0	*	*
Methadone¹	0.2	0.2	0.1	0.0	*	*
Any Other Prescription Pain Reliever^1,3	6.1	6.6	0.2	0.3	3.6	4.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² These estimates include fentanyl products that are available by prescription in the United States. Estimates do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.114A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Pain Reliever Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)
ANY PRESCRIPTION PAIN RELIEVER	63,054	64,153	7,286	6,953	11.6	10.8
Hydrocodone Products¹	33,134	33,562	3,677	3,135	11.1	9.3
Oxycodone Products¹	18,606	18,434	2,153	2,056	11.6	11.2
OxyContin^®	6,089	6,972	732	812	12.0	11.7
Tramadol Products¹	13,181	13,579	1,205	1,194	9.2	8.8
Codeine Products¹	16,897	16,854	1,759	1,470	10.4	8.7
Morphine Products¹	4,064	4,482	343	320	8.4	7.2
Pharmaceutical Fentanyl Products²	2,201	2,299	434	453	19.7	19.7
Buprenorphine Products¹	3,165	3,160	701	612	22.2	19.4
Oxymorphone Products¹	814	869	138	89	*	10.2
Demerol^®1	452	571	44	42	*	*
Hydromorphone Products¹	1,544	1,158	146	83	9.5	7.1
Methadone¹	1,601	1,274	278	195	*	15.4
Any Other Prescription Pain Reliever^1,3	17,300	17,820	415	518	2.4	2.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² These estimates include fentanyl products that are available by prescription in the United States. Estimates do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.114B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 26 or Older; Percentages, 2021 and 2022
Pain Reliever Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)
ANY PRESCRIPTION PAIN RELIEVER	28.6	29.0	3.3	3.1	11.6	10.8
Hydrocodone Products¹	15.1	15.2	1.7	1.4	11.1	9.3
Oxycodone Products¹	8.5	8.3	1.0	0.9	11.6	11.2
OxyContin^®	2.8	3.1	0.3	0.4	12.0	11.7
Tramadol Products¹	6.0	6.1	0.5	0.5	9.2	8.8
Codeine Products¹	7.7	7.6	0.8	0.7	10.4	8.7
Morphine Products¹	1.8	2.0	0.2	0.1	8.4	7.2
Pharmaceutical Fentanyl Products²	1.0	1.0	0.2	0.2	19.7	19.7
Buprenorphine Products¹	1.4	1.4	0.3	0.3	22.2	19.4
Oxymorphone Products¹	0.4	0.4	0.1	0.0	*	10.2
Demerol^®1	0.2	0.3	0.0	0.0	*	*
Hydromorphone Products¹	0.7	0.5	0.1	0.0	9.5	7.1
Methadone¹	0.7	0.6	0.1	0.1	*	15.4
Any Other Prescription Pain Reliever^1,3	7.9	8.1	0.2	0.2	2.4	2.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² These estimates include fentanyl products that are available by prescription in the United States. Estimates do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.115A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Stimulant Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)
ANY PRESCRIPTION STIMULANT	16,878^b	19,674	3,910	4,298	23.2	21.8
Amphetamines or Methylphenidate Products¹	13,047^b	15,332	3,614	4,000	27.8	26.1
Amphetamines¹	11,301^b	13,154	3,364	3,799	29.8	28.9
Methylphenidate Products¹	3,395^a	3,970	575	563	17.1	14.2
Anorectic (Weight-Loss) Stimulants¹	2,588	2,728	243	189	9.4	6.9
Provigil^®1	358	413	107	92	*	*
Any Other Prescription Stimulant^1,2	2,242^a	2,976	25	26	1.2	0.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.115B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Percentages, 2021 and 2022
Stimulant Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)
ANY PRESCRIPTION STIMULANT	6.0^b	7.0	1.4	1.5	23.2	21.8
Amphetamines or Methylphenidate Products¹	4.7^b	5.4	1.3	1.4	27.8	26.1
Amphetamines¹	4.0^b	4.7	1.2	1.3	29.8	28.9
Methylphenidate Products¹	1.2	1.4	0.2	0.2	17.1	14.2
Anorectic (Weight-Loss) Stimulants¹	0.9	1.0	0.1	0.1	9.4	6.9
Provigil^®1	0.1	0.1	0.0	0.0	*	*
Any Other Prescription Stimulant^1,2	0.8^a	1.1	0.0	0.0	1.2	0.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.116A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2021 and 2022
Stimulant Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)
ANY PRESCRIPTION STIMULANT	1,829	1,845	302	226	16.5	12.2
Amphetamines or Methylphenidate Products¹	1,625	1,574	282	218	17.4	13.9
Amphetamines¹	1,227	1,109	220	202	17.9	18.3
Methylphenidate Products¹	638	712	71	39	11.2	5.4
Anorectic (Weight-Loss) Stimulants¹	88	126	17	4	*	*
Provigil^®1	30	25	3	*	*	*
Any Other Prescription Stimulant^1,2	281	337	*	*	*	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.116B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Percentages, 2021 and 2022
Stimulant Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)
ANY PRESCRIPTION STIMULANT	7.0	7.2	1.2	0.9	16.5	12.2
Amphetamines or Methylphenidate Products¹	6.3	6.1	1.1	0.8	17.4	13.9
Amphetamines¹	4.7	4.3	0.8	0.8	17.9	18.3
Methylphenidate Products¹	2.5	2.8	0.3	0.1	11.2	5.4
Anorectic (Weight-Loss) Stimulants¹	0.3	0.5	0.1	0.0	*	*
Provigil^®1	0.1	0.1	0.0	*	*	*
Any Other Prescription Stimulant^1,2	1.1	1.3	*	*	*	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.117A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Stimulant Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)
ANY PRESCRIPTION STIMULANT	15,049^b	17,830	3,608	4,072	24.0	22.8
Amphetamines or Methylphenidate Products¹	11,422^b	13,758	3,331	3,782	29.3	27.5
Amphetamines¹	10,073^b	12,045	3,144	3,596	31.2	29.9
Methylphenidate Products¹	2,757	3,258	504	525	18.5	16.1
Anorectic (Weight-Loss) Stimulants¹	2,500	2,602	227	185	9.1	7.1
Provigil^®1	329	388	104	91	*	*
Any Other Prescription Stimulant^1,2	1,961^a	2,639	25	25	1.3	1.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.117B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Percentages, 2021 and 2022
Stimulant Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)
ANY PRESCRIPTION STIMULANT	5.9^b	7.0	1.4	1.6	24.0	22.8
Amphetamines or Methylphenidate Products¹	4.5^b	5.4	1.3	1.5	29.3	27.5
Amphetamines¹	4.0^b	4.7	1.2	1.4	31.2	29.9
Methylphenidate Products¹	1.1	1.3	0.2	0.2	18.5	16.1
Anorectic (Weight-Loss) Stimulants¹	1.0	1.0	0.1	0.1	9.1	7.1
Provigil^®1	0.1	0.2	0.0	0.0	*	*
Any Other Prescription Stimulant^1,2	0.8^a	1.0	0.0	0.0	1.3	1.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.118A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2021 and 2022
Stimulant Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)
ANY PRESCRIPTION STIMULANT	3,473	3,794	1,359	1,278	39.1	33.7
Amphetamines or Methylphenidate Products¹	3,237	3,564	1,336	1,257	41.3^a	35.3
Amphetamines¹	2,857	3,093	1,270	1,173	44.5^a	37.9
Methylphenidate Products¹	837	1,012	218	234	26.0	23.1
Anorectic (Weight-Loss) Stimulants¹	165	153	48	13	*	*
Provigil^®1	29	35	17	4	*	*
Any Other Prescription Stimulant^1,2	207^b	422	8	12	*	*
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.118B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Percentages, 2021 and 2022
Stimulant Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)
ANY PRESCRIPTION STIMULANT	10.4	10.9	4.1	3.7	39.1	33.7
Amphetamines or Methylphenidate Products¹	9.7	10.3	4.0	3.6	41.3^a	35.3
Amphetamines¹	8.5	8.9	3.8	3.4	44.5^a	37.9
Methylphenidate Products¹	2.5	2.9	0.7	0.7	26.0	23.1
Anorectic (Weight-Loss) Stimulants¹	0.5	0.4	0.1	0.0	*	*
Provigil^®1	0.1	0.1	0.0	0.0	*	*
Any Other Prescription Stimulant^1,2	0.6^b	1.2	0.0	0.0	*	*
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.119A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Stimulant Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)
ANY PRESCRIPTION STIMULANT	11,576^b	14,035	2,249^a	2,794	19.4	19.9
Amphetamines or Methylphenidate Products¹	8,186^b	10,194	1,995^a	2,526	24.5	24.8
Amphetamines¹	7,216^b	8,952	1,874^a	2,423	26.0	27.1
Methylphenidate Products¹	1,920	2,245	286	291	15.2	13.0
Anorectic (Weight-Loss) Stimulants¹	2,335	2,449	179	172	7.7	7.0
Provigil^®1	299	353	87	87	*	*
Any Other Prescription Stimulant^1,2	1,754	2,217	17	13	*	0.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.119B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Percentages, 2021 and 2022
Stimulant Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)
ANY PRESCRIPTION STIMULANT	5.3^b	6.3	1.0^a	1.3	19.4	19.9
Amphetamines or Methylphenidate Products¹	3.7^b	4.6	0.9^a	1.1	24.5	24.8
Amphetamines¹	3.3^b	4.0	0.9^a	1.1	26.0	27.1
Methylphenidate Products¹	0.9	1.0	0.1	0.1	15.2	13.0
Anorectic (Weight-Loss) Stimulants¹	1.1	1.1	0.1	0.1	7.7	7.0
Provigil^®1	0.1	0.2	0.0	0.0	*	*
Any Other Prescription Stimulant^1,2	0.8	1.0	0.0	0.0	*	0.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.120A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Tranquilizer Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)
ANY PRESCRIPTION TRANQUILIZER	32,794	32,783	4,284	4,153	13.1	12.7
Benzodiazepine Tranquilizers¹	24,551	24,774	3,838	3,603	15.6	14.5
Alprazolam Products¹	14,097	13,851	2,759	2,717	19.6	19.6
Lorazepam Products¹	7,074	6,599	630	630	8.9	9.5
Clonazepam Products¹	5,406	6,008	979^a	640	18.2^b	10.7
Diazepam Products¹	4,903	4,833	595	610	12.2	12.6
Muscle Relaxants¹	6,540	7,207	507	597	7.8	8.3
Cyclobenzaprine¹	5,923	6,552	299	492	5.1	7.5
Soma^®1	868	738	229	103	*	*
Any Other Prescription Tranquilizer^1,2	5,942	5,173	77	80	1.3	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.120B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Percentages, 2021 and 2022
Tranquilizer Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)
ANY PRESCRIPTION TRANQUILIZER	11.7	11.6	1.5	1.5	13.1	12.7
Benzodiazepine Tranquilizers¹	8.8	8.8	1.4	1.3	15.6	14.5
Alprazolam Products¹	5.0	4.9	1.0	1.0	19.6	19.6
Lorazepam Products¹	2.5	2.3	0.2	0.2	8.9	9.5
Clonazepam Products¹	1.9	2.1	0.3^a	0.2	18.2^b	10.7
Diazepam Products¹	1.8	1.7	0.2	0.2	12.2	12.6
Muscle Relaxants¹	2.3	2.6	0.2	0.2	7.8	8.3
Cyclobenzaprine¹	2.1	2.3	0.1	0.2	5.1	7.5
Soma^®1	0.3	0.3	0.1	0.0	*	*
Any Other Prescription Tranquilizer^1,2	2.1	1.8	0.0	0.0	1.3	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.121A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2021 and 2022
Tranquilizer Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)
ANY PRESCRIPTION TRANQUILIZER	782	717	220	115	28.2^a	16.1
Benzodiazepine Tranquilizers¹	448	464	198	110	*	23.6
Alprazolam Products¹	371	348	184^a	82	*	23.6
Lorazepam Products¹	70	62	8	19	*	*
Clonazepam Products¹	53^a	127	9	15	*	*
Diazepam Products¹	89	113	38	10	*	*
Muscle Relaxants¹	58	95	13	3	*	*
Cyclobenzaprine¹	46	75	12	3	*	*
Soma^®1	12	21	*	*	*	*
Any Other Prescription Tranquilizer^1,2	329	247	9	*	*	0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.121B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Percentages, 2021 and 2022
Tranquilizer Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)
ANY PRESCRIPTION TRANQUILIZER	3.0	2.8	0.8	0.4	28.2^a	16.1
Benzodiazepine Tranquilizers¹	1.7	1.8	0.8	0.4	*	23.6
Alprazolam Products¹	1.4	1.4	0.7	0.3	*	23.6
Lorazepam Products¹	0.3	0.2	0.0	0.1	*	*
Clonazepam Products¹	0.2^a	0.5	0.0	0.1	*	*
Diazepam Products¹	0.3	0.4	0.1	0.0	*	*
Muscle Relaxants¹	0.2	0.4	0.1	0.0	*	*
Cyclobenzaprine¹	0.2	0.3	0.0	0.0	*	*
Soma^®1	0.0	0.1	*	*	*	*
Any Other Prescription Tranquilizer^1,2	1.3	1.0	0.0	*	*	0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.122A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Tranquilizer Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)
ANY PRESCRIPTION TRANQUILIZER	32,012	32,066	4,063	4,038	12.7	12.6
Benzodiazepine Tranquilizers¹	24,103	24,310	3,640	3,493	15.1	14.4
Alprazolam Products¹	13,726	13,502	2,575	2,635	18.8	19.5
Lorazepam Products¹	7,003	6,536	622	611	8.9	9.3
Clonazepam Products¹	5,353	5,881	970^a	625	18.2^b	10.6
Diazepam Products¹	4,814	4,720	557	601	11.6	12.7
Muscle Relaxants¹	6,482	7,112	494	593	7.6	8.4
Cyclobenzaprine¹	5,877	6,478	287^a	489	4.9	7.6
Soma^®1	856	717	228	103	*	*
Any Other Prescription Tranquilizer^1,2	5,613	4,926	68	79	1.2	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.122B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Percentages, 2021 and 2022
Tranquilizer Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)
ANY PRESCRIPTION TRANQUILIZER	12.6	12.5	1.6	1.6	12.7	12.6
Benzodiazepine Tranquilizers¹	9.5	9.5	1.4	1.4	15.1	14.4
Alprazolam Products¹	5.4	5.3	1.0	1.0	18.8	19.5
Lorazepam Products¹	2.8	2.6	0.2	0.2	8.9	9.3
Clonazepam Products¹	2.1	2.3	0.4^a	0.2	18.2^b	10.6
Diazepam Products¹	1.9	1.8	0.2	0.2	11.6	12.7
Muscle Relaxants¹	2.6	2.8	0.2	0.2	7.6	8.4
Cyclobenzaprine¹	2.3	2.5	0.1	0.2	4.9	7.6
Soma^®1	0.3	0.3	0.1	0.0	*	*
Any Other Prescription Tranquilizer^1,2	2.2	1.9	0.0	0.0	1.2	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.123A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2021 and 2022
Tranquilizer Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)
ANY PRESCRIPTION TRANQUILIZER	2,467	2,592	855	779	34.6	30.1
Benzodiazepine Tranquilizers¹	2,105	2,106	810	744	38.5	35.3
Alprazolam Products¹	1,409	1,505	688	643	49.1	42.7
Lorazepam Products¹	532	510	104	116	19.6	22.7
Clonazepam Products¹	535	485	193^a	91	*	18.7
Diazepam Products¹	328	332	65	72	*	21.6
Muscle Relaxants¹	236	287	57	35	*	12.3
Cyclobenzaprine¹	191	271	25	28	*	10.3
Soma^®1	55^a	19	37^a	8	*	*
Any Other Prescription Tranquilizer^1,2	368	442	22	7	*	1.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.123B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Percentages, 2021 and 2022
Tranquilizer Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)
ANY PRESCRIPTION TRANQUILIZER	7.4	7.5	2.6	2.2	34.6	30.1
Benzodiazepine Tranquilizers¹	6.3	6.1	2.4	2.1	38.5	35.3
Alprazolam Products¹	4.2	4.3	2.1	1.8	49.1	42.7
Lorazepam Products¹	1.6	1.5	0.3	0.3	19.6	22.7
Clonazepam Products¹	1.6	1.4	0.6^a	0.3	*	18.7
Diazepam Products¹	1.0	1.0	0.2	0.2	*	21.6
Muscle Relaxants¹	0.7	0.8	0.2	0.1	*	12.3
Cyclobenzaprine¹	0.6	0.8	0.1	0.1	*	10.3
Soma^®1	0.2^a	0.1	0.1^a	0.0	*	*
Any Other Prescription Tranquilizer^1,2	1.1	1.3	0.1	0.0	*	1.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.124A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Tranquilizer Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)
ANY PRESCRIPTION TRANQUILIZER	29,545	29,474	3,209	3,259	10.9	11.1
Benzodiazepine Tranquilizers¹	21,997	22,204	2,830	2,749	12.9	12.4
Alprazolam Products¹	12,316	11,998	1,887	1,992	15.3	16.6
Lorazepam Products¹	6,471	6,026	519	495	8.0	8.2
Clonazepam Products¹	4,818	5,396	776	534	16.1^a	9.9
Diazepam Products¹	4,486	4,388	492	529	11.0	12.1
Muscle Relaxants¹	6,246	6,825	436	558	7.0	8.2
Cyclobenzaprine¹	5,687	6,207	262^a	461	4.6	7.4
Soma^®1	801	699	191	95	*	*
Any Other Prescription Tranquilizer^1,2	5,244	4,484	46	71	0.9	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.124B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Percentages, 2021 and 2022
Tranquilizer Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)
ANY PRESCRIPTION TRANQUILIZER	13.4	13.3	1.5	1.5	10.9	11.1
Benzodiazepine Tranquilizers¹	10.0	10.0	1.3	1.2	12.9	12.4
Alprazolam Products¹	5.6	5.4	0.9	0.9	15.3	16.6
Lorazepam Products¹	2.9	2.7	0.2	0.2	8.0	8.2
Clonazepam Products¹	2.2	2.4	0.4	0.2	16.1^a	9.9
Diazepam Products¹	2.0	2.0	0.2	0.2	11.0	12.1
Muscle Relaxants¹	2.8	3.1	0.2	0.3	7.0	8.2
Cyclobenzaprine¹	2.6	2.8	0.1	0.2	4.6	7.4
Soma^®1	0.4	0.3	0.1	0.0	*	*
Any Other Prescription Tranquilizer^1,2	2.4	2.0	0.0	0.0	0.9	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.125A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Sedative Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)
ANY PRESCRIPTION SEDATIVE	14,602	15,399	878	959	6.0	6.2
Zolpidem Products¹	6,917	7,403	667	597	9.6	8.1
Eszopiclone Products¹	1,011	1,045	27	16	2.7	1.6
Zaleplon Products¹	428	401	18	26	*	*
Benzodiazepine Sedatives¹	1,762	1,649	102	98	5.8	5.9
Flurazepam¹	93	115	*	15	*	*
Temazepam Products¹	1,034	758	63	32	6.1	4.2
Triazolam Products¹	658	857	34	59	5.2	*
Barbiturates¹	693	744	53	23	7.6	3.1
Any Other Prescription Sedative^1,2	6,070	6,568	88	183	1.5	2.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.125B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Percentages, 2021 and 2022
Sedative Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)
ANY PRESCRIPTION SEDATIVE	5.2	5.5	0.3	0.3	6.0	6.2
Zolpidem Products¹	2.5	2.6	0.2	0.2	9.6	8.1
Eszopiclone Products¹	0.4	0.4	0.0	0.0	2.7	1.6
Zaleplon Products¹	0.2	0.1	0.0	0.0	*	*
Benzodiazepine Sedatives¹	0.6	0.6	0.0	0.0	5.8	5.9
Flurazepam¹	0.0	0.0	*	0.0	*	*
Temazepam Products¹	0.4	0.3	0.0	0.0	6.1	4.2
Triazolam Products¹	0.2	0.3	0.0	0.0	5.2	*
Barbiturates¹	0.2	0.3	0.0	0.0	7.6	3.1
Any Other Prescription Sedative^1,2	2.2	2.3	0.0	0.1	1.5	2.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.126A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2021 and 2022
Sedative Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)
ANY PRESCRIPTION SEDATIVE	410	521	43	27	10.5	5.3
Zolpidem Products¹	102	121	12	4	*	*
Eszopiclone Products¹	16	28	*	*	*	*
Zaleplon Products¹	16	13	2	*	*	*
Benzodiazepine Sedatives¹	56	42	5	*	*	*
Flurazepam¹	14	20	*	*	*	*
Temazepam Products¹	16	14	*	*	*	*
Triazolam Products¹	28	36	4	*	*	*
Barbiturates¹	32	43	3	2	*	*
Any Other Prescription Sedative^1,2	271	366	17	4	*	1.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.126B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Percentages, 2021 and 2022
Sedative Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)
ANY PRESCRIPTION SEDATIVE	1.6	2.0	0.2	0.1	10.5	5.3
Zolpidem Products¹	0.4	0.5	0.0	0.0	*	*
Eszopiclone Products¹	0.1	0.1	*	*	*	*
Zaleplon Products¹	0.1	0.0	0.0	*	*	*
Benzodiazepine Sedatives¹	0.2	0.2	0.0	*	*	*
Flurazepam¹	0.1	0.1	*	*	*	*
Temazepam Products¹	0.1	0.1	*	*	*	*
Triazolam Products¹	0.1	0.1	0.0	*	*	*
Barbiturates¹	0.1	0.2	0.0	0.0	*	*
Any Other Prescription Sedative^1,2	1.0	1.4	0.1	0.0	*	1.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.127A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Sedative Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)
ANY PRESCRIPTION SEDATIVE	14,192	14,878	834	931	5.9	6.3
Zolpidem Products¹	6,815	7,282	654	593	9.6	8.1
Eszopiclone Products¹	996	1,017	26	16	2.6	1.5
Zaleplon Products¹	412	388	16	26	*	*
Benzodiazepine Sedatives¹	1,705	1,607	97	97	5.7	6.1
Flurazepam¹	78	94	*	15	*	*
Temazepam Products¹	1,017	744	61	31	6.0	4.1
Triazolam Products¹	631	821	30	59	4.7	*
Barbiturates¹	661	701	50	21	*	*
Any Other Prescription Sedative^1,2	5,799	6,202	71^a	179	1.2^a	2.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.127B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Percentages, 2021 and 2022
Sedative Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)
ANY PRESCRIPTION SEDATIVE	5.6	5.8	0.3	0.4	5.9	6.3
Zolpidem Products¹	2.7	2.8	0.3	0.2	9.6	8.1
Eszopiclone Products¹	0.4	0.4	0.0	0.0	2.6	1.5
Zaleplon Products¹	0.2	0.2	0.0	0.0	*	*
Benzodiazepine Sedatives¹	0.7	0.6	0.0	0.0	5.7	6.1
Flurazepam¹	0.0	0.0	*	0.0	*	*
Temazepam Products¹	0.4	0.3	0.0	0.0	6.0	4.1
Triazolam Products¹	0.2	0.3	0.0	0.0	4.7	*
Barbiturates¹	0.3	0.3	0.0	0.0	*	*
Any Other Prescription Sedative^1,2	2.3	2.4	0.0^a	0.1	1.2^a	2.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.128A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2021 and 2022
Sedative Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)
ANY PRESCRIPTION SEDATIVE	815^a	1,082	144	93	17.7^b	8.6
Zolpidem Products¹	303	285	78	39	*	13.9
Eszopiclone Products¹	39	71	*	*	*	*
Zaleplon Products¹	28	30	16	*	*	*
Benzodiazepine Sedatives¹	106	132	17	8	*	*
Flurazepam¹	20	11	*	*	*	*
Temazepam Products¹	48	43	15	6	*	*
Triazolam Products¹	39^a	95	*	2	*	*
Barbiturates¹	52	85	11	5	*	*
Any Other Prescription Sedative^1,2	446^b	695	45	21	10.4^a	3.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.128B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Percentages, 2021 and 2022
Sedative Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)
ANY PRESCRIPTION SEDATIVE	2.4^a	3.1	0.4	0.3	17.7^b	8.6
Zolpidem Products¹	0.9	0.8	0.2	0.1	*	13.9
Eszopiclone Products¹	0.1	0.2	*	*	*	*
Zaleplon Products¹	0.1	0.1	0.0	*	*	*
Benzodiazepine Sedatives¹	0.3	0.4	0.0	0.0	*	*
Flurazepam¹	0.1	0.0	*	*	*	*
Temazepam Products¹	0.1	0.1	0.0	0.0	*	*
Triazolam Products¹	0.1^a	0.3	*	0.0	*	*
Barbiturates¹	0.2	0.2	0.0	0.0	*	*
Any Other Prescription Sedative^1,2	1.3^b	2.0	0.1	0.1	10.4^a	3.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.129A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Sedative Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)
ANY PRESCRIPTION SEDATIVE	13,376	13,797	690	839	5.2	6.1
Zolpidem Products¹	6,512	6,997	577	554	8.9	7.9
Eszopiclone Products¹	957	945	25	14	2.6	1.5
Zaleplon Products¹	384	358	*	26	*	*
Benzodiazepine Sedatives¹	1,600	1,475	80	89	5.0	6.1
Flurazepam¹	58	83	*	15	*	*
Temazepam Products¹	969	701	46	25	4.7	3.6
Triazolam Products¹	592	726	28	57	*	*
Barbiturates¹	609	616	39	16	*	*
Any Other Prescription Sedative^1,2	5,354	5,507	26^b	158	0.5^b	2.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.129B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Percentages, 2021 and 2022
Sedative Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)
ANY PRESCRIPTION SEDATIVE	6.1	6.2	0.3	0.4	5.2	6.1
Zolpidem Products¹	3.0	3.2	0.3	0.2	8.9	7.9
Eszopiclone Products¹	0.4	0.4	0.0	0.0	2.6	1.5
Zaleplon Products¹	0.2	0.2	*	0.0	*	*
Benzodiazepine Sedatives¹	0.7	0.7	0.0	0.0	5.0	6.1
Flurazepam¹	0.0	0.0	*	0.0	*	*
Temazepam Products¹	0.4	0.3	0.0	0.0	4.7	3.6
Triazolam Products¹	0.3	0.3	0.0	0.0	*	*
Barbiturates¹	0.3	0.3	0.0	0.0	*	*
Any Other Prescription Sedative^1,2	2.4	2.5	0.0^b	0.1	0.5^b	2.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.130A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Benzodiazepine Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)
ANY PRESCRIPTION BENZODIAZEPINE	25,735	25,703	3,931	3,681	15.3	14.3
Benzodiazepine Tranquilizers¹	24,551	24,774	3,838	3,603	15.6	14.5
Alprazolam Products¹	14,097	13,851	2,759	2,717	19.6	19.6
Lorazepam Products¹	7,074	6,599	630	630	8.9	9.5
Clonazepam Products¹	5,406	6,008	979^a	640	18.2^b	10.7
Diazepam Products¹	4,903	4,833	595	610	12.2	12.6
Benzodiazepine Sedatives¹	1,762	1,649	102	98	5.8	5.9
Flurazepam¹	93	115	*	15	*	*
Temazepam Products¹	1,034	758	63	32	6.1	4.2
Triazolam Products¹	658	857	34	59	5.2	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	24	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.130B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Percentages, 2021 and 2022
Benzodiazepine Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)
ANY PRESCRIPTION BENZODIAZEPINE	9.2	9.1	1.4	1.3	15.3	14.3
Benzodiazepine Tranquilizers¹	8.8	8.8	1.4	1.3	15.6	14.5
Alprazolam Products¹	5.0	4.9	1.0	1.0	19.6	19.6
Lorazepam Products¹	2.5	2.3	0.2	0.2	8.9	9.5
Clonazepam Products¹	1.9	2.1	0.3^a	0.2	18.2^b	10.7
Diazepam Products¹	1.8	1.7	0.2	0.2	12.2	12.6
Benzodiazepine Sedatives¹	0.6	0.6	0.0	0.0	5.8	5.9
Flurazepam¹	0.0	0.0	*	0.0	*	*
Temazepam Products¹	0.4	0.3	0.0	0.0	6.1	4.2
Triazolam Products¹	0.2	0.3	0.0	0.0	5.2	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	0.0	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.131A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2021 and 2022
Benzodiazepine Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)
ANY PRESCRIPTION BENZODIAZEPINE	492	480	203	113	*	23.5
Benzodiazepine Tranquilizers¹	448	464	198	110	*	23.6
Alprazolam Products¹	371	348	184^a	82	*	23.6
Lorazepam Products¹	70	62	8	19	*	*
Clonazepam Products¹	53^a	127	9	15	*	*
Diazepam Products¹	89	113	38	10	*	*
Benzodiazepine Sedatives¹	56	42	5	*	*	*
Flurazepam¹	14	20	*	*	*	*
Temazepam Products¹	16	14	*	*	*	*
Triazolam Products¹	28	36	4	*	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.131B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Percentages, 2021 and 2022
Benzodiazepine Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)
ANY PRESCRIPTION BENZODIAZEPINE	1.9	1.9	0.8	0.4	*	23.5
Benzodiazepine Tranquilizers¹	1.7	1.8	0.8	0.4	*	23.6
Alprazolam Products¹	1.4	1.4	0.7	0.3	*	23.6
Lorazepam Products¹	0.3	0.2	0.0	0.1	*	*
Clonazepam Products¹	0.2^a	0.5	0.0	0.1	*	*
Diazepam Products¹	0.3	0.4	0.1	0.0	*	*
Benzodiazepine Sedatives¹	0.2	0.2	0.0	*	*	*
Flurazepam¹	0.1	0.1	*	*	*	*
Temazepam Products¹	0.1	0.1	*	*	*	*
Triazolam Products¹	0.1	0.1	0.0	*	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.132A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Benzodiazepine Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)
ANY PRESCRIPTION BENZODIAZEPINE	25,244	25,223	3,729	3,569	14.8	14.1
Benzodiazepine Tranquilizers¹	24,103	24,310	3,640	3,493	15.1	14.4
Alprazolam Products¹	13,726	13,502	2,575	2,635	18.8	19.5
Lorazepam Products¹	7,003	6,536	622	611	8.9	9.3
Clonazepam Products¹	5,353	5,881	970^a	625	18.2^b	10.6
Diazepam Products¹	4,814	4,720	557	601	11.6	12.7
Benzodiazepine Sedatives¹	1,705	1,607	97	97	5.7	6.1
Flurazepam¹	78	94	*	15	*	*
Temazepam Products¹	1,017	744	61	31	6.0	4.1
Triazolam Products¹	631	821	30	59	4.7	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	24	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.132B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Percentages, 2021 and 2022
Benzodiazepine Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)
ANY PRESCRIPTION BENZODIAZEPINE	9.9	9.8	1.5	1.4	14.8	14.1
Benzodiazepine Tranquilizers¹	9.5	9.5	1.4	1.4	15.1	14.4
Alprazolam Products¹	5.4	5.3	1.0	1.0	18.8	19.5
Lorazepam Products¹	2.8	2.6	0.2	0.2	8.9	9.3
Clonazepam Products¹	2.1	2.3	0.4^a	0.2	18.2^b	10.6
Diazepam Products¹	1.9	1.8	0.2	0.2	11.6	12.7
Benzodiazepine Sedatives¹	0.7	0.6	0.0	0.0	5.7	6.1
Flurazepam¹	0.0	0.0	*	0.0	*	*
Temazepam Products¹	0.4	0.3	0.0	0.0	6.0	4.1
Triazolam Products¹	0.2	0.3	0.0	0.0	4.7	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	0.0	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.133A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2021 and 2022
Benzodiazepine Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)
ANY PRESCRIPTION BENZODIAZEPINE	2,162	2,178	825	747	38.1	34.3
Benzodiazepine Tranquilizers¹	2,105	2,106	810	744	38.5	35.3
Alprazolam Products¹	1,409	1,505	688	643	49.1	42.7
Lorazepam Products¹	532	510	104	116	19.6	22.7
Clonazepam Products¹	535	485	193^a	91	*	18.7
Diazepam Products¹	328	332	65	72	*	21.6
Benzodiazepine Sedatives¹	106	132	17	8	*	*
Flurazepam¹	20	11	*	*	*	*
Temazepam Products¹	48	43	15	6	*	*
Triazolam Products¹	39^a	95	*	2	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	9	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.133B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Percentages, 2021 and 2022
Benzodiazepine Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)
ANY PRESCRIPTION BENZODIAZEPINE	6.5	6.3	2.5	2.1	38.1	34.3
Benzodiazepine Tranquilizers¹	6.3	6.1	2.4	2.1	38.5	35.3
Alprazolam Products¹	4.2	4.3	2.1	1.8	49.1	42.7
Lorazepam Products¹	1.6	1.5	0.3	0.3	19.6	22.7
Clonazepam Products¹	1.6	1.4	0.6^a	0.3	*	18.7
Diazepam Products¹	1.0	1.0	0.2	0.2	*	21.6
Benzodiazepine Sedatives¹	0.3	0.4	0.0	0.0	*	*
Flurazepam¹	0.1	0.0	*	*	*	*
Temazepam Products¹	0.1	0.1	0.0	0.0	*	*
Triazolam Products¹	0.1^a	0.3	*	0.0	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	0.0	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.134A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2021 and 2022
Benzodiazepine Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)
ANY PRESCRIPTION BENZODIAZEPINE	23,082	23,045	2,904	2,822	12.6	12.2
Benzodiazepine Tranquilizers¹	21,997	22,204	2,830	2,749	12.9	12.4
Alprazolam Products¹	12,316	11,998	1,887	1,992	15.3	16.6
Lorazepam Products¹	6,471	6,026	519	495	8.0	8.2
Clonazepam Products¹	4,818	5,396	776	534	16.1^a	9.9
Diazepam Products¹	4,486	4,388	492	529	11.0	12.1
Benzodiazepine Sedatives¹	1,600	1,475	80	89	5.0	6.1
Flurazepam¹	58	83	*	15	*	*
Temazepam Products¹	969	701	46	25	4.7	3.6
Triazolam Products¹	592	726	28	57	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	16	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

230629

Table 1.134B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Percentages, 2021 and 2022
Benzodiazepine Subtype	Any Use in Past Year (2021)	Any Use in Past Year (2022)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Total Population (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)
ANY PRESCRIPTION BENZODIAZEPINE	10.5	10.4	1.3	1.3	12.6	12.2
Benzodiazepine Tranquilizers¹	10.0	10.0	1.3	1.2	12.9	12.4
Alprazolam Products¹	5.6	5.4	0.9	0.9	15.3	16.6
Lorazepam Products¹	2.9	2.7	0.2	0.2	8.0	8.2
Clonazepam Products¹	2.2	2.4	0.4	0.2	16.1^a	9.9
Diazepam Products¹	2.0	2.0	0.2	0.2	11.0	12.1
Benzodiazepine Sedatives¹	0.7	0.7	0.0	0.0	5.0	6.1
Flurazepam¹	0.0	0.0	*	0.0	*	*
Temazepam Products¹	0.4	0.3	0.0	0.0	4.7	3.6
Triazolam Products¹	0.3	0.3	0.0	0.0	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	0.0	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.